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1A. SUMMARY 
 
miRNAs are small non-coding RNAs involved in the regulation of almost all 
biological pathways in metazoans. miRNAs promote silencing of the mRNA targets 
by translational repression and mRNA degradation. They associate with Argonaute 
(AGO) proteins and bind to complementary mRNA targets. In animals, AGO interacts 
with GW182 family protein, which in turn recruits the main deadenylase complexes, 
the CCR4-NOT and PAN2-PAN3. These interactions trigger deadenylation which is 
followed by 5’ decapping and finally by mRNA degradation. 
GW182 proteins are essential for miRNA-mediated gene silencing. They are 
conserved in vertebrates and insects, and share a similar domain organization. By 
contrast, the Caenorhabditis elegans GW182 proteins, AIN-1 and AIN-2, are highly 
divergent and do not contain any identified domains. In the beginning of my doctoral 
studies, I investigated how C. elegans proteins mediate silencing and showed that 
only AIN-1, but not AIN-2, interacts with the deadenylases and poly(A)-binding 
protein (PABP). My studies demonstrated the evolutionary plasticity of GW182 
proteins, which promote silencing via interaction with the deadenylase complexes and 
PABP across species. I used the information obtained from C. elegans proteins to 
design a functional GW182 protein, in order to understand the minimal requirements 
to mediate silencing. This study highlighted the importance of the CCR4-NOT 
complex and PABP for miRNA mediated translational repression and mRNA decay. 
In order to understand the molecular mechanism of the CCR4-NOT complex 
in miRNA mediated gene silencing, I worked in collaborative projects where I first 
showed that the NOT module containing the NOT1,2,3 proteins, is required for the 
mRNA degradation mediated by the complex. Next, I demonstrated that GW182 
proteins interact directly with CNOT9 (CAF40) subunit of the complex through two 
tryptophan-binding pockets. The collaborative structural project also revealed an 
uncharacterized direct interaction between the scaffold subunit of the complex, NOT1 
and a DEAD-box helicase, DDX6, which functions as translational repressor and 
decapping activator. This interaction provides a direct link between deadenylation, 
decapping and translational repression. 
Finally, I focused on the role of the CCR4-NOT complex in miRNA-mediated 
translational repression. Previous studies proposed that miRNAs inhibit translation 
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initiation by blocking ribosomal scanning through either the direct interaction 
between NOT1 and eIF4A2 or the displacement of eIF4A1 and eIF4A2 from the 
mRNA targets. By contrast, my studies demonstrated that miRNAs can repress 
translation independently of deadenylation and scanning. Moreover, I showed that 
DDX6, which is directly interacting with NOT1, is required for the translational 
repression activity of the CCR4-NOT complex. Overall, my studies placed the CCR4-
NOT complex as a major effector complex in miRNA mediated gene silencing. 
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1B. ZUSAMMENFASSUNG 
Mikro-RNAs sind kleine nicht-kodierende RNAs, die an der Regulation fast 
aller biologischen Prozesse in Metazoa beteiligt sind. Mikro-RNAs bewirken Gen-
Silencing einer Ziel-mRNA entweder durch die Repression der Translation oder 
durch Degradation der Ziel-mRNA. Sie assoziieren mit Proteinen der Argonaut 
Familie (AGO) und binden an komplementäre Stellen in mRNAs. In tierischen 
Systemen interagiert AGO mit einem Protein der GW182 Familie, wodurch die 
Deadenylase-Komplexe CCR4-NOT und PAN2-PAN3 rekrutiert werden. Durch diese 
Interaktionen wird die Deadenylierung der mRNA ausgelöst worauf das Entfernen der 
5‘ Kappe (5‘ CAP; auch als Decapping bezeichnet) folgt und letztlich die mRNA 
Degradation ermöglicht wird. 
GW182 Proteine sind essentiell für das auf Mikro-RNA-basierende Gen-
Silencing. Sie sind in Vertebraten und Insekten konserviert und besitzen eine ähnliche 
Organisation ihrer Proteindomänen. Im Gegensatz dazu sind die GW182 Proteine 
AIN-1 und AIN-2 aus Caenorhabditis elegans (C. elegans) sehr unterschiedlich. 
Zudem besitzen sie keine bislang identifizierte Proteindomäne.  
Zu Beginn meiner Doktorarbeit untersuchte ich den Beitrag dieser Proteine 
aus C. elegans zu Gen-Silencing und beobachtete, dass nur AIN-1 mit Deadenylasen 
und dem Poly(A)-bindenden Protein (PABP) interagiert. Meine Untersuchungen 
demonstrierten eine evolutionäre Plastizität der GW182 Proteine, die Gen-Silencing 
durch diese Interaktionen artübergreifend fördern. Mithilfe, der aus diesen Daten, 
erworbenen Informationen konnte ich ein funktionales GW182 Protein entwerfen, um 
die minimalen Voraussetzungen für Gen-Silencing zu studieren. Meine 
Beobachtungen zeigten die Wichtigkeit des CCR4-Not-Komplexes und PABP für 
Mikro-RNA-basierende translationale Repression und mRNA Degradation. 
Um die molekulare Grundlage für die Beteiligung des CCR4-NOT Komplexes 
am Mikro-RNA-basierenden Gen-Silencing zu verstehen arbeitete ich in 
verschiedenen kollaborativen Projekten. Zunächst konnte gezeigt werden, dass die 
Proteine NOT1, NOT2 und NOT3 ein NOT Modul bilden, das für die Degradation 
der mRNA durch den Komplex benötigt wird. Des Weiteren demonstrierte ich, dass 
GW182 Proteine direkt mit einer Untereinheit von NOT9 (auch als CAF40 
bezeichnet) mittels zweier Tryptophan Bindetaschen interagieren. Darüber hinaus 
wurde in diesem strukturellem Projekt eine bislang unbekannte direkte Interaktion 
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zwischen dem Grundlage-Protein NOT1 und einer Helikase der DEAD-box Klasse, 
namens DDX6, beobachtet. Dieses Protein fungiert zum einen als Repressor der 
Translation und zum anderen als Aktivator des Decapping. Diese Interaktion 
ermöglicht eine Verbindung zwischen Deadenylierung, Decapping und translationale 
Repression. 
Zuletzt fokussierte ich mich auf die Frage nach der Rolle des CCR4-NOT 
Komplexes in der, von Mikro-RNAs-vermittelten, translationalen Repression von 
mRNAs. In frühere Studien wurde vermutet, dass Mikro-RNAs das Scannen von 
Ribosomen blockieren. Dies sollte entweder durch eine direkte Interaktion zwischen 
NOT1 und dem eukaryotischen Initiationsfaktor A2 (eIF4A2) oder dem Verdrängen 
von den Faktoren eIF4A1 und eIFA2 von der Ziel-mRNA erfolgen. Im Gegensatz 
dazu ergaben meine Untersuchungen, dass die Repression unabhängig von 
Deadenylierung oder dem Scannen durch das Ribosom erfolgen kann. Außerdem 
konnte ich zeigen, dass DDX6, neben der direkten Interaktion mit NOT1, für die 
Repression der Translation durch den CCR4-NOT Komplex benötigt wird. 
Zusammenfassend konnte ich dem CCR4-NOT Komplex eine zentrale Bedeutung 
beim Mikro-RNA-basierenden Gen-Silencing in meinen Studien nachweisen. 
2. Introduction 
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2. INTRODUCTION 
 
A messenger RNA (mRNA), which acts as an intermediate product between 
DNA and protein, is initially produced by transcription in the nucleus. Transcription 
is coupled with mRNA processing to produce a mature mRNA. mRNA processing 
includes 5’-end capping, splicing, 3’-end cleavage and polyadenylation. The mature 
mRNA is then exported to the cytoplasm where it associates with ribosomes to 
synthesize proteins and finally is degraded (Moore, 2005). There are other classes of 
RNAs, which do not code any protein but do have regulatory and modifying 
functions: the non-coding RNAs (ncRNA). The importance of ncRNAs is revealed by 
large scale transcriptome analyses showing that only ~1.2% of the human genome 
encodes proteins and 90% of disease-associated single nucleotide polymorphisms are 
located in the non-coding region of the human genome (Amaral et al., 2008; 
Hrdlickova et al., 2014). These numbers uncovered that the non-coding regions of the 
genome, also called as “junk DNA”, are more important than previously anticipated. 
Several studies from various labs reported different regulatory functions for ncRNAs 
in almost all known species. Other than the known ncRNAs (transfer RNAs (tRNAs), 
ribosomal RNAs (rRNA), small nucleolar RNAs (snoRNAs) and small nuclear RNAs 
(snRNAs)), new classes of ncRNAs were also discovered during the last two decades. 
Their broad range of functions in gene regulation from transcription to translation also 
revealed their importance (Mattick and Makunin, 2006). The major ncRNAs 
classified according to their functions and sizes, are listed in Table 2.1. 
The first microRNA (miRNA), lin-4, was characterized in Caenorhabditis 
elegans by Victor Ambros, Gary Ruvkun and their colleagues, while studying its key 
role in larval development in worms (Lee et al., 1993; Wightman et al., 1993). In 
1998, the RNA interference mechanism was discovered by Andrew Fire, Craig Mello 
and their colleagues (Fire et al., 1998), who demonstrated that double-stranded RNA 
can induce gene silencing by base pairing with the target mRNA. A couple of years 
later, studies in plants and Drosophila cells showed that dsRNAs are cleaved to small-
interfering RNAs (siRNAs) that mediate the recognition of the target mRNA to be 
silenced (Hamilton and Baulcombe, 1999; Hammond et al., 2000; Zamore et al., 
2000). Meanwhile, another class of small RNAs present only in germ cells was 
discovered: the Piwi-interacting RNAs (piRNAs) (Kim, 2006; Aravin et al., 2007). 
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All these studies opened a new window in the RNA field and highlighted the 
importance of small RNAs in a very broad range of biological processes from cell 
proliferation to cell death (Bartel, 2004).  
 
Table 2.1 Different classes of non-coding RNAs. Adapted from Cech and Steitz, 2014!
Name Definition Function Size 
tRNA Transfer RNA Protein synthesis 70-90 nt 
 
rRNA Ribosomal RNA Ribosome biogenesis 120, 160, 
1868, 5025 nt 
in human 
 
snRNA Small nuclear RNA Component of spliceosome 100-300 nt 
 
snoRNA Small nucleolar RNA Pre-rRNA modification, 
processing and folding 
70 nt 
 
 
miRNA Micro RNA Gene silencing, translational 
repression and/or mRNA decay 
22 nt 
 
 
siRNA Small interfering RNA Gene silencing, mRNA decay 22 nt 
 
piRNA PIWI-associated RNA Regulation of transcription, 
silencing of transposable 
elements 
27 nt 
 
 
 
lncRNA Long non coding RNA Various  >200 nt 
 
 
2.1 microRNAs and their biogenesis 
 
miRNAs are ~22 nucleotides long small RNAs encoded from introns or exons 
of non-coding or coding transcript units (Kim et al., 2009; Ha and Kim, 2014). Today, 
according to miRbase, there are more than 1800 miRNAs described in the human 
genome (Kozomara and Griffiths-Jones, 2014) and they are responsible for the 
regulation of more than 60% of all mammalian mRNAs (Friedman et al., 2009).  
In general, miRNA genes are transcribed by RNA polymerase II into primary 
miRNA (pri-miRNA) (Cai et al., 2004; Lee et al., 2004), except some viral miRNAs 
transcribed by RNA polymerase III (Pfeffer et al., 2005). Consequently, pri-miRNAs 
have a 5’ cap structure and a 3’ poly(A) tail. They fold into 33-35 bp long stem loop 
structures and single stranded RNA segments at both 5’ and 3’ ends (Fig 2.1). The 
maturation of pri-miRNAs is initiated by the Microprocessor complex which consists 
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of an RNAse III-type endonuclease Drosha and its cofactor DGCR8 (DiGeorge 
syndrome critical region 8, Pasha in Drosophila melanogaster). Drosha contains two 
RNAse III domains (RIIIIDa and RIIIIDb), which cleave the 3’ and 5’ end of the pri-
miRNA, respectively to a precursor miRNA (pre-miRNA) leaving a two nucleotides 
overhang at the 3’ end (Blaszczyk et al., 2001; Han et al., 2004; Zhang et al., 2004). 
Drosha also contains a dsRNA binding domain (dsRBD) which interacts with the pri-
miRNA. This interaction is also facilitated by the two dsRBDs of DGCR8 (Ha and 
Kim, 2014). Then, the pre-miRNA is exported by Exportin 5 (EXP5) from the 
nucleus to the cytoplasm for further maturation, in a GTP dependent manner (Yi et 
al., 2003; Bohnsack et al., 2004; Lund et al., 2004). EXP5 binds to the pre-miRNA 
and to the GTP-binding protein Ran-GTP to mediate the translocation of the pre-
miRNA through the nuclear pore complex. GTP hydrolysis promotes dissociation of 
the complex and releases the pre-miRNA cargo, into the cytoplasm.   
In the last step of maturation, the pre-miRNA binds the PAZ (PIWI-AGO-
ZWILLE) domain of Dicer, another RNAse III endonuclease and is cleaved to 
produce the mature miRNA duplex (Bernstein et al., 2001; Grishok et al., 2001; 
Hutvágner et al., 2001; Ketting et al., 2001; Knight and Bass, 2001).  Dicer associates 
with different dsRBD proteins involved in pre-miRNA processing. In D. 
melanogaster, Dicer-1 interacts with two isoforms of Loquacious (Loqs), Loq-PA and 
Loq-PB (Förstemann et al., 2005; Jiang et al., 2005; Saito et al., 2005). In human 
cells, Dicer binds to the trans-activation response RNA-binding protein, TRBP (a 
homologue of Loq-PB) (Chendrimada et al., 2005; Haase et al., 2005; Lee et al., 
2006)  and protein activator of PKR, PACT (Lee et al., 2006; 2013). Loqs and TRBP 
are important for Dicer cleavage site, they can tune the length of miRNAs (Fukunaga 
et al., 2012). Although the role of PACT is not completely understood, it acts together 
with TRBP on the production of miRNAs with different sizes (Lee et al., 2013).  
Following the cleavage of the pre-miRNA, the miRNA duplex is first loaded 
onto an Argonaute (AGO) protein and then unwinded to form the RNA-induced 
silencing complex (RISC) (Kawamata and Tomari, 2010). The heat shock cognate 70 
protein (HSC70)-heat shock protein 90 chaperone complex (HSP90) mediates the 
opening of AGO, in an ATP dependent manner, to provide a binding platform for the 
miRNA duplex. One strand of the miRNA duplex is then selected as the guide strand 
based on different criteria. According to the assymetry rule, the least 
thermodynamically stable strand at the 5’ end, acts as the guide strand and the other 
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strand is degraded (Khvorova et al., 2003; Schwarz et al., 2003).  Additionally, the 
strand containing uracil as the first nucleotide is also favored to be selected as guide 
strand (Lau et al., 2001; Czech et al., 2009; Hu et al., 2009; Okamura et al., 2009; 
Ghildiyal et al., 2010). Once the miRNA duplex is loaded onto AGO protein, the pre-
RISC quickly removes the passenger strand. Since the miRNA duplex generally 
contains base pairing mismatches, the passenger strand can not be cleaved by AGO; 
instead it is removed (Ha and Kim, 2014) and quickly degraded by exonucleases from 
5’ to 3’ (XRN1) or 3’ to 5’ (Exosome complex) (Rüegger and Großhans, 2012). The 
association with AGO protects miRNAs from degradation. miRNAs then recruit AGO 
to complementary mRNA targets to promote translational repression and mRNA 
degradation. The miRNA biogenesis is summarized in Fig 2.1. 
2. Introduction 
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Figure 2.1 Schematic overview of miRNA biogenesis in humans. miRNAs are generally 
transcribed by RNA Polymerase II (RNA Pol II), processed by the Microprocessor complex 
(consisting of Drosha and DGCR8) and exported by Exportin 5 (EXP5) together with RAN-
GTP. In the cytoplasm, the pre-miRNA is diced by Dicer, which associates with TRBP (TAR 
RNA-binding protein). The mature miRNA is then loaded onto AGO1-4, after the ATP 
hydrolysis by heat shock cognate 70 (HSC70)-heat shock protein 90 (HSP90) complex. After 
the release of the passenger strand, the guide miRNA (red) remains bound to the AGO protein 
as a member of mature RISC (RNA induced silencing complex). Modified from Ha and Kim, 
2014. 
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2.2 miRNA target recognition 
 
miRNAs recognize their target mRNAs by Watson-Crick base-pairing. In 
animals, in contrast to plants, miRNAs are generally not fully complementary to their 
targets. The “seed” region, including the 2-7 nucleotides (nt) from the 5’ end of the 
miRNA, is sufficient to mediate silencing (Fig 2.2) (Huntzinger and Izaurralde, 2011).  
In general, miRNAs bind to the 3’ untranslated regions (3’UTRs) of the 
mRNA by complementarity to the seed sequence. The analyses of different types of 
miRNA target sites revealed that the seed sequence is crucial for binding to the target 
(Fig 2.2). Although the majority of miRNAs use the canonical 7-8 nt seed matched-
sites, in some cases 6 nt complementarity is also enough to mediate miRNA binding 
(Bartel, 2009; Friedman et al., 2009). The context of the 3’UTR is important for 
miRNA silencing and the miRNA sites are more effective when located at least 15 nt 
downstream of the stop codon, to avoid the displacement by the ribosome, and are 
positioned away from the center of long UTRs (Bartel, 2009). Different studies 
showed that miRNAs can also bind to 5’UTRs, as well as to open reading frames 
(Kloosterman et al., 2004; Lytle et al., 2007).  
      
!
Figure 2.2 miRNA target recognition and seed matches. miRNAs generally target the 3’ 
untranslated region, located downstream of the open reading frame (ORF). Except for the 
offset 6mer site, seed matches (blue) contain at least six Watson-Crick bases complementary 
to the miRNA seed (colored as red, nucleotides 2-7). The arrow indicates the increase in 
target recognition efficiency according to the complementarity. Modified from Friedman et 
al., 2009. 
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In the next sections, the key factors involved in miRNA-mediated gene 
silencing pathway will be described.  
 
2.3 Argonaute Proteins 
 
An Argonaute protein was originally described in a study performed in 
Arabidopsis thaliana. Since the phenotype of the mutant plant resembled a small 
squid, the corresponding gene was named after the octopus Argonaute argo (Bohmert 
et al., 1998).  Further studies showed that the Argonaute proteins are highly conserved 
in prokaryotes and eukaryotes and can directly interact with small RNAs. The 
Argonaute family can be divided into two groups: AGO proteins (interacting with 
miRNAs and siRNAs) and PIWI proteins (interacting with piRNAs) (Meister, 2013). 
The number of AGO paralogs differs in each organism. In human, there are four AGO 
proteins, AGO1 to 4, which can function in miRNA-mediated gene silencing. Only 
AGO2 is catalytically active and can degrade the mRNA target by endonucleolytic 
cleavage (Liu et al., 2004; Song et al., 2004). In C. elegans, 27 different AGO 
proteins were identified, but only ALG-1 and ALG-2 are known to function in the 
miRNA pathway (Grishok et al., 2000; Yigit et al., 2006) and none of them has slicer 
activity (Tolia and Joshua-Tor, 2007). On the other hand, D. melanogaster contains 
two different AGOs, AGO1 and 2, both with slicer activity. However they play 
different roles: AGO1 is specific to miRNAs, whereas AGO2 to siRNAs (Höck and 
Meister, 2008).  
 
 
!!
Figure 2.3 The domain organization of Hs AGO2. AGO2 contains four domains: N-
terminal (N), PAZ (PIWI-ARGONAUTE-ZWILLE), MID and PIWI. L1 and L2 
represent linker regions. The functional properties of each domain are summarized.  
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The AGO proteins are characterized by four structured domains (N, PAZ, 
MID, PIWI) connected by two linker regions (L1 and L2) (Song et al., 2004; Schirle 
and MacRae, 2012) (Fig 2.3). The N-terminal domain is critical for the miRNA 
duplex unwinding process. It was shown that after the loading of the RNA duplex, the 
N-terminal domain acts as a wedge to open the duplex in slicer-dependent or 
independent unwinding (Kwak and Tomari, 2012). Additionally, experiments 
performed with AGO3 protein fused to the N-terminal domain of AGO2 to become 
catalytically active, highlighted the role of the N-terminal domain in target cleavage 
(Faehnle et al., 2013; Hauptmann et al., 2013). The PAZ domain is responsible for 
nucleic acid binding. Structural studies revealed the presence of a specific binding 
pocket located in the PAZ domain which accomodates the 3’ end of the small RNAs  
(Lingel et al., 2004; Ma et al., 2004; Wang et al., 2008) . The 5’ end of the small RNA 
interacts with the basic nucleotide-binding pocket located in MID domain of AGO 
(Ma et al., 2005; Parker et al., 2005; Boland et al., 2010; Frank et al., 2010). The 
PIWI domain adopts a RNase H-like fold and is responsible for the slicing activity of 
AGOs (Song et al., 2004; Rivas et al., 2005; Nakanishi et al., 2012). It cleaves the 
target mRNA within the base-paired region opposite to nucleotides 10th and 11th from 
5’ end of the guide strand. The crystal structure of human AGO2 revealed the 
presence of two tryptophan-binding pockets in the PIWI domain, potentially 
important to mediate interaction with GW182 proteins (Schirle and MacRae, 2012). 
 
 
2.4 GW182 Protein Family 
 
Eystathioy and his colleagues identified GW182 proteins as antigens present 
in serum samples isolated from a patient affected by a motor and sensory neuropathy 
(Eystathioy et al., 2002). This protein is localized in cytoplasmic granules, known as 
GW-bodies or P-bodies. Subsequent studies demonstrated that the GW182 protein 
family interacts with AGO proteins and are essential for miRNA-mediated gene 
silencing (Ding et al., 2005; Jakymiw et al., 2005; Liu et al., 2005; Meister et al., 
2005; Rehwinkel et al., 2005; Behm-Ansmant et al., 2006b).  
GW182 proteins are a large family of proteins present in metazoans. Three 
paralogs, termed TNRC6A, TNRC6B and TNRC6C (trinucleotide repeat-containing 
gene protein 6) are present in vertebrates; one (GW182) in D. melanogaster, two 
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paralogs (AIN-1 and AIN-2) in C. elegans and none in fungi and plants (Huntzinger 
and Izaurralde, 2011). They are highly conserved in domain organization with the 
exception the C. elegans proteins (Fig 2.4).  
 !
Figure 2.4 Domain organization of the GW182 protein family. GW182 proteins are highly 
conserved in animals. H. sapiens TNRC6C and D. melanogaster GW182 are shown as 
representative examples of the family. The structured domains, ubiquitin-associated (UBA) 
and RNA-recognition motif (RRM) are colored in yellow and green, respectively. The N-
terminal part of the protein, the AGO-binding domain (ABD), contains several glycine-
tryptophan (GW) repeats shown as red bars. The positions of the CCR4-interacting motifs 
(CIM-1 and CIM-2), the PABP-interacting motif 2 (PAM2) and tryptophan residues located 
in the M2 region (W) are indicated. C. elegans proteins, AIN-1 and AIN-2, do not contain any 
defined domains or motifs, except GW repeats shown as red bars. The numbers represent 
amino acid numbers. QQQ: glutamine-rich domain. 
 
There are only two structured domains characterized in GW182 proteins: A 
central ubiquitin-associated (UBA) domain and an RNA recognition motif (RRM).  
The rest of the protein is predicted to be unstructured and contains several motifs, 
which are essential to mediate interactions with different binding partners (Braun et 
al., 2013). The N-terminal domain of GW182 proteins contains several glycine-
tryptophan (GW) repeats, which mediate binding to AGOs and is termed the AGO-
binding domain (ABD) (El-Shami et al., 2007; Till et al., 2007; Eulalio et al., 2009a; 
Lazzaretti et al., 2009; Takimoto et al., 2009). Additionally, the ABD is required for 
the localization of GW182 protein to P-bodies (Behm-Ansmant et al., 2006b; Eulalio 
et al., 2009a; Lazzaretti et al., 2009). The role of the UBA domain which was initially 
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identified in proteins involved in ubiquitination, is not clear and there is currently no 
evidence showing a contribution of this domain to gene silencing (Chekulaeva et al., 
2009; Eulalio et al., 2009a; Lazzaretti et al., 2009; Zipprich et al., 2009). The Q-rich 
region is important for P-body localization in D. melanogaster (Dm) and human (Hs)  
cells; although the region itself is not sufficient for localization in P-bodies, its 
deletion prevents accumulation of GW182 proteins in P-bodies in Dm cells (Behm-
Ansmant et al., 2006a; Eulalio et al., 2009a). The crystal structure of the RRM 
domain of Dm GW182 protein revealed an additional C-terminal α-helix that lies on 
the β-sheet surface which normally interacts with RNA in canonical RRMs. As such, 
binding to RNA by GW182 is unlikely to occur through the RRM domain (Eulalio et 
al., 2009c). Moreover the aromatic residues required for RNA binding are not present 
in this domain. Although deletion of the RRM domain has effects on some miRNA 
targets, in general this domain is not necessary for silencing and does not provide 
RNA binding activity (Eulalio et al., 2009c; Braun et al., 2013). The C-terminal 
region of GW182 proteins, termed the silencing domain (SD), is crucial for the 
silencing activity of the protein. Several studies showed that GW182 proteins lacking 
the SD are inactive in complementation assays, although they can still interact with 
AGOs. (Eulalio et al., 2009a; Zekri et al., 2009; Huntzinger et al., 2010). The SD acts 
as a binding platform for direct interactions with the poly(A)-binding protein (PABP) 
and mRNA deadenylases (Fabian et al., 2009; 2011; Zekri et al., 2009; Huntzinger et 
al., 2010; Jinek et al., 2010; Kozlov et al., 2010; Braun et al., 2011; Chekulaeva et al., 
2011). In human cells, GW182 proteins directly interact with PABP through their 
PAM2 (PABP interacting motif 2) motif located between the M1 and M2 region of 
the SD (Jinek et al., 2010). Additionally to the PAM2 motif, M2 and C-terminal 
regions also contribute to the interaction with PABP in flies (Zekri et al., 2009; 
Huntzinger et al., 2010). Recent studies showed that tryptophan residues located in 
the SD mediate interactions with subunits of the CCR4-NOT and the PAN2-PAN3 
deadenylase complexes. Two motifs, named as CCR4-NOT interacting motif 1 and 2 
(CIM-1 and CIM-2) were identified in the SD of human GW182 proteins. In contrast 
to CIM-1, CIM-2 is not found in Dm GW182 (Fabian et al., 2011). Other tryptophan 
residues outside of the motifs also contribute to this interaction, as well as to the 
interaction with PAN2-PAN3 complex (Chekulaeva et al., 2011).  
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2.5 The CCR4-NOT Complex 
 
The CCR4-NOT complex is a multi-subunit complex involved in the 
regulation of different steps of gene expression such as transcription, translation and 
mRNA decay. The complex was originally discovered as a transcription regulator; 
however further studies showed a role as the main mRNA deadenylase complex in 
different organisms (Collart and Panasenko, 2012; Wahle and Winkler, 2013; Chapat 
and Corbo, 2014). The conserved features of the complex are the NOT module 
(consisting of three subunits, NOT1, NOT2 and NOT3 proteins) and the catalytic 
module which contains two catalytically active proteins POP2 (CAF1) and CCR4. 
Additionally, CAF40 (NOT9, Rcd1 or RQCD1), CAF130, NOT4, NOT5, NOT10, 
NOT11 (C2orf29) and TAB182 are also subunits of the complex (Bawankar et al., 
2013). The structured domains of each subunits, their conservation between species 
and their binding sites on NOT1 are summarized in Table 2.2. 
Historically, the discovery of the CCR4-NOT complex starts with the 
characterization of NOT1 and NOT2 genes as CDC (Cell Division Cycle) genes 
(Reed, 1980). In 1984, another component, CCR4 (Carbon Catabolite Repressor 4), 
was identified, independently of the complex, as positive regulator of glucose-
repressible enzymes in yeast (Denis, 1984). Eight years later, POP2 (PGK promoter 
directed over production) (Sakai et al., 1992) and one year after, NOT1,2,3 and 4 
(Negative On TATA-less) proteins were identified as repressor of promoters lacking a 
canonical TATA box (Collart and Struhl, 1993; 1994) . It took three more years to 
understand that POP2 (CAF1, CCR4 associated factor 1) is in the same complex 
together with CCR4 (Draper et al., 1995). Finally in 1998, NOT proteins were 
discovered in the same complex with CCR4-CAF1 which was then named as the 
CCR4-NOT complex (Liu et al., 1998). Further studies showed the conservation of 
the complex in humans (Albert et al., 2000) and flies (Temme et al., 2004).  
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Table 2.2 The subunits of the CCR4-NOT complex. Adapted from Chapat and Corbo, 
2014.  
S. 
cerevisiae H. sapiens 
D. 
melanogaster Domains 
Binding 
sites on 
NOT1 References 
NOT1 CNOT1 NOT1 Heat 
repeats 
MIF4G 
 (Maillet et al., 2000; 
Basquin et al., 2012; 
Petit et al., 2012) 
 
NOT2 CNOT2 NOT2 Not-box C-term 
of NOT1 
(Zwartjes et al., 
2004) 
 
NOT3 CNOT3/5 NOT3/5 Not-box C-term 
of NOT1 
(Zwartjes et al., 
2004) 
 
NOT4 CNOT4 NOT4 RING E3 
ligase 
 (Hanzawa et al., 
2001; Albert et al., 
2002) 
 
NOT5 - - Not-box C-term 
of NOT1 
(Maillet et al., 2000) 
 
 
CCR4 CNOT6/ 
CCR4a 
CNOT6L/
CCR4b 
CCR4 EEP, LRR POP2 (Malvar et al., 1992; 
Draper et al., 1995; 
Dupressoir et al., 
2001;) 
 
POP2/ 
CAF1  
CNOT7/ 
CAF1a 
CNOT8/ 
POP2/ 
CAF1b 
CAF1 DEDD MIF4G 
domain 
of NOT1 
(Bai et al., 1999; 
Schwede et al., 
2008) 
 
 
 
CAF40 CNOT9/ 
Rcd1/ 
RQCD1 
CAF40 Armadillo 
Repeats 
Mid part 
of NOT1 
(Chen et al., 2001) 
 
 
 
CAF130 - -  N- and 
C-term 
of NOT1  
(Chen et al., 2001) 
 
 
 
- CNOT10 NOT10  N-term 
of NOT1 
and 
NOT11 
 
(Bawankar et al., 
2013; Mauxion et al., 
2013) 
 
- CNOT11 
(C2orf29) 
NOT11  N-term 
of NOT1 
( Lau et al., 2009; 
Bawankar et al., 
2013; Mauxion et al., 
2013) 
 
- TAB182 -   (Lau et al., 2009) 
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The CCR4-NOT complex was originally thought to be important only for 
transcription, until the discovery of its role as the major deadenylase complex in 2001 
(Tucker et al., 2001). It was shown that CCR4-NOT can catalyze the removal of the 
poly(A) tail of the mRNA, the first step of bulk mRNA degradation. CCR4 and CAF1 
(POP2) were identified as the catalytic subunits of the complex (Chen et al., 2002; 
Tucker et al., 2002; Thore et al., 2003). The experiments performed in yeast knock-
out strains demonstrated that poly(A) tail length generally increases in the absence of 
CCR4 and CAF1 (Tucker et al., 2002). In addition to its role in deadenylation, the 
CCR4-NOT complex was also shown to be involved in nuclear quality control 
(Azzouz et al., 2009; Assenholt et al., 2011) and to be part of the mRNA export 
machinery (Kerr et al., 2011).  
The importance of the CCR4-NOT complex in gene expression was further 
underlined with the discovery of its involvement in the miRNA pathway. Following 
the studies showing that miRNAs promote deadenylation of the mRNA target, the 
CCR4-NOT complex was demonstrated to be required for miRNA-mediated mRNA 
decay (Behm-Ansmant et al., 2006b; Giraldez et al., 2006; Eulalio et al., 2009b; 
Fabian et al., 2009) . However, it was not clear how it was recruited to miRNA targets 
until three independent studies reported the direct interaction between GW182 
proteins and the CCR4-NOT complex (Braun et al., 2011; Chekulaeva et al., 2011; 
Fabian et al., 2011). In the mean time, several studies showed the role of the complex 
in translational repression independently of its deadenylation activity (Chekulaeva et 
al., 2009; Cooke et al., 2010; Bawankar et al., 2013). Overall, in the last decade, 
several studies were performed to elucidate the function and the assembly of the 
CCR4-NOT complex. The papers published after 2011 will be discussed in 
“Results&Discussion” section in the context of the thesis. 
The major studies in the history of the CCR4-NOT complex are summarized 
in Fig 2.5. 
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2.6 Translational Repression and mRNA degradation by miRNAs 
 
miRNAs silence mRNA targets by promoting translational repression and 
mRNA degradation. Several studies provided evidence for the role of miRNAs on 
these two effects at a genome-wide level (Bagga et al., 2005; Farh et al., 2005; Lim et 
al., 2005; Wu and Belasco, 2005; Baek et al., 2008; Selbach et al., 2008; Hendrickson 
et al., 2009; Guo et al., 2010). 
High throughput analyses demonstrated that miRNAs silence their target 
predominantly at the mRNA level (Selbach et al., 2008; Guo et al., 2010). miRNAs 
promote mRNA deadenylation through recruitment of the main deadenylase complex, 
the CCR4-NOT complex (Behm-Ansmant et al., 2006b; Wu et al., 2006; Chen et al., 
2009; Piao et al., 2010). Following deadenylation, miRNAs promote 5’ to 3’ decay. 
Accordingly, miRNA targets are first deadenylated, then decapped by the decapping 
complex and finally degraded by the XRN1 exonuclease (Fig 2.6) (Rehwinkel et al., 
2005; Eulalio et al., 2007; 2009b; Chen et al., 2009; Piao et al., 2010). Deadenylation 
occurs through the consecutive and partially redundant action of two deadenylase 
complexes: CCR4-NOT and PAN2-PAN3. Although depletion of PAN2-PAN3 
complex does not have a general effect on miRNA-mediated mRNA decay (Braun et 
al., 2011), it is thought that PAN2-PAN3 complex initiates the deadenylation process 
which is then completed by the CCR4-NOT complex (Yamashita et al., 2005; Wahle 
and Winkler, 2013). Decapping, the removal of 5’ cap by the decapping complex, 
follows deadenylation. The function of the catalytically active subunit of the complex, 
DCP2, is enhanced by additional proteins: DCP1, EDC3, EDC4 and DDX6 (Jonas 
and Izaurralde, 2013). Finally, the deadenylated and decapped miRNA target is 
degraded by the 5’ to 3’ exonuclease XRN1 (Huntzinger and Izaurralde, 2011). In 
2011, it was shown that GW182 proteins are responsible for the direct recruitment of 
the CCR4-NOT and PAN2-PAN3 deadenylase complexes to promote mRNA 
deadenylation (Braun et al., 2011; Chekulaeva et al., 2011; Fabian et al., 2011). This 
observation demonstrated the main function of GW182 proteins as scaffold protein in 
the miRNA  pathway.  
In contrast to the general agreement about how miRNAs degrade their targets, 
the mechanism by which miRNAs repress translation is under debate. Several 
conflicting models have been proposed. These models involve inhibiting the initiation 
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or post-initiation steps of translation. (Eulalio et al., 2008; Huntzinger and Izaurralde, 
2011; Fabian and Sonenberg, 2012).  
Early studies performed in C. elegans showed that miRNAs repress translation 
at the elongation step, with negligible effect on mRNA levels (Olsen and Ambros, 
1999; Seggerson et al., 2002). Studies using mammalian cultured cells have also 
confirmed this observation (Maroney et al., 2006; Nottrott et al., 2006; Petersen et al., 
2006). All these studies demonstrated that miRNA targets associate with polysomes 
when cell lysates are fractionated through sucrose gradients. Moreover, the use of 
different translation inhibitors provided additional evidence showing that miRISC 
targets actively translated mRNAs (Maroney et al., 2006; Nottrott et al., 2006; 
Petersen et al., 2006). The data proposing active translation during miRNA targeting 
prompted the hypothesis of co-translational degradation of the nascent polypeptide 
chain (Nottrott et al., 2006). However, the protease responsible for the degradation of 
the polypeptide chain was not identified and more importantly, proteasome inhibitors 
do not have any effect on silencing. 
Despite the studies proposing that miRNAs inhibit translation elongation, 
other studies indicated that miRNAs repress translation at the initiation step. These 
studies performed in mammalian cells and in cell-free extracts, showed that mRNAs 
targeted by miRNAs do not associate with polysomes and additionally in the presence 
of miRNAs, they shift towards to lighter fractions in polysome profiles. This 
observation indicated that miRNAs block the initiation step of translation 
(Humphreys et al., 2005; Pillai et al., 2005). In order to investigate the repression 
mechanism in details, several studies made use of reporters translated by cap-
independent mechanisms. Viruses drive translation in their host cells by a 
phenomenon known as Internal Entry of the Ribosome (Deforges et al., 2014). They 
use sequences located upstream of the start codon, named as internal ribosome entry 
sites (IRES) to initiate translation independently of 5’ cap structure. The IRES can 
interact with some of the initation factors or directly bind to the ribosomal subunits 
(Thompson, 2012). With this information, Pillai et al., Humphreys et al. and others 
used IRES-dependent reporters to test miRNA activity when translation is initiated in 
a cap-independent manner. They showed that miRNAs can not repress translation 
when it is driven by an IRES and concluded that miRNAs repress cap-dependent 
translation (Humphreys et al., 2005; Pillai et al., 2005; Mathonnet et al., 2007; 
Wakiyama et al., 2007). However Peterson et al. also used the same reporters and in 
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contrast to the other results, concluded that miRNAs do repress translation in a cap-
independent manner by blocking translation elongation. All these contradictory 
observations highlighted the requirement for further studies to elucidate translational 
repression mechanism by miRNAs. 
In 2007, two different studies proposed distinct mechanisms for miRNA-
mediated inhibition of translation initiation. One suggested a competition between 
eukaryotic initiation factor 4E (eIF4E) and AGO2 for 5’ cap binding (Kiriakidou et 
al., 2007). The authors identified a short sequence in AGO2, which is similar to eIF4E 
cap-binding domain and suggested that AGO2 promotes the removal of eIF4E from 
the cap structure and consequently inhibits translation. Another study (Chendrimada 
et al., 2007) provided evidence that AGO2 can bind to the large ribosomal subunit 
and to eIF6. They proposed that the recruitment of eIF6 by AGO2 blocks the 
association of the large and small ribosomal subunits. However, none of these 
proposals were supported by further studies.  
In addition to the studies focusing on translation initiation complexes and 
potential interactions with different subunits of miRISC, the role of PABP was also 
investigated. PABP is crucial for efficient translation since it interacts with eukaryotic 
initiation factor 4G (eIF4G) which binds to eIF4E and connects the two ends of the 
mRNA promoting circularization (Gallie, 1991; Gingras et al., 1999; Kahvejian et al., 
2005). A study proposed that miRNA-triggered deadenylation inhibits mRNA 
circularization. According to their model, the dissociation of PABP from 
deadenylated mRNAs disrupts the circular form of the mRNA and causes inhibition 
of translation (Wakiyama et al., 2007). Additional studies also supported the 
importance of PABP in miRNA-mediated gene silencing (Fabian et al., 2009; 
Huntzinger et al., 2010). However, further studies provide evidence that mRNAs 
lacking the poly(A) tail can still be repressed, showing that PABP may enhance 
silencing, but it is not essential for translational repression by miRNAs (Mishima et 
al., 2006; Mathonnet et al., 2007; Thermann and Hentze, 2007; Wakiyama et al., 
2007; Zhang et al., 2007; Iwasaki et al., 2009; Zdanowicz et al., 2009; Fukaya and 
Tomari, 2011). 
Overall, despite the fact that several studies were performed by different 
groups to understand how miRNAs repress translation; the mechanism remains 
elusive. However, most of the data supports a model in which miRNAs inhibit 
translation initiation.  
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During my PhD, from 2011 to 2015, additional studies were also published 
supporting that miRNAs repress translation initiation by blocking different steps. 
These studies will be discussed in “Results&Discussion” section, in the context of my 
results. 
!
Figure 2.6 miRNA-mediated gene silencing. A miRNA bound to an Argonaute (AGO) 
protein binds to its mRNA target. AGO recruits the scaffold protein GW182 that directly 
interacts with PABP, the CCR4-NOT and the PAN2-PAN3 complexes. miRNAs promote 
mRNA decay via deadenylation followed by decapping and degradation by the 5’-3’ 
exonuclease XRN1. The mechanism by which miRNAs repress translational is unkown. Here, 
several models are shown according to different studies providing evidence for inhibition of 
initiation, elongation or co-translational protein degradation (See text). 
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3. AIMS & OBJECTIVES 
 
miRNAs regulate gene expression of several different mRNA targets and they 
are involved in the control of almost all known biological processes, such as 
development, apoptosis, cell growth and proliferation. Importantly, they are also 
associated with several diseases, causing changes in the expression of specific 
mRNAs. Their involvement in the regulation of all these processes highlights their 
importance.  
In the last two decades, after their discovery, hundreds of studies focused on 
the mechanism of miRNA-mediated gene regulation. According to the current 
models, miRNAs together with AGOs bind to the mRNA target by sequence 
complementarity. AGO directly interacts with the scaffold protein GW182, which in 
turn recruits the main deadenylase complexes to the mRNA to promote mRNA 
deadenylation followed by decapping and finally mRNA degradation. In addition to 
mRNA degradation, miRNAs also trigger translational repression, but the mechanism 
remains unknown.  
During my PhD, I investigated the mechanism of miRNA-mediated gene 
silencing and in particular the role of the CCR4-NOT complex in this pathway. At the 
beginning of my doctoral studies, I focused on the C. elegans GW182 proteins, AIN-1 
and AIN-2, which are highly divergent from their human and fly orthologs. Previous 
studies demonstrated that GW182 proteins interact with PABP and the deadenylase 
complexes to trigger silencing in Dm and Hs cells. These interactions are mediated by 
the silencing domain located in the C-terminal region of Hs and Dm GW182 proteins. 
Sequence analyses could not identify such a domain in the C. elegans proteins. 
Whether AIN-1/2 interact with PABP and the PAN2-PAN3/CCR4-NOT deadenylase 
complexes was unknown. My aim was to identify the interactions required for AIN-
1/2 to induce silencing and to investigate their mode of interaction. I showed that 
AIN-1, but not AIN-2, interacts with PABP and the deadenylase complexes to 
promote silencing. My work contributed to our understanding of the evolution and 
conservation of silencing mechanisms in metazoans.  
I next examined the function of Hs and Dm GW182 proteins, which interact 
with PABP and the deadenylase complexes. Although the importance of these 
interactions for silencing was known, the contribution of each interaction was unclear. 
Additionally, the contribution of the N-terminal domain of GW182 to the binding to 
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the deadenylase complexes was also not clear. By using an engineered mini-GW182 
protein, I aimed to define the minimal requirements for Hs and Dm proteins to 
mediate silencing. I demonstrated that the interaction with both PABP and the 
deadenylase complexes is required for miRNA-mediated translational repression and 
mRNA target degradation. 
As the CCR4-NOT complex plays a main role in silencing, it was also 
important to understand how the complex degrades the mRNA targets, including 
miRNA targets. The complex consists of two main modules: The catalytic module 
containing the catalytically active subunits involved in deadenylation, and the NOT 
module containing NOT1,2,3 proteins. The NOT module is important for the 
recruitment of the complex to different mRNA targets, however the contribution of 
this module to mRNA decay was unclear. By using biochemical approaches, based on 
the information obtained from the crystal structure of the NOT module, I investigated 
the role of the NOT module in mRNA degradation. My results showed that the NOT 
module is essential for the assembly of the complex and therefore is required for the 
function of the complex in mRNA decay. 
The next question I investigated during my PhD was the molecular mechanism 
of the recruitment of the CCR4-NOT complex to miRNA targets by GW182 proteins. 
GW182 proteins interact with the CCR4-NOT complex via W-containing motifs. 
However, the specific subunits of the CCR4-NOT complex that bind to GW182 were 
not known. I identified the subunits required for this interaction and the mode of 
binding in a collaborative project. The results indicated that CNOT9 (CAF40) 
interacts with GW182 through tandem W-binding pockets. 
In the final part of my doctoral work, I focused on the mechanism of 
translational repression by miRNAs. miRNAs repress translation and promote 
degradation of the mRNA targets. However the mechanism of translational repression 
is not fully understood. Since the CCR4-NOT complex has the ability to repress 
translation independently of deadenylation, I investigated the contribution of the 
CCR4-NOT complex in miRNA mediated translational repression. My studies 
showed that NOT1, the scaffold subunit of the complex, directly interacts with a 
DEAD-box helicase DDX6, which functions as a translational repressor and 
decapping activator. I also showed that this interaction is required for miRNA-
mediated translational repression. 
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4. RESULTS & DISCUSSION 
 
4.1 The silencing mechanism is conserved across species 
 
The work summarized in this section was published by Kuzuoglu-Ozturk et 
al., 2012 and the paper including detailed experimental data and methods is attached.  
 
The GW182 protein family is highly conserved in metazoans with the 
exception of the C. elegans GW182 orthologous proteins, AIN-1 and AIN-2, which 
are highly divergent members of the family with less than 12% sequence identity. 
Their domain organization is completely different from other GW182 proteins: They 
do not contain any defined domains (UBA and RRM), or motifs (PAM2 and CIM-
1/2) (Fig 2.4). AIN-1 and AIN-2 both interact with Ce Argonaute proteins, ALG-1 
and ALG-2, and are involved in miRNA mediated gene silencing; however how they 
promote silencing remained unclear (Ding et al., 2005; Zhang et al., 2007; Ding and 
Großhans, 2009).  
In order to understand how AIN-1 and AIN-2 trigger miRNA mediated gene 
silencing, I first cloned and expressed the proteins in Dm S2 cells. Using co-
immunoprecipitation (co-IP) assays, I confirmed the interaction between AIN-1, AIN-
2 and Ce ALG-1 and validated my approach of using S2 cells to study Ce proteins 
involved in silencing. I defined the AGO-binding domains (ABD) in AIN-1 and AIN-
2, by aligning them with different GW182 proteins (Fig 4.1). The GW repeats located 
in the ABD of AIN-1 and AIN-2 mediate interaction with Ce ALG-1 and Dm AGO1. 
These results indicate that the mode of interaction of AIN-1 and AIN-2 with AGO 
proteins through GW repeats is highly conserved across species. Mutational analyses 
showed that each GW repeat located in the ABD contributes differently to AGO 
binding and more importantly, the GW repeats located outside of the ABD do not 
contribute to this interaction.  
I next tested the binding between AIN-1, AIN-2 and the deadenylase 
complexes, as well as PABP, to investigate whether these interactions are conserved 
across species. In co-IP assays, only AIN-1, but not AIN-2, interacted with PABP, 
PAN3, NOT1 and NOT2. These results indicate a possible functional distinction 
between AIN-1 and AIN-2 in the silencing of miRNA targets. Accordingly, we can 
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speculate that AIN-2 does not promote mRNA degradation through mRNA 
deadenylation as GW182 proteins in flies and humans, however further experiments 
are necessary to make a clear conclusion. This observation is also consistent with the 
weak effect of AIN-2 depletion on the worms phenotype (Ding et al., 2005; Zhang et 
al., 2007). However, we cannot rule out the possibility of transient interactions of 
AIN-2 with PABP and the deadenylase complexes, which cannot be observed by co-
IP assays.  
!
 
Figure 4.1 C. elegans GW182 proteins. AIN-1 and AIN-2 contain seven and four GW 
repeats presented as red bars, respectively. The AGO-binding domain (ABD) is labelled. The 
regions required for interaction with deadenylases and PABP are indicated in the binding 
scheme.  !
The interaction studies showed that AIN-1 interacts with Dm and Ce PABP, 
PAN3, NOT1 and NOT2 through several different binding regions. Although the 
interactions are conserved, the mode of binding is different compared to Dm and Hs 
proteins. The regions responsible for binding to each protein are shown in Fig 4.1. For 
the interaction with Ce NOT1, I could not define a single domain; the full-length 
protein is required for binding. Since Dm and Hs GW182 proteins contain W-rich 
CCR4-NOT interacting motifs (Chekulaeva et al., 2011; Fabian et al., 2011) to 
mediate interaction with the CCR4-NOT complex, I have also mutated all tryptophan 
residues (22 in total) to alanine in the AIN-1 protein. The mutant protein was unable 
to interact not only with Ce NOT1 and NOT2, but also with PABP and PAN3, which 
suggests non-specific disruption of protein-protein interaction. Nonetheless, W-
residues can still be critical for interaction with the CCR4-NOT complex.   
To test the activity of AIN-1 and AIN-2 in translational repression and mRNA 
degradation, I used two independent approaches: Tethering and complementation 
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assays. First, I tethered λN-tagged AIN-1 and AIN-2 to a reporter mRNA. The λN 
peptide binds with high affinity to the Box B hairpins located on the 3’ UTR of the 
Firefly luciferase reporter (F-Luc-5BoxB). Surprisingly, direct tethering of both AIN-
1 and AIN-2 to the 3’ UTR of the reporter mRNA repressed translation and degraded 
the mRNA. Since AIN-1 associates with the deadenylase complexes, this effect was 
expected. However AIN-2, independently of the deadenylases, could still mediate 
degradation of the reporter. This result indicates that either AIN-2 interacts transiently 
with deadenylases and the interaction is not detectable by co-IPs, or it associates with 
an unknown partner, which promotes mRNA decay. In order to investigate whether 
AIN-2 uses the 5’ to 3’ decay pathway, which promotes deadenylation followed by 
decapping, different approaches can be applied: The subunits of deadenylation and 
decapping complexes could be knocked down or the catalytically inactive subunits of 
each complex could be overexpressed to replace the endogenous proteins. In both 
cases, the endogenous complexes would be blocked and under these conditions, the 
requirement of each complex could be investigated for AIN-2-mediated mRNA 
degradation. Additionally, the immunoprecipitation of AIN-2 followed by mass 
spectrometric analysis of associated partners, revealed a potential interaction with a 
micrococcal nuclease homolog TSN-1 (Zhang et al., 2007). TSN-1 was identified as a 
component of RISC in C. elegans, D. melanogaster and mammals. Its catalytic 
activity was shown to be crucial for mRNA degradation by siRNAs (Caudy et al., 
2003). Here, we can speculate that the interaction of AIN-2 with TSN-1 can also 
trigger mRNA degradation of the reporter when AIN-2 is tethered. However, further 
studies are required to understand exactly how AIN-2 contributes to silencing.  
In a second approach, I performed complementation assays. I knocked down 
endogenous Dm GW182 protein and transfected the cells with a F-Luc reporter 
containing the 3’ UTR of the Par-6 gene and a miR-1 plasmid, which regulates Par-6 
expression. Knocking down GW182 protein inhibited silencing of Par-6 mRNA by 
miR-1, as expected. Then, I transfected these cells with AIN-1 and AIN-2 to test 
whether they can complement GW182 depletion in Dm S2 cells. Unexpectedly, none 
of them rescued silencing. This observation demonstrated that although AIN-1 can 
interact with Dm and Ce PABP and deadenylase complexes, it is not sufficient to 
replace endogenous Dm GW182 protein. This result strengthened the hypothesis 
supporting different modes of interaction across species. Although AIN-1 can recruit 
all the partners required for silencing, it cannot promote silencing. It is possible that 
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an additional partner, which is not present in S2 cells, is required for AIN-1 and AIN-
2 to mediate silencing.  
My results revealed different mechanisms used by AIN-1 and AIN-2. One 
possible and simple explanation can be their localization. AIN-1 is localized in P-
bodies and is proposed to target ALG-1 to P-bodies (Ding et al., 2005). However, 
AIN-2 localization was not investigated. Its localization together with AIN-1 in P-
bodies is unlikely, since associated proteins identified in AIN-2 IP, did not reveal any 
P-body marker as the decapping factors (Zhang et al., 2007). Further investigation, 
especially performed in C. elegans, can identify the different mechanisms used by 
AIN-1 and AIN-2. 
Overall, this study highlighted the conservation of the interactions between 
GW182 proteins with deadenylases and PABP across species. It showed that C. 
elegans GW182 protein AIN-1 can mediate these interactions despite its divergent 
sequence and pointed out that the mode of interaction has changed through evolution . 
 
 
 
4.2 The interactions of GW182 proteins with PABP and the CCR4-NOT complex 
are required for both translational repression and degradation of miRNA targets 
 
The work summarized in this section was published by Huntzinger et al., 2013 
and the paper including detailed experimental data and methods is attached.  
 
In this study, I created a chimeric and functional GW182 protein to understand 
the minimal sequence requirements to mediate silencing. When I started this project, 
it was known that the silencing domain (SD) of Hs TNRC6 proteins is sufficient to 
mediate the interaction with deadenylases (Braun et al., 2011; Chekulaeva et al., 
2011; Fabian et al., 2011). However, co-IP assays also indicated additional binding 
sites, located outside of the SD in the Dm GW182 protein. Therefore, I first identified 
the regions of the Dm GW182 protein necessary to bind the deadenylase complexes. I 
showed that the Q-rich region together with the SD (i.e., residues between 635-1384) 
of Dm GW182 contributed to NOT1-binding.  
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Figure 4.2 The schematic overview of the chimeric GW182 proteins. The mini GW182 
proteins, labeled as ABD2-Q+SD or ABD2-6C-SD are constructed by the fusion of Ago-
binding domain of Ce AIN-2 (ABD2) to the Q+SD region of Dm GW182 or to the SD of Hs 
TNRC6C, respectively. The motifs present in the SD are indicated. (CIM-1/2: CCR4-
interacting motif 1/2, PAM2: PABP-interacting motif-2, W: Tryptophan residues located in 
M2 region).    
 
To understand the contribution of N-terminal part of the Dm GW182 protein 
to silencing, I engineered a construct containing the ABD of Ce AIN-2 (ABD2) fused 
to the Q+SD region of Dm GW182. In this way, I bypassed the requirement of the N-
terminal region of the Dm GW182 to interact with AGO1, and obtained a mini-
GW182 protein, which can still interact with AGO1 (Fig 4.2). This chimeric protein 
gave me the chance to investigate more in detail the contribution of each fragment of 
the Dm GW182 protein in the context of silencing, by using them in complementation 
assays. I showed that although the ABD2 fused to the Q+SD domain of Dm GW182 
rescues silencing, it was not as efficient as the wild-type protein. This result indicated 
that N-terminal region of Dm GW182 protein also contributes to silencing. With this 
construct in hand, we analyzed the contribution of each motif present in the SD. As 
discussed in section 2.4, the CIM-1 and PAM2 motifs located in the SD are important 
to mediate the interaction with the CCR4-NOT complex and PABP, respectively. In 
addition to these motifs, tryptophan residues (W) located in the M2 region of the SD 
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also contribute to binding to the deadenylase (Chekulaeva et al., 2011). We mutated 
these motifs individually or in combination and analyzed the effects of mutations in 
complementation assays. These experiments demonstrated that Dm GW182 requires 
the interactions with both PABP and deadenylases to mediate silencing.  
Considering the conservation of the silencing machinery in flies and humans, I 
also generated a chimeric protein consisted of ABD2 fused to the SD of Hs TNRC6C 
(Fig 4.2). This construct was sufficient to rescue silencing in S2 cells and 
demonstrated that, in contrast to the Dm GW182 protein, which contains some 
minimal binding sites in the N-terminal, the Hs TNRC6C-SD alone is sufficient to 
mediate interaction with PABP and deadenylases. The analyses of mutated proteins 
demonstrated that PAM2, CIM-1, CIM-2 motifs and W residues in the M2 region of 
TNRC6C protein have different effect on silencing.  
In summary, the approach of using chimeric proteins revealed differences 
between Dm and Hs GW182 proteins. This study demonstrated that although both Dm 
and Hs GW182 proteins require interactions with deadenylases and PABP to mediate 
silencing, their mode of interaction has changed through evolution, as observed in C. 
elegans proteins (Section 4.1). Dm GW182 has evolved additional binding sites 
located outside of the silencing domain and the Q-rich region, for the interaction with 
deadenylases. On the other hand, the SD of Hs TNRC6C is sufficient to mediate 
interactions with PABP and deadenylases. These differences in binding modes can be 
explained by the unstructured regions of GW182 proteins. GW182 proteins contain 
several intrinsically disordered regions and mediate their interactions via short linear 
motifs (SLiMs). SLiMs are small peptides, 3-10 amino acid in length, which can 
either act as sites for post-translational modifications (PTMs) or mediate interactions 
(Weatheritt and Gibson, 2012). The GW repeats located in the ABD and motifs 
(PAM2 and CIM-1/2) in the SD of GW182 proteins represent SLiMs. All these motifs 
mediate interaction with AGOs, PABP and the deadenylase complexes. One way to 
identify these motifs is to use a screen between overlapping peptides of interested 
protein vs interacting protein. This method was used to investigate the contribution of 
different GW repeats in the N-terminal domain of Hs TNRC6 protein for the 
interaction with AGO2 (Pfaff et al., 2013). A similar approach could be also used to 
investigate the contribution of the N-terminal domain of Dm GW182 protein to PABP 
and deadenylase complex binding.  
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4.3 The assembly of the NOT module of the CCR4-NOT complex is crucial for 
the mRNA degradation 
 
The work summarized in this section was published by Boland et al., 2013 and 
the paper including detailed experimental data and methods is attached.  
 
The CCR4-NOT complex consists of two modules: The NOT module 
containing NOT1,2,3 proteins and a catalytic module containing CAF1 (POP2) and 
CCR4 (Table 2.2). The specific role of the NOT module was not clear, although it 
was thought to be involved in the regulation of stability and activity of the catalytic 
module. In addition, the NOT module is also important for the recruitment of the 
CCR4-NOT complex to mRNA targets, since several RNA binding proteins (Nanos, 
Bicaudal-C, CUP, Smaug) interact with the CCR4-NOT complex through the 
subunits that form the NOT module (Barckmann and Simonelig, 2013).  
To understand the contribution of this module to mRNA decay, we used a 
structural approach. The crystal structure of the human NOT module consisting of C-
terminal regions of CNOT1, CNOT2 and CNOT3 proteins was solved in the lab (Fig 
4.3). These highly conserved regions contain a NOT1 superfamily homology domain 
(NSHD) in CNOT1 and NOT-box domains in CNOT2 and CNOT3. The crystal 
structure revealed that NSHD consists of two perpendicular subdomains, which 
contain six and four heat-repeats, respectively. It also demonstrated that CNOT2 and 
CNOT3 heterodimerize through the NOT-box domains and interact with the CNOT1-
SH domain via unstructured regions.  
My role in this study was to evaluate the significance of the NOT module in 
mRNA degradation in vivo. Since the CCR4-NOT complex is highly conserved in 
human and flies, I tested the effects of mutations in the Dm proteins.  
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Figure 4.3 The domain organization and the structures of Hs NOT module. Domain 
organization of Hs CNOT1-3 proteins. Hs CNOT1 contains three regions: N-terminal (N), 
middle (M) and C-terminal (C). CNOT1-C contains the NOT1 superfamily homology domain 
(NSHD) consisting of N- and C-terminal subdomains (SD). The C-terminal regions of Hs 
CNOT2 and CNOT3 contain a NOT1 anchor region (NAR) consisting of an alpha-helix (αN) 
and NAR-C, a connector sequence (CS) and a NOT-box domain. The cartoon representations 
of each protein and the NOT module are shown. The numbers represent the amino acid 
positions at domain boundaries.   
 
I designed the constructs according to the structure and investigated the 
interaction of the individual proteins with endogenous CCR4-NOT complex in S2 
cells. First of all, I tested the interaction between HA-tagged overexpressed NOT1 
protein with endogenous NOT2 and NOT3. As expected, deletion of the C-terminal 
NOT1 containing NSHD, abolished the interaction. This validated the structural data 
and showed that there are no additional binding sites on NOT1 for Dm NOT2 and 
NOT3 protein. Point mutations in NOT1 designed according to the crystal structure 
prevented the interaction with NOT2 and NOT3. Moreover, when I mutated the 
binding surface between NOT1 and NOT2, this NOT1 mutant was not able to bind to 
NOT3 and vice versa. This result indicated that three subunits exist as a complex in 
vivo. Further results also confirmed this conclusion. The structure demonstrated that 
NOT2 contacts NOT1 through several regions: NOT1 anchor region (NAR, 
consisting of an alpha-helix (αN) and C-terminal unstructured part (NAR-C)) and a 
connector sequence (CS, Fig 4.3). Deletion of each of these binding surfaces 
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prevented the binding of NOT2 to NOT1 and NOT3. I also obtained the same results, 
when NOT3 was mutated. Overall, these results showed that in vivo, each subunit of 
the NOT module requires interaction with other partners to be incorporated into the 
endogenous CCR4-NOT complex.   
Finally, to understand the role of the NOT module in mRNA decay I used two 
different approaches: Overexpression and complementation assays. I used a reporter 
containing the coding sequence of the Dm alcohol dehydrogenase (Adh) gene fused to 
the 3’ UTR of hsp70 mRNA. It was previously shown that Hsp70 mRNA is rapidly 
deadenylated by the CCR4-NOT complex (Temme et al., 2004). I measured the half-
life of this reporter under different conditions. First, I overexpressed the wild-type and 
the NOT1 mutant which does not interact with endogenous NOT2 and NOT3 
proteins. The half-life of the reporter increased two fold in the presence of the NOT1 
mutant. Since this NOT1 mutant is not incorporated into the endogenous complex, its 
effect is most likely explained by titration of the catalytic module from the active 
complex, causing inefficient mRNA decay. Second, I knocked-down endogenous 
NOT1, NOT2 and NOT3 proteins and performed complementation assays using 
different mutants. I showed that depletion of a single subunit (NOT1 or NOT3) co-
depleted the others, in agreement with previous studies (Russell et al., 2002; Temme 
et al., 2010; Ito et al., 2011a; 2011b; Mauxion et al., 2013). Depletion of the different 
subunits had a similar effect on the half-life of the reporter, as expected. As a control, 
I transfected the cells with dsRNA-resistant versions of NOT1 or NOT3, they both 
restored the degradation of the reporter. However, the NOT1 or NOT3 mutants did 
not rescue degradation. These experiments demonstrated the requirement of a 
properly assembled NOT module for the activity and the recruitment of the CCR4-
NOT complex.  
In summary, this study demonstrated how the NOT module is assembled. In 
particular, the crystal structure showed the importance of NAR and CS for the 
assembly of the NOT module. The mutation analysis and functional studies 
highlighted the role of the NOT module for the activity of the CCR4-NOT complex. 
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4.4 CNOT9 contains tandem W-binding pockets that mediate the interaction 
with GW182 proteins 
 
The work summarized in this section was published by Chen et al., 2014 and 
the paper including detailed experimental data and methods is attached.  
 
The interaction between GW182/TNRC6 proteins and the CCR4-NOT 
complex is crucial for miRNA-mediated gene silencing. Although the relevance of 
this interaction was known, the mode of interaction remained unclear.  Previous 
studies reported that tryptophan residues located in the SD of GW182/TNRC6 
proteins were important for this interaction (Chekulaeva et al., 2011; Fabian et al., 
2011; Huntzinger et al., 2013). Structural studies showed the presence of W-binding 
pockets in Hs AGO2 and Dm PAN3 homodimer, which mediate the interaction with 
W-containing motifs in GW182 proteins (Schirle and MacRae, 2012; Christie et al., 
2013).  
Previous work from our lab demonstrated that the NOT1 subunit of the CCR4-
NOT complex interacts with TNRC6A-SD through a DUF domain (Fig 4.4). This 
domain also interacts with another subunit of the complex: CNOT9 (CAF40). In order 
to obtain detailed information about the molecular basis of this interaction, the DUF 
domain (hereby, referred as CNOT9 binding domain, CN9BD) was co-crystallized 
with the ARM (Armadillo repeats) domain of Hs CNOT9 in the absence or presence 
of L-tryptophan.  
The crystal structure revealed the fold of CN9BD, which consists of seven α 
helices, arranged to locate the N- and C-termini of the domain into close proximity. 
The crystal structure also revealed the presence of two tandem W-binding pockets 
located in CNOT9. This information suggested a potential interaction between 
GW182/TNRC6 proteins and CNOT9. To investigate whether these pockets represent 
binding sites for GW182 proteins, I designed mutants and tested the interaction by co-
IPs in human HEK293T cells. The IP results confirmed the binding between the 
proteins and showed that the point mutations designed to disrupt the W-binding 
pockets in CNOT9 abolished the interaction. To understand whether CNOT9 is the 
only subunit interacting with GW182/TNRC6 proteins, I designed mutations on 
CNOT1. A CNOT1 mutant, which does not interact with CNOT9, retains the ability 
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to interact with GW182/TNRC6, indicating the presence of additional binding sites in 
CNOT1.  
   
!!!! !
Figure 4.4 The domain organization of Hs CNOT1-Mid together with CNOT9 and 
TNRC6A-SD. The CNOT9 binding domain (CN9BD or DUF3819) of Hs CNOT1 interacts 
with armadillo repeat (ARM) domain of Hs CNOT9. The cartoon representations of CN9BD 
together with CNOT9-ARM highlight the presence of two W-binding pockets (represented as 
blue Ws) located on the CNOT9. These pockets mediate interaction with Hs TNRC6 proteins.  
 
In order to investigate the role of the interaction between CNOT9 and TNRC6 
proteins in silencing, I performed complementation assays in HeLa cells. I optimized 
the knock-down protocol in the lab and tested different miRNA reporters repressed by 
endogenous let-7. I could not observe any effect on silencing in Hs CNOT9 depleted 
cells, however depletion of Hs CNOT1 inhibited silencing in HeLa cells. Transfection 
of a shRNA-resistant version of wild-type CNOT1 restored silencing of the miRNA 
reporters. Then, I tested different mutants of CNOT1 and concluded that a CNOT1 
mutant which does not interact with CNOT9 can still rescue silencing. This 
observation was in agreement with the results obtained from immunoprecipitation 
assays that revealed additional binding sites of GW182/TNRC6 proteins on CNOT1.  
Overall, this study revealed the presence of two W-binding pockets on 
CNOT9 which mediate interaction with TNRC6 proteins. Although I could confirm 
the interaction in vivo, the functional significance of this interaction remains elusive. I 
could not observe any effect on silencing when CNOT9 was depleted in HEK293T or 
HeLa cells. Moreover, the results of immunoprecipitation assays showed that 
CNOT1, which does not bind to CNOT9 still interacts with TNRC6. This indicates 
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the presence of multiple binding sites for GW182 proteins on the CCR4-NOT 
complex, which mediate the recruitment of the complex to miRNA targets in a 
redundant manner. As miRNAs are crucial for the cell to regulate different pathways, 
we can expect that cells use more than one way to recruit the main effector complex, 
the CCR4-NOT complex, to the mRNA target. Moreover, the presence of multiple 
binding sites can facilitate the recruitment of the complex under specific conditions. 
CNOT9 is a highly conserved protein and is a core member of the CCR4-NOT 
complex. CNOT9 has been implicated in retinoic acid-induced cell differentiation 
(Hiroi et al., 2002) and is overexpressed in breast cancer (Ajiro et al., 2009). We can 
speculate that TNRC6 mediated recruitment of the CCR4-NOT complex is facilitated 
by CNOT9 when it is overexpressed. Further studies focusing on the differential 
expression of CNOT9 and its role in miRNA-mediated gene silencing in different 
tissues can provide more information. 
 
 
 
4.5 The role of DDX6 in miRNA-mediated gene silencing 
 
Part of the work summarized in this section was published by Chen et al., 
2014 and the paper including detailed experimental data and methods is attached. The 
main part of the work is described in the manuscript attached Kuzuoglu-Ozturk et al., 
2015, which is under review in Genes&Development. 
 
In the last part of my PhD, I focused on the role of the CCR4-NOT complex in 
translational repression. My aim was to elucidate the translational repression 
mechanism employed by the deadenylase complex, which will consequently give 
information on how miRNAs repress translation. The studies published during my 
PhD supported the hypothesis of the CCR4-NOT complex is an effector complex in 
silencing, which can mediate the repressive activity of miRNAs as well as their effect 
on mRNA decay. Two studies, in one of which I was involved, showed that GW182 
proteins dissociate PABP from their mRNA target which causes repression at the 
translational level (Moretti et al., 2012; Zekri et al., 2013). More importantly, it was 
demonstrated that GW182 proteins require the CCR4-NOT complex to dissociate 
PABP from the mRNA target (Zekri et al., 2013).  
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In order to elucidate the role of the CCR4-NOT complex in miRNA-mediated 
translational repression, I first investigated whether miRISC and the deadenylase 
complex use a similar mechanism to repress translation of miRNA targets. It was 
proposed that Dm AGO1 can repress translation independently of GW182 and the 
CCR4-NOT complex in vitro (Fukaya and Tomari, 2012). This study suggested that 
AGO1 requires GW182 to recruit the CCR4-NOT complex to mediate mRNA decay, 
but it could still repress translation of mRNA targets in the absence of mRNA 
deadenylation. In 2012, the crystal structure of Hs AGO2 was solved and it revealed 
the presence of two W-binding pockets in the PIWI domain, which can potentially 
mediate the interactions with GW182/TNRC6 proteins (Schirle and MacRae, 2012). I 
used this information to design Dm and Hs AGO1 and AGO2 mutants. The point 
mutations abolished the interaction with GW182. I confirmed the proper folding of 
the mutant proteins by miRNA IP; the mutants retained their ability to bind to 
miRNAs. I tested the activity of these mutants using either tethering or 
complementation assays. The different functional assays in S2 or HEK293T cells 
demonstrated that AGOs couldn’t repress translation or promote mRNA degradation 
when their interaction with GW182 proteins was abolished.  
Next, I focused on whether the miRISC and the CCR4-NOT complex use the 
same decay pathway. Since Dm AGO1 was proposed to act independently of GW182 
proteins, I compared the activities of different proteins (AGO, GW182 and NOT1) in 
tethering assays in the presence of catalytically inactive decapping subunit DCP2. I 
observed that all proteins degrade mRNA targets using 5’ to 3’ decay machinery. 
These experiments also demonstrated that miRISC and the CCR4-NOT complex both 
repress and degrade their targets by a similar mechanism.  
I next investigated whether all proteins use a similar mechanism to repress 
translation. Although different studies showed that the CCR4-NOT complex is 
important for translational repression by miRNAs, independently of its deadenylation 
activity, how this repression is achieved, remains unclear (Chekulaeva et al., 2009; 
Cooke et al., 2010; Bawankar et al., 2013; Zekri et al., 2013). One study reported that 
NOT1 blocks translation via interaction with the eukaryotic initiation factor eIF4A2 
in human cells (Meijer et al., 2013). eIF4A is an RNA helicase responsible for 
unwinding secondary structures within the 5’ UTR of the mRNA to allow the 
ribosome to scan and identify the first AUG to initiate translation. In human cells, two 
isoforms of eIF4A, eIF4A1 and eIF4A2, which share 91% of sequence identity, are 
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present. Meijer et al. demonstrated that miRNAs repress translation by recruiting 
eIF4A2 via NOT1. They proposed that eIF4A2, but not eIF4A1, interacts with NOT1 
and this interaction locks eIF4A2 on the 5’ UTR of the mRNA (Meijer et al., 2013). 
By contrast, two subsequent studies, proposed that miRNAs inhibit translation by 
causing dissociation of eIF4A1 and eIF4A2 from the mRNA target (Fukao et al., 
2014; Fukaya et al., 2014). 
In order to understand the role of the CCR4-NOT complex in miRNA-
mediated translational repression, I generated different reporters. Briefly, I used a 
reporter containing a normal poly(A) tail, which is sensitive to mRNA deadenylation. 
I modified the 3’ end of this parental reporter to generate a reporter, that is not 
deadenylated or degraded. For expression in human cells, I inserted the 3’ end of the 
MALAT1 long non coding RNA which is processed by RNase P (Wilusz et al., 
2012). For expression in Dm cells, I used a reporter containing an internal poly(A) 
stretch protected by a poly(C) stretch of seven residues followed by a self-cleaving 
Hammerhead ribozyme (HhR) sequence (Zekri et al., 2013). I obtained F-Luc or R-
Luc reporters, which are independent of mRNA deadenylation, to express in Dm and 
human cells, respectively. This allowed me to study only translational repression, 
without any effect on mRNA levels. Additionally, I modified the 5’ UTRs of the 
reporter to investigate the role of scanning in miRNA-mediated translational 
repression. I shortened the 5’ UTR of the Dm reporter from 107 to 6 nucleotides to 
obtain a reporter translated independently of scanning. Similarly, I modified the 5’ 
end of Hs reporter to insert a specific sequence (TISU: Translation initiator of short 5’ 
UTR) found in very short 5’ UTRs (Elfakess and Dikstein, 2008). TISU-driven 
translation is dependent on the 5’ cap structure and independent of the eIF4A helicase 
activity (Elfakess and Dikstein, 2008; Elfakess et al., 2011; Sinvani et al., 2015). In 
both cases, I checked the translation efficiency of the reporters. I designed different 
control experiments to be sure that translation measured with the luciferase activity of 
the reporter is not due to leaky translation. In the case of leaky translation, ribosomes 
should initiate translation from the next start codon, which is located 30 residues 
downstream of the first AUG in the F-Luc reporter. When I deleted these 30 amino 
acids, I could not observe any luciferase activity. This showed that the first residues 
are crucial for the activity of the protein and in the case of leaky translation, I would 
not measure any luciferase activity, consistent with a previously published report 
(Sung and Kang, 1998). I also inserted a HA-tag on the 5’end of the R-Luc ORF and 
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translated it in the presence of TISU. I could observe HA-tagged R-Luc in western 
blot showing that translation starts at the first AUG without any scanning. In order to 
test the effect of scanning on silencing, I generated reporters containing different 5’ 
UTRs for expression in human cells. I replaced the 5’ UTR sequences with CAA 
stretches, which were shown to require less eIF4A activity because of their weak 
secondary structure or with CGG stretches, which form a highly structured 5’ UTRs. 
The reporters used in this study are summarized in Table 4.1.  
 
Table 4.1 Reporters used in this study. The length of the 5’ untranslated regions (5’ UTR) 
are given in nucleotide (nt) numbers. The presence of poly(A) tail is indicated. Deadenylation 
and scanning dependency of each reporter are represented.  
 Name of the reporter 5’UTR Poly(A) Deadenylation dependent 
Scanning 
dependent 
Dm 
F-Luc-5BoxB 107 nt + + + 
F-Luc-5BoxB-A95-C7-HhR 107 nt 
 
- 
 
- 
 
+ 
 
6nt-F-Luc-5BoxB-A95-C7-HhR 6 nt - - - 
      
Hs 
R-Luc-6MS2 219 nt + + + 
 
R-Luc-6MS2-A95-MALAT1 219 nt - - + 
TISU-R-Luc-6MS2-A95-
MALAT1 12 nt - - 
 
- 
 
CAA-R-Luc-6MS2-A95-
MALAT1 68 nt - - 
 
+/- 
 
CGG-R-Luc-6MS2-A95-
MALAT1 123 nt - - + 
  
Next, I tested the effect of AGO, GW182 and the CCR4-NOT complex by 
tethering them directly to these reporters. The results demonstrated that none of the 
proteins require scanning or deadenylation to repress translation. This result was 
unexpected, since Meijer et al. showed that miRNAs repress translation by blocking 
scanning. I obtained similar results when I used reporters containing miRNA binding 
sites at their 3’ UTRs and a TISU or short 5’ UTRs. miRNAs also repressed 
translation of the reporters independently of scanning.  
To confirm that the reporters do not require scanning, and consequently eIF4A 
activity, I treated human cells with silvestrol, which blocks eIF4A activity (Bordeleau 
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et al., 2008; Wolfe et al., 2014). The drug reduced the translation efficiency of all 
reporters, except the TISU-dependent reporters. This confirmed that TISU-mediated 
translation does not require eIF4A, as shown previously (Elfakess and Dikstein, 2008; 
Elfakess et al., 2011). In addition to the drug, I also analysed the association of 
eIF4A2 with different reporters. Briefly, endogenous eIF4A2 was 
immunoprecipitated with a specific antibody and total RNA was purified. By northern 
blotting, I analyzed the association of endogenous eIF4A2 with different reporters. 
This experiment demonstrated that the TISU-dependent mRNA reporter does not 
associate with eIF4A2. Overall, silencing of scanning-independent reporters by 
tethered AGO, GW182 and the CCR4-NOT complex or by miRNAs showed that 
scanning is not the step blocked by miRISC.  
Since my results demonstrated that miRNAs does not require scanning or 
eIF4A activity to repress translation, it would be interesting to find out the mechanism 
of the CCR4-NOT-mediated translational repression. As mentioned above, Meijer et 
al. proposed that NOT1 interacts with eIF4A2 through its MIF4G domain, which is 
similar to the middle domain of the eIF4G protein. eIF4G interacts with eIF4A1/2 and 
eIF4E to form the eIF4F complex which is crucial for the initiation of translation. In 
the lab, we did not observe any interaction between NOT1 and eIF4A1/2 in human or 
Dm cells. On the other hand, our immunoprecipitation assays revealed another 
interacting partner of NOT1: A DEAD-box helicase DDX6 (named also as RCK, 
Me31B, Dhh1), which is involved in translational repression and decapping. We 
confirmed that this interaction is direct and the crystal structure of the C-terminal 
RecA domain of DDX6 bound to MIF4G domain of CNOT1 was solved in the lab, as 
shown in Fig 4.5.  
In order to understand whether this interaction is required for silencing, the 
initial complementation assays performed in human cells demonstrated that DDX6 is 
required for silencing. Moreover, a DDX6 mutant which does not interact with NOT1 
could not rescue silencing. This result indicated that the recruitment of DDX6 through 
NOT1 to miRNA targets is important for the activity of the protein. For further 
validation, I performed additional knock-down experiments. To understand the role of 
the interaction between NOT1 and DDX6 for the translation repression activity of the 
CCR4-NOT complex, I depleted endogenous DDX6 and tethered TNRC6 or NOT1 
proteins to a reporter which is not deadenylated. In the absence of DDX6, none of the 
proteins could repress translation showing that NOT1/TNRC6-mediated translational 
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repression requires DDX6. In a different approach, I have also tethered a NOT1 
mutant, which does not interact with DDX6 to a deadenylation-independent reporter. 
The result demonstrated that NOT1 requires the interaction with DDX6 to repress 
translation. Interestingly, when I repeated the same experiment with a reporter, that 
can be deadenylated, I could not observe any change between the wild-type and 
mutant NOT1. This showed that NOT1 degrades the mRNA target independently of 
DDX6; however it requires DDX6 for its repressive activity independently of 
deadenylation. 
 
               !
Figure 4.5 The domain organization of Hs CNOT1-Mid and DDX6. The middle domain 
of Hs CNOT1 contains MIF4G and CN9BD. Hs DDX6 is consisted of two RecA domains 
(RecA-N and RecA-C). MIF4G domain of Hs CNOT1 interacts with Hs DDX6. The crystal 
structure represented here contains RecA-C (pink) and MIF4G (green) domains.  
 
DDX6 is involved in translational repression, however how it represses 
translation is not known. To address this question, I initially tested whether DDX6 
requires deadenylation or scanning to promote translational repression. By using the 
same reporters that I have used for AGO, GW182 and the CCR4-NOT complex, I 
have tethered DDX6 and the DDX6 mutant which does not interact with NOT1. The 
wild-type protein repressed translation independently of scanning and deadenylation, 
as well as the mutant. This showed that DDX6 represses translation independently of 
NOT1. To investigate further this mechanism, I performed polysome profiling 
analysis in human cells. The analysis demonstrated that DDX6 tethering shifts the 
mRNA to the lighter fractions, which indicates that DDX6 inhibits translation 
initiation. 
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Overall, this study showed that miRISC containing a miRNA, AGO, GW182 
and the CCR4-NOT complex use a similar mechanism for silencing. They all degrade 
the mRNA target via the 5’ to 3’ decay pathway. Although how they repress 
translation is not yet clear, this study showed that they do not require scanning or 
deadenylation to inhibit translation. The results demonstrated that the interaction 
between NOT1 and DDX6 is required for translational repression. This interaction 
also provides a direct link between deadenylation and decapping as well as 
translational repression.  
 
 
 
Figure 4.6 Model of miRNA mediated gene silencing. miRISC, consists of miRNA and an 
AGO protein, binds to the 3’ UTR of the target mRNA. AGO recruits the GW182 protein. 
GW182 contains several W residues, represented as “W”. The N-terminal part of the protein 
interacts with AGO and the C-tail mediate the recruitment of the main deadenylase complex, 
the CCR4-NOT complex. GW182 interacts directly with CAF40 (CNOT9) through two W-
binding pockets. NOT1, the scaffold subunit of the CCR4-NOT complex, interacts with the 
decapping activator and translational repressor DDX6. This interaction bridges deadenylation 
to decapping and to translational repression.
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5. CONCLUSION 
 
miRNAs act as post-transcriptional gene regulators in almost all known 
biological pathways. GW182 proteins together with miRISC mediate silencing by 
promoting translational repression and mRNA decay. GW182 proteins are responsible 
for the recruitment of the main deadenylase complex, the CCR4-NOT complex, to 
miRNA targets. My doctoral studies, together with several studies mentioned in this 
thesis, identified the CCR4-NOT complex as a major effector complex in miRNA-
mediated gene silencing. This complex is required for deadenylation, as well as 
translational repression. The data presented in this thesis highlighted the importance 
of the interaction between GW182 proteins and the CCR4-NOT complex for silencing 
by showing that the interaction is conserved across species. My initial studies were 
focused on the C. elegans GW182 proteins, AIN-1 and AIN-2, which are highly 
divergent in sequence from the other members of the family. My results demonstrated 
the conservation of the interactions with the deadenylases and PABP, which are 
essential for silencing, although the mode of binding has changed during evolution. I 
next investigated minimal requirements of Hs and Dm GW182 proteins to mediate 
silencing and showed that the interaction of GW182 with both PABP and 
deadenylases are required to promote translational repression and mRNA degradation. 
In order to understand how GW182 recruits the CCR4-NOT complex to miRNA 
target, I was involved in a collaborative project. In this project, we identified two W-
binding pockets in the CNOT9 (CAF40) subunit of the CCR4-NOT complex. These 
W-binding pockets mediate the interaction with GW182 proteins. My results showed 
additional binding sites on the CCR4-NOT complex for GW182, which remain to be 
identified by further studies. Additionally, this study revealed a direct link between 
deadenylation and decapping pathways, by showing a direct interaction between 
MIF4G domain of NOT1 and DDX6, a translational repressor and decapping 
activator. Importantly, this link also connects the CCR4-NOT complex to translational 
repression.  
In the last part of my PhD, I focused on the translational repression activity of 
the CCR4-NOT complex. My studies demonstrated that the CCR4-NOT complex 
requires the interaction with DDX6 to repress translation of the miRNA targets in 
human cells. However how DDX6 represses translation is still not clear. Previous 
studies performed in yeast showed conflicting results: DDX6 was shown to inhibit the 
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assembly of 43S complex on mRNA (Coller and Parker, 2005) as well as to slow 
down the translation rate thereby causing the accumulation of ribosomes on mRNA 
(Sweet et al., 2012). The Xenopus ortholog of DDX6, Xp54, was also proposed to 
inhibit translation via the interaction with 4E-Transporter (4E-T), a 4E-binding 
protein which competes with eIF4G to bind to eIF4E and therefore represses 
translation (Kamenska et al., 2014). Human DDX6 was reported to be involved in 
translational repression by miRNAs, specially through the interaction with AGO (Chu 
and Rana, 2006).  The polysome profiling experiments that I performed indicated that 
DDX6 inhibits translation initiation. However there are still several unanswered 
questions. Although we have showed that the CCR4-NOT complex and miRISC 
require DDX6 to repress translation, whether its helicase activity is necessary remains 
unclear. One recent study reported that NOT1 binding stimulates ATPase activity of 
DDX6 (Mathys et al., 2014). Further in vitro studies, for example toe-printing 
analyses, can provide more information about the contribution of the interaction 
between NOT1 and DDX6 to translational repression. Another question is whether 
DDX6 requires other decapping subunits to inhibit translation. It has previously been 
shown that DDX6 can repress translation of different mRNAs in yeast strain lacking 
Dcp2 (Sweet et al., 2012). In order to address this question in a more direct way, point 
mutations could be introduced in DDX6 to abolish the interaction with other 
decapping factors and test the effect of the protein in different assays.  
The mechanism of translation could differentiate in various cell types and 
distinct requirements could be necessary. As an example, the length of poly(A) tail, 
was shown not to correlate with translation efficiency in the beginning at gastrulation 
(Subtelny et al., 2014).  This result showed that translation is differentially regulated 
under distinct conditions. We can also speculate that miRNA-mediated repression and 
the contribution of DDX6 also vary according to cell or environmental conditions. 
Future studies focusing on these questions will provide information to understand 
exactly how miRNAs promote translational repression.  
In conclusion, my doctoral studies highlighted the importance of the CCR4-
NOT complex as a main effector complex in miRNA-mediate gene silencing. My 
results contributed to our understanding of miRNA pathway by showing that the 
CCR4-NOT complex does not only promote deadenylation followed by decapping but 
also triggers translational repression of miRNA targets thorough its direct interaction 
with the translational repressor DDX6.  
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4E-T 4E-Transporter 
ABD AGO-binding domain 
Adh Alcohol dehydrogenase 
AGO Argonaute 
AIN ALG-1 interacting protein 
ALG Argonaute-like  
ARM Armadillo repeats 
At Arabidopsis thaliana 
C-term C-terminal 
C2orf29 Chromosome 2 open reading frame 29 
CAF CCR4 associated factor 
CCR4 Carbon catabolite repressor 4 
CDC Cell cycle division 
Ce Caenorhabditis elegans 
CIM CCR4-NOT interacting motif 
CN9BD CNOT9 binding domain 
Co-IP Co-immunoprecipitation 
CS Connector sequence 
DCP Decapping protein 
DDX6 DEAD box protein 6 
DEED Asp-Glu-Asp-Asp 
DGCR8 DiGeorge syndrome critical region 8 
Dhh1 DexD7H-box helicase 1 
Dm Drosophila melanogaster 
DNA Deoxyribonucleic acid 
dsRBD Double-stranded RNA binding domain 
dsRNA Double-stranded RNA 
DUF Domain of unknown function 
EDC Enhancer of decapping 
EEP Endonuclease-exonuclease-phosphatase 
eIF Eukaryotic initiation factor 
EXP5 Exportin 5 
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GW Glycine-tryptophan 
GW182  Glycine-tryptophan repeat containing protein of 182 kDa size, Gawky 
HA Hemagglutinin 
HEAT Huntingtin, elongation factor 3, protein phosphatase 2A, TOR1 
HEK293T Human embryonic kidney 293T cells 
HeLa Henrietta Lacks 
HhR Hammerhead ribozyme 
Hs Homo sapiens 
HSC70 Heat shock cognate 70 protein 
HSP90 Heat shock protein 90 chaperone complex 
IP Immunoprecipitation 
IRES  Internal ribosome entry site 
lncRNA Long non-coding RNA 
Loq Loquacious 
LRR Leucine rich repeat 
MALAT1 Metastasis associated lung adenocarcinoma transcript 1 
Me31B Maternal expression at 31B 
Mid Middle 
MIF4G Middle domain of eukaryotic initiation factor 4G 
miRISC miRNA induced silencing complex 
miRNA Micro RNA 
mRNA Messanger RNA 
mRNP Messanger ribonucleoprotein 
N-term N-terminal 
NAR NOT anchor region 
ncRNA Non-coding RNA 
NOT Negative on TATA-less 
NSHD NOT1 superfamily homology domain 
Nt Nucleotides 
ORF Open reading frame 
PABP Poly(A) binding protein 
PACT Protein activator of PKR 
PAM2 Poly(A) binding motif 2 
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PAN Poly(A) nuclease 
PAZ Piwi-Ago-Zwille 
piRNA Piwi-interacting RNA 
PIWI P-element induced wimpy testis 
POP2 PGK promoter directed over production 
pre-miRNA Precursor micro RNA 
pri-miRNA Primary micro RNA 
PTM Post-translational modification 
Q-rich Glutamine-rich 
Rcd1 Cell differentiation protein 
RIIID RNase III domain 
RISC RNA-induced silencing complex 
RNA Ribonucleic acid 
RQCD1 Required for cell differentiation 1  
RRM RNA-recognition motif 
rRNA Ribosomal RNA 
S2  Schneider 2 cells 
SD Silencing domain 
siRNA Small interfering RNA 
SLiM Short linear motif 
snoRNA Small nucleolar RNA 
snRNA Small nuclear RNA 
TAB182 Tankyrase-binding protein 182 
TISU Translation initiator of short 5’ UTR 
TNRC6 Trinucleotide repeat containing gene protein 6 
TRBP Trans-activation response RNA-binding protein 
tRNA Transfer RNA 
UBA Ubiquitin-associated 
UTR Untranslated region 
XRN1 5’-3’ exoribonuclease 1 
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ABSTRACT
GW182 family proteins are essential for miRNA-
mediated gene silencing in animal cells. They are
recruited to miRNA targets via interactions with
Argonaute proteins and then promote translational
repression and degradation of the miRNA targets.
The human and Drosophila melanogaster GW182
proteins share a similar domain organization and
interact with PABPC1 as well as with subunits of the
PAN2-PAN3 and CCR4-NOT deadenylase complexes.
The homologous proteins in Caenorhabditis elegans,
AIN-1 and AIN-2, lack most of the domains present in
the vertebrate and insect proteins, raising the
question as to how AIN-1 and AIN-2 contribute to
silencing. Here, we show that both AIN-1 and AIN-2
interact with Argonaute proteins through GW
repeats in the middle region of the AIN proteins.
However, only AIN-1 interacts with C. elegans and D.
melanogaster PABPC1, PAN3, NOT1 and NOT2, sug-
gesting that AIN-1 and AIN-2 are functionally distinct.
Our findings reveal a surprising evolutionary plasticity
of theGW182 protein interaction network and demon-
strate that binding to PABPC1 and deadenylase
complexes has been maintained throughout evolu-
tion, highlighting thesignificanceof these interactions
for silencing.
INTRODUCTION
The proteins AIN-1 and AIN-2 have important and par-
tially redundant functions in the miRNA pathway in
Caenorhabditis elegans (Ce) (1–4). They are highly diver-
gent members of the GW182 protein family, which plays
an essential role in miRNA-mediated gene silencing in
animals (5). In vertebrates and several invertebrate
species, there are up to three GW182 paralogs with
partially redundant functions, whereas there is only one
orthologous protein in Drosophila melanogaster (Dm
GW182).
GW182 family proteins are characterized by an
N-terminal region (N-term) containing multiple glycine–
tryptophan repeats (GW repeats), a central ubiquitin-
associated (UBA) domain and a C-terminal RNA
recognition motif (RRM) (Figure 1A) (2,6–9). Additional
regions of the protein include a glutamine-rich (Q-rich)
region, which is located between the UBA domain and the
RRM, and amiddle (Mid) and C-terminal (C-term) regions
containing few or none GW repeats (Figure 1A) (6–9).
The N-term GW repeat region of the proteins mediates
binding to the Argonaute (AGO) proteins and thus is es-
sential for miRNA-mediated gene silencing (7,10–15). The
Mid and C-term regions (collectively termed the silencing
domain, SD) are also required for silencing (12,13,16,17).
Indeed, GW182 protein mutants lacking the silencing
domain fail to rescue silencing of several miRNA
reporters in cells lacking endogenous GW182, even
though these proteins interact with AGO proteins and
are active in tethering assays (12,17–21).
The precise mechanism by which GW182 proteins
mediate silencing is not completely understood.
However, important insight was provided by the observa-
tion that these proteins interact with the cytoplasmic
poly(A)-binding protein (PABPC1) and with subunits of
the two major cytoplasmic deadenylase complexes (the
PAN2-PAN3 and CCR4-NOT complexes) both in D.
melanogaster and human cells (17,19–25).
Binding to PABPC1 is mediated by a conserved PAM2
motif (PABP-binding motif 2) located in the Mid region.
This motif directly binds to the C-term MLLE domain of
PABPC1 (17,22–24). Moreover, the protein sequences
downstream of the PAM2 motif (termed M2) together
with the C-term region mediate indirect binding to
PABPC1 in vivo (17).
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In addition to PABPC1, the silencing domains of
human GW182 proteins (known as TNRC6A, B and C)
confer direct binding to PAN3 and NOT1, which are
subunits of the PAN2-PAN3 and CCR4-NOT
deadenylase complexes, respectively (20,21,25). Binding
to PAN3 is mediated by the M2- and C-term regions of
the silencing domain (20), whereas NOT1 binding requires
W-containing motifs in the M1, M2 and C-term regions
(Figure 1A) (20,21,25). The interactions with the
deadenylase complex subunits are conserved in Dm
(20,21).
Remarkably, the Ce proteins AIN-1 and AIN-2 show
<12% global sequence identity to Dm GW182 and human
TNRC6s and do not contain sequences homologous to the
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Figure 1. Interaction of AIN-1 and AIN-2 proteins with ALG-1. (A) Domain organization of Dm GW182. The N-term ABD is shown in red, with
GW repeats shown as white vertical bars; Mid, Middle domain with PAM2 motif, M1 and M2 regions; The silencing domain includes the Mid and
C-term regions but not the RRM, which is dispensable for silencing (38). (B) Domain organization of AIN-1 and AIN-2. Regions colored in red and
green show limited similarity to the corresponding regions in Dm GW182. Cc, region with helical propensity. Gray lines underneath AIN-1 schematic
represent protein fragments required for the interaction with the indicated partners. (C–E) S2 cells were cotransfected with plasmids expressing
GFP-tagged Dm GW182, AIN-1 or AIN-2, and HA-tagged Ce ALG-1 or Dm AGO1. Cell lysates were immunoprecipitated using a polyclonal
anti-GFP antibody. GFP-tagged firefly luciferase served as a negative control. For the HA-tagged proteins, inputs (1%) and immunoprecipitates
(35%) were analyzed. For the GFP-tagged proteins, 3.5% of the inputs and 8% of the IPs were loaded. In panel D, cell lysates were treated with
Micrococcal nuclease (MNase).
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silencing domain (Figure 1B) (2,8,9). They also lack UBA
and RRM domains, a PAM2 motif, as well as a defined
Q-rich region. One common feature between AIN-1,
AIN-2 and other GW182 proteins is the presence of GW
repeats, which are dispersed within the N-term and Mid
regions of AIN-1 and AIN-2. Accordingly, AIN-1 and
AIN-2 coimmunoprecipitate Ce AGO-like proteins 1
and 2 (ALG-1 and ALG-2) (1,3). However, it is not
known which GW repeats in AIN-1 and AIN-2 contribute
to ALG-1 and ALG-2 binding.
The highly divergent sequences of AIN-1 and AIN-2
raise the question regarding how these proteins contribute
to silencing and whether there are differences in the mech-
anisms of silencing between species. One possibility is that
AIN-1 and AIN-2 perform similar functions as their ver-
tebrate and insect homologs but have evolved different
modes of interaction with PABPC1 and deadenylase
complexes. Alternatively, AIN-1 and AIN-2 may serve
as adaptor proteins between ALG-1,2 and other
protein(s), which in turn mediate binding to PABPC1
and deadenylase complexes. Finally, miRNA-mediated
gene silencing in Ce may occur by a different mechanism
that does not require interactions with PABPC1 or
deadenylase complexes, although miRNA targets have
also been reported to undergo deadenylation in Ce (26).
In this study, we identified the GW repeats that are
required for AIN-1 and AIN-2 to interact with ALG-1.
Despite the low sequence conservation with Drosophila
and human GW182 proteins, we found that AIN-1 inter-
acts with Ce PABPC1 (PAB-1), PAN3, NOT1 and NOT2,
whereas AIN-2 showed no significant interaction. Thus,
despite strong sequence divergence, the interaction of
AIN-1 with PABPC1 and deadenylase complexes has
been conserved throughout evolution, underscoring their
importance for miRNA-mediated gene silencing.
MATERIALS AND METHODS
Sequence analysis
Ce AIN-1 (WBGene00015547) and AIN-2 (WBGene000
15007) sequences were analyzed using sensitive methods
such as PSI-BLAST and HHpred (27,28). The sequence
identity of the paralogous sequences of AIN-1 and AIN-2
is !12%, but the Mid and C-term regions show some
common features, as depicted in Figure 1A and B.
Sequence homology to the AGO-binding region of Dm
GW182 was detected using extensive PSI-BLAST
searches (red region). Sequence homology for another
region (green) to a region in Dm GW182 (amino acids
721–795) was also detected using HHpred. This region
shows helical propensity and is annotated as Q-rich in
Dm GW182.
Plasmids
Luciferase reporters and plasmids for expression of
miRNAs, Dm AGO1, Dm GW182, Dm PABPC1 and
subunits of the Drosophila deadenylase complexes were
described before (7,19,20,29). The AGO1 F2V2 mutant
carries valine substitutions of phenylalanines 594
(F594V) and 629 (F629V) (11). For expression of Ce
proteins, the corresponding cDNAs were cloned into the
pAc5.1A–!N-HA or pAc5.1–EGFP vectors as described
in Supplementary Table S1. Mutations in AIN-1 and
AIN-2 were generated by site-directed mutagenesis using
the QuickChange mutagenesis kit from Stratagene.
Coimmunoprecipitations and western blots
Coimmunoprecipitations were performed as previously
described (17). Briefly, S2 cells were transfected in
six-well plates using the Effectene Transfection Reagent
(Qiagen). The transfection mixtures contained 1, 0.2 and
1 mg of plasmid expressing GFP-tagged Dm GW182,
AIN-1 and AIN-2, respectively, or the corresponding
mutants, and 0.5mg of HA-tagged proteins (Ce PABP,
Ce ALG-1, Dm AGO1 or deadenylation factors). Dm
PABPC1 was expressed with a C-term V5 tag. Cells
(10–12" 106 cells) were harvested 3 days after transfec-
tion, washed with PBS and lysed on ice in 0.5ml of
NET buffer [50 mM Tris (pH 7.4), 150mM NaCl, 1mM
EDTA and 0.1% Triton X-100] containing a protease in-
hibitor cocktail for 30min. Cell lysates were supplemented
with 2.5mM CaCl2 and treated with micrococcal nuclease
for 30min. After removal of insoluble proteins, cell lysates
were incubated with homemade rabbit polyclonal
anti-GFP antibodies (2 ml) for 1 h. Subsequently, Protein
A-Sepharose beads (GE HealthCare, 50 ml) were added
and samples were gently rotated for 1 h at 4#C. Beads
were washed 3 times with NET buffer and once with
NET buffer without Triton X-100. Proteins were eluted
with SDS–PAGE sample buffer and analyzed by western
blotting using conventional procedures. Small aliquots
from cell lysates prior and after Micrococcal nuclease
treatment were analyzed by native agarose gel electro-
phoresis to confirm that rRNA was efficiently degraded.
HA- and GFP-tagged proteins were detected using
HRP-conjugated monoclonal anti-HA (Roche 3F10;
1:5000) and anti-GFP antibodies (Roche 11 814 460 001;
1:2000), respectively. V5-tagged proteins were detected
with anti-V5 antibodies (Invitrogen, 1:5000). All western
blots were developed with the ECL western blotting
detection system (GE Healthcare) as recommended by
the manufacturer.
Complementation and tethering assays in S2 cells
S2 cells were transfected in 24 - or 6-well plates using
Effectene transfection reagent (Qiagen). For the tethering
assay, the following plasmids were cotransfected (amounts
are given for six-well plates): 0.1 mg reporter plasmid
(F-Luc-5BoxB or F-Luc without 5BoxB), 0.4 mg pAc5.1–
R–Luc as transfection control and various amounts of
plasmids expressing !N-HA-protein fusions (adjusted to
obtain equal expression levels for all proteins tested).
Firefly and Renilla luciferase activities were measured 3
days after transfection using the Dual-Luciferase
Reporter Assay System (Promega).
AGO1 complementation assays were performed as
described before (11). The following siRNAs were used:
AGO1 50-CGAAGGAGAUCAAGGGUUUUU-30 and
b-Gal 50-CUACACAAAUCAGCGAUUUUU-30; Dhar-
macon). GW182 complementation assays were performed
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aspreviously described (12).FormiRNA-mediated silencing
assays, the transfection mixtures contained (amounts given
for 24-well plates): 20ngoffirefly luciferase reporterplasmid,
80ng of the Renilla transfection control and 40ng of
plasmids expressing miRNA primary transcripts or the
corresponding vector without insert. When indicated,
10–100ng of plasmid expressing recombinant protein was
cotransfected.
Firefly and Renilla luciferase activities were measured 4
(AGO1 complementation) or 3 (GW182 complementa-
tion) days after transfection using the Dual-Luciferase
Reporter Assay System (Promega). Total RNA was
isolated using TriFast (Peqlab Biotechnologies) and
analyzed as previously described (12).
RESULTS
AIN-1 and AIN-2 interact with ALG-1 through GW
repeats in the Mid region
Sequence comparison and secondary structure predictions
indicated that AIN-1 and AIN-2 consist of five different
regions (Figure 1B): an N-term low-complexity region
containing 5 and 1GW repeats, respectively; a region of
homology to the AGO-binding domain (ABD) of human
TNRC6s and Dm GW182, containing additional 2 and
3GW repeats, respectively; a linker region (L) rich in
serine and glycine residues; a region with limited similarity
to the Q-rich region of Dm GW182 (Cc), which exhibits
helical propensity; and a C-terminal tail (Ct). Overall, the
sequence identity between AIN-1 and AIN-2 and
orthologous vertebrate and insect proteins is <12%,
whereas AIN-1 and AIN-2 exhibit 22.4% identity
(Supplementary Table S2).
To analyze the interaction of AIN-1 and AIN-2 with
potential-binding partners, we used a heterologous system
based on Dm S2 cells. We validated this approach by
showing that AIN-1 and AIN-2 interacted with ALG-1
in these cells. Indeed, GFP-tagged versions of AIN-1
and AIN-2 coimmunoprecipitated HA-tagged ALG-1 in
lysates from S2 cells coexpressing these proteins
(Figure 1C and D, lanes 7 and 8). Interestingly, Dm
GW182 also bound to ALG-1 (Figure 1C and D,
lane 6), indicating that the mode of interaction is
conserved. Conversely, both AIN-1 and AIN-2
coimmunoprecipitated Dm AGO1 (Figure 1E), consistent
with the observation that ALG-1 and AGO1 exhibit 61%
identity (Supplementary Table S3). The interactions with
ALG-1 were observed in cell lysates treated with
Micrococcal nuclease, suggesting that they are not
mediated by RNA (Figure 1D, MNase).
To define the regions in AIN-1 required for ALG-1
binding, we generated mutants lacking either the
N-term, Mid or C-term regions (Figure 1B) and tested
them in coimmunoprecipitation assays. We observed
that deletion of the AIN-1 Mid region abolished ALG-1
binding, whereas deletion of the N-term or C-term regions
had no effect (Figure 2A). Furthermore, protein fragments
containing only the AIN-1 Mid region or the Mid region
without the linker (hereafter termed the AGO-binding
domain, ABD) were sufficient for binding to ALG-1
(Figure 2A, lane 11; Figure 2B, lanes 7 and 8). These
results indicate that the N-term GW repeats do not
significantly contribute to the AIN-1/ALG-1 interaction.
The ABD of AIN-1 contains two GW repeats; to
examine their contribution to ALG-1 binding, we
substituted the tryptophan residues in each repeat with
alanines. These substitutions slightly reduced AIN-1
binding to ALG-1 (Figure 2C, lanes 10 and 11). A
stronger reduction was observed when the substitutions
were combined (Figure 2C, lane 12). However, the
AIN-1 double mutant retained some residual ALG-1
binding relative to the AIN-1 mutant lacking the entire
Mid region (Figure 2C, lane 12 versus 9), indicating that
additional residues in the Mid region contribute to the
interaction.
A similar analysis of the interaction of AIN-2 with
ALG-1 revealed that the corresponding ABD is essential
for this interaction (Figure 2D, lane 13). The AIN-2 ABD
contains 3GW repeats. We observed that alanine substi-
tution of the tryptophan residue in the first repeat
(GW1-A) reduced binding to ALG-1, whereas substitu-
tions in repeats 2 and 3 had no effect (Figure 2D, lanes
14–16). ALG1 binding was abolished when repeats 1 and 2
were substituted simultaneously (Figure 2D, lane 17),
whereas substitutions in repeats 1 and 3 or 2 and 3
reduced but did not abolish binding (Figure 2D, lanes
18 and 19). We conclude that the GW repeats in the
ABD are essential for AIN-2 to interact with ALG-1.
These repeats contribute to ALG-1 binding in an
additive manner as previously observed for the human
and Dm GW182 proteins (10,12,13,15,30). These results
also indicate that a GW repeat present in the
AIN-2N-term region does not detectably contribute to
the interaction with ALG-1.
AIN-1 interacts with the RRM domains of PAB-1
We next tested whether AIN-1 and AIN-2 interact with Ce
PAB-1. Remarkably, only AIN-1 coimmunoprecipitated
HA-tagged Ce PAB-1 (Figure 3A and B, lane 7). In
contrast, AIN-2 did not detectably interact with PAB-1,
although it was expressed at similar levels (Figure 3A and
B, lane 8). Interestingly, although Ce and Dm PABPC1
exhibit 51.5% identity (Supplementary Table S3), Dm
GW182 did not interact with Ce PAB-1 (Figure 3A and
B, lane 6). In contrast, AIN-1 interacted with Dm
PABPC1 (Figure 3C, lanes 11 and 15). The interaction of
AIN-1 with Ce or Dm PABPC1 was observed in extracts
treated with Micrococcal nuclease, suggesting that this
association is not mediated by RNA (Figure 3B and C).
PABPC1 contains four N-term RRM1–4, a proline-rich
unstructured linker, and a C-term domain [termed PABC
or MLLE because of a conserved KITGMLLE signature
motif in this domain; Figure 3D; (24)]. Human TNRC6
and Dm GW182 interact directly with the C-term MLLE
domain of PABPC1 through a conserved PAM2 motif
located in the Mid region of the silencing domain [see
Figure 1A; (17,22–24)]. However, we could not identify
a PAM2 motif in AIN-1. To map the sequences in
AIN-1 required for PAB-1 binding, we performed
coimmunoprecipitations using the deletion mutants
5654 Nucleic Acids Research, 2012, Vol. 40, No. 12
 by guest on August 28, 2014
http://nar.oxfordjournals.org/
Downloaded from 
described above. We observed that deletion of the N-term
or Mid regions of AIN-1 reduced the interaction with
PAB-1, whereas deletion of the C-term region was incon-
sequential (Figure 3E, lanes 9, 10 and 12). However,
neither the N-term nor the Mid regions in isolation were
sufficient for binding (Figure 3E and F). Thus, both the
N-term and Mid regions contribute to PAB-1 binding
(Figure 1B).
We next investigated whether AIN-1 interacts with the
MLLE domain of PAB-1 despite the lack of a PAM2
motif. We observed that AIN-1 interacted preferentially
with the RRM domains of PAB-1 but not with the MLLE
domain (Figure 3G). We conclude that the interaction of
GW182 proteins with PABP is conserved, although the
interaction mode may differ between species.
AIN-1 interacts with the PAN3 C-term kinase-like
domain
We next studied whether AIN-1 and AIN-2 interact with
Ce PAN3. As observed for PAB-1, only AIN-1 interacted
with Ce PAN3 in an RNA-independent manner
(Figure 4A and B, lane 7), whereas AIN-2 or GW182
did not bind (Figure 4A and B, lanes 6 and 8). In
F-L
uc
AIN
-1
GW
1-A
DM
id
GW
2-A
GW
1+
2-A
A
Anti-GFP
HA-CeALG1
F-L
uc
AIN
-1
GW
1-A
DM
id
GW
2-A
GW
1+
2-A
A
130
130
95
72
F-L
uc
AIN
-2
GW
1-A
DA
BD
GW
2-A
GW
3-A
GW
1+
2-A
A
GW
1+
3-A
A
GW
2+
3-A
A
GW
1+
2+
3-A
AA
F-L
uc
AIN
-2
GW
1-A
DA
BD
GW
2-A
GW
3-A
GW
1+
2-A
A
GW
1+
3-A
A
GW
2+
3-A
A
GW
1+
2+
3-A
AA
Anti-GFP
HA-CeALG1 130
130
95
72
C
D
F-L
uc
AIN
-1
DM
id
DN Mi
d
DC F-L
uc
AIN
-1
DM
id
DN Mi
d
DC
Anti-GFP
HA-CeALG-1
A
Input IP (anti-GFP)
1 2 3 4 5 6 7 8 9 10 11 12
Input IP (anti-GFP)
1 2 3 4 5 6 7 8 9 10 11 12
Input IP (anti-GFP)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
F-L
uc
AIN
-1
AB
D
Mi
d
F-L
uc
AIN
-1
AB
D
Mi
d
Anti-GFP
HA-CeALG-1
Input IP (anti-GFP)
1 2 3 4 5 6 7 8
130
95
55
72
36
130
B
130
95
55
72
130
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Figure 3. AIN-1 interacts with the RRM domains of PAB-1. (A–C) S2 cells were cotransfected with plasmids expressing GFP-tagged GW182, AIN-1
or AIN-2, and HA-tagged Ce PAB-1 or V5-tagged Dm PABP as indicated. Cell lysates were immunoprecipitated and analyzed as described in
Figure 1. Asterisks indicate a Dm GW182 degradation product. (D) Domain organization of Ce PAB-1. PAB-1 consists of four N-term RRM1–4, a
proline-rich unstructured linker, and a conserved C-term domain, termed MLLE. (E–G) The interaction of GFP-tagged AIN-1 (wild type or
mutants) with full-length HA-tagged Ce PAB-1 or fragments was analyzed as described in Figure 1. In panels B and E, cell lysates were treated
with Micrococcal nuclease.
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contrast, AIN-1 coimmunoprecipitated Dm PAN3 more
efficiently than Dm GW182 (Figure 4C and D).
Our previous studies showed that human TNRC6
proteins interact with PAN3 through the M2 and
C-term regions of the silencing domains (20). We
observed that deletion of either the N-term or C-term
regions of AIN-1 reduced binding to PAN3 (Figure 4E
and Supplementary Figure S1A). In contrast, a protein
fragment containing both the N-term and C-term
regions but lacking the Mid region (!Mid) interacted
with PAN3 to a similar extent as full-length AIN-1
(Figure 4E, lane 10 and Supplementary Figure S1A),
indicating that the N-term and C-term regions both con-
tribute to the interaction. Accordingly, the isolated
N-term or C-term regions did not interact with PAN3
(Supplementary Figure S1A).
PAN3 proteins contain an N-term region and a C-term
domain with homology to protein kinases (Figure 4F). The
PAN3 N-term region contains a canonical PAM2 motif
and interacts with PABPC1, whereas theC-term kinase-like
domain is required for PAN3 binding to PAN2, the cata-
lytic subunit of the PAN2–PAN3 deadenylase complex
(31–33). Our previous studies showed a direct interaction
between human TNRC6 proteins and the kinase-like
domain of PAN3 (20). Likewise, AIN-1 interacted with
the PAN3 kinase-like domain but not with the N-term
region (Figure 4G). Thus, the interaction of GW182
proteins with the kinase-like domain of PAN3 is conserved.
Since the PAN3 kinase-like domain does not interact with
PABPC1, we conclude that AIN-1 interacts with PAN3
independently of PABPC1, as previously reported for
human TNRC6s (20).
AIN-1 interacts with NOT1 and NOT2
We also examined the interaction of AIN-1 andAIN-2 with
NOT1 and NOT2, which are the subunits of the
CCR4-NOT complex that exhibit the strongest interaction
with Dm GW182 (20). We observed that AIN-1 interacted
withCeNOT1 andCeNOT2 (a.k.a. NTL-2) (Figure 5A–C,
lane 7), aswell as withDmNOT1 andDmNOT2 (Figure 5D
and E), whereas AIN-2 showed very weak binding to Ce
NOT1 (Figure 5B, lane 8). Immunoprecipitations with
AIN-1 deletion mutants, revealed that full-length AIN-1 is
required for binding to NOT1, as deletion of either the
N-term, Mid or C-term regions reduced binding and none
of these regions in isolation was sufficient for binding
(Figure 5F). In contrast, the AIN-1 interaction with
NOT2 is mediated by the N-term and C-term regions, as
an AIN-1 mutant lacking the Mid domain coimmunopre-
cipitated NOT2 to a similar extent as the full-length protein
(Figure 5G, lane 14 versus 10; see Figure 1B).
Recent work showed that the interaction of human
TNRC6s with NOT1 is mediated by W-containing
motifs in the M1, M2 and C-term regions of the silencing
domains (21,25). These motifs contribute to the affinity of
the interaction in an additive manner. AIN-1 contains a
total of 22 tryptophan residues (of which 7 are in GW
repeats) in the N-term and Mid regions, whereas the
C-term region lacks tryptophan residues. To investigate
the potential contribution of W-containing motifs to
deadenylase binding, we generated an AIN-1 mutant in
which all tryptophan residues were substituted with
alanines (AIN-1-22"W-A). This mutant displayed lower
mobility in SDS–PAGE and no longer interacted with
NOT1 and NOT2 (Supplementary Figure S1B and S1C).
As expected, the substitutions abrogated AGO1 and
ALG-1 binding (Supplementary Figure S1D and S1E).
Unexpectedly, interaction with PAB-1 and PAN3 was
also abolished (Supplementary Figure S1F and S1G), sug-
gesting that simultaneous substitution of 22 tryptophan
residues by alanines non-specifically disrupted protein–
protein interactions. Nevertheless, our data do not rule
out that a subset of tryptophan residues is involved in
mediating NOT1 binding, as shown recently (21, 25).
ALG-1 rescues silencing in cells depleted of AGO1
Given that the interactions of GW182 proteins with AGOs
are conserved and that Dm GW182 interacts with Ce
ALG-1, we tested if ALG-1 could rescue silencing in S2
cells depleted of AGO1, which is the AGO protein
dedicated to the miRNA pathway in D. melanogaster
(34). To this end, we made use of a complementation
assay as previously described (11). In this assay, S2 cells
were transfected with either siRNA specific to AGO1 or a
control siRNA against b-Gal. We then tested ALG-1 for
its ability to restore silencing in AGO1-depleted cells.
We monitored miRNA activity using previously
characterized firefly luciferase reporters, including the
F-Luc-Par-6 reporter (silenced by miR-1) and the
F-Luc-Nerfin-1 reporter [silenced by miR-9b; (7,29)].
Depletion of endogenous AGO1 suppressed silencing of
the reporters, leading to a 6- to 7-fold increase in firefly
luciferase expression (Figure 6A–D). Transfecting AGO1-
depleted cells with a plasmid expressing a siRNA-resistant
form of AGO1 fully restored silencing (Figure 6A–D) as
reported previously (11). Interestingly, ALG-1 also
restored silencing in AGO1-depleted cells (Figure 6A–D)
when expressed at similar levels (Figure 6E). In contrast,
neither ALG-1 nor AGO1 rescued silencing in cells in
which AGO1 and Dm GW182 were codepleted
(Figure 6F and G), indicating that both AGO1 and
ALG-1 interact with Dm GW182 to silence miRNA
targets. Accordingly, coexpression of AGO1 or ALG-1
with a dsRNA-resistant form of Dm GW182 rescued
silencing in cells codepleted of AGO1 and GW182
(Figure 6F and G). These results indicate conservation
in the mechanisms of miRNA loading and target silencing.
AIN-1 and AIN-2 repress expression of bound mRNAs
To investigate the conservation of the pathway down-
stream of AGOs, we tested whether AIN-1 and AIN-2
could repress expression of target mRNAs using a
tethering assay as previously described (35). AIN-1 and
AIN-2 were expressed with two tags: a peptide derived
from the bacteriophage ! N protein (!N tag) to enable
tethering to a firefly luciferase (F-Luc) reporter and an
HA tag (hemagglutinin) to allow detection of the
expressed protein by western blot. The F-Luc reporter
contains five Box B hairpins (5BoxB) inserted in the
30-UTR; these bind the !N tag with high affinity and
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thus recruit AIN-1 or AIN-2 to the F-Luc-5BoxB mRNA.
A plasmid encoding Renilla luciferase served as a trans-
fection control (R-Luc).
We observed that both AIN-1 and AIN-2 repressed
expression of the F-Luc-5BoxB reporter relative to the
!N-HA tag or a negative mutant of Dm AGO1 termed
F2V2 [Figure 7A–C; (11)]. The repression was similar to
that observed with Dm GW182, which served as the
positive control (Figure 7A–C). Furthermore, the repres-
sion was specific; the expression of an F-Luc reporter
lacking the BoxB hairpins was unaffected by Dm
GW182, AIN-1 or AIN-2 expression (Supplementary
Figure S2A–C). Importantly, AIN-1 and AIN-2 silenced
the F-Luc-5BoxB reporter in AGO1-depleted cells,
indicating that their activity in tethering assays is not
mediated by AGO1 (Supplementary Figure S2D and E).
These results are not due to inefficient depletion because
silencing of the F-Luc-Par-6 reporter by miR-1 was
completely suppressed in these cells (Supplementary
Figure S2E). To confirm that AIN-1 and AIN-2 activities
are independent of AGO proteins, we tested protein
mutants that do not interact with ALG1 (i.e. carrying de-
letions of the Mid domain or mutations in the GW repeats
of the ABD). All mutants repressed the F-Luc-5BoxB
reporter similar to the wild-type protein (Figure 7D and
Supplementary Figure S2F), but did not affect the
expression of a reporter lacking the BoxB hairpins
(Supplementary Figure S2G–S2I). In contrast, the
AIN-1 mutant with 22 tryptophan-to-alanine substitu-
tions was inactive in this assay (Figure 7D, 22"W-A).
Northern blot analysis of the F-Luc-5BoxB mRNA
revealed that bothAIN-1andAIN-2 reduced the abundance
of the F-Luc-5BoxB mRNA by !2.5-fold relative to the
R-Luc mRNA transfection control (Figure 7A and B).
Remarkably, all of the tested AIN-1 or AIN-2 protein
fragments that were active in the tethering assays
promoted mRNA degradation (Figure 7D and E).
However, the decrease in mRNA levels was smaller than
the reduction observed in firefly luciferase activity, suggest-
ing a net contribution of translational repression. Similarly,
previous studies showed that almost all fragments of Dm
GW182 promoted translational repression andmRNAdeg-
radation in tethering assays, including N-term fragments
that do not interact with PABPC1 (18,21,36). Therefore,
we conclude that the activity of the GW182 protein frag-
ments in tethering assays is not correlated with AGO,
deadenylase or PABPC1 binding in coimmunoprecipitation
assays.However,we cannot rule out that transient andweak
interactions occur in vivo that are not detectable under the
conditions used for coimmunoprecipitations.
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Figure 6. ALG-1 rescues silencing in S2 cells depleted of AGO1. (A–D)
S2 cells were transfected with a siRNA targeting AGO1 mRNA.
Control cells were treated with an siRNA targeting "-Gal. The
siRNAs were cotransfected with a mixture of three plasmids: one
expressing the indicated F-Luc reporters; another expressing miRNA
primary transcripts or the corresponding empty vector ($); and a third
expressing Renilla luciferase (R-Luc). Plasmids expressing HA-AGO1
(siRNA resistant), HA-ALG-1 or HA-MBP (Maltose-binding protein)
were included in the transfection mixtures as indicated. Firefly
luciferase activities were normalized to those of the Renilla luciferase
transfection control and set to 100 in cells transfected with the empty
vector (i.e. in the absence of miRNA) for each condition. Panels (A and
C) show normalized firefly luciferase activities in the absence or
presence of miRNAs in control cells (i.e. cells treated with
b-Gal siRNA and expressing MBP). (B and D) show the relative fold
derepression for each condition. Mean values± standard deviations
from three independent experiments are shown. (E) Western
blot analysis showing equivalent expression of the HA-tagged
proteins. (F and G) S2 cells were codepleted of AGO1 and GW182,
transfected with the indicated plasmids and analyzed as described in
panels (A–D).
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AIN-1 and AIN-2 do not rescue silencing in cells depleted
of GW182
As mentioned above, previous reports documented that
multiple and non-overlapping fragments of Dm GW182
are active in tethering assays including N-term fragments
(18,21,36). However, despite their activity in tethering
assays, GW182 N-term protein fragments did not rescue
silencing in cells lacking endogenous GW182 in comple-
mentation assays (except for the Nerfin reporter silenced
by miR-9b), but rather inhibited silencing in a
dominant-negative manner (12,18). Therefore, we next
tested the silencing activity of AIN-1 and AIN-2 in com-
plementation assays.
Knockdown of endogenous Dm GW182 in S2 cells was
achieved using dsRNA targeting GW182 mRNA. This
depletion inhibited silencing of the reporters tested,
leading to a 2.5- to 3-fold increase in firefly luciferase ex-
pression (Figure 8A–D). GW182-depleted cells were then
transfected with a plasmid expressing a dsRNA-resistant
version of GW182, which restored silencing (Figure 8A–D)
as previously reported (12). Despite similar expression
levels, neither AIN-1 nor AIN-2 restored silencing in
GW182-depleted cells (Figure 8A–E and Supplementary
Figure S3A–S3D). Moreover, coexpression of AIN-1 and
AIN-2 also failed to rescue silencing (Figure 8A–D).
Likewise, coexpression of AIN-1 with Ce ALG-1, PAN3,
NOT1 or PAB-1 did not rescue silencing (Supplementary
Figure S3A–S3D). Additionally, both AIN-1 and AIN-2
inhibited silencing in a dominant-negative manner in
control cells (Supplementary Figure S4A and S4B). This
dominant-negative effect was reduced when AIN-1 and
AIN-2 mutants that do not interact with ALG-1 were
tested (Supplementary Figure S4A), suggesting that
AIN-1 and AIN-2 inhibit silencing at least in part by
competing with GW182 for AGO1 binding.
Finally, coexpression of AIN-1 and ALG-1 did not
rescue silencing in S2 cells codepleted of Dm GW182 and
AGO1, whereas coexpression of Dm GW182 with ALG-1
did (Figure 6F and G). Thus, although AIN-1 and AIN-2
were active in tethering assays (Figure 7), both proteins
were inactive in complementation assays (Figure 8).
Together, our results indicate that AIN-1 and AIN-2
are probably too divergent to rescue silencing in
GW182-depleted cells despite that AIN-1 interacts with
Dm AGO1, PABPC1, NOT1, NOT2 and PAN3.
DISCUSSION
GW182 proteins play a central role in the miRNA
pathway in animal cells. Vertebrate and insect members
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Figure 7. AIN-1 and AIN-2 promote degradation of bound mRNAs.
(A–F) S2 cells were transfected with a mixture of three plasmids: one
expressing the F–Luc-5BoxB reporter; another expressing the !N-HA
peptide or the indicated !N-HA-tagged proteins; and a third expressing
Renilla luciferase (R–Luc). Firefly luciferase activity and mRNA levels
were normalized to those of Renilla luciferase. The normalized values
of F–Luc activity and mRNA levels were set to 100 in the presence of
the !N-HA peptide. Mean values± standard deviations from three in-
dependent experiments are shown. Panels (B and E) show a northern
blot of representative RNA samples quantified in panels (A) and (D).
Panels (C and F) show equivalent expression of the !N-HA-tagged
proteins. 22"W-A: AIN-1 mutant in which all tryptophan residues
were substituted with alanines. GW1+2+3: AIN-2 mutant in which
tryptophan residues in the three GW repeats of the ABD were
substituted with alanine.
Nucleic Acids Research, 2012, Vol. 40, No. 12 5661
 by guest on August 28, 2014
http://nar.oxfordjournals.org/
Downloaded from 
of the family interact with the AGO proteins, PABPC1
and subunits of the two cytoplasmic deadenylase
complexes (the PAN2-PAN3 and the CCR4-NOT
complexes) (5,20,21,25). Despite strong sequence diver-
gence, we demonstrated that Ce AIN-1 interacts with Ce
or Dm PABPC1, PAN3, NOT1 and NOT2, whereas
AIN-2 shows no significant interactions. In contrast,
both AIN-1 and AIN-2 interact with ALG-1, as previ-
ously reported (1,3). Our findings suggest that AIN-1
and AIN-2 are functionally distinct and may silence
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Figure 8. AIN-1 does not rescue silencing in S2 cells depleted of GW182. (A–D) S2 cells were treated with a dsRNA targeting GW182 mRNA.
Control cells were treated with GFP dsRNA. These cells were subsequently transfected with a mixture of three plasmids: one expressing the indicated
F-Luc reporters; another expressing miRNA primary transcripts or the corresponding empty vector ($); and a third expressing Renilla luciferase
(R-Luc). Plasmids expressing wild-type HA-GW182 (dsRNA resistant), HA-AIN-1, HA-AIN-2 or HA-MBP were included in the transfection
mixtures, as indicated. Firefly luciferase activities were normalized to those of the Renilla luciferase transfection control and set to 100 in cells
transfected with the empty vector (i.e. in the absence of miRNAs) for each condition. Panels (A and C) show normalized firefly luciferase activities in
the absence or presence of miRNAs in control cells (i.e. cells treated with GFP dsRNA and expressing MBP). Panels (B and D) show the relative fold
derepression for each condition. Mean values± standard deviations from three independent experiments are shown. (E) Western blot showing that
the HA-tagged proteins were expressed to equivalent levels.
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miRNA targets using different mechanisms. Indeed,
AIN-2 may not promote miRNA target deadenylation
and subsequent degradation, potentially explaining why
AIN-2 depletion has no overt phenotype but enhances
the delayed heterochronic phenotype observed in worms
lacking AIN-1 (2,3). This phenotype includes defects in
alae formation, drastic increase in seam-cell numbers
and protruding vulva (2,3). Alternatively, AIN-2 may be
expressed at lower levels and/or regulate fewer targets.
Finally, AIN-2 may use a similar mechanism but may
recruit PABPC1 and deadenylases through transient
low-affinity interactions or through an adaptor protein(s).
Evolutionary plasticity of the GW182 protein interaction
network
The finding that AIN-1 interacts with PABPC1, PAN3,
NOT1 and NOT2 is surprising given that AIN-1 shows
<12% sequence identity with Dm GW182 or human
TNRC6s, whereas the binding partners (e.g. PABPC1,
PAN3, NOT1 and NOT2) are conserved (Supplementary
Tables S2 and S3). However, although the interactions of
GW182 proteins with PABPC1, NOT1 and PAN3 are
conserved in humans and D. melanogaster, the mode of
interaction is not. For example, human TNRC6s interact
with PABPC1 through a PAM2 motif in the silencing
domain (17,22–24). This motif is also present in Dm
GW182 and interacts with PABPC1 in vitro; nevertheless,
deletion of the Dm GW182 PAM2 motif does not
abrogate PABPC1 binding in vivo (17). In our previous
studies, we showed that Dm GW182 interacts with
PABPC1 through additional regions in the silencing
domain. Although indirect, this interaction is dominant
over that mediated by the PAM2 motif in vivo (17,19).
Another example of change in the binding mode is the
interaction of GW182 proteins with NOT1. Indeed, recent
work showed that binding of human TNRC6s to NOT1 is
mediated by short motifs in the M1, M2 and C-term
regions of the silencing domains, which contribute to the
interaction in an additive manner (20,21,25). The motif in
the M1 region (termed CCR4-interacting motif 1, CIM-1)
is conserved in Dm GW182 (25). However, in contrast to
human TNRC6s, the silencing domain of Dm GW182 is
not sufficient for binding to NOT1 (our unpublished
results), suggesting that additional motifs upstream of
the silencing domain are present in Dm GW182.
Finally, although the interaction of GW182 proteins
with AGOs is mediated by GW repeats (i.e. GW, WG
or GWG), the exact location and number of repeats is
not conserved (10,12,13,15,30). Here, we show that only
a few repeats in the Mid region of AIN-1 and AIN-2 con-
tribute to their interaction with ALG-1; in contrast, 12
and >20GW repeats in the N-term regions of Dm
GW182 and human TNRC6s, respectively, contribute to
AGO protein binding (12,13).
How can the GW182 protein interaction network be
conserved while the location of the binding sites appears
to be rapidly evolving? The regions of GW182 proteins
mediating the interactions with AGO1, PABPC1 and
deadenylase subunits are predicted to be unstructured.
These unstructured regions interact with (predicted or
known) globular domains in AGO1, PABPC1, PAN3,
NOT1 and NOT2, suggesting that the interactions might
be mediated by short linear motifs [SLiMs; (37)] in the
GW182 unstructured regions. This provides one explan-
ation for why the location of the binding sites is rapidly
evolving. Linear motifs are evolutionarily plastic, as only a
small number of point mutations in a disordered region of
a protein sequence are required to relocate these motifs. In
doing so, the interactions between GW182 and binding
partners can be maintained, but the details can change
during evolution. Additionally, the possibility that
GW182 proteins interact with their partners via SLiMs,
potentially explains why the binding of AIN-1 to
PABPC1, PAN3, NOT1 and NOT2 requires multiple
protein regions (Figure 1B), as SLiMs may be dispersed
along the protein sequence and collectively contribute to
high-affinity interactions. In this context, we can envision
a scenario in which nematode AIN-1 proteins gained add-
itional motifs to interact with PABP and deadenylases, so
that the silencing domain became progressively redundant
and was eventually lost.
Conservation of silencing mechanisms
The present work shows that ALG-1 can rescue silencing
in Drosophila cells depleted of AGO1, demonstrating con-
servation in the miRNA pathway including the mechan-
ism of AGO loading, target recognition and target
silencing. However, despite conservation of the basic
interactions, AIN-1 could not rescue silencing in cells
depleted of Dm GW182. Furthermore, both AIN-1 and
AIN-2 inhibited silencing in a dominant-negative manner
in wild-type cells. This effect was at least in part mediated
by the ABD, suggesting that these proteins compete with
GW182 for binding to AGO1 but assemble non-functional
miRISC complexes. Why are these complexes non-
functional? One possibility is that the assembly of func-
tional silencing complexes requires GW182 proteins to
interact with unknown partners (other than PABPC1
and deadenylase complexes), and that these interactions
are not conserved. Alternatively, changes in protein con-
formation may be required to activate silencing complexes
but may not occur for complexes assembled with AIN-1 or
AIN-2 proteins in S2 cells.
An important message from our study is that AIN-1
and AIN-2 do not complement the Dm GW182 depletion,
although both proteins silence an mRNA reporter to
which they are artificially tethered. Furthermore, there is
no correlation between activity in tethering assays and
binding to AGO, deadenylases or PABPC1. Similarly,
non-overlapping fragments of Dm GW182, including
N-term fragments that do not interact with PABPC1,
have been shown to be active in tethering assays
(18,21,36). These results were interpreted as evidence
that interactions of GW182 proteins with PABPC1 are
not required for silencing (36). However, in complemen-
tation assays, TNRC6 mutants that do not interact with
PABPC1 (i.e. PAM2 mutants) are impaired in silencing
both in human and S2 cells, indicating that the PABPC1
interaction is critical for silencing in vivo (17,20). One
possible explanation for the discrepancies between
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tethering assays and complementation assays is that
tethering assays involve direct high-affinity binding of
multiple GW182 proteins to the mRNA target and thus
bypass upstream steps in the silencing pathway. Therefore,
although tethering assays are an invaluable tool in the
dissection of the role of GW182 protein domains in
silencing, conclusions from these assays should be
validated in complementation assays.
In summary, our work extends and confirms the evolu-
tionary conservation of GW182 interactions with
PABPC1 and deadenylase complexes, unveiling their im-
portance for silencing. Further elucidating the molecular
basis for these interactions will be key to understanding
their roles in both miRNA-mediated translational repres-
sion and mRNA target degradation.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables S1–S3 and Supplementary Figures
S1–S4.
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Supplementary Figure S1. AIN-1 interactions with binding partners.  (A) Interaction 
of GFP-tagged AIN-1 (wild type or mutants) with HA-tagged Ce PAN3. Cell lysates 
were treated with Micrococcal nuclease. (B, C, D, E, F and G) Substitution of all 
tryptophan residues in AIN-1 by alanines nonspecifically abolished all protein-protein 
interactions. S2 cells were cotransfected with plasmids expressing the indicated HA-
tagged proteins and wild type GFP-tagged AIN-1 or the 22xW-A mutant (in which all 
tryptophan residues were substituted with alanines). Cell lysates were 
immunoprecipitated using a polyclonal anti-GFP antibody. GFP-tagged firefly 
luciferase served as a negative control. Samples were analyzed as described in Figure 
1. The AIN-1 22xW-A mutant exhibited a lower mobility in SDS-PAGE.  
 
Supplementary Figure S2. AIN-1 and AIN-2 silence bound mRNAs in tethering 
assays. (A, B and C) S2 cells were transfected with a mixture of three plasmids: one 
expressing a control F-Luc reporter (without Box B hairpins); another expressing the 
λN-HA peptide or the indicated λN-HA-tagged proteins; and a third expressing 
Renilla luciferase (R-Luc). Firefly luciferase activity and mRNA levels were 
normalized to those of Renilla luciferase. The normalized values of F-Luc activity and 
mRNA levels were set to 100 in the presence of the λN-HA peptide. Mean values ± 
standard deviations from three independent experiments are shown. Panel (B), 
Kuzuoğlu-Öztürk et al. 
 
2 
Northern blot analysis of representative RNA samples quantified in panel (A). Panel 
(C) shows the expression levels of the λN-HA-tagged proteins. (D and E) S2 cells 
were transfected with an siRNA targeting AGO1 mRNA. Control cells were treated 
with a control siRNA targeting β-Gal. The siRNAs were cotransfected with a mixture 
of three plasmids: one expressing the F-Luc-5BoxB reporter; another expressing the 
λN-HA peptide or the indicated λN-HA-tagged proteins; and a third expressing 
Renilla luciferase (R-Luc). Firefly luciferase activity was normalized to that of 
Renilla luciferase. For each condition, the normalized values of F-Luc activity and 
mRNA levels were set to 100 in the presence of the λN-HA peptide. Mean values ± 
standard deviations from three independent experiments are shown. To monitor in 
parallel the efficiency of the depletion, the siRNAs were cotransfected with the F-
Luc-Par-6 reporter, a plasmid expressing the miR-1 primary transcript or the 
corresponding empty vector (-); and a third expressing Renilla luciferase (R-Luc). 
Firefly luciferase activities were normalized to those of the Renilla luciferase 
transfection control and set to 100 in cells transfected with the empty vector (i.e., in 
the absence of miR-1) for each condition (black bars). (F) S2 cells were transfected 
with a mixture of three plasmids: one expressing the F-Luc-5BoxB reporter; another 
expressing the λN-HA peptide or the indicated λN-HA-tagged proteins; and a third 
expressing Renilla luciferase (R-Luc). Firefly luciferase activity and mRNA levels 
were normalized to those of Renilla luciferase. The normalized values of F-Luc 
activity and mRNA levels were set to 100 in the presence of the λN-HA peptide. (G, 
H and I) AIN-1 and AIN-2 mutants were tested for nonspecific activity using the F-
Luc reporter lacking the Box B hairpins as described in (A–C). 
 
Supplementary Figure S3. AIN-1 does not complement Dm GW182 depletion. (A, 
Kuzuoğlu-Öztürk et al. 
 
3 
B, C and D) S2 cells were treated with a dsRNA targeting GW182 mRNA. Control 
cells were treated with GFP dsRNA. These cells were subsequently transfected with a 
mixture of three plasmids: one expressing the indicated F-Luc reporters; another 
expressing miRNA primary transcripts or the corresponding empty vector (-); and a 
third expressing Renilla luciferase (R-Luc). Plasmids expressing the indicated C. 
elegans HA-tagged proteins were included in the transfection mixtures. Firefly 
luciferase activities were normalized to those of the Renilla luciferase transfection 
control and set to 100 in cells transfected with the empty vector (i.e., in the absence of 
the miRNAs) for each condition. Panels (A and C) show normalized firefly luciferase 
activities in the absence or presence of miRNAs in control cells (i.e., cells treated with 
GFP dsRNA and expressing MBP). Panels (B and D) show relative fold derepression 
for each condition. Mean values ± standard deviations from three independent 
experiments are shown.  
 
Supplementary Figure S4. AIN-1 and AIN-2 inhibit silencing in a dominant-
negative manner in S2 cells. (A and B) S2 cells were transfected with a mixture of 
three plasmids: one expressing the indicated F-Luc-Par-6 reporter; another expressing 
the miR-1 primary transcript or the corresponding empty vector (-); and a third 
expressing Renilla luciferase (R-Luc). Increasing amounts of plasmids expressing 
HA-tagged proteins were included in the transfection mixtures as indicated. Firefly 
luciferase activities were normalized to those of the Renilla luciferase transfection 
control and set to 100 in cells transfected with the empty vector (i.e., in the absence of 
miR-1) for each condition (shown only for control cells expressing MBP, black bar). 
Mean values ± standard deviations from technical replicates are shown. Panel (B) 
shows the expression levels of the λN-HA-tagged proteins. 
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Supplementary Table S1. DNA constructs 
 
Protein /ORF length in amino acids / 
accession  
Cloning sites 
AIN-1 / 1-641 / NP_510687.2 Cloned EcoRI-XhoI into pAc5.1-λN-HA and 
pAc5.1-GFP 
AIN-1 - ∆N / 351-641 Cloned EcoRI-XhoI into pAc5.1-λN-HA and 
pAc5.1-GFP 
AIN-1 - N-term / 1-350 Cloned EcoRI-XhoI into pAc5.1-λN-HA and 
pAc5.1-GFP 
AIN-1 - ∆Mid / ∆351-504 Cloned into pAc5.1-λN-HA and pAc5.1-GFP 
AIN-1-Mid / 351-504 Cloned EcoRI-XhoI into pAc5.1-λN-HA and 
pAc5.1-GFP 
AIN-1-∆C / 1-504 Cloned EcoRI-XhoI into pAc5.1-λN-HA and 
pAc5.1-GFP 
AIN-1-C / 505–641 Cloned EcoRI-XhoI into pAc5.1-λN-HA and 
pAc5.1-GFP 
AIN-1- W378A Mutagenesis using pAc5.1-λN-HA-AIN-1 
and pAc5.1-GFP-AIN-1 as templates 
AIN-1- W437A Mutagenesis using pAc5.1-λN-HA-AIN-1 
and pAc5.1-GFP-AIN-1 as templates 
AIN-1- W378A+W437A Mutagenesis using pAc5.1-λN-HA-AIN-1 
and pAc5.1-GFP-AIN-1 as templates 
AIN-2 / 1-706 / AAC24251.2 Cloned NotI-XhoI into pAc5.1-λN-HA and 
pAc5.1-GFP 
AIN2-∆ABD /∆254-400 Mutagenesis using pAc5.1-λN-HA-AIN-2 
and pAc5.1-GFP-AIN-2 as templates 
AIN-2- W282A Mutagenesis using pAc5.1-λN-HA-AIN-2 
and pAc5.1-GFP-AIN-2 as templates 
AIN-2- W366A Mutagenesis using pAc5.1-λN-HA-AIN-2 
and pAc5.1-GFP-AIN-2 as templates 
AIN-2- W390A Mutagenesis using pAc5.1-λN-HA-AIN-2 
and pAc5.1-GFP-AIN-2 as templates 
AIN-2- W282A+W366A Mutagenesis using AIN-2-W282A as 
template 
AIN-2- W282A+W390A Mutagenesis using AIN-2-W282A as 
template 
AIN-2- W366A+W390A Mutagenesis using AIN-2-W366A as 
template 
AIN-2- W282A+W366A+W390A Mutagenesis using AIN-2-W282A+W366A 
as template 
ALG1 / 1-1002 / CAA93496.2 Cloned NotI-SacII into pAc5.1-λN-HA  
Ce PAB-1 / 1-646 / AAA65224.1 Cloned NotI-XbaI into pAc5.1-λN-HA  
Ce PAB-1-RRM / 1-400 Cloned NotI-XbaI into pAc5.1-λN-HA  
Ce PAB-1-MLLE / 569-646 Cloned NotI-XbaI into pAc5.1-λN-HA  
Ce PAN3 / 1-632 / NP_499177/ 
WP:CE37601 
Cloned NotI-XbaI into pAc5.1-λN-HA  
Ce PAN3-N term / 1-244 Cloned NotI-XbaI into pAc5.1-λN-HA  
Ce PAN3-C term / 245-632 Cloned NotI-XbaI into pAc5.1-λN-HA  
Ce NOT1 / 1-2527 / AAA21168.2 (GB) 
WP:CE28239 
Cloned HindIII-SacII into pAc5.1-λN-HA 
Ce NOT2 (NTL-2) / 1-444 / NP_494772.1 Cloned NotI-XbaI into pAc5.1-λN-HA 
 
 Supplementary Table S2. Amino acid sequence identities (similarities) between Dm and Ce 
GW182 proteins. ! Ce#AIN$1& Ce#AIN$2&
Dm#GW182# 11.9!(19)! 11.7!(18.8)!
Ce#AIN$1# ! 22.4!(31.9)!
 
The pairwise identities (similarities) were calculated using the global alignment tool “needle” 
from the European Molecular Biology Open Software Suite (EMBOSS). !
Supplementary&Table&S3.&Amino acid sequence identities (similarities) between Dm and Ce 
PABP and deadenylase subunits.!! Ce&ALG1& Ce&PAB1& Ce&PAN3& Ce#NOT1& Ce&NOT2&
Drosophila#
orthologs#
61.1!(72.7)! 51.5!(62.4)! 28!(40.2)! 29.1!(44.3)! 21.8!(32.6)!
 
The pairwise identities (similarities) were calculated using the global alignment tool “needle” 
from the European Molecular Biology Open Software Suite (EMBOSS). 
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ABSTRACT
Animal miRNAs silence the expression of mRNA
targets through translational repression,
deadenylation and subsequent mRNA degradation.
Silencing requires association of miRNAs with an
Argonaute protein and a GW182 family protein. In
turn, GW182 proteins interact with poly(A)-binding
protein (PABP) and the PAN2–PAN3 and CCR4–NOT
deadenylase complexes. These interactions are
required for the deadenylation and decay of miRNA
targets. Recent studies have indicated that miRNAs
repress translation before inducing target
deadenylation and decay; however, whether transla-
tional repression and deadenylation are coupled or
represent independent repressive mechanisms is
unclear. Another remaining question is whether trans-
lational repression also requires GW182 proteins to
interact with both PABP and deadenylases. To
address these questions, we characterized the inter-
action of Drosophila melanogaster GW182 with
deadenylases and defined the minimal requirements
for a functional GW182 protein. Functional assays in
D. melanogaster and human cells indicate that
miRNA-mediated translational repression and deg-
radation are mechanistically linked and are triggered
through the interactions of GW182 proteins with
PABP and deadenylases.
INTRODUCTION
miRNAs belong to a large family of non-coding RNAs
that post-transcriptionally silence the expression of
mRNAs containing fully or partially complementary
binding sites. To exert their regulatory functions,
miRNAs assemble into miRNA-induced silencing
complexes (miRISCs), minimally comprising an
Argonaute protein (AGO) and a protein of the GW182
family (1,2). GW182 proteins function downstream of
AGOs and play an essential role in miRNA-mediated
gene silencing in animal cells (1,2).
Three GW182 paralog proteins (termed TNRC6A,
B and C) exist in vertebrates and various invertebrate
species; however, only one family member exists in
Drosophila melanogaster [GW182 (1,2)]. These proteins
typically contain an N-terminal (N-term) Argonaute-
binding domain (ABD) and a C-terminal (C-term)
silencing domain (SD) [Figure 1 (1,2)]. The SDs of the
human proteins are required for silencing and serve as
binding platforms for the cytoplasmic poly(A)-binding
protein (PABP), as well as PAN3 and NOT1, which are
subunits of the PAN2–PAN3 and CCR4–NOT
deadenylase complexes, respectively (3–10).
The SD is bipartite and comprises the middle (Mid) and
C-term regions of the GW182 proteins that flank an
RNA-recognition motif (RRM). The Mid region is
further divided into the M1 and M2 regions (Figure 1),
which, together with the C-term, contribute to the inter-
actions with deadenylases in an additive manner (8–10).
For example, the interaction between human TNRC6 SDs
and PAN3 requires both the M2 and C-term regions of the
SD (8,9). NOT1 binding is mediated through tryptophan-
containing sequences in the M1, M2 and C-term regions of
the SD [Figure 1 (9,10)]. The motifs in the M1 and C-term
regions were termed CCR4–NOT-interacting motifs 1 and
2 (CIM-1 and CIM-2), respectively [Figure 1 (10)].
However, in addition to the CIM-1 and CIM-2 motifs,
tryptophan residues in the M2 region of the SD contribute
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to interactions with NOT1 and PAN3 (9). Finally, PABP
binds directly to a conserved PAM2 motif (PABP-
interacting motif 2) located between the M1 and M2
regions of the SD (Figure 1 (3–7)).
Remarkably, although the interactions between GW182
proteins and PABP and deadenylase complexes are
conserved in D. melanogaster, the mode of interaction
differs (5,8). For example, the CIM-2 motif is absent in
D. melanogaster GW182 (9,10). Moreover, in contrast to
the human SDs, which are necessary and sufficient for
NOT1 and PAN3 binding, the deletion of the SD from
D. melanogaster GW182 reduces but does not abolish
binding to deadenylases (8), indicating that sequences
upstream of the SD contribute to these interactions
(8,9). Finally, in contrast to the human proteins,
D. melanogaster GW182 also indirectly interacts with
PABP through the M2 and C-term regions in cultured
cells (4,5). Consequently, the D. melanogaster GW182
PAM2 motif is dispensable for PABP binding and
silencing in Drosophila cells (5,9,11,12).
The interactions between GW182 proteins and
deadenylase complexes are required for miRNA target
deadenylation and degradation (8–10). Whether these
interactions are also required for miRNA-mediated trans-
lational repression remains unclear. Three lines of
evidence support a role for the CCR4–NOT deadenylase
complex in translational repression of miRNA targets.
First, the direct tethering of subunits of the CCR4–NOT
complex to mRNA reporters lacking poly(A) tails
represses translation in the absence of deadenylation
(9,13). Second, depletion of subunits of the CCR4–NOT
complex partially suppresses the silencing of mRNA re-
porters that lack a poly(A) tail; these reporters are silenced
at the translational level without undergoing
deadenylation (8,9). Third, mutations or deletions in
GW182 proteins that disrupt the interactions with the
CCR4–NOT complex suppress silencing, that is, transla-
tional repression and degradation of miRNA targets (8,9).
However, other studies reported that although the deple-
tion of CCR4–NOT complex subunits abolished the
deadenylation and degradation of miRNA reporters,
some reporters remained translationally repressed, sug-
gesting that an additional mechanism could contribute
to the repression (8,14,15). In addition, several studies
have indicated that translational repression precedes
deadenylation (3,15–19), although it remains unclear
whether these two modes of regulation are linked or
whether they represent independent mechanisms that are
used by miRNAs to silence their mRNA targets.
In this study, we investigated whether the interactions
of GW182 proteins with PABP and deadenylase
complexes are also required for the translational repres-
sion of miRNA targets and thus, for target silencing, in-
dependently of the extent of target mRNA degradation.
Accordingly, we first identified the regions in
D. melanogaster GW182 that are required for deadenylase
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Figure 1. Domain organization of Drosophila melanogaster GW182, Hs TNRC6C and the corresponding chimeric proteins. ABD, AGO-binding
domain; ABD2, AGO-binding domain from Caenorhabditis elegans AIN-2; NED, N-terminal effector domain; UBA, ubiquitin associated-like
domain; QQQ, region rich in glutamine; Mid, middle region containing the PAM2 motif (dark blue), which divides the Mid region into the M1
and M2 regions; RRM, RNA recognition motif; C-term, C-terminal region; SD, silencing domain. The position of the conserved CIM-1, CIM-2 and
P-GL motifs are indicated. Amino acid positions at domain boundaries are indicated below the protein outlines. Vertical red lines indicate the
positions of GW repeats. Vertical green lines indicate the positions of tryptophan residues in the M2 region that are involved in NOT1-binding (9).
Sequence alignments of the PAM2, CIM-1, CIM-2 and P-GL motifs and the amino acids mutated in this study are shown in Supplementary
Figure S7.
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complex binding. We subsequently generated mutants that
are unable to interact with PABP and deadenylases and
demonstrated that these mutants cannot rescue silencing
in cells depleted of endogenous D. melanogaster GW182.
These observations, when combined with the study of
engineered minimal functional GW182 proteins, indicate
that translational repression and target degradation are
mechanistically linked and depend on the interaction of
GW182 proteins with PABP and deadenylase complexes
in both D. melanogaster and human cells.
MATERIALS AND METHODS
Plasmids
Luciferase reporters and plasmids for the expression of
miRNAs, AGO1, GW182, PABP and subunits of the
two deadenylase complexes studied in this article have
been described previously (8,14,20).
Co-immunoprecipitation analyses and western
blotting in S2 cells
S2 cells were transfected in six-well plates using Effectene
transfection reagent (Qiagen). For co-immunopre-
cipitation assays, the transfection mixtures contained
1 mg of plasmid-expressing Green fluorescent Protein
(GFP)-tagged GW182 or the corresponding mutants and
0.5mg of human influenza hemagglutinin (HA)-tagged
deadenylation subunits. Co-immunoprecipitations and
western blots were performed as described by Braun
et al. (8), except that cell lysates were supplemented with
CaCl2 and treated with micrococcal nuclease before
immunoprecipitation. HA- and GFP-tagged proteins
were detected using horseradish peroxidase–conjugated
monoclonal anti-HA (Roche 3F10; 1:5000) and
anti-GFP antibodies (Roche 11814460001; 1:2000), re-
spectively. V5-tagged proteins were detected using
anti-V5 antibodies (Invitrogen, 1:5000). Endogenous
AGO1 and a-tubulin were detected using commercial
antibodies at the following dilutions: D. melanogaster
AGO1 (Abcam ab5070; 1:1000) and a-tubulin (Sigma
T6199; 1:2000). Endogenous D. melanogaster GW182
was detected with a rat polyclonal antibody prepared in
our laboratory (14). All western blots were developed
using the ECL western blotting detection system (GE
Healthcare) as recommended by the manufacturer.
Complementation assays in S2 cells
Complementation assays were performed as described
previously (5). For miRNA-mediated silencing assays,
the transfection mixtures contained 0.1 mg of firefly
luciferase reporter plasmid, 0.4 mg of a Renilla transfection
control and 0.1mg of plasmids expressing miRNA primary
transcripts or the corresponding vector without insert.
Unless otherwise indicated, 20 ng (Figure 3) or 100 ng
(all other Figures) of plasmids expressing recombinant
proteins were cotransfected. Firefly and Renilla luciferase
activities were measured 3 days after transfection using the
Dual-Luciferase Reporter Assay System (Promega). Total
RNA was isolated using TriFast (Peqlab Biotechnologies)
and analyzed as described previously (21).
Immunoprecipitation analyses and luciferase assays
in human cells
The R-Luc-3xlet-7 reporter and the corresponding
R-Luc-Mut have been described previously (22). The
R-Luc-Hmga2 wild-type and the R-Luc-Hmga2 m7
mutant described by Mayr et al. (23) were subcloned
into the pCI-neo (Promega) expression vector.
Immunoprecipitation assays were performed in human
cells as described by Braun et al. (8). GFP- and HA-
tagged proteins and endogenous a-tubulin were detected
as described above. Endogenous PABP and TNRC6A
were detected using commercial antibodies at the follow-
ing dilutions: PABP (Abcam ab21060; 1:10 000) and
human TNRC6A (Bethyl A302-329A; 1:2000).
For luciferase assays, human HeLa cells were seeded in
six-well plates and transfected using Lipofectamine 2000
(Life technologies). The transfection mixtures contained
0.05 mg of R-Luc-3xlet-7 or 0.2 mg R-Luc-HMG2a
reporter plasmids, or the corresponding reporters
carrying mutations in the let-7 binding sites (R-Luc-Mut
and R-Luc-Hmga2-mut7), and 0.3mg of the pEGFP-
N3-F-Luc transfection control. In the overexpression
experiment described in Figure 9, the transfection
mixtures contained in addition 1.5 mg of plasmids express-
ing GFP-CNOT1 fragments or the GFP-CNOT7 catalyt-
ically inactive mutant. The CNOT7 mutant carries alanine
substitutions of the catalytic residues D40 and E42.
A plasmid expressing GFP-tagged maltose binding
protein (GFP-MBP) served as a negative control. R-Luc
and F-Luc activities were measured 48 h after transfection
using the Dual-Luciferase Reporter Assay System
(Promega). Complementation assays were performed as
described previously (5). The following siRNAs were
used: TNRC6A 50-GCCUAAUCUCCGUGCUCA
ATT-30; TNRC6B 50-GGCCUUGUAUUGCCAGCA
ATT-30 and b-Gal 50-CUACACAAAUCAGCGAUU
UUU-30 (Dharmacon).
Reverse transcription and quantitative real-time poly-
merase chain reaction were performed as described by
Zekri et al. (4) using the following oligos: R-Luc
forward (50-ACTTCGAAAGTTTATGATCC-30), R-Luc
reverse (50-TGTTCATTTTTGAGAACTCG-30), F-Luc
forward (50-GGTGAGCAAGGGCGAGGAGC-30) and
F-Luc reverse (50-CGCCGGACACGCTGAACTTG-30).
GST pull-down assays
A cDNA encoding the SD of TNRC6A was cloned into
the BamH1–Not1 restriction sites of plasmid pGEX6P
(GE Healthcare) and expressed in Escherichia coli as an
N-term GST-fusion. Mutations were introduced using the
QuikChange mutagenesis kit (Stratagene) and the appro-
priate oligonucleotides. For the GST pull-down assays
shown in Figure 8, lysates from E. coli cells expressing
GST, GST-TNRC6A-SD or the indicated mutants were
incubated with 40 ml of Protino Glutathione Agarose 4B
beads (Macherey Nagel; 50% slurry) in lysis buffer
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(10mM Hepes [pH 7.5], 300mM NaCl and 1mM DTT)
for 1 h at 4!C. The beads were washed three times using
1ml of lysis buffer each time. The pre-coated beads were
then incubated with lysates from HEK293T cells
(ca. 2" 106 cells/pull down) expressing CNOT1 in a
total volume of 1ml of NET buffer (10mM Hepes [pH
7.5], 150mM NaCl, 1mM EDTA and 1% [v/v]
Triton-X100) for 1 h at 4!C. The beads were washed
three times using 1ml of NET buffer each time. Proteins
were eluted with 40 ml of sample buffer and separated on a
10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis.
RESULTS
Drosophila melanogaster GW182 interacts with NOT1
through an extended silencing domain
The conserved core of the D. melanogaster CCR4–NOT
complex consists of NOT1, NOT2, NOT3 and two cata-
lytic subunits, CCR4 and POP2 (24). Of these, NOT1 and
NOT2 are efficiently co-immunoprecipitate with
D. melanogaster GW182 from Schneider cell (S2 cells)
lysates (8,9). In addition, similar to human TNRC6
proteins, D. melanogaster GW182 interacts with PAN3
(8,9). In contrast to the human proteins, however, the
deletion of the SD from D. melanogaster GW182 does
not prevent interactions with deadenylation factors,
indicating that sequences upstream of the SD also contrib-
ute to binding (8,9). In agreement with these observations,
an N-term region of D. melanogaster GW182 (containing
the N-term effector domain [NED]; Figure 1) has been
shown to bind NOT1 and possess silencing activity
(9,11,25).
To precisely define the regions of D. melanogaster
GW182 involved in deadenylase binding, we performed
co-immunoprecipitation experiments in S2 cells using a
series of GW182 deletion mutants. First, we confirmed
that deletion of the GW182 SD (!SD) reduced but did
not abolish D. melanogaster GW182 binding to NOT1,
whereas the binding to NOT2 and PAN3 was unaffected
(Figure 2A–C, lanes 8). As expected, deletion of the SD
did not prevent binding to AGO1 (which is mediated
through the ABD); however, PABP binding was
abrogated [Figure 2D and E, lanes 8 (4,5,12)].
Notably, although the SD is sufficient for PABP
binding (Figure 2D, lane 9 (4,5)), in isolation, this
domain interacted with NOT1 much less efficiently than
full-length D. melanogaster GW182 and did not interact
with NOT2 and PAN3 (Figures 2A–C, lanes 9). These
results indicate that sequences upstream of the SD con-
tribute to the interaction between GW182 and
deadenylases. Furthermore, these results also indicate
that deadenylases and PABP can independently interact
with D. melanogaster GW182. The interactions with
deadenylases are also independent of AGO1, because a
D. melanogaster GW182 mutant that does not interact
with AGO1, that is, in which all 12 N-term GW-repeats
are mutated to alanines (12xGW mutant; Figure 2E, lane
10), interacted with NOT1, NOT2 and PAN3 as efficiently
as wild-type D. melanogaster GW182 (Figure 2A–C,
lanes 10).
To further delineate the regions of D. melanogaster
GW182 required for NOT1 deadenylase binding, we
extended the SD to include additional N-term sequences
of increasing length (Figure 2F). We observed that full
binding activity required fragment 713–1384 or the com-
bination of the entire Q-rich region and the SD (Q+SD;
i.e. 635–1384) (Figure 2F and G). Conversely,
a D. melanogaster GW182 protein lacking both the
Q-rich region and the SD (!Q+SD) did not interact
with NOT1 (Figure 2G, lane 7). Surprisingly, PAN3 inter-
acted with these two non-overlapping protein fragments,
whereas NOT2 interacted primarily with the Q+SD region
(Supplementary Figure S1A and B, lanes 7 and 8).
We conclude that the interaction of D. melanogaster
GW182 with NOT1 is mediated by the Q-rich region
together with the SD. Another important conclusion
from these results is that PAN3 can interact with the
D. melanogaster GW182 fragment 1–634 (i.e. !Q+SD)
independently of NOT1, although the binding efficiency
in this case is reduced relative to that observed with
full-length D. melanogaster GW182. In addition, PAN3
and NOT2 also interact with the Q+SD region.
A complex network of interactions recruits deadenylases
to D. melanogaster GW182
To identify the sequences sufficient for NOT2 and PAN3
binding, we performed co-immunoprecipitation assays
using a series of D. melanogasterGW182 N-term fragments
of increasing length (Supplementary Figure S1). These frag-
ments were chosen based on the published activity of these
fragments in tethering assays (11,25,26). Collectively, these
experiments revealed the following observations.
First, GW182 residues 1–830 and 1–1115 are sufficient
for NOT2 and PAN3 binding, respectively (Supplementary
Figure S1C–E), whereas, as mentioned earlier, NOT1
binding requires residues 635–1384 (i.e. Q+SD).
Second, the GW182 ABD (residues 1–539) does not
interact with deadenylase subunits (Supplementary
Figure S1C–E, lanes 11) despite the fact that this
fragment contains the NED. In accordance with these
results, deletion of the NED from D. melanogaster
GW182 did not affect NOT1, NOT2 or PAN3 binding
(Supplementary Figure S1C–E, lanes 16). All fragments
interacted with endogenous AGO1 as expected
(Supplementary Figure S1C).
Third, the contribution of GW182 N-term sequences
(residues 1–539) to deadenylase binding becomes
apparent only when the C-term region is deleted
(Supplementary Figure S1F and G; compare fragments
1–1115 versus 539–1115 for PAN3, and fragments 1–830
versus 539–830 for NOT2).
We conclude that D. melanogaster GW182 interacts
with deadenylases through multiple binding sites that
appear to contribute additively to the affinity of the inter-
action. Moreover, because deadenylase subunits interact
with each other (24), these subunits could bind
D. melanogaster GW182 either directly or indirectly. For
example, although NOT2 interacts with GW182 N-term
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sequences, it also interacts with the Q+SD region (most
likely via NOT1). This connectivity and redundancy of the
GW182 interaction network helps to explain why the con-
tribution of the NED to deadenylase binding becomes
apparent only when SD regions are deleted.
GW182 generally requires the SD to silence
miRNA targets
Our previous results demonstrated that deleting the SD
from D. melanogaster GW182 abrogates its silencing
activity in complementation assays, wherein GW182
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Figure 2. Interaction of Drosophila melanogaster GW182 with NOT1, NOT2 and PAN3. (A–G) S2 cells were cotransfected with plasmids expressing
GFP-tagged D. melanogaster GW182 (wild-type or mutants) and HA-tagged deadenylase subunits or V5-tagged PABP as indicated. Cell lysates were
immunoprecipitated using a polyclonal anti-GFP antibody. GFP-tagged firefly luciferase served as a negative control. Inputs (1%) and immunopre-
cipitates (5% for GFP-tagged proteins or 40% for HA- or V5-tagged proteins) were analyzed by western blotting using the corresponding antibodies.
In all panels, cell lysates were treated with micrococcal nuclease before immunoprecipitation. The presence of endogenous AGO1 in the immunopre-
cipitates was determined using a specific anti-AGO1 antibody (E).
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protein mutants are tested for their ability to restore
silencing in cells that are depleted of endogenous
GW182 (5,8,12). In contrast, other studies have shown
that N-term fragments of D. melanogaster GW182
(e.g. 1–605 and 1–830) can rescue the silencing of at
least one miRNA reporter in S2 cells (11,25).
Furthermore, D. melanogaster GW182 N-term fragments
confer strong repression in vivo when artificially tethered
to reporter mRNAs, independently of whether the
reporter contains a poly(A) tail [Supplementary Figure
S2A and B (11,25–27)]. Because D. melanogaster GW182
N-term fragments do not interact with PABP, it was im-
portant to determine whether these fragments complement
silencing in cells that are depleted of endogenous
D. melanogaster GW182.
For these complementation assays, we used two previ-
ously characterized firefly luciferase reporters: the
F-Luc-Nerfin-1 and F-Luc-Par-6 reporters silenced by
miR-279 and miR-1, respectively (20,21). At steady
state, the F-Luc-Nerfin-1 reporter is predominantly
repressed at the level of translation, with a small reduction
in mRNA abundance (Figure 3A and B, lane 2 versus 1);
however, the F-Luc-Par-6 mRNA is degraded in a
miR-1-dependent manner (Figure 3E and F, lane 2
versus 1). The depletion of endogenous D. melanogaster
GW182 suppressed the silencing of both reporters, leading
to a 4- to 5-fold increase in firefly luciferase expression
(Figure 3C and G). For the F-Luc-Par-6 reporter, a cor-
responding increase in mRNA levels was also observed
(Figure 3F and H). These results confirm that
D. melanogaster GW182 is required for both miRNA-
mediated translational repression and mRNA degrad-
ation, as previously reported (14,28).
In depleted cells, a dsRNA-resistant version of
D. melanogaster GW182 fully rescued the silencing of
both reporters (Figure 3B–D and F–H). In contrast,
D. melanogaster GW182 fragments lacking the SD
(1–539, 1–605 and !SD) did not restore silencing,
whereas a protein lacking the NED was fully active
(Figure 3B–D and F–H). All proteins were expressed at
comparable levels (Figure 3I). Notably, the inactive
GW182 protein fragments and fragment 1–830 remained
inactive, even when expressed at higher levels
(Supplementary Figure S3A–C). Finally, a D. melanogaster
GW182 mutant lacking the RRM and the C-term region
(fragment 1–1115) complemented silencing, although less
efficiently than full-length GW182 (Figure 3B–D and F–
H and Supplementary Figure S3A and B). A western blot
analysis indicated that the levels ofD. melanogasterGW182
in the depleted cells were reduced below 10% of the control
levels (Supplementary Figure S3D). We concluded that the
ability of GW182 protein fragments to complement
silencing is independent of whether silencing occurs at the
level of translation (the F-Luc-Nerfin-1 reporter) or mRNA
stability (the F-Luc-Par-6 reporter), suggesting that these
two modes of regulation are not mediated through different
GW182 protein domains; thus, these effects might be mech-
anistically linked.
Previous studies have reported that GW182N-term frag-
ments can rescue the silencing of the F-Luc-Nerfin-1
reporter when silenced by miR-9b (11,25). In line with
those studies, we observed that GW182 protein fragments
1–605and1–830 (but not 1–539) restored the silencingof the
F-Luc-Nerfin-1 reporter bymiR-9b (Supplementary Figure
S4A–C). Paradoxically, as shown above, these N-term
protein fragments did not rescue the silencing of the
F-Luc-Par-6 and F-Luc-Nerfin-1 reporters when silencing
was mediated via miR-1 and miR-279, respectively.
To resolve this apparent discrepancy, we further
examined the silencing of additional reporters, including
the F-Luc-CG3548, F-Luc-CG5281 and F-Luc-CG7709 re-
porters silenced by miR-12; the F-Luc-Vha-68-1 reporter
silenced by miR-9b and the F-Luc-CG11206 reporter
silenced by both miR-9b and miR-12 (20,21). We
observed that D. melanogaster GW182 N-term fragments
(1–605, 1–830 and !SD) did not rescue the silencing of
these reporters (Figure 4A–F). Furthermore, these N-term
fragments inhibited silencing in a dominant-negative
manner in control cells (Supplementary Figure S5A–G).
We conclude that although the N-term region of
D. melanogaster GW182 is sufficient for the silencing of
the F-Luc-Nerfin-1 reporter via miR-9b, this region was
not sufficient to rescue the silencing of the additional
miRNA reporters tested. Furthermore, in the context of
the full-length protein, the SD is required for the silencing
of a majority of the reporters tested, whereas the NED is
dispensable. Finally, an N-term fragment containing the
NED (1–539) was not sufficient to rescue silencing,
although this fragment binds AGO1. On the basis of
these results and our previous observations (12), we
conclude that the SD is required for the silencing of
most miRNA targets (5,8,12). Nevertheless, because one
of nine reporters was silenced independently of the SD, it
would be interesting to determine how many targets are
SD independent (and thus independent of the GW182–
PABP interaction) on a genome-wide level, and what
features confer this independence.
Design of a minimal functional GW182 protein
Having established that the SD is generally required for
silencing, we next examinedwhether this domain is also suf-
ficient for silencing. Because the SD does not interact with
AGO1, we therefore generated a chimeric protein contain-
ing a minimal AGO-binding domain fused to the
D. melanogaster GW182 SD. We selected the
AGO-binding domain (ABD) of the highly divergent
Caenorhabditis elegans GW182 protein AIN-2, which
binds to D. melanogaster AGO1 [Figure 5 (29)]. The
AIN-2 ABD (herein referred to as ABD2) comprises 147
amino acids and contains only 3 GW repeats (Figure 1).
Importantly, and in contrast to the D. melanogaster
GW182 ABD, ABD2 does not interact with deadenylases
and has no silencing activity in complementation assays
(Figure 5).
We constructed a chimeric protein containing ABD2
fused to the isolated D. melanogaster GW182 SD or the
SD plus additional N-term sequences. We also generated
chimeric proteins containing the NED, the Q+SD
fragment (635–1384) or the complementary N-term
fragment (1–634, i.e. !Q+SD). Remarkably, in cells
depleted of endogenous D. melanogaster GW182, the
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Figure 3. The Drosophila melanogaster GW182 SD is generally required for miRNA-mediated translational repression and target degradation. (A–I)
Control S2 cells (treated with glutathion S-transferase (GST) dsRNA) or cells depleted of endogenous GW182 were transfected with a mixture of
three plasmids: one expressing the indicated F-Luc reporters; a second expressing miRNA primary transcripts or the corresponding empty vector (!)
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Figure 3. Continued
and a third expressing Renilla luciferase (R-Luc). Plasmids encoding HA-GW182 (wild-type or deletion mutants) or HA-MBP (negative control) were
included in the transfection mixtures as indicated. For each condition, firefly luciferase activities and mRNA levels were normalized to those of the
Renilla luciferase transfection control and set at 100% in cells transfected with the empty vector (i.e. in the absence of the miRNAs). (A and E)
Normalized firefly luciferase activities and mRNA levels in the absence or presence of miRNAs in control cells (i.e. cells treated with GFP dsRNA
and transfected with a plasmid expressing MBP). (B and F) Northern blot analysis of representative RNA samples. Numbers in italics below the
panels indicate the levels of the F-Luc reporters normalized to that of R-Luc mRNA and set at 100 in the absence of the miRNAs. (C and G)
Relative derepression of F-Luc activity for each condition. (D and H) Relative F-Luc mRNA levels. Throughout this study, error bars represent
standard deviations from at least three independent experiments. Upper and lower dashed lines indicate maximal derepression and repression,
respectively, observed in depleted cells. (I) A western blot showing that GW182 mutants were expressed at levels equivalent to that of the
wild-type protein.
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Figure 4. The Drosophila melanogaster GW182 SD is generally required for silencing. (A–F) Complementation assays using the indicated miRNA
reporters were carried out as described in Figure 3. The graphs on the left of each panel show normalized firefly luciferase activities in the absence or
presence of miRNAs in control cells (i.e. cells treated with GFP dsRNA and expressing MBP). The graphs on the right of each panel show the
relative derepression of the F-Luc reporters for each condition. Mean values± standard deviations from three independent experiments are shown.
Labels are as described in Figure 3.
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chimeric protein containing the Q+SD region rescued the
silencing of the F-Luc-Nerfin-1 and F-Luc-Par6 reporters
although not as efficiently as wild-type D. melanogaster
GW182 (Figure 5A and B), suggesting that sequences
upstream of the Q-rich region although not essential, con-
tribute to silencing. The chimeric protein containing the
isolated SD or the SD and additional N-term sequences
partially rescued silencing (Figure 5A and B, and
Supplementary Figure S5H and I). In contrast, the
chimeric proteins containing the NED or residues 1–634
did not rescue silencing, even when expressed at higher
levels (Figure 5A and B, and Supplementary Figure
S6A–C). Notably, a chimeric protein containing only the
Q-rich region was also inactive in complementation assays
(Supplementary Figure S6A and B), although this region
is active in tethering assays (11,25,26). All proteins were
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Figure 5. The Drosophila melanogaster GW182 Q+SD region is sufficient for silencing. (A and B) The silencing activity of chimeric proteins
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except that control cells were treated with GST dsRNA and transfected with a plasmid expressing GFP. (C–E) The interactions of the chimeric
ABD2–GW182 proteins with AGO1, PABP and NOT1 were analyzed as described in Figure 2.
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expressed at comparable levels and interacted with D.
melanogaster AGO1 (Figure 5C and Supplementary
Figure S6C).
Consistent with the results shown in Figure 2, the
chimeric protein containing the Q+SD region interacted
with PABP and NOT1 as efficiently as the full-length
D. melanogaster GW182 (Figure 5D and E, lanes 12)
and also bound PAN3 and NOT2 (Supplementary
Figure S7A and B). The chimera containing the SD inter-
acted with PABP (Figure 5D, lane 13), whereas the
chimera containing the NED did not exhibit any binding
affinity towards PABP or NOT1 (Figure 5D and E, lanes
14). Finally, the chimeric protein that contained fragment
1–634 did not rescue silencing, despite the observation that
this fragment interacts with PAN3 and NOT2 (Figure 5A
and B and Supplementary Figure S1A and B). We
concluded that the silencing activity of the chimeric
GW182 protein correlates with binding to both PABP
and deadenylases because only the Q+SD fragment effi-
ciently rescues silencing.
A minimal GW182 protein reveals interactions that
are required for silencing
Recent studies have identified W-containing motifs in the
M1, M2 and C-term regions of human SDs that are
required for the interaction with NOT1 and PAN3 and
described mutations in these motifs that abolish binding
and silencing (9,10). The motifs in the M1 and C-term
regions were termed CIM-1 and CIM-2, respectively
(10). The CIM-2 motif is absent in D. melanogaster
GW182; however, D. melanogaster GW182 contains a
CIM-1 motif and six tryptophan residues in the M2
region (9,10). The contribution of these motifs to
deadenylase binding in the context of the full-length
D. melanogaster GW182 protein has not been analyzed.
The finding that a minimal chimeric protein consisting
of ABD2 and the D. melanogaster GW182 Q+SD region
could complement silencing in S2 cells provided an op-
portunity to test how the specific disruption of PABP or
deadenylase binding interferes with silencing in a cellular
context in the absence of the contribution of the GW182
N-term sequences. Therefore, we introduced amino
acid substitutions into the PAM2 and CIM-1 motifs
and in the M2 region (individually or in combination)
and assessed the interaction of the mutant proteins
with PABP and deadenylases using immunoprecipitation
assays; the silencing activity was also tested using com-
plementation assays. We again used a reporter
silenced at the translational level (F-Luc-Nerfin-1) and
a reporter that is degraded under steady-state conditions
(F-Luc-Par-6). These studies revealed the following
observations.
First, a single amino acid substitution in the PAM2
motif (F961A) or mutations in the CIM-1 motif did not
affect PABP or NOT1 binding (Figure 6A and B, lanes 10
and 11) and had no significant effect on silencing activity
(Figure 6C and D). The alanine substitution of all six
tryptophan residues in the M2 region (6xW) reduced
both PABP and NOT1 binding and, consequently,
silencing activity (Figure 6A and B, lanes 12 and Figure
6C and D), as previously reported (9). For all mutants
tested, PAN3 and NOT2 binding mirrored NOT1
binding (Supplementary Figure S7A and B).
Second, when combined, mutations in the CIM-1 motif
and the M2 region strongly reduced PABP and NOT1
binding and silencing activity (Figure 6A and B, lanes 13
and Figure 6C and D). The silencing activity of the
chimeric protein was abolished when the PAM2 motif
was mutated in combination with the CIM-1 and the
6xW mutations (Figure 6C and D). Importantly, similar
results were obtained when F-Luc-Par-6 mRNA levels
were analyzed (Figure 6E and F), indicating that the
mutations affect translational repression and mRNA deg-
radation in a similar way. Together, these results indicate
that the silencing activity of GW182 proteins correlates
with both PABP and deadenylase binding.
A recent study reported the identification of another
conserved motif, the P-GL motif, in the M2 region of
GW182 proteins [Figure 1 and Supplementary Figure
S7F (30)]. This motif was shown to contribute to the
translational repression and deadenylation of
polyadenylated targets in zebrafish embryos (30). We
observed that the corresponding mutations in the
D. melanogaster GW182 P-GL motif did not affect the
silencing activity of the chimeric ABD2-Q+SD protein
and did not exacerbate the effect of mutations in the
CIM-1 or PAM2 motifs (Supplementary Figure S8A and
B). Furthermore, mutations in the P-GL motif did not
affect binding to PABP and deadenylases
[Supplementary Figure S8C–E (30)]. These results
confirm that the P-GL motif does not contribute to
silencing in S2 cells (9).
The human TNRC6C SD is sufficient for silencing
Because the mechanism of silencing is conserved and we
have previously shown that human TNRC6 proteins com-
plement silencing in Drosophila cells (5), we next
determined whether a minimal protein consisting of
ABD2 fused to the human TNRC6C SD could rescue
silencing in S2 cells depleted of endogenous
D. melanogaster GW182. This question was particularly
interesting because, unlike the D. melanogaster GW182
SD, human SDs are sufficient for the interaction with
PABP and deadenylases (3,5,8–10). Quite remarkably,
we observed that a chimeric protein containing ABD2
fused to the TNRC6C SD complemented the silencing
of the F-Luc-Nerfin-1 and F-Luc-Par-6 reporters in
GW182-depleted cells (Figure 7A and B).
We next examined the contribution of the CIM-1, CIM-2
and PAM2 motifs to PABP and NOT1 binding and
silencing activities. We observed that mutations in the
CIM-1 or CIM-2 motifs reduced silencing activity, and the
effect of mutations in CIM-2 was stronger (Figure 7A and
B); these findings are in agreement with the observation that
the CIM-1 and CIM-2 motifs are not functionally equiva-
lent (10). The CIM-1 and CIM-2 mutations reduced NOT1
binding without affecting the interaction with PABP
(Figure 7C and D, lanes 11 and 12). When combined, mu-
tations in the CIM-1 and CIM-2 motifs strongly reduced
NOT1 binding and silencing activity (Figure 7A–D). The
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double mutations also abrogated PABP binding (Figure 7C,
lane 13), consistent with the observation that the
GW182-PABP interaction in S2 cells is predominantly
indirect. The effect of the CIM-1+2 double mutation was
exacerbated when combined with the F1389A substitution
in the PAM2 motif (Figure 7A–D). The F1389A mutation
alone abolished PABP binding (Figure 7C, lane 10)
and impaired silencing activity, particularly for the
F-Luc-Nerfin-1 reporter [Figure 7A and B (5,8)], although
NOT1 binding was only slightly reduced (Figure 7D, lane
10). Collectively, the results obtained with the chimeric
proteins demonstrate that full silencing activity requires
interactions between GW182 proteins and both PABP and
deadenylases.
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Figure 6. PABP and deadenylase binding are required for silencing. Mutations in the PAM2 and CIM-1 motifs and the M2 region were introduced
in a minimal GW182 protein consisting of Caenorhabditis elegans ABD2 fused to the GW182 Q+SD region (ABD2-Q+SD). The PAM2 mutant
carries a single amino acid substitution (F961A) in the PAM2 motif. Mutations in the CIM-1 motif are shown in Supplementary Figure S7. The 6xW
mutant carries alanine substitutions of all six tryptophan residues in the M2 region of the SD. (A and B) The interactions of the ABD2-Q+SD
protein (wild-type or mutant) with PABP and NOT1 were analyzed as described in Figure 2. (C–F) The silencing activity of the ABD2-Q+SD protein
(wild-type or mutants) was tested in complementation assays as described in Figure 5.
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The interaction of TNRC6s with PABP and deadenylases
is required for silencing in human cells
Having established that the interaction with NOT1 and
PABP is important for silencing in the context of the
chimeric ABD2-TNRC6C SD, we subsequently investi-
gated the contribution of these interactions to the silencing
activity of TNRC6A protein in human cells. Accordingly,
we used a previously characterized F-Luc reporter con-
taining three Let-7 miRNA binding sites in the 30 UTR,
which is primarily regulated at the translational level
[Figure 8A (22)]. The knockdown of TNRC6 proteins
was achieved using siRNAs targeting TNRC6A and
TNRC6B. This double depletion inhibited the silencing
of the reporter, leading to a 2.8-fold increase in F-Luc
activity (Figure 8A and B). A western blot analysis
indicated that the levels of TNRC6A in the depleted
cells were reduced to 10% of the control levels (Figure
8C). The silencing of F-Luc-3xlet-7 was rescued in cells
expressing a siRNA-resistant form of wild-type
TNRC6A (Figure 8B).
As shown above, mutations in either the CIM-1 or the
CIM-2 motifs or alanine substitutions of the six trypto-
phan residues in the M2 region (6xW) reduced human
NOT1 (CNOT1), but not PABP binding (Figure 8D).
These mutations impaired silencing activity in comple-
mentation assays; a stronger effect was observed for the
mutations in the M2 region and CIM-2 motif (Figure 8B).
The CIM-1+2 double mutant was strongly impaired with
respect to CNOT1 binding and silencing activity
(Figure 8B and D). However, in contrast to the results
observed in S2 cells, this mutant retained the ability to
bind PABP in human cells (Figure 8D). Thus, the inter-
action of TNRC6A with PABP is not sufficient for
silencing. Conversely, CNOT1 binding is also insufficient
for full silencing activity because a TNRC6A mutant
carrying a F1359A substitution in the PAM2 motif inter-
acted with CNOT1, but not with PABP, and was impaired
in complementation assays (Figure 8B and D). The
silencing activity was reduced further when the mutation
in the PAM2 motif was combined with the mutations in
the CIM-1 and CIM-2 motifs or in the M2 region
(Figure 8B). A protein carrying mutations in the M2
region and the CIM-1, CIM-2 and PAM2 motifs was
inactive as observed using a protein lacking the entire
SD (Figure 8B). All proteins were expressed at compar-
able levels (Figure 8E) and have no dominant negative
effects in control cells (Supplementary Figure S9). These
results demonstrated that the interactions of human
TNRC6 proteins with PABP and CNOT1 are also
required for full silencing activity in human cells.
Overexpression of the CNOT1 Mid domain
suppresses silencing
The experiments described above suggest that silencing
(i.e. translational repression and target degradation)
requires an interaction between GW182 proteins and the
CCR4–NOT complex. We next sought to further validate
the contribution of this complex to silencing using an
overexpression approach. These experiments were con-
ducted in human cells, wherein the interaction of
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Figure 7. The TNRC6 SD is sufficient for silencing. Mutations in the
PAM2, CIM-1 and CIM-2 motifs were introduced in a minimal
GW182 protein consisting of Caenorhabditis elegans ABD2 fused to
the human TNRC6C SD region (ABD2-6C-SD). The PAM2 mutant
carries a single amino acid substitution (F1389A) in the PAM2 motif.
Mutations in the CIM-1 and CIM-2 motifs are shown in
Supplementary Figure S7. (A and B) The silencing activity of the
chimeric ABD2-6C-SD protein (wild-type or mutant) was tested in
complementation assays as described in Figure 5. (C and D) The inter-
actions of the ABD2-6C-SD protein (wild-type or mutant) with PABP
and NOT1 were analyzed as described in Figure 2.
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TNRC6s with CNOT1 is direct and mediated through
the SD, without any contribution from N-term sequences
(8–10).
CNOT1 is a large protein containing 2376 amino
acids and is predicted to be mainly a-helical. Sequence
alignments and secondary structure predictions sug-
gest that CNOT1 consists of N-term (CNOT1-N), Mid
(CNOT1-M) and C-term (CNOT1-C) domains
(Figure 9A). In immunoprecipitation assays, we observed
that the CNOT1-M domain was sufficient for the inter-
action with the TNRC6A SD (Figure 9B, lane 9).
CNOT1-N showed no detectable binding, whereas
CNOT1-C exhibited some residual binding affinity
(Figure 9B, lane 10). The CNOT1-M domain also interacts
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with CNOT7 [also known as CAF1 (31)]. Therefore, we
tested whether overexpression of the CNOT1-M domain,
either alone or together with a catalytically inactive
CNOT7 mutant, could inhibit silencing in a dominant
negative manner.
Previous studies have demonstrated that the
overexpression of a catalytically inactive CNOT7 mutant
or the depletion of the subunits of the CCR4–NOT
complex suppressed miRNA-mediated mRNA
deadenylation and degradation, although translation of
the reporters was not fully restored (14,15,21,31–33).
Consistent with these studies, we observed that
overexpression of the CNOT7 catalytically inactive
mutant partially suppressed silencing of the
R-Luc-3xlet-7 reporter (Figure 9C). Interestingly,
overexpression of the CNOT1-M domain also partially
suppressed the silencing of the R-Luc-3xlet-7 reporter
(Figure 9C). Silencing was abrogated in cells coexpressing
the NOT1-M domain together with the CNOT7 catalytic-
ally inactive mutant (Figure 9C).
To further confirm these results, we analyzed the effects
of coexpressing the CNOT1-M domain together with the
CNOT7 mutant on silencing of the R-Luc-Hmga2
reporter, which is also silenced by Let-7 (23). Silencing
of this reporter was also suppressed in cells that
coexpressed both proteins (Figure 9D). Taken together
with results of recent reports showing that translational
repression precedes target degradation and decay (15–17),
these results further support the conclusion that the inter-
action of GW182 proteins with the CCR4–NOT complex
is required for both miRNA-mediated translational re-
pression and target degradation. Thus, the CCR4–NOT
complex is a major effector complex of silencing.
DISCUSSION
Recent studies indicate that translational repression of
miRNA targets precedes deadenylation and decay
(3,15–19). Here, we show that these two functional
outcomes of miRNA regulation are linked and both
require the interaction of GW182 proteins with PABP
and deadenylases.
The GW182–PABP interaction is required for
maximal silencing activity
The interaction of GW182 proteins with PABP has been
well documented using biochemical and structural studies,
and the PAM2 motif is highly conserved among vertebrate
and insect GW182 proteins (3–7). Despite conservation,
the study of the role of PABP in silencing in different
systems has led to conflicting conclusions. For example,
several studies have reported that the PABP–GW182
interaction is important for silencing in D. melanogaster
and human cells and in cell-free systems that recapitulate
silencing (3,5,6,8,10,34,35). Furthermore, PABP depletion
prevented miRNA-mediated deadenylation in cell-free
extracts from mouse Krebs-2 ascites cells (3), and muta-
tions in the PAM2 motif of TNRC6C reduced the rate of
deadenylation in tethering assays (6). In addition, a study
in D. melanogaster cell-free extracts wherein silencing is
mediated through endogenous preloaded miRISCs
indicated that PABP stimulates silencing by facilitating
the association of miRISC complexes with mRNA
targets (35). It was also shown that on miRISC binding,
PABP progressively dissociated from the mRNA target, in
the absence of deadenylation (35).
In contrast to the studies mentioned above, studies
in zebrafish embryos and in a D. melanogaster cell-free
assay wherein miRISCs are loaded with exogenously sup-
plemented miRNA duplexes indicate that PABP is dis-
pensable for miRNA-mediated silencing (26,30).
Intriguingly, efficient silencing in zebrafish embryos
required the GW182 PAM2 motif (30). Moreover, the ob-
servation that multiple and non-overlapping fragments
of D. melanogaster GW182 (including N-term fragments
that do not interact with PABP) silenced mRNA reporters
in tethering assays was interpreted as evidence that
the interaction of GW182 proteins with PABP is not
required for silencing (26). In this study, we show
that unlike in tethering assays, N-term fragments of
GW182 fail to restore the silencing of a majority of the
reporters tested in complementation assays. Thus,
tethering assays bypass the requirement for PABP
binding, and may not faithfully recapitulate silencing.
Furthermore, the observation that PABP dissociates
from the poly(A) tail of miRNA targets in the absence
of deadenylation (35) provides one explanation for the
occurrence of silencing in extracts in which PABP has
been depleted or displaced from the poly(A) tail using
an excess of Paip2 (26,30).
In summary, our results confirm and further extend
previous observations that a single amino acid substitu-
tion in the PAM2 motif of human TNRC6 proteins
abolishes PABP binding and impairs silencing activity,
despite the interaction of this mutant with deadenylases
(3–8). Furthermore, D. melanogaster GW182 N-term
protein fragments that bind deadenylases, but not
PABP, failed to complement the silencing of eight of the
nine reporters tested, although they are active in tethering
assays. These results provide evidence for a role of PABP
in silencing in human and Drosophila cells. However, it is
possible that PABP becomes dispensable for silencing de-
pending on cellular conditions or the nature of the specific
mRNA target, as shown, for example, for the
F-Luc-Nerfin-1 reporter when silencing is mediated by
miR-9b [this study (11,25,26,30)].
Drosophila melanogaster GW182 establishes an intricate
network of interactions with deadenylases
The SDs of human TNRC6 proteins directly interact
with CNOT1 through tryptophan-containing motifs
in the M1, M2 and C-term regions of the SD (9,10).
Here, we show that these motifs contribute additively to
CNOT1 binding and silencing activity in human cells.
Indeed, when at least two motifs are simultaneously
mutated, CNOT1 binding is strongly reduced and
silencing activity impaired.
The interaction between GW182 and deadenylases is
conserved in D. melanogaster; however, in contrast to
human SDs, the D. melanogaster SD is not sufficient for
Nucleic Acids Research, 2013, Vol. 41, No. 2 991
 at M
ax Planck Institut on December 12, 2014
http://nar.oxfordjournals.org/
Downloaded from 
NOT1 binding. Here, we show that in addition to the SD,
the Q-rich region is required for full NOT1 binding
activity. Thus, although D. melanogaster GW182 has
lost the CIM-2 motif, this protein has acquired additional
motifs that can interact with NOT1. We also show that in
contrast to the human proteins, D. melanogaster GW182
can interact with NOT2 and PAN3 via N-term sequences.
Consequently, D. melanogaster GW182 can recruit
deadenylases in multiple ways. Considering that
(i) NOT1 interacts with NOT2 [reviewed in (36)], (b) the
PAN2–PAN3 complex interacts with PABP (37) and
(c) the CCR4–NOT and PAN2–PAN3 complexes form a
larger multiprotein complex in vivo (38), our observations
indicate a high degree of connectivity and redundancy
within the GW182 interaction network, which could
explain why mutations in individual motifs do not
abolish partner binding or silencing activity, but a com-
bination of two or more mutations is required to abrogate
binding and silencing activity.
In addition, the ability of D. melanogaster GW182
N-term fragments to bind deadenylases also explains
why these fragments are potent triggers of translational
repression and mRNA degradation in tethering assays
(9,11,25–27), whereas the corresponding fragments of the
human proteins exhibit only residual activity
(11,25,39,40). As discussed previously, despite their
activity in tethering assays, D. melanogaster GW182
N-term fragments failed to complement the silencing of
several of the reporters tested. The reason for the different
activities of these fragments in tethering and complemen-
tation assays remains unknown.
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Definition of a minimal protein interaction network
required for silencing
In this study, we demonstrated that silencing (i.e. transla-
tional repression and target degradation) requires the
interaction between GW182 proteins and both PABP
and deadenylases. Several lines of evidence support this
conclusion. First, the TNRC6C SD, which is sufficient
for PABP and deadenylase binding, rescues silencing
when fused to a minimal ABD. Similarly, the minimal
fragment of D. melanogaster GW182 that rescues silencing
comprises the Q+SD region, which also binds both
deadenylases and PABP. Second, the D. melanogaster
GW182 N-term fragments that bind deadenylases but
not PABP are generally inactive in complementation
assays. Third, mutations that specifically disrupt TNRC6
binding to PABP or deadenylase impair silencing, and
mutations that disrupt deadenylase binding exhibit a
stronger deleterious effect. Silencing activity is abolished
when these mutations are combined. Finally, silencing is
inhibited in human cells overexpressing the CNOT1 Mid
domain together with a catalytically inactive CNOT7
mutant. In combination with the previously published
data (1,2), our results indicate that silencing minimally
requires an AGO, a GW182 protein, PABP and
deadenylases, thus defining the minimal interaction
network required for silencing. Our findings do not rule
out that additional interactions are potentially required to
achieve maximal repression, depending on the cellular
context or the mRNA target. For example, the P-GL
motif is highly conserved and important for silencing in
zebrafish embryos (30). This motif may mediate inter-
actions with additional partners.
The finding that deadenylase complexes, in particular,
are required for miRNA-mediated translational repression
has broad implications regarding post-transcriptional
mRNA regulation. Indeed, in addition to the GW182
proteins, various sequence-specific mRNA-binding
proteins, such as Nanos, Bicaudal-C and Pumilio, recruit
the CCR4–NOT complex to their mRNA targets
[reviewed in (36)]. Furthermore, the direct tethering of
the subunits of the CCR4–NOT complex represses the
translation of mRNA reporters lacking a poly(A) tail, sug-
gesting that the CCR4–NOT complex promotes transla-
tional repression in the absence of deadenylation (9,13).
Therefore, elucidating the mechanism by which the
CCR4–NOT complex regulates the fates of mRNA
targets promises to increase our understanding of the
mechanism underlying repression by miRNAs and
diverse sequence-specific RNA-binding proteins.
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Figure S5. GW182 N-term fragments generally inhibit silencing in a dominant negative manner in control cells. 
The effects of expressing Dm GW182 N-term protein fragments on silencing of the indicated reporters were 
analyzed in control cells. The corresponding experiment, which was performed in parallel in depleted cells is 
shown in Figure 4. (A–G) Normalized F-Luc activities in cells in the absence or presence of miRNAs. Cells 
were co-transfected with plasmids expressing MBP or Dm GW182 (wild-type or mutant) as indicated. For some 
reporters, overexpression of wild-type GW182 enhances silencing (panels C, D and G). For all reporters, overex-
pression of Dm GW182 N-term fragments (1–605, 1–830 and ΔSD) inhibits silencing in a dominant negative 
manner. Mean values ± standard deviations from three independent experiments rare shown.  (H, I) Complemen-
tation assays using the indicated miRNA reporters were carried out as described in Figure 5. The graphs on the 
left of each panel show normalized firefly luciferase activities in the absence or presence of miRNAs in control 
cells. The graphs on the right of each panel show the relative derepression of the F-Luc reporters for each 
condition.
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Figure S6. A chimeric GW182 protein containing the Q+SD region rescues silencing in cells 
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Figure S7. Conserved motifs in GW182 family proteins. (A, B) The interactions of the chimeric 
ABD2-Q+SD protein (wild-type or mutants) with PAN3 and NOT2 were analyzed as described in 
Figure 2. (C–F) Sequence alignment of the conserved PAM2 (C), CIM-1 (D), CIM-2 (E) and PG-L 
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are indicated by asterisks. CIM-2 is absent in Dm GW182. 
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Figure S8. The PG-L motif of Dm GW182 does not contribute to silencing in S2 cells. Mutations 
in the PG-L motif were introduced in a minimal GW182 protein consisting of Ce AIN-2 ABD 
(ABD2) fused to the GW182 Q+SD region (ABD2-Q+SD). The mutations are shown in Supple-
mentary Figure S7F. (A, B) The silencing activity of the ABD2-Q+SD protein (wild-type or 
mutants) was tested in complementation assays as described in Figure 3. (C–F) The interactions of 
ABD2-Q+SD protein (wild-type or mutants) with PABP, PAN3 and NOT1 were analyzed as 
described in Figure 2. 
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Figure S9. TNRC6A mutants do not inhibit silencing in a dominant negative manner 
in control cells. The effect of expressing TNRC6A mutants on silencing of the 
R-Luc-3xlet-7 reporter was analyzed in control cells. The corresponding experiment, 
which was performed in parallel in depleted cells is shown in Figure 8. HeLa cells 
were transfected with a mixture of three plasmids: the R-Luc-3xlet-7 or the corre-
sponding reporter carrying mutations in let-7-binding sites (R-Luc-Mut), a plasmid 
expressing F-Luc as a transfection control, and a plasmid expressing GFP or siRNA-
resistant versions of GFP-TNRC6A (wild-type or mutant). For each condition, 
Renilla luciferase activity was measured, normalized to that of the F-Luc transfection 
control and set at 100% in cells expressing R-Luc-Mut. Normalized Renilla luciferase 
activities are shown. The expression levels of the proteins tested is shown in Figure 
8E.
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The CCR4–NOT deadenylase complex has a crucial role in post-
transcriptional mRNA regulation. It catalyzes the removal of mRNA 
poly(A) tails and consequently represses translation and promotes 
mRNA degradation1,2. Remarkably, the CCR4–NOT complex can also 
repress translation independently of deadenylation, and it facilitates 
dissociation of the cytoplasmic poly(A)-binding protein (PABP) from 
mRNA poly(A) tails3–6.
In addition to its central role in bulk and specific mRNA degrada-
tion, the CCR4–NOT complex has been implicated in transcription 
initiation and elongation, in DNA repair and in ubiquitination and 
protein modification1,2. Given the diverse activities associated with 
the CCR4–NOT complex, it is not surprising that it has a role in a 
wide range of biological processes, including cell proliferation, apop-
tosis, oogenesis and embryogenesis, spermatogenesis, heart function, 
bone formation and energy metabolism1,2.
The conserved core of the CCR4–NOT complex consists of two 
major modules: a catalytic module comprising two deadenylases 
(CAF1 or its paralog POP2, and CCR4a or its paralog CCR4b) and the 
NOT module, which minimally consists of NOT1, NOT2 and NOT3. 
Additional subunits within the complex have been described, includ-
ing NOT4, CAF40 and the species-specific subunits CAF130, NOT10 
and NOT11 (refs. 1,2). NOT1 functions as a modular scaffold to pro-
vide binding sites for the NOT10–NOT11 module at its N terminus, 
the CAF1–CCR4 catalytic module and CAF40 in its middle region and 
the NOT2 and NOT3 subunits at the C terminus. Thus, NOT1 is essen-
tial for the assembly of the complete CCR4–NOT complex3,7–16.
The precise molecular function of the NOT module remains 
unclear. Current evidence indicates that it regulates the stability and 
activity of the catalytic module. Another crucial role for the NOT 
module is the recruitment of the CCR4–NOT complex to a plethora 
of specific mRNAs2,17. These include microRNA targets and mRNAs 
containing AU-rich elements, to which the CCR4–NOT complex 
is recruited through interactions of NOT1 with GW182 proteins 
and tristetraprolin, respectively4,18–21. Furthermore, a multitude of 
translational regulators, which include Nanos, Bicaudal-C, CUP and 
Smaug, recruit the CCR4–NOT complex to their targets through 
interactions with NOT-module subunits17.
The mechanistic understanding of the assembly, regulation and 
function of the NOT module requires elucidation of its three- 
dimensional structure, specifically of the C-terminal regions of NOT1, 
NOT2 and NOT3, which mediate NOT-module assembly1–3,12,22,23. 
These regions comprise a highly conserved NOT1 superfamily homol-
ogy (SH) domain in NOT1 and a conserved NOT-box domain22,23 in 
NOT2 and NOT3. Currently there are no structural models available 
for these regions, owing to the lack of sequence homology to known 
structural folds.
To provide the missing structural framework for understanding 
the assembly and functions of the NOT module, we determined 
the crystal structure of a ternary complex formed by the human 
CNOT1-C, CNOT2-C and CNOT3-C regions. This was achieved by 
a stepwise approach wherein we first determined the boundaries and 
crystal structures of the isolated human CNOT2 and CNOT3 NOT-
box domains and of the Chaetomium thermophilum (Ct) NOT1 SH 
domain. We then used this information for the assembly and struc-
ture determination of the ternary CNOT1–CNOT2–CNOT3 com-
plex. The structures reveal a rigid scaffold for the NOT1 SH domain, 
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Structure and assembly of the NOT module of the human 
CCR4–NOT complex
Andreas Boland1,2, Ying Chen1,2, Tobias Raisch1,2, Stefanie Jonas1,2, Duygu Kuzuoğlu-Öztürk1, Lara Wohlbold1, 
Oliver Weichenrieder1 & Elisa Izaurralde1
The CCR4–NOT deadenylase complex is a master regulator of translation and mRNA stability. Its NOT module orchestrates 
recruitment of the catalytic subunits to target mRNAs. We report the crystal structure of the human NOT module formed by 
the CNOT1, CNOT2 and CNOT3 C-terminal (-C) regions. CNOT1-C provides a rigid scaffold consisting of two perpendicular 
stacks of HEAT-like repeats. CNOT2-C and CNOT3-C heterodimerize through their SH3-like NOT-box domains. The heterodimer 
is stabilized and tightly anchored to the surface of CNOT1 through an unexpected intertwined arrangement of peptide regions 
lacking defined secondary structure. These assembly peptides mold onto their respective binding surfaces and form extensive 
interfaces. Mutagenesis of individual interfaces and perturbation of endogenous protein ratios cause defects in complex  
assembly and mRNA decay. Our studies provide a structural framework for understanding the recruitment of the CCR4–NOT 
complex to mRNA targets.
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consisting of two perpendicularly arranged stacks of A-helices, and 
an SH3-like fold for the CNOT2 and CNOT3 NOT boxes, which 
mediate heterodimerization. Perhaps the most remarkable structural 
features are the intertwined N-terminal extensions of CNOT2 and 
CNOT3 that wrap around their partners in the heterodimer and also 
form an extended interface with CNOT1. Functional studies reveal 
the relevance of the interaction interfaces for complex assembly and 
mRNA degradation.
RESULTS
Mutual interactions between CNOT1, CNOT2 and CNOT3
Our previous studies indicated that the interactions between 
Drosophila melanogaster (Dm) NOT1, NOT2 and NOT3 are medi-
ated by their C-terminal regions3. Coimmunoprecipitations in human 
cells demonstrated that this mode of interaction is conserved in the 
human orthologs (Supplementary Fig. 1a–e). Moreover, although 
CNOT1 interacted with both CNOT2 and CNOT3, the inter-
action with CNOT3 was enhanced in cells coexpressing CNOT2 
(Supplementary Fig. 1f).
To determine whether the observed interactions are direct and to 
further define the domain boundaries, we performed pulldown assays 
with isolated C-terminal protein fragments expressed in Escherichia 
coli. We observed direct interactions for all possible binary domain 
combinations (Supplementary Fig. 1g–j). Further analysis indi-
cated that the CNOT2-C fragment (residues 344–540) interacts with 
both CNOT1 and CNOT3, whereas a shorter fragment (residues 
429–540) binds CNOT3 but is not sufficient for CNOT1 binding 
(Fig. 1a and Supplementary Fig. 1g,h). The 
smallest CNOT3 fragment that maintained 
CNOT2 binding comprised residues 656–753 
(Supplementary Fig. 1i). On the basis 
of these results and our structural analysis, 
we will refer to residues 429–525 of CNOT2 and residues 656–747 
of CNOT3 as the NOT-box domains (Fig. 1a). We conclude that the 
NOT-box domains mediate the CNOT2-CNOT3 interaction, whereas 
additional N-terminal sequences are required for CNOT1 binding.
The NOT1 SH domain features two perpendicular HEAT stacks
To determine the structure of the CNOT1-C domain, we initially 
identified a proteolytically stable fragment in CNOT1 (residues 
1842–2371; Fig. 1a) that was expressed in a soluble form but failed 
to crystallize. We then expressed an equivalent fragment of Ct NOT1 
(residues 1676–2193; Supplementary Fig. 2), which yielded crystals 
that diffracted X-rays to 3.2-Å resolution (Table 1).
The overall architecture of Ct NOT1-C is L-shaped and consists of 
two tightly interacting subdomains connected by a surface-attached 
and well-structured linker loop (loop L11; Fig. 1b–d). The two 
subdomains correspond to two perpendicularly arranged stacks of 
A-helices: an N-terminal subdomain (N-SD, helices A1–A14) that runs 
left to right and a C-terminal subdomain (C-SD, helices A15–A23) 
that runs bottom to top (Fig. 1b–d). The helices are packed as antipar-
allel HEAT-like pairs, with six hairpins in the N-SD and four hairpins 
in the C-SD. The arrangement of HEAT-like repeats in perpendicular 
stacks is different from the usually continuous arrangement24, and it 
occurs more than once in the context of NOT1 (ref. 10).
Our structural analysis redefines the boundaries of the NOT1 
SH domain and reveals that most of the highly conserved residues 
map to the extensive interface (1,151 Å2) between the N- and C-SDs 
(Supplementary Fig. 2), indicating that the mutual arrangement 
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Figure 1 Domain organization of Homo sapiens 
(Hs) CNOT1–CNOT3 and the structure of  
the Ct NOT1 superfamily homology domain.  
(a) Diagrams of CNOT1 with N-terminal, middle 
and C-terminal regions (CNOT1-N, CNOT1-M 
and CNOT1-C, respectively). The CNOT1-N 
consists of two HEAT-repeat domains. CNOT1-M 
contains a MIF4G domain and a domain of 
unknown function (DUF3819). CNOT1-C 
contains the NOT1 superfamily homology (SH) 
domain. The C-terminal regions of both CNOT2 
and CNOT3 contain a NOT1 anchor region 
(NAR), a connector sequence (CS) and a NOT-
box domain (38% sequence identity for the 
CNOT2 and CNOT3 NOT boxes)22,23. CNOT3 
displays an N-terminal coiled coil domain 
(CNOT3-N) and a linker region (CNOT3-M).  
The numbers below the protein outline  
represent amino acid positions at the domain 
boundaries as defined in this study. (b,c) Cartoon 
representations of the Ct SH domain. Two views, 
related by 60° rotation, are shown in b and c.  
The N- and C-terminal subdomains (N-SD 
and C-SD, respectively) are each colored in a 
gradient from green to dark blue from the N to 
C terminus. HEAT repeats are indicated. Loop 
L11 linking the two lobes is highlighted in red. 
(d) Schematic drawing of the Ct NOT1 structure 
with the same colors as in b. (e) Surface 
conservation of NOT1 SH domain colored in a 
gradient from white to blue. The orientation of 
the top structure corresponds to that shown in c.
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between the two subdomains is evolutionarily conserved. Additional 
conserved surface residues map to only one of the two helical surfaces 
of the domain (Fig. 1e).
The NOT-box domain adopts an SH3-related fold
The CNOT3 NOT-box domain crystallized as a homodimer (2.4-Å  
resolution; Table 1 and Fig. 2a), consistent with the results from 
multiangle static laser light scattering and size-exclusion chromatog-
raphy, which also indicated that the protein was dimeric in solution 
(Supplementary Fig. 3a).
The structure of the NOT-box domain consists of three N-terminal 
A-helices (A1–A3) followed by a C-terminal SH3-like five-stranded 
open B-barrel (B1–B5), with B-strands B4 and B5 strongly bent 
(Fig. 2a,b). The N-terminal helices form an antiparallel bundle that 
packs against one side of the B-barrel. Notably, the inner core of the 
B-barrel and the interface with the N-terminal helices consist almost 
exclusively of aromatic side chains (Supplementary Fig. 3b,c).
The N-terminal helices also provide the interface for the dimeriza-
tion of the NOT-box domain (Fig. 2a). The dimer has a two-fold sym-
metry with a parallel arrangement of the A2 helices, which provide 
Table 1 Data collection and refinement statistics
Ct NOT1 (Se) Ct NOT1 Hs CNOT2 (Se) Hs CNOT2 Hs CNOT3 (Se) Hs CNOT3 Hs CNOT1–2–3
Data collectiona
Space group P212121 P21 P41 P6522 P212121 P212121 P21212
Cell dimensions
 a, b, c (Å) 126.6, 129.6, 
154.1
77.8, 127.2,  
130.2
76.4, 76.4,  
86.3
64.8, 64.8,  
412.3
52.2, 97.3,  
142.3
52.3, 97.6,  
141.5
91.6, 165.9,  
78.8
 A, B, G (°) 90, 90, 90 90, 93.1, 90 90, 90, 90 90, 90, 120 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (Å) 90.9–3.6  
(3.69–3.6)
90.9–3.2  
(3.28–3.2)
76.4–3.4  
(3.49–3.4)
49.3–2.4  
(2.46–2.4)
80.3–2.5  
(2.57–2.5)
49.1–2.4  
(2.46–2.4)
48.5–3.2  
(3.28–3.2)
Rsym (%) 17.2 (73.1) 10.6 (54.5) 16.2 (68.4) 9.6 (80.2) 8.6 (73.5) 5.4 (70.4) 11.9 (55.9)
I / SI 16.4 (5.1) 11.3 (2.9) 17.5 (4.9) 13.2 (2.4) 17.7 (3.7) 18.1 (3.2) 10.1 (2.2)
Completeness (%) 100.0 (100.0) 99.9 (99.9) 99.7 (96.0) 99.2 (99.1) 99.9 (99.1) 99.5 (99.8) 98.9 (98.9)
Redundancy 26.8 (27.9) 5.4 (5.2) 20.1 (18.1) 6.7 (6.7) 12.9 (12.9) 5.9 (6.2) 3.3 (3.4)
Refinement
Resolution (Å) 63.6–3.2 49.3–2.4 49.1–2.4 48.5–3.2
No. reflections 41,820 21,287 28,937 20,241
Rwork / Rfree (%) 21.7 / 25.9 21.7 / 26.3 22.1 / 25.7 22.4 / 27.3
No. atoms
 Protein 15,737 3,483 4,984 6,864
 Water – 102 76 –
B factors (Å2)
 Protein 88 51 69 71
 Water – 48 52 –
r.m.s. deviations
 Bond lengths (Å) 0.002 0.002 0.002 0.002
 Bond angles (°) 0.53 0.64 0.62 0.52
aOne crystal was used per data set. Values in parentheses are for highest-resolution shell.
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Figure 2 Structures of the CNOT2 and CNOT3 NOT-box domains. (a) 
Structure of the CNOT3 NOT-box dimer. Monomers are colored in dark and 
light green. Secondary-structure elements are labeled. (b) Structure of the 
CNOT3 NOT-box monomer. (c,d) Structure of the CNOT2 NOT-box dimer 
in two orientations. Monomers are colored purple and rose. The three A-
helices involved in the domain swap are labeled in d. (e,f) Superposition 
of CNOT2 (purple) and CNOT3 (green) monomers. The similarity of the 
B-barrels and the open (CNOT2) and closed (CNOT3) conformations of the 
N-terminal A-helices are highlighted (e). A cross-connection of the two 
peptide backbones at the dashed line in d results in a compact model of 
the CNOT2 NOT box that is highly similar to the CNOT3 NOT box (b,f).
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most of the contacts with additional contributions from helices A1 
and loops L1. The contacts are mainly hydrophobic and lead to an 
interface of 560 Å2.
The CNOT2 NOT-box domain forms a domain-swapped dimer
The CNOT2 NOT-box domain packs as a dimer of dimers (2.4-Å  
resolution, Fig. 2c,d and Table 1), consistent with its behavior in 
solution (Supplementary Fig. 3d,e). As expected on the basis of 
sequence homology (Supplementary Fig. 3f), 
the CNOT2 and CNOT3 NOT boxes adopt 
a similar fold (Fig. 2c–f). However, in the 
CNOT2 crystals the N-terminal helices 
adopt an extended (open) conformation 
(Fig. 2c–e), in which helices A1 and A2 of 
one monomer interact with helix A3 and 
the open B-barrel of the other monomer 
(Fig. 2d). Consequently, the dimers that 
result from this domain swap are structur-
ally distinct from the CNOT3 homodimers, 
burying a large interface of 1,900 Å2.
The ability of the NOT-box domains to homodimerize in two 
different ways and to adopt an open (CNOT2) or a closed (CNOT3) 
conformation is intriguing. With regard to the assembly of the NOT 
module, CNOT2 and CNOT3 may form heterodimers that corres-
pond to one of the two crystallized arrangements. To discriminate 
between these two potential interaction modes, we determined the 
structure of the ternary complex, which also includes CNOT1.
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Figure 3 Structure of the CNOT1–CNOT2–
CNOT3 ternary complex. (a,b) Structural 
overview. CNOT2 (purple) and CNOT3 (green) 
form a heterodimer through their NOT-box 
domains and preceding connector sequences 
(CS; magenta and cyan, respectively). The NOT1 
anchor regions (NAR) tether the heterodimer 
onto the surface of CNOT1 (gray). They consist 
of an N-terminal A-helix (AN) and a NAR  
C-terminal region (NAR-C). The CNOT2  
C-terminal tail is shown in orange.  
(c) Schematic drawing of the CNOT1–CNOT2–
CNOT3 structure with colors as in a.  
(d) Superposition of the CNOT2 NOT-box 
domain in the complex (purple) with the 
isolated domain (gray). (e) Superposition of the 
CNOT2–CNOT3 heterodimer (purple and green) 
with the CNOT3 NOT-box homodimer (gray). 
(f) Structures of CNOT2 and CNOT3 from the 
ternary complex. The heterodimer (left) is taken 
apart (right) to show the extended conformation 
of the NAR and CS regions.
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Figure 4 The CNOT2–CNOT3 heterodimerization interface. (a) Close-up of the interface between the NOT-box domains of CNOT2 and CNOT3, with 
interface residues shown as sticks. (b) The corresponding interface of the CNOT3 homodimer. Underlined residues indicate marked differences between 
the interfaces of the CNOT2–CNOT3 heterodimer and the CNOT3 homodimer. (c) Packing of the CNOT2 CSs (magenta) against the CNOT3 NOT-box 
domain (green surface) and of the CNOT3 CS (cyan) against the CNOT2 NOT-box domain (purple surface). Interacting residues are shown as sticks in 
purple (CNOT2) and green (CNOT3). Proline residues in CNOT3 CS are shown in gray. (d,e) Circular locks for CNOT2 (d) and CNOT3 (e). Residues locking 
back the N-terminus of the CS to its own NOT-box domain are drawn as sticks. For CNOT2, contacts are mediated by hydrogen bonds (orange).  
For CNOT3, contacts are hydrophobic.
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Crystal structure of the assembled NOT-module core
The core of the human NOT module comprising CNOT1 (residues 
1565–2371), CNOT2 (residues 344–540) and CNOT3 (residues 
607–753) was coexpressed in E. coli cells and co-purified. Limited 
proteolysis by thermolysin removed the N-terminal part of CNOT1, 
resulting in a stable fragment corresponding to the NOT1 SH domain 
(Supplementary Fig. 4a). Surprisingly, limited proteolysis did not 
affect the N-terminal extensions of the CNOT2-C and CNOT3-C 
fragments, although they are predicted to lack secondary structure. In 
the absence of CNOT1, thermolysin rapidly degraded CNOT2-C and 
CNOT3-C, a result suggesting that large portions of the two proteins 
are flexible and unfolded in isolation (Supplementary Fig. 4a,b).
The 3.2-Å-resolution structure of the heterotrimeric complex 
(Fig. 3, Supplementary Fig. 4c–f and Table 1) contains CNOT1 
(1842–2353), CNOT2 (350–540) and CNOT3 (607–748) in a stoi-
chiometry of 1:1:1. The complex is organized into two lobes: an 
asymmetric lobe containing CNOT1 is fixed by an unusual junction 
to a roughly two-fold-symmetric lobe containing the NOT boxes of 
CNOT2 and CNOT3 (Fig. 3a–c).
The structure of human CNOT1 in the complex is similar 
to the structure of the isolated Ct NOT1-C (r.m.s. deviation of 
1.99 Å over 397 equivalent CA positions; Supplementary Fig. 4g), 
thus indicating that CNOT1 does not 
undergo major structural rearrangements 
upon binding the CNOT2–CNOT3 hetero-
dimer. Similarly, the CNOT3 NOT-box 
domain in the complex adopts an almost 
identical conformation as does its isolated 
counterpart (r.m.s. deviation of 0.55 Å over 
90 equivalent CA atoms; Supplementary 
Fig. 4h). In contrast to the isolated structure, 
the CNOT2 NOT-box domain adopts the 
closed conformation in the ternary complex, 
and its helix A1 is partially melted (Fig. 3d 
and Supplementary Fig. 4i).
The symmetric lobe
CNOT2 and CNOT3 interact with each 
other through their NOT-box domains in 
the same arrangement that was observed for 
the CNOT3 homodimer (Fig. 3e,f), thereby 
leading to a highly symmetric heterodimer. 
Heterodimerization is mediated by hydropho-
bic interactions between helices A1 and A2 and loop L7 of both pro-
teins. Importantly, the interface of the CNOT2–CNOT3 heterodimer 
exhibits a higher degree of complementarity than does the interface 
in the CNOT3 homodimer (Fig. 4a,b). This is especially apparent for 
CNOT2 residues Y439 and L443, which form knobs that fit neatly into 
the holes on the CNOT3 surface, whereas the corresponding CNOT3 
residues L666 and T670 fill these holes less efficiently.
The heterodimer interface is extended by N-terminal sequences 
that we named connector sequences (CSs) and that wrap like clamps 
around the NOT-box domains of their partners (Figs. 3f and 4c and 
Supplementary Fig. 5a,b). The CSs describe a full circle starting 
from their C termini and wrap around the L2 loops of their respec-
tive partners (Fig. 3f), inserting into the cleft formed between the 
B-barrel and the N-terminal A-helices (Fig. 4c). In the vicinity of 
their N termini, the CSs lock themselves back through side chain inter-
actions with helix A2 of their own NOT-box domain (Fig. 4c–e). The 
side chain interactions at the locks are different for the two proteins. 
In CNOT2, polar residues are involved for the most part (interaction 
of CS residues R409, P410 and Q411 with Y446, M450 and N451 in 
helix A2; Fig. 4d), whereas in CNOT3, the interactions are mainly 
hydrophobic (interaction of CS residues Y637 and L638 with resi-
dues F673, Y677 and L678 in helix A2; Fig. 4e). Most remarkably, 
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Figure 5 The interface between CNOT1 and 
the CNOT2–CNOT3 heterodimer. (a) Packing 
of the NARs (purple, CNOT2; green, CNOT3) 
against the surface of CNOT1 (gray, cartoon 
representation on the right). Interacting  
residues are shown as sticks and are labeled  
on the left for CNOT2 and CNOT3 and on the 
right for CNOT1. Highlighted labels correspond 
to CNOT1 mutants M1 (yellow) and M5 (cyan). 
(b) Close-up view of a hydrophobic canyon on 
the surface of CNOT1 filled with side chains  
of CNOT2. (c) Interactions of the CNOT2  
C-terminal tail (C-term, orange) with CNOT3 
and CNOT1. Labeling of interacting residues 
is as in a. (d) Close-up views of the junction 
between the symmetric and asymmetric lobes of 
the ternary NOT-module complex. (e) Overview 
of the trimeric complex for orientation. The 
rectangles indicate the views shown in a–d.
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the CSs are interlocked, thereby providing a 
topological constraint for the dissociation of 
the two proteins and suggesting a hierarchi-
cal assembly.
The CSs probably favor heterodimeriza-
tion over homodimerization because they 
differ substantially in sequence and in length 
(Figs. 3f and 4c). Notably, the CNOT3 CS is 
shorter and highly enriched in prolines (38%; 
Fig. 4c and Supplementary Fig. 5a,b). Thus, 
the interactions mediated by the CSs in the 
heterodimer are unlikely to occur in the 
context of the homodimers. This view is supported by the observa-
tion that the CNOT2 and CNOT3 fragments (containing the CSs 
in addition to the NOT boxes) aggregate and precipitate in isola-
tion, thus indicating that the CSs do not participate favorably in the 
formation of homodimers. Upon coexpression, however, CNOT2-C 
and CNOT3-C remain soluble and form exclusively heterodimers 
(Supplementary Fig. 3g).
The asymmetric lobe
The CNOT2–CNOT3 heterodimer interacts predominantly with 
the conserved helical surface of the CNOT1 N-SD (Fig. 3a,b). 
The interaction does not use the NOT-box domains and involves only 
the NOT1 anchor regions (NARs) of both proteins, which consist 
of an N-terminal A-helix (AN) and a C-terminal region (NAR-C) 
entirely devoid of secondary structure (Fig. 3f and Fig. 5a–d). The AN 
helices insert into grooves on the lateral surface of CNOT1 (Fig. 5a). 
The extreme N-terminal residues of CNOT2 enter a cleft formed by 
loops L15 and L19 and helix A21 in the CNOT1 C-SD (Fig. 5a).
The NAR-Cs mold into the conserved helical surface of the 
CNOT1 N-SD (Fig. 5a). The short CNOT3 NAR-C crosses over the 
surface of helices A4, A6 and A8 of CNOT1, with which it interacts 
through hydrophobic and polar residues (Fig. 5a) before entering 
the junction. The long CNOT2 NAR-C zigzags across the CNOT1 
surface and contains a series of aromatic residues (Y396, F399 and 
W403) that stick into the hydrophobic cleft between CNOT1 heli-
ces A8, A9 and A11 (Fig. 5a,b). Furthermore, residues 382–395 
extensively interact with helix A11 of CNOT1 and exhibit several 
well-defined contacts (Fig. 5a).
The junction and the orientation of the two lobes
The NAR-Cs link to the CSs at the junction of the two lobes in the 
structure (Fig. 3a). The core of this junction is stabilized by hydrophilic 
interactions between the N-terminal ends of the CSs, which include res-
idues from CNOT2 (R409, Q411, D412 and D414) and CNOT3 (E632, 
R633, R635 and R640; Fig. 5d). Furthermore, the relative orientation 
of the two lobes is stabilized by the C-terminal tail of CNOT2, which 
clamps the CNOT3 CS into a tunnel and hooks back onto CNOT1 
(helix A11) while crossing over the CNOT3 NAR-C (Fig. 5c). Clearly, 
the interactions of the CNOT2 C-terminal tail must occur late in the 
assembly of the NOT module and impose additional topological con-
straints, thereby preventing the dissociation of CNOT3 in the presence 
of CNOT2. Surface conservation analysis indicated that the interfaces 
in the trimeric complex are conserved (Supplementary Fig. 6a–e), 
suggesting a similar assembly mode across multiple species.
In vivo assembly and mutagenesis of the NOT module
To determine the structural requirements for the assembly of the NOT 
module in vivo, we tested whether overexpressed protein variants 
are incorporated into endogenous CCR4–NOT complexes in human 
cells. To this end, we performed coimmunoprecipitation assays and 
used available anti-CNOT1 and anti-CNOT3 antibodies (Fig. 6). We 
included hemagglutinin (HA)-tagged CNOT2 in the transfection 
mixtures because of the lack of specific antibodies. Collectively, these 
experiments revealed the following observations.
First, GFP-CNOT1 interacted with HA-CNOT2 and endogenous 
CNOT3 (Fig. 6a, lane 8). As expected, a deletion of the CNOT1 N-SD 
($N-SD) prevented these interactions (Fig. 6a, lane 9). Remarkably, 
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Figure 6 Mutagenesis of the NOT1-NOT2- 
NOT3 interfaces in human and Dm S2 cells. 
(a–c) Interaction of GFP-tagged CNOT1,  
CNOT2 or CNOT3 (either wild-type or the 
indicated mutants) with the indicated proteins 
(either endogenous CNOT3 and CNOT1 
or CNOT2 tagged with human influenza 
hemagglutinin (HA)). GFP-tagged maltose 
binding protein (MBP) served as a negative 
control. (d) Interaction of HA-tagged Dm NOT1 
(either wild-type or mutants) with the indicated 
endogenous proteins in S2 cells. HA-MBP 
served as a negative control. (e,f) Interaction 
of GFP-tagged Dm NOT2 or NOT3 (either wild-
type or mutants) with the indicated endogenous 
proteins in S2 cells. GFP-tagged firefly 
luciferase (GFP-F-Luc) served as a negative 
control. In all panels, cell lysates were treated 
with RNase A before immunoprecipitation.  
IP, immunoprecipitated fraction. Size markers 
(kDa) are shown on the right of each panel. 
Original western blots shown in this figure  
can be found in Supplementary Figure 8.
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it was sufficient to substitute only two or three surface residues on 
CNOT1 that make direct contact with CNOT2 (mutants M5 and M6) 
or CNOT3 (mutant M1; Fig. 5a and Supplementary Fig. 2) to achieve 
a similar effect (Fig. 6a, Supplementary Fig. 7a and Supplementary 
Table 1). These CNOT1 mutants still interacted with CNOT7 
(Supplementary Fig. 7b,c), a result suggesting that the mutations 
do not affect the CNOT1 fold. Consequently, subtle alterations of the 
CNOT1 binding surface are sufficient to prevent its interaction with 
CNOT2 and CNOT3 in vivo, a result consistent with a specific but 
rather weak, entropically costly interaction.
Second, GFP-CNOT2 interacted with endogenous CNOT1 and 
CNOT3 (Fig. 6b, lane 8). A deletion of the NAR-C region strongly 
reduced binding to endogenous CNOT1 (Fig. 6b, lane 12). This dele-
tion also abolished binding to endogenous CNOT3 (Fig. 6b, lane 12), 
although a CNOT2 mutant lacking the entire NAR still interacted with 
CNOT3 in vitro (Supplementary Fig. 1h). This observation confirms 
that our assay detects the incorporation of CNOT2 into endogenous 
CCR4–NOT complexes, rather than detecting binary interactions alone. 
The results also suggest that there is no excess of free CNOT3 in the 
cell to interact with CNOT2. Conversely, a deletion of the CNOT2 CS 
also prevented the interaction with both CNOT1 and CNOT3 (Fig. 6b, 
lane 9). In contrast, a point mutation at the NOT-box interface (W507E) 
or the deletion of AN were ineffectual (Fig. 6b, lanes 10,11). These 
results highlight the importance of the CNOT2 CS and the NAR-C for 
NOT-module assembly.
Third, GFP-CNOT3 interacted with endogenous CNOT1 and with 
HA-CNOT2 (Fig. 6c, lane 7). As observed for CNOT2, the deletion of 
the CS prevents interaction not only with HA-CNOT2 but also with 
endogenous CNOT1 (Fig. 6c, lane 8), thus indicating that mutated 
GFP-CNOT3 is not incorporated into endogenous NOT modules. 
In contrast, a single amino acid substitution in CNOT3 helix A2 (F673E) 
disrupted HA-CNOT2 binding, but this mutant maintained inter-
action with endogenous CNOT1 (Fig. 6c, lane 9), a result suggest-
ing that the CNOT3 NAR could be sufficient for incorporation into 
NOT modules even when the interaction with CNOT2 is disrupted. 
Consistent with this, the deletion of the NAR abrogated binding to 
endogenous CNOT1 (Fig. 6c, lane 10).
Finally, analogous experiments in Dm Schneider cells (S2 cells), dem-
onstrated that all of the aforementioned mutations and deletions abol-
ished the interaction of Dm NOT1, NOT2 and NOT3 with the other 
two endogenous partners (Fig. 6d–f). These results confirm the conclu-
sion that endogenous NOT1, NOT2 and NOT3 are fully assembled into 
NOT modules and indicate that each subunit requires interaction with 
both of its partners to be incorporated into the NOT modules in Dm 
S2 cells. Together with the topological constraints seen in the structure, 
the results also suggest a highly coordinated and hierarchical assembly 
with built-in quality controls.
The integrity of the NOT module and mRNA degradation
To test whether a disturbed assembly of the NOT module has conse-
quences on mRNA degradation, we used a heat-shock mRNA reporter 
containing the coding region of the Dm alcohol dehydrogenase gene 
(Adh) fused to the hsp70 (official symbol Hsp70Ab) 3` untrans-
lated region (construct denoted adh-hsp70), which is sufficient to 
recapitulate hsp70 mRNA decay25 and results in a half-life of 25 o  
6 min (Fig. 7a).
In the first round of experiments, we overexpressed the NOT1 protein 
in S2 cells. We found that wild-type NOT1 had no effect on mRNA 
half-life (Fig. 7a and Supplementary Fig. 7d), whereas the expres-
sion of the NOT1 $N-SD mutant resulted in a two-fold increase of 
the mRNA half-life (57 o 11 min; Fig. 7a and Supplementary Fig. 7d). 
Because this mutant still interacts with CAF1 (Supplementary Fig. 7e), 
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Figure 7 Effects on mRNA degradation. (a) Northern blot analysis showing the decay of the adh-hsp70 mRNA in control cells (expressing MBP) and in 
cells expressing NOT1 (either wild-type or mutant). The mRNA half-lives (t1/2) o s.d. calculated from the decay curves obtained from three independent 
experiments (Supplementary Fig. 7d) are indicated at bottom. Rp49 served as a loading control. (b) Western blot analysis of S2 cells depleted of NOT1, 
NOT2 or NOT3. Dilutions of control cell lysates were loaded in lanes 1–4 to estimate the efficacy of the depletion. Tubulin served as a loading control.  
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it probably sequesters the catalytic module into inactive complexes or 
it is assembled into defective complexes that are no longer recruited to 
the mRNA reporter.
In the second round of experiments, we depleted the individual 
subunits. Western blot analysis indicated that the depletion of single 
subunits of the ternary NOT1–NOT2–NOT3 complex co-depleted 
the other two subunits (Fig. 7b), in agreement with previous 
studies11,13,15,25,26 (Fig. 7b). These observations demonstrate that the 
respective protein ratios are strictly controlled in the cell.
Because the depletions of NOT1 and NOT3 efficiently co-depleted 
the other two partners, we expected that such depletions would affect 
adh-hsp70 mRNA degradation in a similar manner. Consistent with 
this expectation and a previous study25, the half-life of the hsp70 
mRNA reporter in NOT1- and NOT3-depleted cells increased almost 
ten-fold relative to control cells (210 o 30 and 220 o 20 min, respec-
tively; Fig. 7c,d and Supplementary Fig. 7f,g).
Next, we performed complementation assays, wherein NOT1 or 
NOT3 mutants were tested for their ability to restore mRNA degra-
dation in cells that were depleted of the corresponding endogenous 
protein. Reintroduction of a double-stranded RNA (dsRNA)-resistant 
version of wild-type NOT1 partially restored the degradation of the 
reporter and reduced the mRNA half-life to 49 o 3 min in NOT1-
depleted cells (Fig. 7c and Supplementary Fig. 7f). In contrast, 
the NOT1 $N-SD mutant did not restore degradation, and the 
adh-hsp70 mRNA half-life (220 o 23 min) was similar to that observed 
in NOT1-depleted cells (Fig. 7c and Supplementary Fig. 7f), even 
though expression was higher for the NOT1 mutant than for the 
wild-type (Fig. 7e).
Similarly, the reintroduction of a dsRNA-resistant version of 
wild-type NOT3 restored the degradation of the reporter and 
reduced the mRNA half-life to 62 o 30 min in NOT3-depleted cells 
(Fig. 7d and Supplementary Fig. 7g). In contrast, the NOT3 $NAR 
mutant did not restore degradation (half-life > 240 min; Fig. 7d), 
even though the mutant was expressed at similar levels to wild-type 
NOT3 (Fig. 7e).
In summary, these experiments demonstrate a strict requirement 
for the cell to balance the levels of the NOT-module protein compo-
nents. They also show that a properly assembled NOT module, as 
observed in the crystal structure, is essential for the activity and/or 
recruitment of the CCR4–NOT complex and hence is crucial for 
mRNA degradation.
DISCUSSION
Unusual assembly principles for the NOT module
A remarkable and unexpected structural feature of the NOT mod-
ule is the role that the NAR and CS regions of CNOT2 and CNOT3 
have in the assembly of the trimer. Particularly striking is that these 
regions not only hook up onto their prefolded molecular partners, 
as observed in assemblies such as the ribosome27,28, but also stabi-
lize each other and exclusively orchestrate the three-dimensional 
assembly of the entire NOT module. This mode of assembly is rather 
unusual and is clearly distinct from the classical principle of mutual 
recognition by complementary tertiary structures such as observed 
for the interaction of CAF1 with the NOT1 MIF4G domain10,14. 
In particular, the embracement of the NOT-box domains by the CSs, 
the formation of the junction and the adaptation of the NAR-Cs to the 
CNOT1 surface could not happen without disorder-to-order transi-
tion and cofolding29.
According to the most general definition, the NAR and CS regions 
could be classified as intrinsically disordered, i.e., as protein sequences 
that are largely unstructured in the absence of their specific binding 
partners and that adopt their three-dimensional shape only upon bind-
ing30,31. This classification is based primarily on the lack of secondary-
structure elements and of intramolecular contacts, which means that 
the relative orientation of the amino acids as observed in the complex 
will not be fixed in the absence of the binding partner. Consequently, 
the sequences are presumably disordered in isolation, as reflected 
by the susceptibility to proteolytic degradation (Supplementary 
Fig. 4a,b). However, sequence analysis does not identify the NAR and 
CS regions as typical intrinsically disordered regions30,31.
In summary, we report the following new observations: first, even 
upon binding, the NAR and CS regions remain largely devoid of 
A-helices and B-strands, thus demonstrating that specific surface rec-
ognition and the formation of the structured core in the junction are 
possible without such elements. Second, rather than only threading 
along surface grooves, peptide regions of sufficient length, such as 
the CNOT2 NAR-C, can read out entire molecular surfaces by zig-
zagging back and forth. Third, synergistic cofolding29 of the CNOT2 
and CNOT3 assembly peptides leads to a mutual stabilization and 
a specific hydrophilic core at the junction between the two lobes of 
the complex. Fourth, the interaction with these peptides is the sole 
determinant for NOT-module assembly and for the relative orienta-
tion of the two structured lobes, thus demonstrating that assembly 
peptides without secondary structure can guide and determine the 
shape of multimolecular complexes. Finally, topological constraints 
such as the described interlocks between the CSs increase the struc-
tural complexity and additionally stabilize the assembly.
Control of protein ratios and NOT-module assembly
The unexpected topological complexity of the NOT module suggests a 
requirement for a hierarchical and coordinated assembly of the individ-
ual subunits with the CNOT3 NAR binding the CNOT1 surface before 
CNOT2. Additional complexity arises from both CNOT2 and CNOT3 
being able to form homodimers in the absence of their preferred bind-
ing partner, and these homodimers might compromise CCR4–NOT 
complex assembly or interfere with its function. Consequently, it is not 
surprising that the relative protein ratios of the NOT-module compo-
nents are tightly controlled in the cell. In this context, the NAR and 
CS regions could have additional functions. They could interact with 
general chaperones or even specialized assembly factors that prevent 
nonspecific aggregation and/or promote the ordered incorporation 
into the CCR4–NOT complex. Alternatively, the NAR and CS regions 
could trigger an accelerated degradation of the proteins in the absence 
of their binding partners32, owing to their susceptibility to cellular pro-
teases, thus providing a simple mechanism to coordinate the expres-
sion of the subunits of the complex.
Recruitment of the CCR4–NOT complex to mRNA targets
The CCR4–NOT complex is assembled through the interaction of a 
catalytic module with the NOT module. Although the catalytic subunits 
catalyze deadenylation, the NOT module orchestrates the recruitment 
of these subunits to mRNA targets. This is achieved through interac-
tions with RNA-associated proteins2,17 (including GW182, Bicaudal-C, 
Nanos, CUP and Roquin), which have been shown to interact with 
NOT-module components4,18–20,33–37. The molecular details of these 
interactions remain unknown. In this context, our structural analysis 
reveals a highly conserved solvent-exposed surface on the NOT mod-
ule that extends from the CNOT1 C-SD over the CNOT2 NAR to the 
CNOT3 NOT box (Supplementary Fig. 6a), and this surface probably 
provides a binding platform for conserved binding partners.
Remarkably, for the binding partners that have been characterized 
in more detail (GW182, Nanos and CUP)4,18–20,35,36, the regions that 
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mediate binding to the NOT module are predicted to be unstruc-
tured. Thus their interactions with the NOT module may follow a 
similar structural principle as observed for the NAR and CS regions of 
CNOT2 and CNOT3. For example, the GW182 proteins interact with 
the CCR4–NOT complex through tryptophan-containing motifs4,18–20 
that probably bind in hydrophobic pockets along the CNOT1 scaf-
fold and that may function similarly to the aromatic residues in the 
CNOT2 NAR-C. Understanding such interactions in molecular terms 
remains an important challenge for future studies.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. Coordinates for the structures have been deposited 
in the Protein Data Bank under accession codes 4C0D (ternary com-
plex of CNOT1–CNOT2–CNOT3), 4C0E (SH domain of Ct NOT1), 
4C0F (NOT-box domain of CNOT2) and 4C0G (NOT-box domain 
of CNOT3).
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METHODS
Coimmunoprecipitation assays and western blotting. Plasmids expressing 
CCR4–NOT deadenylase subunits and coimmunoprecipitation assays in human 
and Dm S2 cells have been previously described18. HA- and GFP-tagged proteins 
were detected with horseradish peroxidase–conjugated anti-HA18 (Roche 3F10; 
1:3,000) and anti-GFP antibodies18 (Roche 11814460001; 1:2,000), respectively. 
Endogenous human CNOT1 was detected with a polyclonal anti-CNOT1 anti-
body generated by immunization of rabbits with the purified untagged MIF4G 
domain of human NOT1 expressed in E. coli14 (1:2,000). Endogenous CNOT3 was 
detected with a commercially available anti-CNOT3 antibody (Abcam ab55681; 
1:1,000). The specificity of this antibody is shown in Figure 6. Endogenous Dm 
NOT1, NOT2 and NOT3 were detected with antibodies kindly provided by 
E. Wahle25,33. All western blots were developed with the ECL western blotting 
detection system (GE Healthcare).
In vitro pulldown assays. The indicated GST- or MBP-tagged CNOT1, CNOT2 
and CNOT3 fragments were expressed separately in BL21 (DE3) Star cells 
(Invitrogen) at 20 °C overnight. Cells were lysed in 10 mM HEPES, pH 7.6, 
300 mM NaCl and 1 mM DTT supplemented with lysozyme (1 Mg/ml), DNaseI 
(5 Mg/ml) and protease inhibitors. Cell lysates were sonicated and cleared by 
centrifugation. The cleared supernatants containing the respective binding part-
ners were mixed to obtain an approximately 1:1 ratio of the protein partners and 
incubated in binding buffer (10 mM HEPES, pH 7.6, 150 mM NaCl, 0.4% Triton 
X-100, 1 mM DTT, and protease inhibitors) for 20 min at 4 °C. After this, 50 Ml 
(50% slurry) of Protino Glutathione agarose 4B beads (Macherey Nagel) or 50 Ml 
(50% slurry) of amylose resin (New England BioLabs) was added to each sample, 
and incubation was continued for another hour at 4 °C with gentle rotation. Beads 
were washed three times with binding buffer. Bound proteins were eluted with 
2× sample buffer and analyzed by SDS-PAGE.
His6-tagged CNOT1 (residues 1565–2371) was expressed in E. coli BL21 (DE3) 
Star cells in LB medium at 20 °C overnight and purified through nickel-affinity 
chromatography followed by anion-exchange chromatography and finally size-
exclusion chromatography, with a running buffer containing 50 mM HEPES, 
pH 8.0, 400 mM NaCl, 10% glycerol and 2 mM DTT. The purified protein 
(20 Mg) was added to 200 Ml of lysate expressing the respective MBP-tagged 
CNOT2 or CNOT3 and incubated in binding buffer (10 mM HEPES, pH 7.6, 
300 mM NaCl, 1 mM DTT and protease inhibitors) for 20 min at 4 °C. After this, 
50 Ml (50% slurry) of amylose resin was added to each sample, and incubation was 
continued for another hour at 4 °C with gentle rotation. Beads were washed three 
times with binding buffer. Bound proteins were eluted with 2× sample buffer and 
analyzed by SDS-PAGE.
In the experiment shown in Supplementary Figure 3g, MBP-tagged CNOT2 
and His6-tagged CNOT3 were coexpressed in E. coli. The heterodimers were 
co-purified with MBP pulldown and subsequent Ni-affinity purification (lanes 1 
and 2) or Ni-affinity purification and subsequent MBP pulldown (lanes 3 and 4). 
The stoichiometry of the complex was similar in all cases, thus indicating that the 
proteins heterodimerize in solution and that there was no excess of MBP-NOT2 
or His6-NOT3 homodimers.
Protein expression and purification. The DNA encoding Ct NOT1-C (residues 
1676–2193) was amplified by PCR from a synthetic template (Gene Art, codon-
optimized for E. coli) and inserted into XhoI and BamHI restriction sites of the 
pnYC vector, which provides an N-terminal His6-tag followed by a TEV protease 
site38. His6-tagged Ct NOT1-C was expressed in E. coli BL21 Star (DE3) cells at 
20 °C overnight. After an initial Ni-affinity purification step (Hi-Trap chelating 
HP Nickel column; GE Healthcare), the protein was purified by gel filtration 
(HiLoad Superdex 200 26/60; GE Healthcare), in a buffer containing 10 mM 
HEPES, 200 mM NaCl and 2 mM DTT, and concentrated to 7 mg/ml.
The DNA encoding the CNOT2 NOT-box domain (residues 429–540) was 
amplified from total human cDNA and inserted into the NdeI and BamHI restric-
tion sites of a pnYC vector downstream of a His6-MBP tag. The fusion protein was 
expressed in E. coli BL21 Star cells at 37 °C for 5 h and purified over a Ni-NTA 
column. After cleavage by HRV3C protease at 4 °C overnight, the His6-MBP tag 
was removed from the solution by binding to amylose resin and subsequent size-
exclusion chromatography (HiLoad 16/60 Superdex 75; GE Healthcare). Finally, 
the protein was purified with a MonoQ GL 15/50 column, dialyzed overnight 
into 10 mM CHES, pH 9.0, 100 mM NaCl and 1 mM DTT and concentrated 
to 3.5 mg/ml.
The DNA encoding the CNOT3 NOT-box domain (residues 656–753) was 
amplified by PCR using total human cDNA as template and inserted into the 
NcoI and KpnI sites of the pETM60 vector, which provides an N-terminal His6-
NusA tag (Novagen). The fusion protein was expressed in E. coli BL21 Star cells 
at 20 °C overnight. After initial purification with Ni-NTA affinity chromatogra-
phy, the His6-NusA tag was cleaved by TEV protease at 4 °C overnight. CNOT3 
was separated from the tag by size-exclusion chromatography (HiLoad 16/60 
Superdex 75, GE Healthcare) and concentrated to 4.5 mg/ml in 10 mM CHES, 
pH 9.0, 150 mM NaCl and 1 mM DTT.
To obtain selenomethionine-substituted proteins, the CNOT2 NOT-box, 
CNOT3 NOT-box and Ct NOT1-C proteins were expressed in minimal medium 
supplemented with selenomethionine39 and purified as described for the respec-
tive native proteins.
The trimeric complex consisting of CNOT1 (residues 1565–2371), CNOT2 
(residues 344–540) and CNOT3 (residues 607–753) was coexpressed in E. coli 
BL21 (DE3) Star cells in LB medium at 20 °C overnight. CNOT1 was expressed 
with an N-terminal His6-tag cleavable with TEV protease. CNOT2 and CNOT3 
were expressed from a bicistronic plasmid, wherein CNOT2 contained an 
N-terminal MBP tag cleavable by HRV3C protease, and CNOT3 contained a 
noncleavable His6 tag.
CNOT1, CNOT2 and CNOT3 were co-purified from crude lysates in 
lysis buffer (50 mM sodium phosphate, pH 7.5, 300 mM NaCl and 2 mM 
B-mercaptoethanol, supplemented with protease inhibitors, lysozyme and 
DNaseI) with amylose resin and eluted with lysis buffer supplemented with 
25 mM maltose. The purified complex was digested overnight with HRV3C and 
TEV proteases during dialysis into imidazole buffer (10 mM Tris-HCl, pH 8.6, 
200 mM NaCl, 2 mM B-mercaptoethanol, 10% glycerol and 20 mM imidazole). 
The complex was further purified by Ni-affinity chromatography and finally 
by size-exclusion chromatography (HiLoad Superdex 75 16/60 column; GE 
Healthcare) in gel-filtration buffer (10 mM Tris-HCl, pH 8.6, 200 mM NaCl and 
2 mM DTT). The ternary complex was subjected to limited proteolysis for 4.5 h 
in proteolysis buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 50 MM CaCl2 and 
2 mM DTT) supplemented with 21 Mg/ml thermolysin (Sigma-Aldrich) and 
separated from the protease and smaller CNOT1 fragments by gel filtration.
For the experiment shown in Supplementary Figure 4b, the ternary complex 
was assembled in 30 Ml of proteolysis buffer with CNOT2 (residues 344–540) and 
CNOT3 (residues 607–753) at a concentration of 0.3 mg/ml and 0.63 mg/ml 
CNOT1 (residues 1833–2361). The binary complex of CNOT2 (residues 344–
540) and CNOT3 (residues 607–753) was diluted in 30 Ml of proteolysis buffer 
to a concentration of 0.3 mg/ml. After addition of 8 Ml thermolysin (0.3 mg/ml) 
and incubation on ice, the reaction was stopped at different time points with 
10 Ml 5× SDS gel loading buffer and analyzed on a 15% SDS-PAGE gel.
Crystallization. Crystals of the native and selenomethionine-substituted 
Ct NOT1-C constructs were obtained by hanging-drop and sitting-drop vapor 
diffusion, respectively, at 18 °C and 22 °C. The best crystals for data collection and 
phase determination were obtained with selenomethionine-substituted protein, 
from a condition containing 0.1 M MES, pH 6.0, 0.18 M MgCl2, 5% PEG 20000 
and 10 mM proline with a 1:1 protein/reservoir ratio. Crystals were cryoprotected 
by addition of a final concentration of 25% glycerol to the reservoir solution and 
then flash-frozen in liquid nitrogen before data collection.
Crystals of the native CNOT2 NOT-box domain were grown by hanging-drop 
vapor diffusion at 18 °C. The protein solution was mixed in a 1:1 ratio with a 
reservoir solution containing 100 mM trisodium citrate, pH 5.6, 10% PEG 4000 
and 10% isopropanol. Crystals were optimized by hair seeding. Before being flash 
frozen in liquid nitrogen, the crystals were cryoprotected in the reservoir solution 
supplemented with 15% or 20% glycerol (final concentration). Crystals of the 
selenomethionine-substituted CNOT2 construct were obtained by sitting-drop 
vapor diffusion at 22 °C over a reservoir of 100 mM HEPES, pH 7.5, 10% PEG 
4000 and 10% isopropanol.
Crystals of the native and selenomethionine-substituted CNOT3 NOT-box 
domain were grown by hanging-drop vapor diffusion in a 1:1 protein/reservoir 
ratio, with the reservoir buffer containing 100 mM HEPES, pH 7.8, 13% PEG 
4000, 2% glycerol and 12% isopropanol at 18 °C. Crystals were optimized by hair 
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seeding and were flash frozen in liquid nitrogen. Glycerol (supplemented to 20% 
in the reservoir solution) was used as a cryoprotectant.
Crystals of the CNOT1–CNOT2–CNOT3 complex were obtained once in a 
single condition. They grew after one day by sitting-drop vapor diffusion at 22 °C 
in a drop consisting of 0.2 Ml of the protein complex solution (5 mg/ml) and 
0.2 Ml of the reservoir solution containing 0.1 M MES, pH 6.5 and 12% PEG 
20000. The crystals were cryoprotected with the reservoir solution supplemented 
with glycerol (15% final concentration) and flash frozen in liquid nitrogen.
Data collection, structure solution and refinement. All diffraction data sets 
were recorded on a PILATUS 6M detector at the PXII beamline of the Swiss Light 
Source (SLS) at a temperature of 100 K. Data sets for different crystal forms of Ct 
NOT1-C were collected at a wavelength of 0.97925 Å with high redundancy and 
processed with XDS40. Selenium sites were identified with data sets from crystal 
form I (space group P212121, 3.6 Å) with SHELX41. These sites were used to 
obtain phases, and an initial backbone model was built with PHENIX AutoSol42. 
This model was fed into Buccaneer43 from the CCP4 package44 for assigning and 
autobuilding side chains. The sequence register was confirmed by inspection 
of the anomalous difference Fourier maps from the selenomethionine data set, 
with peaks corresponding to the methionine positions. After several rounds of 
refinement in PHENIX45 and manual model improvement in Coot46, the model 
was used for molecular replacement (Phaser)47 with a data set of crystal form II 
(space group P1211, 3.2 Å). The structure was finalized by several cycles of man-
ual building in Coot and refinement in PHENIX against this high-resolution 
data set. For Ct NOT1, 98.3% of all residues lie in the favored regions of the 
Ramachandran plot, with outliers totaling 0.2%.
Data for the native CNOT2 NOT-box domain were collected at a wavelength 
of 1.0 Å, whereas data from selenomethionine-labeled crystals were recorded 
at a wavelength of 0.97925 Å (peak). The best native crystal of CNOT2 led to a 
data set of 2.4-Å resolution with space group P6522, whereas the best data set 
of selenomethionine-substituted protein reached a resolution of 3.4 Å with a 
space group of P41. Data sets were processed in XDS40. Initial selenium sites 
were identified by SAD with SHELX and refined with SHARP48. Additional sites 
were identified upon inspection of the anomalous difference density map and 
refined with SHARP. The resulting electron density map was used for initial 
model building with Buccaneer. The model was subsequently improved manually 
in Coot and refined with PHENIX. The high-resolution structure of the native 
protein was solved by molecular replacement (Phaser) with the structure of the 
selenomethionine-substituted protein as the search model. The structure of the 
native protein was finalized by iterative refinement cycles with PHENIX and 
model building in Coot.
The data sets for the CNOT3 NOT-box domain were collected at wavelengths 
of 0.9795 Å (peak) and 1.0000 Å (low-energy remote) and processed with XDS. 
Selenium sites were identified by SAD with SHELX. The heavy-atom model was 
further improved with SHARP as described for CNOT2. The model was ini-
tially built with Buccaneer and manually completed in Coot. Refinement was 
done in PHENIX against the low-energy remote data set, which had the highest 
resolution (2.4 Å). For the NOT-box domains of CNOT2 and CNOT3, there are 
98.3% and 97.4% of all residues in the favored regions of the Ramachandran plot, 
respectively, and no outliers.
Diffraction data for the complex of CNOT1–CNOT2–CNOT3 were recorded 
at a wavelength of 0.99999 Å. The best data set was processed and scaled with 
XDS/XSCALE. Initial phase information was obtained by molecular replace-
ment with Phaser, with the structure of Ct CNOT1-C as a search model. The 
initial electron density was improved by solvent flattening with PARROT49 from 
the CCP4 package, and the previously determined models of the CNOT2 and 
CNOT3 NOT-box domains were manually placed into the density map with 
Coot. The CNOT1 model was subsequently rebuilt with the sequence of the 
human protein. Additional parts of the structure, which primarily consisted of 
the N-terminal extensions of the CNOT2 and CNOT3 NOT-box domains, were 
manually built in Coot. The model was subsequently improved by iterative cycles 
of refinement and building with PHENIX and Coot. For the ternary complex, 
96.7% of all residues were in the favored regions of the Ramachandran plot, and 
there were no outliers. The correct stereochemical properties of all the structures 
were verified with MolProbity50, and structure figures were generated in PyMOL 
(http://www.pymol.org/). The data collection and refinement statistics are sum-
marized in Table 1.
Multiangle static laser light scattering (MALLS). The purified CNOT2 NOT-
box and CNOT3 NOT-box proteins were diluted to a final concentration of 
20 MM in their respective storage buffers. For both proteins, a volume of 100 Ml 
was loaded onto an analytical gel-filtration column (Superdex 200 10/300, 
GE Healthcare) connected to the miniDAWN TREOS and Optilab rEX instru-
ments (Wyatt Technologies). Samples were analyzed by static light scattering, and 
the absolute molecular weight of each protein was calculated from the MALLS 
data with ASTRA (Wyatt Technologies).
Functional assays in S2 cells. The adh-hsp70 reporter was described previ-
ously51. Cells were transfected with 300 ng of plasmid DNA for expression of 
the adh-hsp70 reporter per well in six-well plates. Knockdowns with dsRNA were 
performed as described previously18. For the measurement of the mRNA half-life, 
transfected cells were treated with actinomycin D (final concentration 5 Mg/ml) 
3 d after transfection and harvested at the indicated time points. Total RNA was 
isolated with TriFast (PeqLab Biotechnologies) and analyzed as described previ-
ously51. Adh-hsp70 mRNA levels were normalized to the levels of long-lived rp49 
mRNA and were plotted against time.
Original images of gels and western and northern blots used in this study can 
be found in Supplementary Figure 8.
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Supplementary Figure 1 CNOT1, CNOT2 and CNOT3 interact via their C-termini. (a,b) Interaction between GFP-tagged 
CNOT2 (full-length or fragments) and HA-tagged CNOT1 (a) and CNOT3 (b). GFP-tagged MBP served as a negative control. 
In all panels, cell lysates were treated with RNase A. (c,d) Interaction between GFP-tagged CNOT3 (full-length or fragments) 
and HA-tagged CNOT2 (c) and CNOT1 (d). (e,f) Interaction between GFP-tagged CNOT1 (full-length or fragments) and 
HA-tagged CNOT2 (e) and CNOT3 (f). In panel (f), the interaction with CNOT3 was analyzed in the absence (lanes 2 and 6) 
or presence (lanes 4 and 8) of CNOT2. (g) Interaction between MBP-CNOT2 fragments and His6-tagged CNOT1 (residues 
1565–2371). (h) Interaction between MBP-CNOT2 fragments and GST-CNOT3 (residues 589–753). (i) Interaction between 
MBP-CNOT2 (residues 344–540) and GST-CNOT3 fragments. (j) Interaction between MBP-CNOT1 (residues 1595–2376) 
and GST-CNOT2 (residues 344–540) or GST-CNOT3 (residues 589–753). 
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Supplementary Figure 2 Structure-based sequence alignment of the NOT1 superfamily homology (SH) domain. Secondary 
structure elements as determined from the Hs CNOT1 structure are shown above the alignment. Residues conserved in all aligned 
sequences are shown with a yellow background and residues with >70% similarity are highlighted in orange. Residues interacting 
with CNOT2 and CNOT3 are indicated by purple and green dots, respectively. Residues involved in CNOT1 subdomain interactions 
are indicated by blue dots. Residues mutated in this study are marked by red asterisks. Residues substituted in mutant M1 and M5 
are indicated. The species abbreviations are as follows: Hs (Homo sapiens), Dm (Drosophila melanogaster), Xt (Xenopus tropicalis), 
Ce (Caenorhabditis elegans), Ct (Chaetomium thermophilum) and Sc (Sacchromyces cerevisiae).
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Supplementary Figure 3 CNOT2 and CNOT3 multimerize in solution. (a,d) MALLS analysis of the CNOT3 and CNOT2 NOT-box domains, 
respectively. The molecular weight of the protein in solution is indicated in the elution profile. (b) Interfaces between the CNOT3 NOT-box 
α-helices and the β-barrel. Residues along the interfaces are shown as sticks. (c) Hydrophobic core of the CNOT3 NOT-box β-barrel.
(e) Structure of the CNOT2 tetramer as observed in the crystal. The tetramer consists of two pairs of dimers (orange-yellow vs. purple-rose) 
with a perpendicular orientation to each other. (f) Structure-based sequence alignments of the NOT2 and NOT3 NOT-box domains. 
Secondary structure elements as determined from the CNOT2 and CNOT3 structures are shown above the alignment. Residues conserved 
in all aligned sequences are shown with a yellow background, and residues with >70% similarity are highlighted in orange. A NOT2-specific 
insertion is boxed in purple. Black squares mark residues that form the interface between the NOT-Box N-terminal α-helices and the 
β-barrel. Gray squares mark residues that form the hydrophobic core of the β-barrel. The species abbreviations are the same as those in 
Supplementary Fig. 2. (g) Pulldowns showing that CNOT2-C and CNOT3-C exclusively form heterodimers in solution. MBP-tagged CNOT2 
and His6-tagged CNOT3 were coexpressed in E. coli. The heterodimers were copurified using MBP pulldown followed by Ni-affinity 
purification (lanes 1 and 2) or Ni-affinity purification followed by MBP pulldown (lanes 3 and 4). 
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Supplementary Figure 4 Structure of the NOT module. (a) Time course of a limited proteolysis of the ternary complex between CNOT1 
(residues 1565–2371), CNOT2 (residues 344–540) and CNOT3 (residues 607–753) by thermolysin. CNOT1 is digested into a stable 
C-terminal fragment corresponding to the SH and an N-terminal fragment (which comigrates with CNOT2), while CNOT2 and CNOT3 
remain uncleaved. (b) Time course of a limited proteolysis of CNOT2 (residues 344–540) and CNOT3 (residues 607–753) by thermolysin 
in the absence or presence of CNOT1 SH (1833–2361). In the absence of CNOT1, CNOT2 and CNOT3 are digested into stable C-terminal 
fragments corresponding approximately to the NOT-boxes and the CSs, but they remain largely uncleaved in the presence of CNOT1 
(c,d) Omit electron density map of the CNOT2 (c) and CNOT3 (d) NAR-Cs folded onto the CNOT1 surface. The electron density (black 
mesh, 2F0-FC of a composite omit map, calculated with Phenix.AutoBuild) is contoured at 1.0 σ. (e,f) Refined electron density of the 
CNOT2 (e) and CNOT3 (f) NAR-C regions in stereo view. The views correspond to panels (c) and (d), respectively. The electron density 
(black mesh, 2F0-FC map) is contoured at 1.0 σ. (g) Superposition of Ct NOT1 (blue) and Hs CNOT1 (gray) showing strong structure 
conservation. (h) Superposition of the CNOT3 NOT-box domain in isolation (gray) and in the complex (green). (i) Superposition of the 
NOT-box domains of CNOT2 (purple) and CNOT3 (green) as observed in the ternary complex. 
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Supplementary Figure 5 Structure-based sequence alignment of the CNOT2 and CNOT3. Secondary structure elements as 
determined from the CNOT2 and CNOT3 structure are shown above the alignment. Symbols are as described in Supplementary Fig. 2. 
Residues interacting with the respective partner proteins are indicated by dots above the alignments and are colored blue for CNOT1, 
purple for CNOT2 and green for CNOT3. Residues forming the lock are marked with black diamonds, and residues at the junction 
between the symmetric and asymmetric lobes of the ternary complex are marked with pink triangles. The species abbreviations are the 
same as those in Supplementary Fig. 2.
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Supplementary Figure 6 Surface conservation of the trimeric complex. (a–e) The conservation scores of the 
individual residues are represented on the surface by color gradients from light (no conservation) to dark colors 
(100% conservation) for CNOT1 (blue), CNOT2 (purple) and CNOT3 (green). Conservation scores were calculated 
based on well-balanced multiple alignments covering all eukaryotic strata. (a) View from the CNOT1 surface that 
binds CNOT2 and CNOT3 (a) or the opposite surface (b). Conservation of the CNOT1 surface contacting CNOT2 
and CNOT3 (c). The view is the same as that shown in Fig. 5a. (d) Conservation of CNOT2 surface residues 
contacting the CNOT3 connector sequence (CS). The CNOT3 residues involved in the interaction with CNOT2 are 
shown as sticks. (e) Conservation of CNOT3 surface contacting the CNOT2 connector sequence (CS). The CNOT2 
residues involved in CNOT3 binding are shown as sticks.
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Supplementary Figure 7 Mutagenesis of the NOT1-NOT2-NOT3 interfaces in human and Dm S2 cells. (a) Interaction of 
GFP-CNOT1 (either wild-type or the indicated mutants) with endogenous CNOT3 and HA-CNOT2. (b,c) Interaction of 
GFP-CNOT1 (either wild-type or the indicated mutants) with HA-CNOT7 in human cells. (d) The decay of the adh-hsp70 
mRNA was monitored in control cells (expressing MBP) and in cells expressing NOT1 (either wild-type or mutant). Adh-hsp70 
mRNA levels were normalized to the levels of long-lived rp49 mRNA and plotted against time. A representative Northern blot is 
shown in Fig. 7a. The mRNA half-lives (t1/2) ± standard deviations calculated from the decay curves obtained from three 
independent experiments are indicated. (e) Interaction of GFP-tagged Dm CAF1 with wild-type NOT1 or NOT1ΔN-SD in S2 
cells. F-Luc-GFP served as a negative control. (f,g) The decay of adh-hsp70 mRNA was analyzed in control cells (treated with 
GFP dsRNA and expressing MBP) or in cells depleted of NOT1 or NOT3 and expressing MBP or the indicated proteins. 
Northern blots corresponding to the decay curves are shown in Fig. 7c and 7d, respectively. Adh-hsp70 mRNA levels were 
normalized to the levels of rp49 mRNA and plotted against time. The mRNA half-lives (t1/2) ± standard deviations obtained 
from three independent experiments are indicated. 
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Supplementary Figure 8 Original images of gels, western and northern blots used in this 
study.
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Supplementary Table 1. Mutants used in this study 
 
Name Dm NOT1 Hs CNOT1 
ΔN-SD Δ1967-2251 Δ1844-2133 
M1 P2150Y, F2152C, 
E2158A, P2205Q, 
L2208E 
P2032Y, Y2036C, 
E2040A 
M2 P2150Y, F2152C, 
E2158A, P2205Q, 
L2208E, E2421A 
P2032Y, Y2036C, 
E2040A, P2087Q, 
I2090E, E2302A 
M3 P2150Y, F2152C, 
E2158A, P2205Q, 
E2421A, L2208E, 
R2215D 
P2032Y, Y2036C, 
E2040A, P2087Q, 
I2090E, R2097D, 
E2302A, I2313R 
M4  P2150Y, F2152C, 
E2158A, P2205Q, 
E2421A, L2208E, 
R2215D, I2432R 
 
M5  E2302A+I2313R 
M6  R2097D+I2313R 
CNOT1-N  1–1089 
CNOT1-M  1085–1605 
CNOT1-C  1595–2376 
 
 
Name Dm NOT2 Hs CNOT2 
ΔN-CS Δ 458−482 Δ 409−432 
ΔαN Δ 393−429 Δ 344−380 
ΔN-NAR-C Δ 429−453 Δ 380−404 
L7 W556E W507E 
CNOT2-N  1–352 
CNOT2-C  344–540 !!
Name Dm NOT3 Hs CNOT3 
ΔN-CS Δ 723−745 Δ 632−654 
ΔNAR Δ 698−725 Δ 607−634 
α2 F764E F673E 
CNOT3-N  1–241 
CNOT3-M  239–590 
CNOT3-C  589–753 !
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SUMMARY
CCR4-NOT is a major effector complex in miRNA-
mediated gene silencing. It is recruited to miRNA
targets through interactions with tryptophan (W)-
containing motifs in TNRC6/GW182 proteins and is
required for both translational repression and degra-
dation of miRNA targets. Here, we elucidate the
structural basis for the repressive activity of CCR4-
NOT and its interaction with TNRC6/GW182s. We
show that the conserved CNOT9 subunit attaches
to a domain of unknown function (DUF3819) in the
CNOT1 scaffold. The resulting complex provides
binding sites for TNRC6/GW182, and its crystal
structure reveals tandemW-binding pockets located
in CNOT9. We further show that the CNOT1 MIF4G
domain interacts with the C-terminal RecA domain
of DDX6, a translational repressor and decapping
activator. The crystal structure of this complex dem-
onstrates striking similarity to the eIF4G-eIF4A com-
plex. Together, our data provide themissing physical
links in a molecular pathway that connects miRNA
target recognition with translational repression,
deadenylation, and decapping.
INTRODUCTION
miRNAs are endogenous noncoding RNAs that associate with
Argonaute proteins (AGOs) into miRNA-induced silencing com-
plexes (miRISCs) and posttranscriptionally silence the expres-
sion of mRNAs containing complementary sequences (Ameres
and Zamore, 2013). In animals, most mRNA targets are only
partially complementary to the miRNA. As a result, even catalyt-
ically active AGOs cannot cleave the mRNA target and recruit
additional proteins to mediate silencing (Fabian and Sonenberg,
2012; Braun et al., 2013).
GW182 proteins are the best-characterized AGO-binding
partners required for miRNA-mediated silencing in animal
cells (Fabian and Sonenberg, 2012; Braun et al., 2013). There
are three GW182 paralogs (termed TNRC6A, TNRC6B, and
TNRC6C) in vertebrates and only one family member in
Drosophila melanogaster (DmGW182; Braun et al., 2013). These
proteins bind directly to AGOs via multiple GW (glycine and tryp-
tophan) repeats present in the N-terminal AGO-binding domain
and then recruit effector complexes, such as the CCR4-NOT
and PAN2-PAN3 deadenylase complexes (Braun et al., 2013).
Similar to the interaction with AGOs, GW182 proteins interact
with the deadenylase complexes through W-containing motifs,
which in this case are located in their C-terminal silencing do-
mains (SDs) (Figure 1A; Braun et al., 2011; Chekulaeva et al.,
2011; Christie et al., 2013; Fabian et al., 2011; Huntzinger
et al., 2013). The crystal structures of human AGO2 and Dm
PAN3 homodimers have revealed the molecular basis for their
interaction with the W-containing motifs in GW182 proteins
(Schirle and MacRae, 2012; Christie et al., 2013). However, it is
not known how the W motifs interact with the CCR4-NOT
complex.
The CCR4-NOT complex consists of several independent
modules that dock with the NOT1 subunit, which serves as a
scaffold for complex assembly (Wahle and Winkler, 2013).
NOT1 consists of an N-terminal (NOT1-N), middle (NOT1-M),
and C-terminal (NOT1-C) region (Figures 1A and S1A available
online). The NOT1-M region comprises two domains: a MIF4G
domain that is structurally related to the middle domain of
eIF4G and a domain of unknown function (DUF3819). The
MIF4G domain interacts with the catalytic module of the
CCR4-NOT complex, comprising the two deadenylases CAF1
(or its paralog POP2) and CCR4a (or its paralog CCR4b) (Wahle
and Winkler, 2013). The DUF3819 domain interacts with the
highly conserved Armadillo (ARM) repeat domain of the
CNOT9 subunit (Figure 1A; also known as CAF40, RQCD1, or
RCD1) (Bawankar et al., 2013). Importantly, the CNOT1-M region
has been shown to mediate the interaction of CCR4-NOT with
the silencing domain of TNRC6C (6C-SD) (Huntzinger et al.,
2013). Furthermore, the RNA helicase DDX6 (also known as
Dhh1, RCK/p54, or Me31B) also interacts with CNOT1 (Coller
et al., 2001; Hata et al., 1998; Maillet and Collart, 2002). DDX6
functions as a translational repressor and decapping activator
(Presnyak and Coller, 2013) and has previously been implicated
in the miRNA pathway (Chu and Rana, 2006; Eulalio et al., 2007;
Nishihara et al., 2013).
The CCR4-NOT complex not only mediates mRNA deade-
nylation, but it is also required both for the translational
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repression and degradation of miRNA targets (Braun et al., 2011;
Chekulaeva et al., 2011; Fabian et al., 2011; Huntzinger et al.,
2013; Zekri et al., 2013). miRNA target degradation is catalyzed
by the enzymes of the 50-to-30 mRNA decay pathway (Hunt-
zinger and Izaurralde, 2011). In this pathway, mRNAs are first
deadenylated by the CCR4-NOT complex, decapped by the
decapping enzyme DCP2 and additional coactivators, and
finally degraded from the 50 end by the exonuclease XRN1.
However, it has remained unclear whether and how decay
factors, including the decapping enzyme DCP2 and the 50
exonuclease XRN1, would be recruited directly by the CCR4-
NOT complex. Similarly, the mechanism of translational repres-
sion by CCR4-NOT has remained elusive, although it has
recently been proposed that the DEAD-box protein eIF4A2
may play a role (Meijer et al., 2013). In particular, it was sug-
gested that the CNOT1 MIF4G domain could recruit eIF4A2
via an interaction similar to the one observed in the eIF4G-
eIF4A complex (Meijer et al., 2013). eIF4A2 could then prevent
ribosome scanning by clamping onto the 50 UTR of the mRNA
(Meijer et al., 2013).
In this study, we investigated the molecular basis for the inter-
actions mediated by the human CNOT1-M region and its role in
silencing. We show that the CNOT1 DUF3819 domain forms a
binary complex with the ARM repeat domain of the CNOT9 sub-
unit and was hence termed the CN9BD (CAF40/CNOT9 binding
domain). We pinpoint the CN9BD-CNOT9 complex as a primary
binding site for the TNRC6 silencing domains (TNRC6-SDs) in
the CNOT1-M region. The crystal structure of the CN9BD-
CNOT9 complex shows that the CN9BD adopts a defined fold
that is recognized and stabilized by CNOT9 binding. This struc-
ture also reveals tandemW-binding pockets in CNOT9, suggest-
ing a mechanism for the recruitment of the CCR4-NOT complex
by W-rich GW182/TNRC6 proteins. Furthermore, we identified
the CNOT1 MIF4G domain as a specific binding partner for
DDX6 rather than eIF4A2. The crystal structure of the MIF4G-
DDX6 complex reveals an eIF4G-eIF4A-like interaction, which
is compatible with the simultaneous binding of CAF1 to the
MIF4G domain and the recruitment of decapping factors
(EDC3, LSm14A, or Pat) by DDX6. Together, our data now allow
us to trace the direct molecular interactions that ultimately lead
from miRNA target recognition to the translational repression,
deadenylation, and decapping of the mRNA target.
RESULTS
Dual Functions of the CNOT1 DUF3819 Domain in
TNRC6 and CNOT9 Binding
To pinpoint the TNRC6-SD binding site within the CNOT1-M re-
gion (Figures 1A andS1A), we performed coimmunoprecipitation
assays in human embryonic kidney 293T (HEK293T) cells. We
found that TNRC6A-SD and TNRC6C-SD interacted primarily
with the DUF3819 domain rather than with the MIF4G domain
(Figures 1B and 1C, lane 9), overlapping with the sequences
required to bind the ARM repeat domain of CAF40/CNOT9 in
human cells (Figures 1B and 1C, lane 9, and S1B) and in Dm
Schneider (S2) cells (Figure S1C; Bawankar et al., 2013). The
DUF3819 domain was therefore termed the CAF40/CNOT9
binding domain or CN9BD.
To elucidate the molecular basis for the observed interac-
tions, we expressed suitable protein constructs in Escherichia
coli (Table S1) and used specific tags for pull-down assays
(Figure S1B) and protein purification. The ARM repeat domain
of CNOT9 (residues 19–285) formed homodimers in solution,
as observed previously (Garces et al., 2007) and as con-
firmed by size-exclusion chromatography and multiangle static
laser light scattering (MALLS; Figure S1D). Protein constructs
corresponding to the CN9BD precipitated upon removal of
the solubility tag, indicating instability or improper folding
in the absence of CNOT9. However, several CN9BD con-
structs (residues 1,356–1,581, 1,356–1,607, and 1,356–1,628)
could be coexpressed and copurified with the ARM repeat
domain of CNOT9 (Figure S1B). Under these conditions, size-
exclusion chromatography and MALLS indicate the forma-
tion of a binary CN9BD-CNOT9 complex that appears to
be mutually exclusive with CNOT9 homodimerization (Figures
S1D and S1E).
We obtained crystals of the CN9BD-CNOT9 complex that
diffracted X-rays to a 1.65 A˚ resolution (Table 1). Crystals
were exclusively obtained using the CN9BD 1,356–1,607
construct, although a shorter construct (CN9BD 1,356–1,581)
was also soluble and formed a binary complex with CNOT9
(Figure S1B). In a bid to identify putative TNRC6 binding sites,
we also crystallized the complex in the presence of L-trypto-
phan (W). These crystals diffracted X-rays to a 2.05 A˚ resolution
(Table 1).
Figure 1. Structure of the CNOT1 CN9BD Bound to the CNOT9 ARM Repeat Domain
(A) Diagram of CNOT1 with N-terminal, middle, and C-terminal regions (CNOT1-N, CNOT1-M, and CNOT1-C, respectively). CNOT1-N consists of two HEAT-like
repeat domains. CNOT1-M contains an MIF4G domain and the CN9BD (previously DUF3819). CNOT1-C contains the NOT1 superfamily homology domain
(SHD). CNOT9 contains an armadillo (ARM) repeat domain. TNRC6C contains and N-terminal AGO-binding domain (ABD), a ubiquitin-associated-like domain
(UBA), and a C-terminal silencing domain (SD). The SD comprises a Mid region, an RNA recognition motif (RRM), and a C-terminal (C-term) region. The positions
of the CCR4-NOT interacting motifs 1 and 2 (CIM-1 and CIM-2) and the PAM2motif (PABP-interacting motif 2) are indicated. Vertical green and red lines indicate
the positions ofW-containingmotifs binding to AGOs and deadenylases, respectively. Amino acid positions at domain boundaries are indicated below the protein
outlines. See also Figure S1A.
(B and C)Western blot showing the interaction between GFP-CNOT1 fragments and HA-MBP-tagged CNOT9 and HA-tagged TNRC6A-SD (6A-SD) or TNRC6C-
SD (6C-SD) in HEK293T cells. GFP-F-Luc served as a negative control. See also Figures S1B–S1H.
(D and E) Overall structure of the CN9BD-CNOT9 binary complex in two orientations. CNOT9 is shown in cyan; the three long a helices in the CNOT1 CN9BD are
shown in pink, yellow, and green. Bound W residues are shown as magenta sticks. Secondary structure elements are labeled in blue for CNOT9 and in black for
CNOT1.
(F) Cartoon representation of the ARM repeat domain of CNOT9. The ARM repeats are colored in a gradient from pink to dark blue from the N to C terminus.
(G) Surface representation of the CN9BD-CNOT9 binary complex in the same orientation as that in (D) and colored according to surface potential contoured
from !5 kT/e (red) to +5 kT/e (blue). The position of the DNA/RNA binding surface is indicated. See also Figures S1F and S1G.
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Crystal Structures of the CN9BD-CNOT9 Complex
The structures were solved by molecular replacement using the
CNOT9 structure (Protein Data Bank ID code [PDB] 2FV2; Gar-
ces et al., 2007) as a search model and refined to final Rfree
values of 17.9% in the absence and 21.5% in the presence of
L-tryptophan (Table 1 and Figures 1D and 1E). Overall, the two
structures are highly similar and superpose with a root-mean-
square deviation (rmsd) of 0.16 A˚ over 431 Ca atoms. The
CN9BD-CNOT9 complex adopts a V-shaped architecture result-
ing from the rod-shaped CN9BD bound to the N-terminal,
convex surface of the crescent-shaped CNOT9 (Figure 1E).
CNOT9 consists of 17 a helices arranged into 6 imperfect ARM
repeats (Figures 1F and S2). The structure of CNOT9 in the com-
plex is virtually identical to the structure of the isolated CNOT9
ARM repeat domain (rmsd of 0.51 A˚ over 246 equivalent Ca
positions; Figure S1F; Garces et al., 2007), indicating that
CNOT9 does not undergo major structural rearrangements
upon binding to CNOT1. The CN9BD-CNOT9 interface partially
overlaps with the CNOT9 homodimerization interface, as deter-
mined from the structure of the isolated CNOT9 (Figure 1D
versus S1G and Figures S3A–S3D; Garces et al., 2007). This
observation explains why CNOT1 binding is mutually exclusive
with CNOT9 homodimerization. In both of these alternative com-
plexes, a positively charged cleft located on the opposite,
concave face of the CNOT9 crescent remains exposed and fully
accessible to interact with potential RNA or DNA ligands (Fig-
ure 1G; Garces et al., 2007).
Intriguingly, the C-terminal tail of the CN9BD (residues 1,589–
1,607) is largely disordered but required for crystallization. It
makes a crystal contact with a neighboring CNOT9 molecule,
inserting W1603 into a specific W-binding pocket (pocket 1).
Consequently, W1603 is clearly defined in both structures
(Figures 1D and 1E; W1); at 1.65 A˚ resolution, the back-
bone of the flanking residues 1,601–1,604 is also visible (see
below). A second W-binding pocket (pocket 2) on CNOT9
becomes apparent and occupied in the presence of addi-
tional L-tryptophan in the crystallization solution (Figures 1D
and 1E; W2).
CN9BD Folds into a Defined Domain Arranged as a
Three-Helix Bundle
In contrast to all CNOT1 subdomains structurally determined so
far, the CN9BD is not organized into HEAT-like repeats. Instead,
it is composed of seven a helices, with helices a2–a4 arranged as
an antiparallel, rod-shaped bundle of three kinked a helices (Fig-
ures 1D and 1E). These helices comprise 42–44 residues and are
kinked once (a3) or twice (a2 and a4). The side of the bundle that
binds CNOT9 is flanked by three additional short helices (helices
a5–a7; Figures 1E and S4). Two of these helices (a6 and a7),
together with the connecting loop L6, are part of the interaction
interface and are likely adaptable. In the crystal, their position
might also be influenced by packing interactions because loop
L6 and helix a6 contact the equivalent structural elements of a
neighboring symmetry mate (Figure S4B). However, a CNOT1
fragment lacking helix a7 (1,356–1,561) did not interact with
CNOT9 in solution (Figure S1B), indicating that these helices
and the spatial arrangement observed in the crystal are indeed
relevant for complex formation.
One remarkable structural feature of the CN9BD is that both
the N- and C-terminal peptides fold back on the three-helix
bundle, forming multiple hydrophobic interactions (Figures 2A,
2B, and S4C). As a result, the N and C termini of the domain
enter close proximity and form a main-chain contact between
Y1357 and F1582 (Figures 2A and 2B). Furthermore, the C-ter-
minal peptide (around P1580-G1581) becomes locked into its
conformation by interactions with CNOT9 residues V71 and
P75 (Figure 2C), consistent with the observation that a deletion
of the C-terminal peptide destabilizes the interaction between
the Dm proteins (Figure S1C). Overall, the CN9BD adopts a
rather unique protein fold that has no close structural homologs
in the PDB.
Table 1. Data Collection and Refinement Statistics
Data Set
CNOT1-
CNOT9
Complex
CNOT1-
CNOT9-W
Complex
CNOT1-
DDX6
Complex
Space group C2 C2 P21 21 21
Unit Cell
Dimensions
(a / b / c) (A˚)
154.8 / 67.2 /
72.3
154.1 / 66.8 /
72.0
43.9 / 90.8 /
95.8
Angles (a / b / g) (!) 90 / 99.6 / 90 90 / 100.3 / 90 90 / 90 / 90
Data Collection
Wavelength (A˚) 1.000 1.000 1.000
Resolution range (A˚) 76.3–1.65
(1.69–1.65)
61.1–2.05
(2.10–2.05)
65.9–1.75
(1.80–1.75)
Rsym (%) 2.9 (63.6) 6.0 (78.6) 5.3 (78.9)
Completeness (%) 99.5 (99.0) 99.5 (99.0) 99.2 (99.5)
Mean I/s(I) 19.8 (1.8) 14.9 (1.8) 17.1 (2.3)
No. of unique
reflections
87,658 (6,377) 45,149 (3,317) 39,120 (2,837)
Multiplicity 3.4 (3.4) 6.8 (6.4) 5.0 (5.0)
Refinement
Data range (A˚) 76.3–1.65 61.1–2.05 47.9–1.75
Rwork (%) 16.0 17.6 16.2
Rfree (%) 17.9 21.5 20.3
No. of Atoms per Asymmetric Unit
All atoms (no H) 4,590 4,178 3,386
Nonsolvent 4,116 4,030 3,193
Water 474 148 193
Average B Factor (A˚2)
All atoms 38.5 64.3 31.3
Nonsolvent 37.9 64.5 30.7
Water 43.6 58.7 41.3
Ramachandran Plot
Favored regions (%) 99.0 98.8 99
Disallowed
regions (%)
0 0 0
Root-Mean-Square Deviation from Ideal Geometry
Bond lengths (A˚) 0.011 0.006 0.011
Bond angles (!) 1.27 0.88 1.31
Values in parentheses are for highest-resolution shell.
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CNOT9Recognizes and Stabilizes the Fold of theCN9BD
The interface between CNOT1 and CNOT9 is larger than the
interface for CNOT9 homodimerization (3,170 A˚2 versus
2,005 A˚2; Figures S3B–S3D) and thus likely favored in vivo. It is
predominantly hydrophobic and centered on the first three
N-terminal ARM repeats (ARM1–ARM3) of CNOT9, which
engage a surface composed of helices a2, a3, a6, a7, loop L6,
and the very C-terminal end (C-term) of the CNOT1 CN9BD (Fig-
ures 1D, 1E, 2A, 2C, and 2D).
ARM1 includes an important serine (S30) and fixes loop L6
and helix a7, whereas ARM3, which includes an important
phenylalanine (F118), contacts helices a2 and a3 (Figure S2).
ARM2 makes numerous contacts, including each of the
CNOT1 interface elements. In particular, the central F60 in
the elbow loop L3, between ARM2 helices a3 and a4, and the
following helix a4 insert into a hydrophobic groove of the
CN9BD that is flanked by CNOT1 helices a2, a3, and a7 (Figures
2A–2D, S2, and S4). The respective interface residues include
F60 (L3), G61 (L3), A64 (a4), L67 (a4), V71 (a4), Y74 (L4), P75
(L4), and P79 (L4) on the side of CNOT9. On the side of
CNOT1, there are T1419 (a2), I1423 (a2), K1426 (a2), D1427
(a2), F1428 (a2), M1444 (a3), L1448 (a3), G1451 (a3), I1455
(a3), M1452 (a3), R1458 (a3), L1559 (L6), V1564 (L6), Q1568
(L6), L1569 (L6), V1571 (a7), Y1572 (a7), F1575 (a7), P1580
(C-term), and G1581 (C-term). These complex hydrophobic
contacts allow CNOT9 to recognize and stabilize the CN9BD
as a folded domain.
Additional polar flanking interactions provide further speci-
ficity and, in particular, allow helix a6 of the CN9BD to adapt to
the surface of CNOT9. Here, CNOT9 H58 plays an important
role. It is read out by water-mediated hydrogen bonds from
Q1549 (a6) and from the invariant lysine K1426 (a2) of the
CN9BD and additionally stacks on Y1548 (a6; Figure 2D).
To validate the interface, we initially generated single point
mutations, but these only reduced the interaction (e.g., F60A)
or had no effect (A64Y; Figure S4D). To disrupt the interface, it
was necessary to introduce four mutations in CNOT9 (Mut1;
H58A, F60A, A64Y, V71Y) or in the CNOT1 CN9BD (43M;
K1426S, G1451Y, R1458A, Q1549A; Figures S4D and S4E).
Importantly, the CNOT9 Mut1 retained the ability to homodimer-
ize (Figure S1H), indicating that themutations do not disrupt pro-
tein folding.
For in vivo coimmunoprecipitation assays in HEK293T cells, it
was also necessary to use the quadruple CNOT9 mutation
(Mut1) to disrupt the interaction with full-length CNOT1 or with
the CNOT1-M region (Figures 2E and S4F). In CNOT1, it was
even necessary to generate a quintuple mutation (53M;
I1423D plus 43M) because the quadruple mutation still showed
residual binding (Figures 2F and S4G). These results are consis-
tent with a rather extensive and high-affinity interaction.
Finally, to demonstrate the conservation of the interface, we
repeated the coimmunoprecipitation experiments in Dm S2
cells. Notably, double mutations in CNOT9 and single G1562E
or K1537S mutations in CNOT1 (corresponding to human
G1451 and K1426) were sufficient to disrupt the interaction in
this case (Figures 2G, 2H, and S4H). These results suggest
that the interface is indeed conserved, but that affinities may
vary among orthologs.
CNOT9 Harbors Tandem Tryptophan-Binding Pockets
Perhaps one of the most striking features of the CNOT1-CNOT9
structure is the presence of tryptophan residues bound to tan-
dem hydrophobic pockets in CNOT9. These pockets are located
on ARM5, on either side of the kink between helices a12 and a13,
on the convex surface of the crescent (Figures 3 and S2).
Pocket 1 is flanked by helix a15 of ARM6 and lined by residues
C200, Q201, T202, Y203, F206, R244, A245, and A248 (Figures
3A–3C). It accommodates W1603 (W1) from a symmetry-related
CNOT1 molecule in both crystal structures. W1603 stacks be-
tween Y203 and R244 and is specifically recognized on its N7 ni-
trogen by the carbonyl group of C200 (Figures 3A–3C). Pocket 2
is flanked by helix a10 of ARM4 and lined by residues I164, P165,
L168, Y198, I199, R205, H208, and V209. It accommodates a
free L-tryptophan (W2) that is absent in the high-resolution struc-
ture obtained in the absence of L-tryptophan in the crystallization
condition. W2 stacks between P165 and R205 and is also recog-
nized specifically on its N7 nitrogen by a hydrogen bond to H208
(Figures 3B, 3D, and S2).
Similar to the situation in the AGO2 structure, the distance be-
tween the two bound tryptophan residues is 20–25 A˚. This is a
typical intervening distance between tryptophan residues in
TNRC6 proteins and can be spanned by approximately 8–10 res-
idues in an extended conformation (Schirle and MacRae, 2012).
The CNOT9 W-Binding Pockets Are Binding Sites for
GW182/TNRC6 Proteins
To test whether the W-binding pockets in CNOT9 represent
bona fide binding sites for TNRC6 proteins, we substituted
residues lining the pockets and performed pull-down assays
in vitro. In pocket 1, we substituted A248 with phenylalanine to
fill the cavity with a bulky side chain. We also substituted Y203
and R244 with alanine to prevent stacking interactions. In pocket
2, we substituted P165with glycine and R205with alanine to pre-
vent stacking interactions and H208 with alanine to prevent spe-
cific recognition of theW ligand via hydrogen bonding (Table S1).
We observed that the TNRC6A-SD (6A-SD), which was ex-
pressed in E. coli with a maltose-binding protein (MBP) tag,
pulled down CNOT9 in the absence of CNOT1, indicating that
the interaction is direct (Figures 4A, lane 7, and 4B). Furthermore,
efficiently disrupting this interaction required mutating both
W-binding pockets simultaneously, demonstrating that they
are indeed responsible for binding TNRC6 SDs (Figure 4A, lanes
10–12 as compared to lanes 8 and 9). Similar results were
obtained for the TNRC6C-SD (Figure S5A). Importantly, the
mutations in the W-binding pockets did not affect CNOT9
homodimerization (as shown by MALLS; Figures S5B–S5G) or
binding to the CNOT1 CN9BD (Figure S5H), indicating that the
mutations do not disrupt the CNOT9 fold.
Finally, a complex containing the CN9BD bound to the CNOT9
P1+P2a mutant did not interact with the 6A-SD (Figure S5I), indi-
cating that the W-binding pockets in CNOT9 represent the pri-
mary binding sites for TNRC6 proteins in the CN9BD-CNOT9
complex and that the CN9BD is not sufficient to recruit TNRC6
proteins.
Next, we investigated the contribution of the CNOT9 W-bind-
ing pockets to TNRC6 binding in a cellular context. To this end,
the mutations described above were introduced into full-length
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Figure 2. The CN9BD-CNOT9 Binding Interface
(A–D) Overview and close-up views of the interface between the CNOT1 CN9BD and the CNOT9 ARM domain, with selected interface residues shown as
sticks. Residues mutated in this study are underlined and shown as red sticks (CNOT1) or dark blue sticks (CNOT9). The small and large rectangles in (A)
indicate the views shown in (C) and (D), respectively. Residues and secondary structure elements are labeled in black for CNOT1 and in blue for CNOT9.
Hydrogen bonds are shown as red dashed lines. See also Figures S2–S4.
(E) Interaction of GFP-CNOT9 (full-length wild-type or quadruple mutant, Mut1) with HA-CNOT1 (full length) in human cells. See also Figure S4.
(legend continued on next page)
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CNOT9 and tested for interaction with TNRC6s. The CN9BD-
CNOT9 complex interacts with the 6A-SD and 6C-SD (Figures
4C and S5J, lane 8). These interactions were abolished by muta-
(F) Interaction of GFP-CNOT1 (full-length wild-type or mutants) with CNOT9-HA-MBP in HEK293T cells.
(G) Interaction of GFP-tagged Dm NOT9 (wild-type or mutants) with HA-NOT1 in Dm S2 cells.
(H) Interaction of GFP-tagged Dm NOT9 with HA-NOT1 (wild-type or mutants) in Dm S2 cells. In all panels, cell lysates were treated with RNase A prior to
immunoprecipitation. See also Figure S4 and Table S1.
A
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Figure 3. CNOT9 Harbors Tandem W-Bind-
ing Pockets
(A) Overview of the CN9BD-CNOT9 complex is
shown for orientation. The W residues (W1 and
W2 corresponding to CNOT1 W1603 and free W,
respectively) bound to CNOT9 are shown as sticks.
(B) Close-up views of the W-binding pockets. The
right panel shows a surface representation of the
view in the left panel, with the CNOT9 surface
colored white to yellow with increasing hydropho-
bicity (scores according to Kawashima et al., 2008).
(C and D) Close-up views of W-binding pocket 1 (C)
(high-resolution structure) and W-binding pocket 2
(D) (low-resolution structure). The electron differ-
ence densities (Fo-Fc, contoured at 2.5 s) for the
W-containing peptide and the free W residue are
shown as a gray mesh, and the corresponding
structural models are displayed as magenta sticks.
Residues mutated in this study are underlined.
Hydrogen bonds are shown as red dashed lines.
See also Figures S2 and S4 and Table S1.
tions in the CNOT9 W-binding pockets
(Figures 4C and S5J, lanes 9–11). As ex-
pected, the pocket mutations did not
interfere with CNOT1 binding (Figures
4C, 4D, and S5J). Surprisingly, CNOT9
Mut1, which cannot interact with CNOT1,
also failed to interact with the TNRC6 pro-
teins (Figures 4C and S5J, lane 12),
although this mutant interacts with the
6A-SD in vitro (Figure 4B, lane 12). These
observations suggest that, in vivo,
CNOT9 only binds TNRC6s when it is
assembled into the CCR4-NOT complex.
Importantly, CNOT1 (or the CCR4-NOT
complex) provides binding sites for
TNRC6s independentlyofCNOT9because
full-length CNOT1 mutants (43M and
53M) that are defective in binding CNOT9
(Figure 2F) still interact with 6C-SD and
6A-SD (Figures 4E and S5K).
To investigate whether the role of the
W-pockets in NOT9 is conserved, we
performed similar coimmunoprecipitation
assays with the Dm NOT9 and GW182
proteins in Dm S2 cells. In agreement
with the results in human cells, we made
the following observations. First, the
NOT9 W-binding pockets are the major
GW182-binding sites in the CN9BD-
NOT9 complex because mutations in these pockets abrogate
the interaction with GW182 without affecting complex formation
(Figure 4F, lanes 8–11). Second, NOT9 interacts with GW182
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only when bound to NOT1 in cell lysates (Figure 4F, lane 12).
Third, an extended M region of NOT1 is sufficient for binding to
GW182 proteins, independent of CNOT9 (Figures S5L and
S5M, lane 6 versus 5).
Collectively, our results indicate that CNOT1 (or the CCR4-
NOT1 complex) provides multiple binding sites for GW182/
TNRC6 proteins, with two sites located in the CN9BD-CNOT9
module. The presence of multiple binding sites in CNOT1 is
consistent with the observation that the GW182/TNRC6 pro-
teins contact CNOT1 through multiple W-containing motifs that
A B
C
D
E
F
G H
Figure 4. The CNOT9 W-Binding Pockets
Mediate Binding to the TNRC6s
(A) MBP pull-downs using recombinant MBP-
tagged 6A-SD and His-tagged CNOT9 ARM
domain (wild-type or the indicated mutants). MBP
served as a negative control. See also Figure S5.
(B) MBP pull-downs using recombinant MBP-
tagged 6A-SD and His-tagged CNOT9 ARM
domain (wild-type or the indicated mutants).
(C) Interaction between GFP-CNOT9 (wild-type
or the indicated mutants) and HA-6A-SD in the
presence of HA-MBP-tagged CN9BD in HEK293T
cells.
(D) Interaction between GFP-CNOT9 (wild-type or
the indicated mutants) and full-length HA-CNOT1
in HEK293T cells.
(E) Interaction between GFP-CNOT1 (wild-type or
the 43M and 53M mutants that do not bind
CNOT9) and HA-6A-SD in HEK293T cells.
(F) Interaction between GFP-CNOT9 (wild-type or
the indicated mutants) and HA-GW182 in the
presence of HA-tagged CN9BD in Dm S2 cells.
See also Figure S5 and Table S1.
(G) HeLa cells (transfected with a control shRNA)
or cells depleted of CNOT1were transfectedwith a
mixture of three plasmids: the psiCHECK-83Let-7
or the corresponding reporter carrying mutations
in Let-7-binding sites (R-Luc-Mut), a plasmid ex-
pressing F-Luc as a transfection control, and a
plasmid expressing shRNA-resistant versions of
GFP-CNOT1 (wild-type or 53M mutant) or GFP.
For each condition, Renilla luciferase activity was
measured, normalized to that of the F-Luc trans-
fection control, and set at 100% in cells expressing
R-Luc-Mut (black bars). Mean values ± SD from
five independent experiments are shown.
(H) Western blots showing the efficiency of the
CNOT1 knockdown and the expression levels of
endogenous CNOT9. Dilutions of control cell
lysates were loaded in lanes 1–4 to estimate the
efficacy of the depletion. a-tubulin served as a
loading control. The asterisk indicates the position
of the GFP-CNOT1 used in the complementation
assay. See also Figures S5N and S5O.
contribute additively to the interaction
(Braun et al., 2011; Chekulaeva et al.,
2011; Fabian et al., 2011; Huntzinger
et al., 2013).
In agreement with the redundancy of
binding sites, we observed that the
CN9BD-CNOT9 interaction contributes
to, but is not essential for, silencing. Indeed, the CNOT1 53M
mutant that does not interact with CNOT9was still able to rescue
silencing of a Let-7 reporter (psiCHECK-83Let-7; Iwasaki et al.,
2009) in cells depleted of endogenous CNOT1, although not as
efficiently as wild-type CNOT1 (Figure 4G). Western blot analysis
indicated that the levels of CNOT1 in the depleted cells were
reduced to 10% of the control levels (Figure 4H). Interestingly,
CNOT9 levels were also strongly reduced, suggesting that
CNOT9 is destabilized in the absence of CNOT1 (Figure 4H,
lane 5). In contrast, the levels of endogenous AGO2 and TNRC6A
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were not affected (Figure S5N). The CNOT1 proteins were ex-
pressed at comparable levels (Figure S5O). We conclude that
the W-binding pockets in CNOT9 assist in the recruitment of
the CCR4-NOT complex to miRNA targets.
The MIF4G Domain of CNOT1 Interacts with DDX6
To investigate the hypothesis that the CNOT1 MIF4G domain
could directly recruit eIF4A2, we performed coimmunoprecipita-
tion assays using HEK293T cell lysates treated with ribonuclease
A
B C D
E F
G H
I J
Figure 5. Structure of the CNOT1 MIF4G
Domain Bound to the DDX6 RecA-C Domain
(A) DDX6 consists of two RecA-like domains,
termed RecA-N and RecA-C, connected by a
flexible linker.
(B–D) Interaction of GFP-CNOT1 or GFP-eIF4G
with HA-tagged DDX6 (B), eIF4A1 (C), or eIF4A2 (D)
in HEK293T cells. See also Figure S6.
(E and F) Overall structure of the CNOT1 MIF4G-
DDX6 RecA-C complex (this study) (E) and
the Saccharomyces cerevisiae eIF4G MIF4G-
eIF4A complex (2VSO; Schu¨tz et al., 2008) (F).
Selected secondary structure elements are
indicated.
(G and H) Close-up views of the interface between
the CNOT1 MIF4G domain and the DDX6 RecA-C
domain showing the DDX6 arginine anchor residue
R375 (G) and loop L3 (H). Selected interface resi-
dues are shown as sticks and colored green
(CNOT1) or orange (DDX6). Residues and sec-
ondary structural elements are labeled in green for
CNOT1 and in black for DDX6. Residues mutated
in this study are underlined.
(I) Superposition of Sc eIF4A loop L3 (residues
255–262) onto Hs DDX6 L3 (329–336). Selected
interface residues in loop L3 of the DDX6 and
eIF4A RecA-C domains are shown as sticks and
colored in orange (DDX6) and gray (eIF4A). The
CNOT1 MIF4G residues that specifically form
hydrogen bonds with DDX6 residues are shown in
green. The residues that contribute to the speci-
ficity of the interaction are underlined and shown in
bold. eIF4A residues are labeled in italics. Back-
bone cartoons of Sc eIF4G and eIF4A are omitted
for clarity.
(J) A structural model built by superposition of
DDX6 bound to the EDC3 FDF peptide (PDB
2WAX), DDX6 bound to the CNOT1MIF4G domain
(this study), and the CNOT1MIF4G bound to CAF1
(PDB 4GMJ). The RNA is modeled based on the
structure of Vasa bound to RNA (PDB 2DB3). See
also Figure S6J.
A (RNase A). We included eIF4A1 as well
as DDX6 (Figure 5A) because this helicase
has previously been shown to interact
with the CCR4-NOT complex in yeast
and Dm cells (Coller et al., 2001; Hata
et al., 1998; Maillet and Collart, 2002;
Temme et al., 2010).
We could not observe an interaction
between the CNOT1 MIF4G domain
and either eIF4A2 or eIF4A1, but we obtained a clear signal
with DDX6 (Figures 5B–5D, lane 5). Conversely, eIF4G
interacted with both eIF4A1 and eIF4A2 as expected (Yoder-
Hill et al., 1993) but exhibited no affinity for DDX6 (Fig-
ures 5B–5D, lane 6), indicating that the respective interactions
are specific. Further studies indicated that the C-terminal
RecA (RecA-C) domain of DDX6 interacted with the CNOT1
MIF4G domain and that this interaction was direct (Figures
S6A–S6D).
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Crystal Structure of CNOT1 MIF4G-DDX6 RecA-C
Complex
To understand themolecular basis for the CNOT1-DDX6 interac-
tion, we cocrystallized the CNOT1 MIF4G domain with the DDX6
RecA-C domain and determined the structure of the complex at
a 1.75 A˚ resolution with a final Rfree of 20.3% (Table 1). Themodel
contains all residues of the CNOT1 MIF4G domain, as well as all
residues from the DDX6 RecA-C domain, with the exception of
the DDX6 C-terminal residues (454–472). The structures of the
two domains from the complex superpose very well with the pre-
viously reported structures of the MIF4G domain in isolation
(rmsd 0.34 A˚; Petit et al., 2012) and the DDX6 RecA-C domain
bound to EDC3 (rmsd 0.37 A˚; Tritschler et al., 2009), indicating
that the domains do not undergo major structural rearrange-
ments upon binding.
Most importantly, the arrangement of the CNOT1 MIF4G and
DDX6 RecA-C domains is highly similar to the arrangement of
the complex of the eIF4G MIF4G domain bound to eIF4A
RecA-C (Figures 5E and 5F; Schu¨tz et al., 2008), adding to a
growing number of structurally similar, yet specific, MIF4G-
RecA-C complexes (Buchwald et al., 2013). Similar to the
eIF4G-eIF4A interaction, the RecA-C domain binds the concave
surface of the MIF4G domain, and the interface is formed by
equivalent secondary structural elements. In particular, helix a1
and the loops L3, L5, and L7 of the RecA-C domains interact
with the first two N-terminal HEAT repeats of the MIF4G domain,
A B
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Figure 6. Validation of the CNOT1 MIF4G-
DDX6 Binding Interface
(A) Interaction between HA-DDX6 (wild-type or the
indicated mutants) and GFP-CNOT1 in HEK293T
cells. GFP-MBP served as negative control.
(B) MBP pull-downs using recombinant MBP-
tagged CNOT1 MIF4G domain and His-tagged
DDX6 RecA-C (wild-type or the R375A mutant).
MBP served as a negative control.
(C) Interaction between GFP-CNOT1 (wild-type or
the indicated mutants) and HA-DDX6 in HEK293T
cells. See also Figure S6 and Table S1.
(D) Western blots showing the efficiency of the
DDX6 knockdown. Dilutions of control cell lysates
were loaded in lanes 1–4 to estimate the efficacy of
the depletion. a-tubulin served as a loading con-
trol. The asterisk indicates the position of the
HA-DDX6 used in the complementation assay
shown in (E).
(E) A complementation assay was performed as
described in Figure 4G in cells depleted of DDX6.
Mean values ± SD from three independent ex-
periments are shown. See also Figures S5N, S6E,
and S6H.
(F) Western blot analysis showing the equivalent
expression of the DDX6 proteins used in the
complementation assay.
including mainly residues from helix a1
and a3 plus their adjacent interrepeat
loops L2 and L4 (Figures 5G and 5H).
The interface area in the CNOT1-DDX6
complex is relatively small (640 A˚2) and
dominated by polar interactions. Of particular interest is R375
in loop L7 of DDX6 (Figure 5G), which inserts deeply into a highly
conserved patch in CNOT1 and makes hydrogen bonds with the
main-chain oxygens of CNOT1 residues F1103 (helix a1) and
L1106 (loop L2) while stacking onto F1145 (loop L4). This arginine
is remarkably conserved in eIF4A1, eIF4A2, eIF4A3, and other
DEAD-box proteins (Figure S6I) and plays an equivalent role in
mediating interactions with MIF4G domains (Buchwald et al.,
2013; Schu¨tz et al., 2008). Consequently, this ‘‘arginine anchor’’
likely contributes significantly to the affinity of MIF4G-RecA-C in-
teractions, but does not explain the specificity of individual pairs.
This situation is different for residues R320, Q322, and N324 in
loop L3 of DDX6 (Figures 5H and 5I). Although the length of
this specificity loop is identical in eIF4A1-3 and other DEAD-
box helicases, the sequence is not, thereby allowing the forma-
tion of unique polar contacts to residues E1097, R1138, E1142,
and N1144 of CNOT1 and explaining the preference of CNOT1
for DDX6 (Figures 5H, 5I, and S6I).
To validate the interface experimentally, we mutated specific
interface residues to alanine and performed pull-downs and
coimmunoprecipitation assays. In DDX6, we substituted the
anchor arginine (R375) or both Q322 and N324 (Q,N) from the
specificity loop. These mutations abolished or strongly reduced
binding of DDX6 to CNOT1 full length, the CNOT1-M fragment,
or the MIF4G domain (Figures 6A, 6B, and S6E–S6G). In
CNOT1, the deletion of helix a1 and loop L2 (CNOT1 Dhl) led
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to a reduced interaction with DDX6, which was disrupted
completely when we additionally substituted R1138 (in a3) and
N1144 and F1145 in loop L4 with alanine (Figure 6C, lanes
9–12, and S6H). Importantly, the mutations did not destroy the
fold of the MIF4G domain because CAF1 binding was not
affected (Figure S6H).
A Role for the CNOT1-DDX6 Interface in Silencing
To test the functional relevance of the CNOT1-DDX6 interaction
in silencing, we used the complementation assay described
above with the exception that DDX6 was depleted. Western
blot analysis indicated that the levels of DDX6 in the depleted
cells were reduced to 10% of the control levels (Figure 6D),
without affecting endogenous AGO2 and TNRC6A expres-
sion (Figure S5N). In DDX6-depleted cells, silencing of the
psiCHECK-83Let-7 reporter was suppressed, leading to a
7-fold increase in F-Luc activity (Figure 6E), in agreement with
previous studies (Chu and Rana, 2006; Eulalio et al., 2007).
Silencing was rescued by expression of an shRNA-resistant
version of wild-type DDX6, but not by the DDX6 R375A mutant,
whereas the Q322A N324A double mutant was partially active
(Figure 6E), in agreement with its residual binding to CNOT1
(Figure S6E, lane 12). The DDX6 proteins were expressed at
similar levels (Figure 6F). These levels were comparable to the
levels of endogenous DDX6 in control cells (Figure 6D, lane 6
versus lane 1). Our data support a role for the DDX6-CNOT1
interaction in silencing.
The CNOT1 MIF4G Domain Is a Central Node for
CCR4-NOT Function
Structural superposition of the human CNOT1MIF4G-DDX6 and
CNOT1MIF4G-CAF1 complexes demonstrates that CNOT1 can
bind DDX6 and the CAF1 deadenylase simultaneously (Figures
5J and S6J). Similar superpositions show that the interaction of
the DDX6 RecA-C domain with the isolated CNOT1 MIF4G
domain does not interfere structurally with the recruitment of
either EDC3, LSm14A, or Pat to their common binding surface
on DDX6 RecA-C (reviewed by Jonas and Izaurralde, 2013).
Together, these interactions provide a missing direct physical
link between the major deadenylation complex (CCR4-NOT)
and the decapping network where EDC3 and Pat act as decapp-
ing activators. In other words, the interaction of DDX6 with the
CNOT1 MIF4G domain provides a plausible molecular explana-
tion for the coupling of deadenylation to decapping and for the
ability of the CCR4-NOT complex to repress translation in the
absence of deadenylation. TNRC6-binding to the adjacent
CN9BD-CNOT9 complex illustrates how the CCR4-NOT com-
plex is recruited to miRNA targets.
DISCUSSION
The mechanisms by which the CCR4-NOT complex is recruited
to miRNA targets and represses translation have remained
elusive. Here, we show that the middle region of CNOT1 assists
in the recruitment of the complex tomiRNA targets viaW-binding
pockets in the CN9BD-CNOT9 module and orchestrates deade-
nylation, translational repression, and decapping via the MIF4G
domain, which can bind to the CAF1 and CCR4 deadenylases
and to the translational repressor and decapping activator
DDX6. Notably, similar findings are reported by Mathys et al.
(2014) in this issue.
The Functional Repertoire of CNOT9
In this study, we reveal an unexpected role for the highly
conserved CNOT9 subunit of the CCR4-NOT complex in
miRNA-mediated gene silencing. CNOT9 is required for retinoic
acid-induced cell differentiation in mammals and is overex-
pressed in breast cancer cells (Hiroi et al., 2002; Ajiro et al.,
2009). However, it remains unclear whether the role of CNOT9
in cell differentiation and proliferation is linked to or independent
of its role as subunit of the CCR4-NOT complex. Through our
structural analysis, we have generated CNOT9 mutants that
retain the ability to homodimerize but are not incorporated in
the CCR4-NOT complex, which provides an important tool to
study CNOT9 function in vivo.
CNOT9 interacts with several protein partners in different
cellular contexts. These interacting partners include Grb10 inter-
acting proteins GIGYF1 and GIGYF2 that are involved in
epidermal growth factor receptor (EGFR) signaling (Ajiro et al.,
2009). Notably, GIGYF2 (also known as TNRC15) is aW-rich pro-
tein, which raises the possibility that some CNOT9 partners may
compete with TNRC6s for binding to the W pockets. Clearly, the
identification of the W-binding pockets increases the functional
repertoire of CNOT9 that needs to be considered when studying
CNOT9 function.
Interaction of GW182 Proteins with Their Binding
Partners
GW182 proteins interact with AGOs and the PAN2-PAN3 and
CCR4-NOT deadenylase complexes through W-containing mo-
tifs (Fabian and Sonenberg, 2012; Braun et al., 2013). Previous
studies on the interaction of these motifs with AGOs and PAN3
indicate that molecular recognition is predominantly restricted
to the W residues, which insert into hydrophobic pockets on
the respective protein partners (Schirle and MacRae, 2012;
Christie et al., 2013; Pfaff et al., 2013).
Here, we show that this mode of molecular recognition is also
observed for the interaction of GW182 proteins with the CN9BD-
CNOT9 complex. This raises the question of how binding spec-
ificity and affinity are achieved. One possibility is that the flanking
sequences and the spatial arrangement of the Ws contribute to
the affinity of the interaction (Schirle and MacRae, 2012; Pfaff
et al., 2013). For example, a common feature of the W-binding
pockets in AGO2 and CNOT9 is that the spatial arrangement of
the pockets is similar, and both proteins can accommodate
consecutive W residues provided that they are at least 8–10 res-
idues apart (this study; Schirle and MacRae, 2012; Pfaff et al.,
2013). Concerted binding of adjacent W residuesmay contribute
to the affinity of the interaction via additive or avidity effects.
A remarkable aspect of the interaction of GW182 proteins with
the CCR4-NOT complex is that it involves multiple binding sites
(in addition to the ones identified on CNOT9), presumably lead-
ing to higher affinity and specificity. The precise location of these
additional sites remains unclear because the isolated CNOT1-N,
MIF4G, and CNOT1-C regions do not detectably interact with
TNRC6s in coimmunoprecipitation assays. However, these
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regions seem to synergize in the context of full-length CNOT1
because a CNOT1 mutant that does not bind CNOT9 retains
full TNRC6-binding capacity (Figures 4E and S5M). A key direc-
tion for future work will be to identify these multiple and redun-
dant binding sites and determine how they contribute to the
recruitment of the CCR4-NOT complex to miRNA targets.
CNOT1-M Coordinates Deadenylation, Translational
Repression, and Decapping
MIF4G domains are present in a wide variety of proteins and
have been shown to interact with and regulate the activity of
DEAD-box proteins (Buchwald et al., 2013). The MIF4G domain
of eIF4G specifically binds to eIF4A1 (Schu¨tz et al., 2008).
Remarkably, other MIF4G domain-containing proteins, such as
DAP5, CWC22, and Gle1, interact with the RecA-C domains of
eIF4A1, eIF4A3, and Dbp5, respectively, using a recognition
mode similar to that observed in the eIF4G-eIF4A complex (re-
viewed by Buchwald et al., 2013). Based on these observations,
it has been proposed that the CNOT1 MIF4G domain interacts
with eIF4A2 (Meijer et al., 2013). Here, we show that the
CNOT1 MIF4G domain interacts preferentially with DDX6. The
binding specificity is imparted by a few amino acid substitutions,
in particular in loop L3 of the RecA-C domains, which establish
specific hydrogen bonds (Figure 5I).
DDX6 plays a role in repressing translation by slowing transla-
tion elongation (Presnyak and Coller, 2013). Its role as an acti-
vator of decapping has been proposed to be an indirect
consequence of the inhibition of translation (Presnyak and
Coller, 2013). However, DDX6 interacts directly with the decapp-
ing factors EDC3 and Pat and indirectly with the catalytic core of
the decapping complex formed by the decapping enzyme DCP2
and its coactivator DCP1 (Jonas and Izaurralde, 2013). Thus,
DDX6 could play a direct role in decapping by promoting recruit-
ment of decapping complexes to the mRNA target. These
observations, together with our studies, indicate that the
CNOT1-DDX6 complex provides a missing direct physical link
between deadenylation and decapping.
The structure of the NOT1-DDX6 complex together with avail-
able structures of DDX6 bound to EDC3, EDC3 bound to meta-
zoan DCP1, and the Dcp1-Dcp2 complex (reviewed by Jonas
and Izaurralde, 2013) present snapshots of consecutive steps
in the 50-to-30 mRNA decay pathway. Along with the structure
of the CN9BD-CNOT9 complex, these structures establish a
chain of physical interactions to describe in molecular terms
how the CCR4-NOT complex is recruited to miRNA targets
and enrolls a translational repressor, which in turn engages the
decapping machinery (Figures 5J and S6J).
EXPERIMENTAL PROCEDURES
DNA constructs are described in detail in the Supplemental Information.
Mutations used in this study are listed in Table S1.
Pulldowns, Coimmunoprecipitation Assays, and Western Blotting
Coimmunoprecipitation assays in human and Dm S2 cells were performed as
previously described (Bawankar et al., 2013; Braun et al., 2011). Antibodies
used in this study are listed in Table S1. All western blots were developed using
the ECLWestern Blotting Detection System (GE Healthcare). A detailed proto-
col for the pull-down assays using recombinant proteins can be found in the
Supplemental Experimental Procedures.
Protein Expression and Purification
The CNOT1 CN9BD and the CNOT9 ARM domain were coexpressed in E. coli
BL21 Star (DE3) cells (Invitrogen) and induced at an optical density 600 (OD600)
of 0.6 with 1 mM Isopropyl b-D-1-thiogalactopyranoside (IPTG). Following in-
duction, the proteins were expressed overnight at 20!C. The complex was
purified using amylose resin, a heparin column, and finally by size-exclusion
chromatography as described in the Supplemental Experimental Procedures.
The CNOT1 MIF4G domain and the DDX6 RecA-C domain were expressed
separately in E. coli Rosetta 2 cells (Novagen). The proteins were purified as
described previously (Petit et al., 2012; Tritschler et al., 2009), mixed at a ratio
of 1:1.2 (CNOT1:DDX6), and concentrated to 10 mg/ml in 10 mM HEPES
(pH 7.0), 300 mM NaCl, and 5 mM dithiothreitol (DTT).
Crystallization, Data Collection, and Structure Determination
Crystals of the CNOT1 CN9BD-CNOT9 ARM complex were obtained using the
hanging-drop and sitting-drop vapor diffusion methods over a 500 ml reservoir
at 18!C. The protein solution was mixed in a 1:1 ratio (0.8 ml + 0.8 ml) with a
reservoir solution containing 100 mM MES (pH 6.0), 8% polyethylene glycol
(PEG) 6,000, and 80mMMgCl2. Alternatively, crystals were obtained bymixing
the protein solution in a 1:1 ratio (0.8 ml + 0.8 ml) with the reservoir solution con-
taining 100 mM MES (pH 6.0), 11% PEG 6,000, and 50 mM MgCl2 supple-
mented with 40 mM L-tryptophan. Crystals of the CNOT1 MIF4G-DDX6
RecA-C complex were obtained using the hanging-drop vapor diffusion
method over a 500 ml reservoir (100 mM Tris (pH 8.0) and 16% PEG 6,000)
at 20!C by mixing 1.5 ml of the protein solution with 1.5 ml of the reservoir
solution. All crystals were cryoprotected using the corresponding reservoir
solution supplemented with 25% glycerol and subsequently flash frozen in
liquid nitrogen.
All diffraction data sets were recorded on a PILATUS 6Mdetector at the PXII
beamline of the Swiss Light Source (SLS) at a temperature of 100 K. A detailed
description of the structure determination process can be found in the Supple-
mental Experimental Procedures. The refinement statistics are summarized in
Table 1.
Complementation Assays in Human Cells
Knockdowns and complementation assays were performed as described in
the Supplemental Experimental Procedures.
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The atomic coordinates of CNOT1-CN9BD bound to the CNOT9 ARM repeat
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SUPPLEMENTAL FIGURES 
 
Figure S1, related to Figure 1. Interaction of NOT1 with NOT9 and MALLS 
analysis  
(A) Domain organization of Dm NOT1. Abbreviations are as in Figure 1A. 
(B) MBP pulldown showing the direct interaction between recombinant MBP-
CNOT1 fragments and the His-tagged CNOT9 ARM-repeat domain (residues 19–
285). See also Figure 1B,C. 
(C) Western blot showing the interaction between GFP-NOT1 fragments and HA-
   
tagged NOT9 ARM-repeat domain in Dm S2 cells.  
(D,E,H) Analytical size exclusion chromatography and multi-angle laser light 
scattering (MALLS). Isolated CNOT9 (D) or its CNOT9 Mut1 (H) form homodimers, 
which are incompatible with the CN9BD-CNOT9 binary complex (E). The expected 
molecular weights of the proteins (Mr) and the values measured in solution are 
indicated. 
(F) Superposition of the CNOT9 ARM domain from the CNOT1-CNOT9 complex 
with CNOT1 (colored as in Figure 1F) with isolated CNOT9 (gray; PDB code 2FV2). 
See also Figure 1D–G. 
(G) Cartoon representation of the CNOT9 ARM-repeat homodimer (PDB code 2FV2; 
Garces et al., 2007). The CNOT9 molecule in cyan is shown in the same orientation 
as in Figure 1D. 
   
 
Figure S2, related to Figure 2. Structure-based multiple sequence alignment of 
the CNOT9 ARM-repeat domain  
Secondary structure elements as determined from the structure are shown above the 
alignment. Residues conserved in all aligned sequences are shown with a yellow 
background, and residues with >70% similarity are highlighted in orange. Residues 
that form the interface with CNOT1 are indicated by green dots. Residues in pocket 1 
and 2 are indicated by cyan and orange dots, respectively. Residues mutated in this 
study are marked by red asterisks. The species abbreviations are as follows: Hs 
(Homo sapiens), Dm (Drosophila melanogaster), Xt (Xenopus tropicalis), Ce 
   
(Caenorhabditis elegans), At (Arabodopsis thaliana) and Sc (Saccharomyces 
cerevisiae). See also Figures 1–3. The alignments were carried out using ESPript 
(Gouet et al., 2003).  
 
 
Figure S3, related to Figures 2 and 3. Conservation and hydrophobicity of the 
CN9BD-CNOT9 interface  
   
(A) Cartoon representation of the CN9BD-CNOT9 complex (oriebtation as in Figure 
1E). To visualize the interacting surfaces, the binding partners seen in (A) were 
rotated around the horizontal axis by 90º; upwards for the surface of CNOT9 (B–F), 
and downwards for the surface of the CN9BD (G–I). Selected interface residues are 
labeled for orientation.  
(B–D) View of the CNOT9 surface that binds either CNOT9 in the homodimer or 
CNOT1 in the binary complex. The residues involved in CNOT1 binding and CNOT9 
homodimerization are shown in dark cyan (B) and gray (C), respectively. Panel D 
shows a superposition of the views in panels B and C. The overlap between the two 
binding interfaces is shown in salmon. See also Figure 2. 
(E and F) Surface representation of CNOT9 colored according to hydrophobicity (E) 
and conservation (F). The upper panels show a view of the CNOT1-binding interface 
in the same orientation as in panel (B). The lower panels show the opposite surface. 
(G) View of the CN9BD surface that binds CNOT9 in the binary complex. The 
residues involved in CNOT9 binding are shown in purple.  
(H and I) Surface representation of the CN9BD colored according to hydrophobicity 
(H) and conservation (I). The upper panels show a view in the same orientation as in 
panel (G). The lower panels show the opposite surface. The conservation scores of the 
individual residues are represented on the surface by color gradients from light (no 
conservation) to dark orange. Surfaces are colored white to yellow with increasing 
hydrophobicity as described in Figure 3. 
   
 
Figure S4, related to Figure 4. Structure-based sequence alignment of the 
CNOT1 CN9BD and interaction with CNOT9 
(A) Secondary structure elements as determined from the CN9BD structure are shown 
above the alignment. Residues interacting with CNOT9 are indicated by cyan dots. 
   
Residues that are not visible in the structure are shown in gray. Residue W1603, 
which inserts into the W-binding pocket in CNOT9, is shown in orange. Colors and 
species abbreviations are as described in Figure S2. See also Figures 1–4. 
(B) Cartoon representation showing the crystal packing (left panel) and close-up view 
on the interactions between symmetry mates in the crystal lattice around a two-fold 
axis (right panel).  
(C) Cartoon representation of the CN9BD (top panel) and close-up view (lower panel) 
showing how the N-terminal extension folds back and interacts with helix α4. N-
terminal residues are shown in bold and are underlined. See also Figure 2. 
(D and E) MBP pulldown using recombinant MBP-CNOT1 CN9BD (wild-type or the 
indicated mutants) and His-tagged CNOT9 ARM-repeat domain (wild-type or the 
indicated mutants).  
(F) Western blot showing the interaction between GFP-CNOT9 (wild-type or the 
indicated mutants) and HA-CNOT1-M region in HEK293T cells. See also Figure S2. 
(G) Western blot showing the interaction between GFP-CNOT1-M (wild-type or the 
indicated mutants) and HA-MBP-CNOT9 in HEK293T cells.  
(H) Interaction between GFP-NOT1 CN9BD (wild-type or the indicated mutants) and 
HA-NOT9-ARM repeat domain in Dm S2 cells.  
   
 
Figure S5, related to Figures 4 and 6. NOT9 W-binding pockets interact with 
GW182/TNRC6 proteins  
(A) MBP pulldowns using recombinant MBP-tagged 6C-SD and His-tagged CNOT9 
ARM-repeat domain (wild-type or the indicated pocket mutants). MBP served as a 
negative control. See also Figure 4 and Table S1. 
(B-G) Analytical size exclusion chromatography and MALLS analysis of the wild-
type CNOT9 homodimers or the indicated pocket mutants. The molecular weight of 
   
the proteins measured in solution is indicated. The expected molecular weight for a 
dimer is 62 kDa. 
(H) MBP pulldown showing the interaction of MBP-CNOT1 CN9BD with His-
tagged CNOT9 ARM-repeat domain (wild-type or the indicated W-binding pocket 
mutants).  
(I) MBP pulldown using recombinant MBP-tagged 6A-SD and pre-assembled 
CNOT1 CN9BD-CNOT9 ARM complexes containing CNOT9 wild-type or the 
P1+2a mutant. MBP served as a negative control.  
(J) Interaction between GFP-CNOT9 (wild-type or the indicated mutants) and HA-
6C-SD in the presence of HA-MBP tagged CN9BD in HEK293T cells.  
(K) Interaction between GFP-CNOT1 (wild-type or the 4xM and 5xM mutants that do 
not bind CNOT9) and HA-6C-SD in HEK293T cells. The mutations are described in 
Table S1. 
 (L and M) Interaction of GFP-Dm NOT1 (residues 812-1945, either wild-type or the 
3xM mutant) with CNOT9 (L) and Dm GW182 (M). 
(N) Western blot analysis showing that the expression of endogenous AGO2 and 
TNRC6A is not affected in cells depleted of either CNOT1 or DDX6. The samples 
correspond to the depletions shown in Figures 4G and 6E. 
(O) Western blot analysis showing the equivalent expression of the CNOT1 proteins 
used in the complementation assay shown in Figure 4G. 
   
 
Figure S6, related to Figures 5 and 6. The CNOT1 MIF4G-DDX6 RecA-C 
   
interaction 
(A-C) Interaction between GFP-CNOT1-M and either full-length HA-tagged DDX6 
(A), the RecA-N (B) or RecA-C (C) domains in HEK293T cells. See also Figure 5. 
(D and E) MBP pulldowns using recombinant MBP-tagged CNOT1 MIF4G domain 
and His-tagged DDX6 RecA-C domain (wild-type or mutants). MBP served as a 
negative control.  
(F and G) Interaction between GFP-CNOT1-M and HA-tagged wild-type DDX6 or 
the indicated DDX6 mutants in HEK293T cells. The coimmunoprecipitation shown in 
panel (A) was performed in parallel and served as positive control.  
(H) Interaction between GFP-CNOT1-M (wild-type or the indicated mutants) and 
HA-tagged DDX6 in HEK293T cells. The presence of endogenous CAF1 in the 
immunoprecipitates was confirmed using specific anti-CAF1 antibodies. The asterisk 
indicates crossreactivity of the antibody with an endogenous protein in the input 
lysate. See also Figures 5 and 6, Figure S8 and Table S1. 
(I) Structure-based multiple sequence alignment of DDX6 RecA-C domains with 
members of the eIF4A family and the DEAD box helicases UAP56 and DDX46. 
Secondary structure elements as determined from the structure are shown above the 
alignment. Residues that form the interface with the CNOT1 MIF4G domain are 
indicated by blue dots. Residues providing specificity are highlighted by dark blue 
dots. Residues mutated in this study are marked by red asterisks. Colors and species 
abbreviations are as described in Figure S2. See also Figures 5, 6, S7 and Table S1. 
(J) The structure of the CNOT1-DDX6 complex described in this study together with 
the available structures of CNOT1 bound to deadenylases and of DDX6 in complex 
with decapping factors, present snapshots of consecutive steps of the 5'-to-3' mRNA 
decay pathway. Together with the structure of the CN9BD-CNOT9 complex, these 
structures establish a chain of physical interactions to describe how the CCR4-NOT 
   
complex is recruited to miRNA targets and enrolls DDX6, which in turn represses 
translation and recruits the decapping machinery. See also Figure 5J. The letters in 
italics indicate the interactions supported by crystal or NMR structures. (a) Structure 
of human AGO2 bound to tryptophan (Schirle and MacRae, 2012); (b,c,d) Structures 
described in the present study. (e,f) Structure of the human CNOT1 MIF4G domain 
bound to CAF1 (Petit et al., 2012) and of S. cerevisiae Not1 bound to the Caf1-Ccr4 
complex (Basquin et al., 2012). (g) Structure of DDX6 bound to EDC3 (Sharif et al., 
2013; Tritschler et al., 2009). (h) Structure of EDC3 bound to an helical leucine rich 
motif (HLM) present in DCP1 in metazoans (Fromm et al., 2012).  (i) Structure of the 
S. pombe Dcp1-Dcp2 complex (She et al., 2008).  
  
   
 
Table S1. Mutants and antibodies used in this study 
 
Name Hs CNOT1 (1-2376) Dm NOT1 (1-2505) Location 
CNOT1-N 1–1089 1–1148  
CNOT1-M 1085–1605 1147–1717  
CNOT1-C 1595–2376 1710–2505  
CNOT1 
MIF4G 
1093–1317 1152–1377  
CNOT1 SHD 1842-2353 1963–2478  
 1318–1605   
 1386–1535   
CBD/DUF3819 1356–1588 1467–1704  
 1356–1561   
 1356–1607   
 1356–1628   
 K1426S K1537S Interface with 
CNOT9 
 G1451Y G1562E, G1562Y Interface with 
CNOT9 
 R1458A K1569A Interface with 
CNOT9 
 Q1549A Q1658A Interface with 
CNOT9 
3xM K1426S, G1451Y, R1458A K1537S,G1562E,Q1658A Interface with 
CNOT9 
4xM K1426S, G1451Y, R1458A, 
Q1549A 
 Interface with 
CNOT9 
5xM I1423D, K1426S, G1451Y, 
R1458A, Q1549A 
 Interface with 
CNOT9 
∆hl ∆1097–1110  Interface with 
DDX6 
∆hl,N,F ∆hl,N1144A,F1145A  Interface with 
DDX6 
∆hl,R1138A ∆hl,R1138A  Interface with 
DDX6 
∆hl,R,N,F ∆hl,R1138A,N1144A,F1145A  Interface with 
DDX6 
 
 
Name Hs CNOT9 (1-299) Dm NOT9 (1-304) Location 
ARM 19–285 25-291  
H58A H58A N63A Interface with 
CNOT1 
F60A F60A F65A Interface with 
CNOT1 
A64Y A64Y C69Y Interface with 
CNOT1 
V71Y V71Y V67Y Interface with 
CNOT1 
Quadruple 
Mut1 
H58A,F60A,A64Y,V71Y N63A,F65A,C69Y,V67Y Interface with 
CNOT1 
Mut2  N63A,F65A,C69Y  
P1a Y203A Y208A Pocket 1 
P1b R244A R249A Pocket 1 
P1c A248F A235F Pocket 1 
P1 Y203A,R244A Y208A,R249A Pocket 1 
P1d Y203A,A248F Y208A,A253F Pocket 1 
   
P2a P165G  Pocket 2 
P2b R205A  Pocket 2 
P2c H208A  Pocket 2 
P2 R205A,H208A R210A,H213A Pocket 2 
P1+2a Y203A,R205A,H208A,R244A  Pocket 1+2 
P1+2b Y203A,R205A,H208A,A248F Y208A,R210A,H253F,A253F Pocket 1+2 
P1+2c P165G,Y203A,R205A, R244A  Pocket 1+2 
 
 
Name Hs DDX6 (1-472)  
NCBI: NM_004397.3 
Location 
RecA-N 85–295  
RecA-C 296–463  
R375A R375A Interface with CNOT1 
Q322A Q322A Interface with CNOT1 
N324A N324A Interface with CNOT1 
Q,N Q322A,N324A Interface with CNOT1 
 
 
 
Antibody Source Catalog Number Dilution Monoclonal/ 
Polyclonal 
Anti-HA-HRP Roche 12 013 819 001 1:5,000 Monoclonal 
Anti-GFP (for western 
blotting) 
Roche 11 814 460 001 1:2,000 Monoclonal 
Anti-GFP (for 
immunoprecipitations) 
In house   Rabbit polyclonal 
Anti-tubulin Sigma Aldrich T6199 1:5,000 Monoclonal 
Anti-mouse-HRP GE Healthcare NA931V 1:10,000 Polyclonal 
Anti-rabbit-HRP GE Healthcare NA934V 1:10,000 Polyclonal 
Anti-DDX6 Bethyl Laboratories A300-461A 1:3,000 Rabbit polyclonal 
Anti-Hs CAF1 In house  1:2,000 Rabbit polyclonal 
Anti-Hs CNOT1 In house  1:1,000 Rabbit polyclonal 
Anti-Hs CNOT9 Proteintech 22503-1-AP 1:1,000 Rabbit polyclonal 
Anti-Hs AGO2 Sigma Aldrich SAB4200085 1:2,000 Monoclonal 
Anti-Hs GW182 
(TNRC6A) 
Bethyl Laboratories A302-329A 1:1,000 Rabbit polyclonal 
Anti-V5 AbD Serotec MCA1360GA 1:5,000 Monoclonal 
  
   
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
Plasmids  
Plasmids expressing epitope-tagged proteins in human and Dm S2 cells have been 
previously described (Bawankar et al., 2013; Braun et al., 2011; Tritschler et al., 
2009). For expression in E. coli, the DNAs coding for the human CNOT1 CN9BD 
domain (residues 1356–1607) and the ARM-repeat domain of CNOT9 (residues 19–
285) were amplified by PCR using total human cDNA as the template and inserted 
between the XhoI and BamHI restriction sites of the pnYC-NpM (which provides an 
N-terminal MBP tag followed by a HRV3C protease cleavage site; Diebold et al., 
2011) and pnEA-NpH (which provides an N-terminal 6xHis tag, followed by a 
HRV3C protease cleavage site; Diebold et al., 2011) vectors, respectively. Plasmids 
for expression of the CNOT1 MIF4G domain (residues 1093–1317) and the DDX6 
RecA-C domain (residues 296–472) were described previously (Petit et al., 2013; 
Tritschler et al., 2009). DNA fragments encoding the TNRC6 silencing domains 
(TNRC6A residues 1462–1962 and TNRC6C residues 1261–1690) were amplified by 
PCR and inserted between the XhoI and AvrII restriction sites of the pnYC-NpM 
vector. A non-cleavable C-terminal 6x-His tag was introduced by PCR. Mutations 
were introduced using the QuikChange mutagenesis kit (Stratagene) with the 
appropriate oligonucleotides and confirmed by sequencing. The mutations used in this 
study are described in Table S1.  
 
Protein Expression and Purification  
The CNOT1 CN9BD domain and the CNOT9 ARM domain were co-expressed in E. 
coli BL21 Star (DE3) cells (Invitrogen) and induced at an OD600 of 0.6 with 1 mM 
Isopropyl β-D-1-thiogalactopyranoside (IPTG). Following induction the proteins were 
expressed overnight at 20oC. The CN9BD-CNOT9 ARM complex was purified in 
   
lysis buffer (50 mM potassium phosphate (pH 7.5), 300 mM NaCl, 2 mM ß-
mercaptoethanol) supplemented with protease inhibitors (Roche complete EDTA-
free, 1 tablet per 50 ml of lysis buffer), lysozyme (SIGMA, 1 mg/ml) and DNase I (10 
µg/ml), using amylose resin (New England Biolabs Inc.) to capture MBP tagged 
CNOT1 CN9BD as an initial purification step. The complex was digested with 
HRV3C protease while dialyzing into 20 mM HEPES buffer (pH 7.5), 150 mM NaCl 
and 1 mM DTT. The complex was further purified on a heparin column (HiTrap 
Heparin HP 5 ml, GE Healthcare) and a final size exclusion chromatography step 
(HiLoad Superdex 200 26/60 column, GE Healthcare) equilibrated in storage buffer 
(10 mM HEPES (pH 7.5), 150 mM NaCl and 1 mM DTT). The protein complex was 
concentrated to 5 mg/ml prior to use for crystallization.  
 
Structure Solution and Refinement 
Diffraction data were collected at a wavelength of 1.000 Å and processed with XDS 
(Kabsch, 2010). The structures were solved by molecular replacement in PHASER 
(McCoy et al., 2007) using the CNOT9 monomer (PDB ID code 2FV2; Garces et al., 
2007) as a search model for the CN9BD-CNOT9 complex (1.65 Å resolution). For the 
MIF4G-DDX6 complex (1.75 Å resolution), previously determined structures of the 
isolated domains were used as search models (PDB ID code 4GML; Petit et al., 2012; 
PDB ID code 2WAX; Tritschler et al., 2009). The structures were then built 
automatically using the PHENIX AutoSol wizard (Terwilliger et al., 2009) and 
BUCCANEER (Cowtan, 2006) from the CCP4 package (Winn et al., 2011). The 
models were subsequently improved manually in COOT (Emsley et al., 2010) and 
refined using PHENIX (Afonine et al., 2012). Final refinement rounds were carried 
out in PHENIX, refining TLS parameters in addition to individual B-factors and 
including hydrogens in the riding positions. The final model of the CN9BD-CNOT9 
   
complex was then used as a molecular replacement model for the complex at 2.05 Å 
resolution using PHASER. This structure contains additional free tryptophan as a 
ligand and was refined without the use of hydrogens. All models were subsequently 
improved by iterative cycles of refinement and building using PHENIX and COOT. 
The correct stereochemical properties of the structures were verified with 
MOLPROBITY (Chen et al., 2010). Figures were generated in PyMOL 
(http://www.pymol.org). The data collection and refinement statistics are summarized 
in Table 1. 
 
In vitro Pulldown Assays 
The TNRC6 silencing domains were expressed overnight in E. coli BL21 (DE3) Star 
cells (Invitrogen) at 20oC. All purification steps were performed on ice in lysis buffer 
(50 mM potassium phosphate (pH 7.5), 300 mM NaCl, 2 mM ß-mercaptoethanol), 
supplemented with protease inhibitors (Roche complete EDTA-free, 2 tablets per 50 
ml of lysis buffer), lysozyme (1 mg/ml) and DNAse I (5 µg/ml). The bacterial lysates 
were incubated with amylose resin for 1 hour and eluted in lysis buffer supplemented 
with 30 mM maltose. The silencing domain was subsequently loaded onto a Ni-
column (HiTrap IMAC HP; GE Healthcare) to separate C-terminally truncated 
fragments from the full-length protein. The fusion protein was dialyzed into HEPES 
buffer (20 mM HEPES pH (7.5), 150 mM NaCl, 1 mM DTT) and further purified by 
size-exclusion chromatography (HiLoad Superdex 200 26/60 column, GE 
Healthcare). CNOT9 mutants were purified as described for the wild-type protein.  
MBP pulldown assays were performed in a final volume of 100 µl of PBS buffer 
using 6.25 µM of purified silencing domain and CNOT9 (wild-type and mutants). The 
purified proteins were incubated for 30 min at room temperature before adding 50 µl 
(50% slurry) of amylose resin followed by another 30 min incubation. The beads were 
   
washed four times with PBS buffer and eluted in elution buffer (PBS supplemented 
with 30 mM maltose). The eluted proteins were precipitated with TCA 
(trichloroacetic acid) and analyzed on a 14% SDS-PAGE.  
For the CNOT9-CNOT1 pulls downs shown in Figures S1B and S5C,D, His-tagged 
Hs CNOT9 (residues 19–285, wild-type or mutants) and MBP-tagged Hs CNOT1 
(wild-type, fragments or mutants) were co-expressed in E. coli BL21 (DE3) star cells. 
The cells were lysed in suspension buffer containing 50 mM Tris (pH 7.5), 150 mM 
NaCl, 0.1% Triton X-100 supplemented with protease inhibitors, lysozyme, DNAse I 
and 10% glycerol. Cell lysates were sonicated four times for 30 s and cleared by 
centrifugation at 20,000 ×g. The cleared supernatants were incubated with 50 µl (50% 
slurry) of amylose resin for 45 min at 25oC. The beads were washed four times with 
suspension buffer, bound proteins were eluted using 2x protein sample buffer and 
analyzed on a 14% SDS-PAGE.   
The DDX6-MIF4G pulldowns were performed at room temperature with purified 
proteins in binding buffer containing 25 mM HEPES (pH 7.0), 20 mM NaCl and 
2mM DTT. The proteins were incubated for 30 min before adding 50 µl (50% slurry) 
of amylose resin at room temperature, followed by another 30 min incubation. 
Proteins were eluted and analyzed as described above. 
 
Complementation Assays 
Plasmids expressing short-hairpin RNAs (shRNAs) for knockdowns are derived from 
the pSUPER plasmid containing the puromycin-resistance gene for selection. The 
vector backbone was a kind gift from O. Mühlemann (University of Bern). The 19 nt 
target sequences are as follows: control ATTCTCCGAACGTGTCACG, CNOT1 
ATTCAACATTCCCTTATA, and DDX6 GCAGAAACCCTATGAGATT. HeLa 
cells were grown in DMEM supplemented with 10% heat inactivated fetal calf serum, 
   
2 mM L-Glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were 
transfected in 6-well plates using Lipofectamine 2000 (Invitrogen) according to the 
manufacturers protocol. Transfection mixtures contained 4 µg of plasmids expressing 
the relevant shRNA. Twenty-four hours after transfection, cells were selected in 
medium supplemented with 1.5 µg/ml puromycin. After 1 day of selection, cells were 
counted and seeded in 12-well plates in medium without puromycin for recovery. 
Twenty-four hours after reseeding, cells were re-transfected using Lipofectamine 
2000. The transfection mixtures contained 0.36 µg of plasmids expressing the relevant 
shRNA, 0.12 µg of the reporter pSiCHECK-8xLet7 plasmid or the corresponding 
reporter carrying mutations in the Let-7 binding sites and 0.12 µg of the pEGFP-N3-
F-Luc transfection control. For the CNOT1 complementation assays, the transfection 
mixtures contained either 1 µg pT7-EGFP-CNOT1 (wild-type or mutants) or pT7-
EGFP as a control. For the DDX6 complementation, the transfection mixtures 
contained either 0.4 µg pCIneo-λN-HA-MBP or pCIneo-λN-HA-DDX6 (wild-type or 
mutants). Cell were harvested 72 hours after the second transfection. R-Luc and F-
Luc activities were measured using the Dual-Luciferase Reporter Assay System 
(Promega).  
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ABSTRACT 
miRNAs associate with Argonaute (AGO) proteins to silence the expression of 
mRNA targets by inhibiting translation and eliciting deadenylation, decapping 
and mRNA degradation. A current model for silencing indicates that AGOs 
mediate these effects through the sequential recruitment of GW182 proteins, the 
CCR4-NOT deadenylase complex and the translational repressor and decapping 
activator DDX6. An alternative model posits that AGOs repress translation by 
interfering with eIF4A function during 43S ribosomal scanning and that this 
mechanism is independent of GW182 and the CCR4-NOT complex in Drosophila 
melanogaster. Here we show that miRNAs, AGO, GW182 and NOT1 do not 
require 43S ribosomal scanning or eIF4A activity to repress translation but 
require DDX6 in human cells. We further show that the repressive activity of 
AGOs depends on their interaction with GW182, which in turn recruits the 
CCR4-NOT complex to mediate silencing in both human and D. melanogaster 
cells. Collectively, our data indicate that CCR4-NOT is a major downstream 
effector complex in the miRNA pathway. 
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Introduction 
miRNAs are a class of small noncoding RNAs that assemble with Argonaute proteins 
into miRNA-induced silencing complexes (miRISCs) to mediate post-transcriptional 
repression of complementary mRNA targets (Ameres and Zamore 2013). In animal 
cells, silencing is effected by a combination of translational repression and mRNA 
destabilization, with the latter accounting for most of the miRNA-mediated repression 
observed in mammalian cell cultures (Hendrickson et al. 2009; Guo et al., 2010; 
Eichhorn et al. 2014).  
miRNA target degradation is catalyzed by the enzymes of the 5'-to-3' mRNA 
decay pathway (Rehwinkel et al. 2005; Behm-Ansmant et al. 2006, Eulalio et al. 
2007; Chen et al. 2009; Eulalio et al. 2009; Piao et al. 2010). In this pathway, mRNAs 
are first deadenylated by the PAN2-PAN3 and the CCR4-NOT complexes, then 
decapped by the decapping enzyme DCP2 and finally degraded from the 5'-end by the 
XRN1 exonuclease (Huntzinger and Izaurralde 2011). The GW182/TNRC6 proteins 
play a central role in this process by interacting with AGOs and recruiting the PAN2-
PAN3 and the CCR4-NOT deadenylase complexes to miRNA targets, thereby 
accelerating their degradation (Fabian and Sonenberg 2012; Braun et al. 2013).  
In addition to accelerating mRNA degradation, miRNAs also trigger 
translational repression, but the precise repressive mechanism remains poorly 
understood, and several models have been proposed (Fabian and Sonenberg 2012). 
One possible model is that the recruitment of the CCR4-NOT complex is sufficient to 
mediate silencing (Braun et al. 2013). This model is based on the following 
observations. First, the interaction of GW182 proteins with the CCR4-NOT complex 
is not only required for degradation but also for translational repression of miRNA 
targets (Braun et al. 2011; Chekulaeva et al. 2011; Fabian et al. 2011; Huntzinger et 
al. 2013; Zekri et al. 2013; Chen et al. 2014; Mathys et al. 2014). Second, like 
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miRISC, the CCR4-NOT complex represses translation in the absence of 
deadenylation (Cooke et al. 2010; Braun et al. 2011; Chekulaeva et al. 2011; 
Bawankar et al. 2013; Zekri et al. 2013). Translational repression by the CCR4-NOT 
complex can, at least in part, be explained by a direct interaction between the NOT1 
subunit and the DEAD box RNA helicase DDX6 (also known as RCK). Human 
DDX6 and its Dm ortholog Me31B repress translation, activate decapping and play a 
role in silencing (Chu and Rana 2006; Eulalio et al. 2007; Nishihara et al. 2013; 
Presnyak and Coller 2013; Chen et al. 2014; Mathys et al. 2014, Rouya et al. 2014).  
An alternative model of silencing involves the translation initiation factor 
eIF4A. eIF4A proteins are DEAD-box RNA helicases that unwind secondary 
structures within mRNA 5' UTRs, allowing the 43S preinitiation complex (PIC) to 
scan the 5'-UTR toward the start codon (Jackson et al. 2010). Several studies have 
indicated that miRISCs inhibit 43S scanning by interfering with eIF4A function 
(Meijer et al. 2013, Ricci et al. 2013; Fukao et al. 2014; Fukaya et al. 2014). How this 
interference is achieved remains unclear. One study reported that NOT1 interacts with 
eIF4A2, but not with its paralog eIF4A1 in human cells (Meijer et al. 2013). It was 
suggested that this interaction locks eIF4A2 onto the mRNA 5'-UTR and represses 
translation by blocking 43S scanning (Meijer et al. 2013). However, the interaction 
between NOT1 and eIF4A2 was not confirmed in subsequent studies (Chen et al. 
2014; Mathys et al. 2014; Rouya et al. 2014).  
Furthermore, in contrast to the model proposed by Meijer et al., two recent 
studies indicated that miRNAs repress translation by releasing rather than recruiting 
eIF4A2 and that both eIF4A1 and eIF4A2 are dislodged from silenced mRNAs 
(Fukao et al. 2014; Fukaya et al. 2014). Remarkably, Dm AGO1 promotes eIF4A 
displacement independently of GW182, and Dm GW182 caused eIF4A and eIF4E 
displacement independently of AGO1 (Fukaya et al. 2014). These and additional 
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observations suggested that Dm AGO1 exhibits silencing activity independently of 
GW182 proteins in D. melanogaster (Fukaya and Tomari 2012; Wu et al. 2013; 
Fukaya et al. 2014). Whether this is also the case for human AGOs has not been 
investigated.  
In sum, the mechanism by which miRNAs repress translation is still not fully 
understood, and it is not known whether the recruitment of the CCR4-NOT complex 
fully explains silencing or whether parallel and potentially species-specific repressive 
mechanisms exist. To clarify these open questions, we adopted a comparative 
approach and investigated the silencing mechanisms in human and Dm cells. We 
found that miRNAs, AGOs, GW182, the CCR4-NOT complex and DDX6/Me31B 
repress and degrade polyadenylated mRNA targets that are translated via scanning 
and eIF4A independent mechanisms in both human and Dm cells. Collectively, our 
results indicate that the CCR4-NOT complex is a major conserved downstream 
effector of silencing.  
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Results 
The W-binding pockets of AGOs mediate binding to the GW182/TNRC6 proteins 
Structural studies of human (Hs) AGO2 revealed the presence of tandem W-binding 
pockets (pockets P1 and P2) on the surface of the AGO2 PIWI domain opposite to the 
miRNA-binding site (Supplemental Fig. S1A; Schirle and MacRae 2012). These 
pockets represent potential binding sites for the GW182/TNRC6 proteins and are 
conserved in Hs AGO1, AGO3 and AGO4 as well as in Dm AGO1 (Supplemental 
Fig. S1B; Schirle and MacRae 2012). To determine whether AGOs exhibit silencing 
activity independently of GW182 proteins, we designed mutations to disrupt the W-
binding pockets in Hs AGO2 and Dm AGO1 (mutants P1 and P2, Supplemental Fig. 
S1A,B and Table S1). The ability of the mutated proteins to interact with 
GW182/TNRC6 proteins was tested in coimmunoprecipitation assays.  
Mutations in either of the two Dm AGO1 pockets abolished the interaction with 
endogenous Dm GW182 in Schneider cells (S2 cells; Fig. 1A, lanes 8 and 9 vs. 7). 
The mutant proteins were expressed at levels comparable to wild-type and associated 
with endogenous miR-2a, indicating that the mutations do not disrupt the fold of the 
PIWI domain (Fig. 1A). Similarly, combined mutations in the two pockets of Hs 
AGO2 abolished its interaction with TNRC6A, TNRC6B and TNRC6C in HEK293T 
cells (Fig. 1B–D, lanes 10 vs. 7). Mutations in only one of the two pockets disrupted 
the interaction of Hs AGO2 with TNRC6C but only reduced TNRC6A binding (Fig. 
1B,D). The binding of TNRC6B was impaired by mutations in P2 but not in P1 (Fig. 
1C). These results reveal differences in the binding properties of the three TNRC6 
proteins. Importantly, the mutations in the Hs AGO2 W-binding pockets did not 
interfere with miR-16 loading (Fig. 1D). We concluded that the integrity of the W-
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binding pockets is required for Hs AGO2 and Dm AGO1 to interact with 
GW182/TNRC6 proteins. 
 
The silencing activity of AGOs requires the integrity of the W-binding pockets 
Next, we examined the silencing activity of the AGO mutants using previously 
described λN- or MS2-based tethering assays (Pillai et al. 2004; Rehwinkel et al. 
2005). Tethered Dm AGO1 and Hs AGO2 repressed translation and promoted 
degradation of polyadenylated mRNA reporters, as shown previously (Fig. 2A–D; 
Rehwinkel et al. 2005; Pillai et al. 2004; Eulalio et al. 2008; Chen et al. 2009; Piao et 
al. 2010). Mutations in P2 were sufficient to abolish the activity of the Dm and Hs 
AGOs in tethering assays (Fig. 2A–D). The activity of Dm AGO1 was also abolished 
by mutations in P1 (Fig. 2A,B). 
Because the reporters were degraded, it was possible that the recruitment of 
deadenylases by GW182/TNRC6 masked any additional repressive activity that 
AGOs might have independently of these proteins. Therefore, we next tested the 
activity of the AGO mutants using mRNA reporters that are refractory to 
deadenylation and subsequent decay. In Dm cells, we used an mRNA reporter with a 
3'-end generated by a self-cleaving hammerhead ribozyme (HhR). Immediately 
upstream of the ribozyme cleavage site, the reporter contains an internal poly(A) 
stretch of 95 residues followed by a poly(C) stretch of 7 residues, which blocks 
deadenylation (F-Luc-5BoxB-A95-C7-HhR; Zekri et al. 2013). Tethered Dm AGO1 
repressed this reporter predominantly at the translational level (Fig. 2E,F). The 
mutations in either P1 or P2 abolished Dm AGO1 repressive activity (Fig. 2E,F). The 
protein mutants were expressed at levels comparable to wild-type (Fig. 2G). 
In human cells, we used an R-Luc-5BoxB reporter containing the 3'-end of the 
MALAT1 non-coding RNA, which is processed by RNase P and thus lacks a poly(A) 
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tail (Wilusz et al. 2012). Hs AGO2 repressed the translation of this reporter without 
causing mRNA degradation (Fig. 2H–J). The repression was relieved by mutations in 
either of the two W-binding pockets (Fig. 2H–J). The Dm or Hs AGO proteins did not 
repress the corresponding reporters that lacked the BoxB sites (Supplemental Fig. 
S2A,B). Taken together, our results indicate that the activity of tethered AGO proteins 
depends on the integrity of the W-binding pockets.  
 
Dm AGO1 requires the interaction with GW182 to silence miRNA targets 
Because tethering assays bypass some steps in silencing, we next tested the activity of 
the AGO mutants in complementation assays in Dm cells, wherein miRNAs 
predominantly associate with AGO1. For these assays, we used previously 
characterized firefly luciferase reporters containing 3'-UTRs of natural miRNA 
targets (e.g., par-6 and cg5281, silenced by miR-1 and miR-12, respectively; and 
nerfin-1 silenced by miR-9b and miR-279; Eulalio et al. 2007). The depletion of 
endogenous Dm AGO1 suppressed the silencing of all reporters, as expected, and 
both F-Luc expression and mRNA levels were restored (Fig. 2K,L; Supplemental Fig. 
S2C,D).  
In depleted cells, a siRNA resistant version of Dm AGO1 fully restored 
silencing of all reporters (Fig. 2K,L; Supplemental Fig. S2C,D). By contrast, the 
double P1+P2 mutant did not restore silencing. The single pocket mutants partially 
rescued silencing to different extents depending on the reporters (Fig. 2K,L; 
Supplemental Fig. S2C,D). Thus, the integrity of the W-binding pockets is also 
required for Dm AGO1 to silence miRNA targets in complementation assays.  
 
AGOs, GW182/TNRC6s and CCR4-NOT share a common mechanism to degrade 
mRNAs 
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It is well established that GW182/TNRC6 proteins and AGOs induce mRNA 
degradation through the 5'-to-3' decay pathway (Rehwinkel et al. 2005; Behm-
Ansmant et al. 2006, Eulalio et al. 2007; Chen et al. 2009; Piao et al. 2010). In this 
pathway, deadenylation precedes decapping. Consequently, mRNAs degraded 
through this pathway accumulate in a deadenylated form in cells in which decapping 
is inhibited (Eulalio et al. 2007).  
To investigate whether GW182/TNRC6 AGOs and NOT1 all elicit first 
deadenylation and then decapping, we sought to inhibit decapping. To this end, we 
overexpressed a DCP1 mutant that inhibits decapping in a dominant negative manner 
(DCP1* mutant; Chang et al. 2014; Supplemental Table S1). Tethered Dm GW182, 
AGO1 and NOT1 degraded the F-Luc-5BoxB-poly(A) reporter (Fig. 2M, lanes 3, 5, 7 
vs. 1). Overexpression of the DCP1 mutant prevented this degradation in S2 cells. 
The reporter accumulated as a fast migrating form (Fig. 2M, lanes 4, 6 and 8 vs. 2), 
which corresponds to the deadenylated decay intermediate. Thus, as observed 
previously for GW182 and AGOs, tethered NOT1 caused deadenylation-dependent 
decapping. 
Likewise, in human cells, MS2-tagged TNRC6A-SD, AGO2 and NOT1 
degraded a β-globin reporter containing 6 binding sites for the MS2 protein in the 3' 
UTR (Fig. 2N, lanes 3, 5 and 7 vs.1). This degradation was prevented in cells 
expressing a DCP2 catalytic inactive mutant (DCP2*), and the reporter accumulated 
in the deadenylated form (Fig. 2N, lanes 4, 6 and 8). Our results indicate that 
miRNAs, AGOs, GW182/TNRC6 proteins and the CCR4-NOT complex share a 
common mechanism to degrade target mRNAs.  
 
AGOs, GW182/TNRC6s and CCR4-NOT silence mRNAs translated via a scanning-
independent mechanism 
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It has been reported that miRNAs silence gene expression by interfering with 
ribosome scanning (Meijer et al. 2013; Ricci et al. 2013; Fukao et al. 2014; Fukaya et 
al. 2014). To test whether AGO, GW182/TNRC6 and CCR4-NOT all require 
ribosome scanning to repress translation, we generated reporters translated via a 
scanning-independent mechanism. 
The reporter for expression in Dm cells was derived from the F-Luc-5BoxB-
A95C7-HhR reporter but contained a 5'-UTR of only 6 nucleotides (6nt-F-Luc-5BoxB-
A95-C7-HhR (Fig. 3A). Notably, the translation efficiency of this reporter (this means 
F-Luc activity normalized to mRNA levels) was reduced only 1.4-fold relative to the 
parental reporter containing a 107-nt 5'-UTR (Supplemental Fig. S3A–D). Given that 
F-Luc proteins lacking the N-terminal 3–10 amino acids are inactive (Supplemental 
Fig. S3E–G; Sung and Kang 1998), and considering that the translation efficiencies of 
the reporters with a short and a long 5'-UTR are comparable (Supplemental Fig. S3A-
D), it is reasonable to assume that a significant fraction of ribosomes initiate 
translation at the first AUG (or minimally at codon 3) in the mRNA with a 6-nt 5'-
UTR. Consequently, translation of the 6nt-F-Luc-5BoxB-A95C7-HhR occurs without 
scanning. Accordingly, when the F-Luc ORF was replaced by HA-GST, the HA-
tagged protein could be detected by western blotting using anti-HA antibodies further 
validating the conclusion that a substantial fraction of ribosomes start translation at 
the first AUG (Supplemental Fig. S3H). 
Remarkably, the reporter containing a 6-nt 5'-UTR was repressed by tethered 
AGO1, GW182 and NOT1 (Fig. 3B) in the absence of mRNA degradation due to the 
lack of a poly(A) tail (Fig. 3B,C; Supplemental Fig. S4A). The repression was 
comparable to that observed for the parental reporter containing a 107-nt long 5'-UTR 
as well as for the reporter also containing a poly(A) tail, which was consequently 
degraded (Fig. 3B,C; Supplemental Fig. S4A). 
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The observation that a reporter translated via a scanning-independent 
mechanism is nevertheless repressed in Dm cells was unexpected given previous 
reports (Meijer et al. 2013; Ricci et al. 2013; Fukao et al. 2014; Fukaya et al. 2014) 
and prompted us to reanalyze the requirement for 43S scanning in human cells. To 
this end, we replaced the 5'-UTR of the R-Luc-5BoxB-MALAT1 reporter with a 
TISU motif (Translation Initiator of Short 5'-UTR, Fig. 3D), which directs efficient 
cap-dependent translation initiation of very short 5'-UTRs via a scanning- and eIF4A-
independent mechanism (Elfakess et al. 2011; Sinvani et al. 2015). The translation 
efficiency of the TISU reporter was 8-fold lower relative to the parental reporter 
containing a 219-nt long 5'-UTR and the MALAT1 3'-end (Supplemental Fig. S3I–L). 
Nevertheless, TNRC6A-SD, AGO2 and NOT1 repressed the expression of these two 
reporters and that of a corresponding polyadenylated reporter to comparable extents. 
The polyadenylated reporter was degraded, whereas the reporters containing the 
MALAT1 3'-end were resistant to degradation (Fig. 3E,F; Supplemental Fig. S4B). 
Notably, insertion of an HA-tag immediately downstream of the first AUG in the 
TISU reporter, enabled detection of R-Luc by western blotting using anti-HA 
antibodies (Supplemental Fig. S3M), confirming that TISU directs translation 
initiation at the first AUG, and therefore in the absence of scanning. 
We further confirmed that translation of the TISU reporter was independent of 
scanning, and thus of eIF4A, using silvestrol, a compound that stimulates eIF4A1/2 
RNA binding activity reducing the pool of the protein available for translation 
(Bordeleau et al. 2008; Cencic et al. 2009). Silvestrol inhibited cap-dependent 
translation of the Renilla luciferase, but the translation driven by the TISU sequence 
was not inhibited (Fig. 3G; Supplemental Fig. S4C), as expected (Elfakess et al. 
2011).  
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Because the translation efficiency of the reporter containing the TISU sequence 
was strongly reduced, to investigate the dependence on eIF4A for silencing we 
generated reporters containing 5'-UTRs with different degrees of secondary structure, 
which were expected to exhibit different eIF4A requirements (Supplemental Tables 
S2 and S3). In particular, we generated a reporter containing a 5'-UTR consisting of 
18 CAA repeats, which is unlikely to adopt secondary structures, and its translation is 
thought to be independent of eIF4A (Meijer et al. 2013). This 5'-UTR was also shown 
to confer resistance to silencing (Meijer et al. 2013). Unexpectedly, translation of this 
reporter was partially inhibited by silvestrol (Fig. 4A; Supplemental Fig. S5A). 
Furthermore, the reporter coimmunoprecipitated with eIF4A2 almost as efficiently as 
a reporter containing a 219-nt long 5'-UTR (Fig. 4B,C), indicating that the CAA 
repeats do not confer independence from eIF4A in a cellular context. As a control, the 
corresponding TISU-containing reporter was the least affected by silvestrol treatment 
and did not efficiently associate with eIF4A2 in coimmunoprecipitation assays (Fig. 
4A–C; Supplemental Fig. S5A), further confirming that translation driven by TISU 
does not require eIF4A activity. We observed that TNRC6A-SD, AGO2 and NOT1 
repressed the CAA reporter without causing mRNA degradation due to the presence 
of the MALAT1 3'-end (Fig. 4D,E).  
We also tested a 5'-UTR that contains four 12-nucleotide guanine quartet 
(CGG)4 motifs in tandem, and is predicted to form G-quadruplex structures and thus 
requires eIF4A for translation (Cencic et al. 2009; Wolfe et al. 2014). Accordingly, 
the translation of this reporter was sensitive to silvestrol treatment (Fig. 4A; 
Supplemental Fig. S5A), and the reporter was efficiently coimmunoprecipitated with 
eIF4A2 (Fig. 4B,C). TNRC6A-SD, AGO2 and NOT1 repressed the CGG reporter to 
an extent comparable to that of the CAA reporter (Fig. 4F,G vs. Fig. 4D,E) as well as 
to the corresponding reporters containing a TISU motif or a 219-nt long 5'-UTR 
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(Supplemental Fig. S5B,C). The repression caused by the tethered proteins was not 
influenced by differences in the translation efficiencies of the reporters (Supplemental 
Fig. S5D–G). 
In sum, AGO, GW182/TNRC6s and NOT1 silence mRNA targets 
independently of whether their translation requires ribosome scanning or eIF4A 
activity and independently of the 5'-UTR secondary structure.  
 
eIF4A2 binding to mRNAs does not correlate with silencing efficiency 
eIF4A2 was reported to be either recruited to or dislodged from silenced miRNA 
targets (Meijer et al. 2013; Fukao et al. 2014; Fukaya et al. 2014). To resolve this 
discrepancy, we investigated eIF4A2 association with the R-Luc-6MS2-A95-
MALAT1 reporter containing a 5'-UTR of 219-nt. This reporter associates with 
eIF4A2 and its translation is sensitive to silvestrol treatment (Fig. 4A–C). The 
reporter was silenced to different extents by tethered AGO2, TNRC6A-SD or NOT1 
(Fig. 4H). Nevertheless, eIF4A2 associated with the reporter to comparable levels 
(Fig. 4I,J). Moreover, the association was comparable to that observed for the 
unrepressed reporter in cells expressing the MS2 protein alone (Fig. 4I,J). The 
possibility that the observed eIF4A2 binding is unspecific and occurs upon cell lysis 
is unlikely, as eIF4A2 did not associate with the TISU reporter (Fig. 4B,C). Thus, 
eIF4A2 association with mRNAs correlates with their sensitivity to silvestrol 
treatment but is neither enhanced nor reduced by silencing. 
 
Ribosome scanning is not required for mRNA degradation caused by tethered 
AGOs, GW182/TNRC6s and NOT1 
It has been reported that ribosome scanning is also required for miRNAs to degrade 
their targets (Meijer et al. 2013). Given our observations that translational repression 
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occurs independently of scanning, we next analyzed whether AGO, NOT1 and 
GW182/TNRC6 degraded polyadenylated mRNA reporters that are translated via a 
scanning-independent mechanism. In Dm cells, a polyadenylated reporter containing a 
6-nt 5'-UTR was degraded by tethered AGO1, GW182 and NOT1 (Fig. 5A,B). 
Similarly, the TISU-R-Luc-6MS2-poly(A) reporter was also degraded by AGO2, 
TNRC6A-SD and NOT1 in human cells (Fig. 5C,D). Thus, in the absence of 
scanning, deadenylation and subsequent mRNA decay still occur.  
We also investigated whether a β-globin reporter containing a 114-nt 5'-UTR 
could be degraded in the presence of silvestrol. This reporter was selected because it 
is very efficiently degraded by tethered AGO2, TNRC6A-SD and NOT1 in human 
cells. This degradation was not prevented in the presence of silvestrol (Fig. 5E–G), 
although translation of a cotransfected R-Luc reporter was inhibited 2.5-fold (Fig. 
5E). Taken together, our results indicate that mRNA degradation induced by tethered 
AGO, GW182 and NOT1 does not require eIF4A activity or prior ribosomal 
scanning.  
 
miRNAs silence reporters translated via a scanning independent mechanism 
Next, we investigated whether miRNAs (as opposed to tethered silencing factors) also 
repress reporters translated via a scanning independent mechanism. To this end, we 
generated F-Luc-nerfin-1 and F-Luc-par6 reporters containing a 6nt 5'-UTR. These 
reporters were efficiently silenced by the corresponding miRNAs as the parental 
reporters containing 107-nt long 5'-UTR (Fig. 6A–D). Furthermore, the nerfin-1 
reporter was repressed predominantly at the translational level whereas the par-6 
reporter was predominantly degraded independently of the length of the 5'-UTR (Fig. 
6A–D).  
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For expression in human cells, we generated a polyadenylated R-Luc reporter 
containing the TISU motif or a 219-nt 5'-UTR and eight let-7 miRNA binding sites in 
the 3'-UTR. Both of these reporters were efficiently silenced and degraded by 
endogenous let-7 independently of the length of the 5'-UTR (Fig. 6E,F). We conclude 
that miRNAs also silence mRNA reporters translated via scanning-independent 
mechanisms in both human and Dm cells. 
 
The CCR4-NOT complex requires DDX6 to represses translation  
We and others have proposed that the RNA helicase DDX6 acts downstream of the 
CCR4–NOT complex to mediate translational repression and stimulate decapping in 
human cells (Chen et al. 2014; Mathys et al. 2014; Rouya et al. 2014). To further 
confirm that DDX6 function lies downstream of CCR4-NOT we used tethering assays 
to analyze the repressive activity of a NOT1 mutant that is strongly impaired in the 
interaction with DDX6 (Fig. 6G, NOT1 Mut; Supplemental Table S1). The NOT1 
mutant failed to repress the translation of the R-Luc-5BoxB-MALAT1 mRNA, which 
is not degraded (Fig. 6H,I). These results indicate that full length NOT1 requires 
interaction with DDX6 to repress translation of a reporter that is resistant to 
deadenylation. However, the NOT1 mutant was active when tethered to the 
corresponding polyadenylated reporter and the reporter was degraded (Fig. 6J,K). 
Thus, the deadenylase subunits degrade mRNA poly(A) tails independently of 
whether DDX6 is bound to NOT1. 
Additionally, DDX6 depletion suppressed NOT1-mediated silencing of the R-
Luc-5BoxB-MALAT1 reporter in human cells (Supplemental Fig. S6A,B), further 
validating the conclusion that NOT1 requires DDX6 to repress translation. In contrast 
to the results obtained in human cells, depletion of Me31B in S2 cells had a modest 
effect on the silencing activity of AGO1, GW182 and NOT1 tethered to a reporter 
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that is not degraded (Supplemental Fig. S6C,D). These results suggest the existence of 
alternative silencing mechanisms in these cells. Alternatively, the residual amounts of 
Me31B in depleted cells (<10% of control) might still be sufficient for silencing 
(Supplemental Fig. S6D). 
 
DDX6 represses translation initiation independently of 43S scanning 
If DDX6/Me31B act downstream of AGOs, GW182/TNRC6 and CCR4-NOT, it is 
expected that they also repress reporters translated via an eIF4A-independent 
mechanism. Consistent with this expectation, tethered DDX6 repressed the expression 
of all reporters containing the MALAT1 3'-end, including the TISU and CAA 
reporters in human cells (Fig. 7A–D). Thus, DDX6 represses translation in the 
absence of 43S scanning and deadenylation. DDX6 activity was only slightly 
impaired by the mutations that prevent binding to NOT1, consistent with the notion 
that DDX6 acts downstream of the CCR4-NOT complex (Fig. 7A–E). Similarly, 
Me31B repressed the F-Luc-5BoxB-A95-C7-HhR reporter independently of the length 
of the 5'-UTR (Fig. 7F), indicating that the ability to repress translation in the absence 
of scanning is conserved among DDX6 orthologs. 
In yeast, Dhh1 (the DDX6 ortholog) was shown to repress translation at 
initiation (Coller and Parker 2005) or at elongation (Sweet et al. 2012). To help to 
resolve this discrepancy, we analyzed the association of the R-Luc-6MS2-A95-
MALAT1 reporter with polysomes upon repression by DDX6. Sucrose gradient 
analyses indicated that tethered DDX6 changed the distribution of the reporter in the 
polysome profile toward lighter polysomes/nonpolysomal fractions, indicating that 
DDX6 represses translation initiation in human cells (Fig. 7G,H; Supplemental Fig. 
S6E,F).  
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Discussion 
AGOs require interaction with GW182/TNRC6 to mediate silencing 
Previous studies reported that Dm AGO1 can repress miRNA targets independently of 
GW182/TNRC6 proteins and of the CCR4-NOT complex (Fukaya and Tomari 2012; 
Wu et al. 2013; Fukaya et al. 2014). Here we show that amino acid substitutions in the 
two W-binding pockets present on the surface of the PIWI domain of Dm AGO1 and 
Hs AGO2 (Schirle and MacRae 2012) abolish the binding of AGOs to 
GW182/TNRC6 proteins without disrupting miRNA loading. These mutations also 
abolish the silencing activity of AGOs in both tethering and complementation assays. 
The most parsimonious explanation for our results is that AGOs require interaction 
with GW182/TNRC6 proteins to mediate silencing. Although we cannot rule out the 
possibility that AGOs interact with another, yet-unidentified, W-containing protein 
using a mode of interaction similar to that used with GW182/TNRC6, we consider 
this possibility unlikely because AGOs, like GW182/TNRC6, NOT1 and miRNAs, 
degrade polyadenylated mRNA targets via the 5'-to-3' decay pathway. Furthermore, 
all three proteins as well as miRNAs repress the translation of mRNA targets that are 
refractory to deadenylation. Finally, we show that all three proteins and miRNAs 
repress and/or degrade mRNA targets that do not require eIF4A and 43S ribosomal 
scanning for translation. These results point to a common mechanism used by these 
proteins and miRNAs to mediate silencing. 
 
eIF4A2 is unlikely to act as a repressor in the miRNA pathway  
We and others have previously reported that human NOT1 interacts with DDX6 but 
not with eIF4A2, arguing against specific recruitment of eIF4A2 by NOT1 (Chen et 
al. 2014; Mathys et al. 2014; Rouya et al. 2014). Rather, eIF4A2 was shown to bind to 
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eIF4G and to stimulate translation (Chen et al. 2014; Mathys et al. 2014; Rouya et al. 
2014; Fukao et al. 2014). Furthermore, although it has been reported that eIF4A2 is 
recruited to silenced mRNAs (Meijer et al. 2013), our results demonstrate that eIF4A2 
efficiently associates with reporter mRNAs in the absence of silencing. The only 
mRNA reporter that did not associate efficiently with eIF4A2 was the reporter 
containing the TISU motif, as expected given that the translation of this reporter is 
insensitive to silvestrol treatment. Collectively, these observations suggest that 
recruitment of eIF4A2 by NOT1 is unlikely to represent a repressive mechanism 
acting in the miRNA pathway.  
 
Ribosomal scanning is not a prerequisite for silencing 
A previous study reported that mRNAs with highly structured 5'-UTRs, which depend 
on eIF4A for translation, are susceptible to silencing whereas mRNAs with 
unstructured 5'-UTRs are refractory to silencing in human cells (Meijer et al. 2013). 
By contrast, Ricci et al. failed to detect a correlation between silencing on 5'-UTR 
secondary structure in rabbit reticulocyte lysates. Like Ricci et al. (2013), we found 
no evidence for the requirement of structured 5' UTRs for silencing in either human or 
Dm cells. Our conclusions are based on the use of reporters that have very short 5'-
UTRs (in Dm cells) or contain the TISU motif (human cells). These reporters direct 
translation independently of scanning. We could also not confirm that a reporter 
containing 18 CAA-repeats in the 5'-UTR is resistant to silencing as reported by 
Meijer et al. (2013). Furthermore, the CAA reporter was sensitive to silvestrol 
treatment and associated with eIF4A2, indicating that it partially depends on eIF4A 
activity for translation as reported by Pestova and Kolupaeva (2002). 
In summary, all reporters tested in our study were partially degraded when they 
contained a poly(A) tail or were repressed predominantly at the translational level 
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when they contained 3' termini that conferred resistance to deadenylation. Similar 
results were obtained for tethered human AGO2, TNRC6, NOT1, DDX6 and their 
Dm orthologs as well as for miRNAs in the absence of tethering, indicating that 43S 
scanning is not a prerequisite for translational repression, deadenylation and decay of 
miRNA targets. The reasons for the differences from the results reported by Meijer et 
al. (2013) remain unclear, but one possible explanation is that Meijer et al. (2013) 
performed RNA transfections of the CAA reporter whereas our reporters were 
transcribed in the cells. Furthermore, RNA transfections preclude conclusions 
regarding changes in mRNA levels because of the inherent difficulty in estimating the 
fraction of the transfected mRNA that enters the cytoplasm and is ultimately 
assembled into functional RNPs and translated (Barreau et al. 2006). 
 
Silencing does not require eIF4A activity 
Previous studies made use of eIF4A inhibitors (hippuristanol, silvestrol or pateamine 
A) to demonstrate a role for eIF4A in silencing. However, this approach has yielded 
conflicting results, as these drugs were reported either to have no effect (Petersen et 
al. 2006) or to partially inhibit miRNA-mediated silencing (Meijer et al. 2013; Fukao 
et al. 2014). These discrepancies most likely result from the difficulty of finding 
appropriate normalization controls that are not affected by the treatment. By contrast, 
our conclusion that eIF4A activity is not required for silencing is based on the results 
obtained with the reporters containing a very short 5'-UTR (in Dm cells) or the TISU 
motif (human cells), which are not subjected to the normalization problem linked to 
the use of translational inhibitors. Using these reporters we determined that 43S 
scanning and eIF4A activity are not required for silencing.  
We further confirmed the conclusion that eIF4A is not required for silencing 
through the analysis of mRNA levels, which in principle is not subject to 
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normalization caveats because eIF4A inhibitors do not cause global mRNA 
destabilization (Cencic et al. 2009). We observed that AGO2, GW182/TNRC6 and 
NOT1 degrade polyadenylated reporters in the presence of silvestrol. These results 
indicate that silencing complexes assemble and degrade the mRNA target also when 
translation and eIF4A activity are inhibited. In accordance with these results, we also 
show that miRNAs, AGO, GW182/TNRC6 and NOT1 degrade polyadenylated 
reporters that do not require scanning for translation.  
Moreover, because eIF4A2 did not efficiently bind to the TISU-containing 
mRNA, our results indicate that miRNAs can repress translation by a mechanism that 
is independent of eIF4A2 and does not involve either eIF4A2 dissociation or 
recruitment. The observation that eIF4A1,2 dissociate from silenced mRNAs is based 
on studies performed in cell-free extracts, wherein the coupling between 
deadenylation and decapping is disrupted, as in these systems mRNAs are 
deadenylated but not further degraded (Fukao et al. 2014; Fukaya et al. 2014). 
Therefore, it is possible that the assembly and/or composition of silencing complexes 
varies when the relative abundance and/or activity of the factors involved is altered, 
resulting in different functional outcomes. Alternatively, our results with the reporters 
containing very short 5'-UTRs may have revealed the existence of a mechanism that 
acts independently of eIF4A or downstream of eIF4A dissociation.  
 
The role of DDX6 in silencing 
Our data together with previous studies indicate that human DDX6 is required for 
translational repression mediated by the CCR4-NOT complex in human cells (Chen et 
al. 2014; Matthys et al. 2014; Rouya et al. 2014). The contribution of DDX6 to this 
repression becomes apparent in particular for reporters that lack a poly(A) tail and 
hence are not degraded. In the presence of a poly(A) tail the dominant effect of the 
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CCR4-NOT complex is deadenylation and decay in human and Dm cells. mRNA 
destabilization is observed even when the NOT1-DDX6 interaction is disrupted, 
suggesting that the recruitment of decapping factors and XRN1 still occurs. 
Therefore, it is possible that in addition to DDX6, other factors are involved in 
coupling deadenylation to decapping. For example, the decapping activator Pat 
interacts with the CCR4-NOT complex (Jonas and Izaurralde 2013) and can also 
facilitate the recruitment of decapping factors to mRNAs undergoing deadenylation.  
A question that remains unanswered is how DDX6 represses translation. Our 
polysome profiles indicate that DDX6 inhibits translation predominantly at initiation 
in human cells. Furthermore, we found that DDX6-mediated repression does not 
require ribosomal scanning, suggesting that DDX6 may interfere with eIF4E or eIF4G 
function. In this context, it is interesting that DDX6 interacts with the eIF4E-
transporter protein (4E-T; Kamenska et al. 2014), an eIF4E-binding protein that 
competes with eIF4G for binding to eIF4E and represses translation initiation. 
However, depletion of 4E-T only partially alleviates silencing (Kamenska et al. 2014; 
D.K.O., D.B. and E.I. unpublished results), which implies that DDX6 may employ 
additional mechanisms to repress translation that are thus far unknown. 
Through its interaction with the CCR4-NOT complex, DDX6 is likely to be 
involved in the repression of many mRNAs in addition to miRNA targets. Indeed the 
CCR4-NOT complex is recruited to specific mRNAs by numerous RNA-associated 
proteins, including Bicaudal-C, Smaug, CUP, Nanos, Pumilio and tristetraprolin 
(TTP; Barckmann and Simonelig 2013; Fabian et al. 2013). Thus, elucidating the 
precise mechanism by which DDX6 represses translation is expected to provide 
valuable insight into a widespread post-transcriptional repressive mechanism 
operating in eukaryotic cells.  
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Materials and Methods 
DNA constructs 
Plasmids for expression of λN-HA- and MS2-tagged proteins in Dm S2 and human 
cells, as well as miRNA reporters and luciferase reporters for tethering assays have 
been previously described (Rehwinkel at al. 2005; Eulalio et al. 2007; Eulalio et al. 
2008; Braun et al. 2011; Zekri et al. 2013; Chen et al. 2014). We generated Hs AGO2 
and Dm AGO1 mutants via site-directed mutagenesis. Protein mutants used in this 
study are listed in Supplemental Table S1. The reporters lacking the 5' UTR or 
containing the TISU motif, the (CAA)18 repeats and the 12-nucleotide guanine quartet 
(CGG)4 were generated by site-directed mutagenesis using the corresponding parental 
plasmids as template. The sequences of the corresponding 5'-UTRs are listed in 
Supplemental Table S3. Additional constructs used in this study are described in the 
Supplemental Material and Table S2. 
 
Cell culture and transfections 
The S2 cells were transfected in 6-well plates using Effectene transfection reagent 
(Qiagen). The human cells were transfected using Lipofectamine  2000 or TurboFect 
reagents (Life Technologies). In all experiments, firefly and Renilla luciferase 
activities were measured using the Dual-Luciferase Reporter Assay System 
(Promega), three days after transfection of the S2 cells and 48 hrs after transfection of 
the human cells. Total RNA was isolated from the S2 and human cells using TriFast 
(Peqlab Biotechnologies) and analyzed as described previously (Behm-Ansmant et al. 
2006). All western blots were developed using the ECL western blotting detection 
system (GE Healthcare). Antibodies used in this study are listed in Supplemental 
Table S4. Silvestrol (MedChem Express, HY-13251) was resuspended in DMSO at 1 
mg/ml concentration and added to the cells at a final concentration of 0.25 µM. The 
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treatment was for 16 hrs.  
 
Tethering, complementation and coimmunoprecipitation assays  
The interaction of AGO (wild-type or mutants) with endogenous miRNAs and 
GW182/TNRC6 was tested as described previously (Rehwinkel et al. 2005; Eulalio et 
al. 2008). Tethering assays in S2 cells and human cells were performed as described 
before (Braun et al. 2011). Detailed protocols can be found in the Supplemental 
Material. AGO1 complementation assays in S2 cells were performed as described 
previously (Huntzinger et al. 2013).  
 
Polysome profiling in HEK293T cells 
HEK293T cells (9 × 106/15-cm dish) were transfected with Lipofectamine 2000. The 
transfection mixtures contained 20 µg of the R-Luc-6xMS2-(A)95-MALAT1 reporter, 
4 µg of the pEGFP-N3-F-Luc transfection control and 6 µg of a plasmids expressing 
MS2-HA or MS2-HA-DDX6. Cells were treated with cycloheximide 48 hrs after 
transfection at a final concentration of 50 µg/ml for 30 min. Cell lysis and sucrose 
gradients were performed as described in the Supplemental Materials.  
 
RNA immunoprecipitation in HEK293T cells 
To study the association of eIF4A2 with mRNA reporters in HEK293T cells, cells (4 
× 106/10-cm dish) were transfected with Lipofectamine 2000. The transfection 
mixtures contained 5 µg of pEGFP-N3-F-Luc transfection control reporter and any 
one of the following reporters: pCIneo-R-Luc-6xMS2-A95-MALAT1 (10 µg), 
pCIneo-TISU-R-Luc-6xMS2-MALAT1 (8 µg), pCIneo-CAA-R-Luc-6xMS2-A95-
MALAT1 (15 µg) or pCIneo-CGG-R-Luc-6xMS2-A95-MALAT1 (8 µg). A detailed 
description of the precipitation procedure in found in the Supplemental Material.  
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Supplemental Material 
Supplemental Material includes five Figures, four tables, Supplemental Methods and 
Supplemental References. 
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FIGURE LEGENDS 
Figure 1. The W-binding pockets are required for AGOs to bind GW182/TNRC6 
proteins. (A) Lysates from S2 cells expressing HA-tagged versions of MBP or AGO1 
(wild-type or pocket mutants) were immunoprecipitated using an anti-HA antibody. 
Inputs (1% for the HA-tagged proteins and 2.5% for GW182) and immunoprecipitates 
(20% and 35%, respectively) were analyzed by western blotting using an anti-HA 
antibody. Endogenous GW182 was detected using anti-GW182 antibodies. The 
association between HA-AGO1 and endogenous miR-2a was analyzed by northern 
blotting. tRNAAla served as a loading control. (B–D) Lysates from HEK293T cells 
expressing HA-tagged AGO2 (wild-type or pocket mutants) and GFP-tagged TNRC6 
proteins were immunoprecipitated using an anti-HA antibody. HA-tagged MBP 
served as a negative control. Inputs (1.5% for the HA-tagged proteins and 2% for the 
GFP-tagged proteins) and immunoprecipitates (20% and 35%, respectively) were 
analyzed by western blotting using the corresponding antibodies. The presence of 
endogenous miR-16 in the immunoprecipitates was determined by northern blotting 
(D). tRNAAla served as a loading control. AGO mutants are described in 
Supplemental Fig. S1 and Table S1. 
 
Figure 2. The silencing activity of AGOs depends on the integrity of the W-binding 
pockets. (A,B) Tethering assay using the F-Luc-5BoxB-poly(A) reporter and λN-HA-
AGO1 (wild-type or pocket mutants) in S2 cells. A plasmid expressing R-Luc served 
as a transfection control. (A) F-Luc activity and mRNA levels were normalized to 
those of the R-Luc transfection control and set to 100% in cells expressing the λN-
HA peptide. (B) Northern blot of representative RNA samples. (C,D) Tethering assay 
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using the R-Luc-5BoxB-poly(A) reporter and λN-HA-AGO2 (wild-type or mutants) 
in human HEK293T cells. A plasmid expressing F-Luc served as a transfection 
control. R-Luc activity and mRNA levels were normalized to those of the F-Luc 
transfection control and analyzed as described in panels (A,B). (E,F) Tethering assay 
using the F-Luc-5BoxB-A95-C7-HhR reporter and λN-HA-AGO1 (wild-type or 
mutants) in S2 cells. Samples were analyzed as described in panels (A,B). (G) 
Western blot analysis showing the equivalent expression of the λN-HA-AGO1 
proteins used in the tethering assays shown in panels (A,B,E,F). (H,I) Tethering assay 
using the R-Luc-5BoxB-MALAT1 reporter and λN-HA-AGO2 (wild-type or 
mutants) in HEK293T cells. (J) Western blot analysis showing the equivalent, 
expression of the λN-HA-AGO2 proteins used in the tethering assays shown in 
(C,D,H,I). (K,L) Complementation assays using F-Luc-par6 reporter in S2 cells 
depleted of endogenous AGO1. Plasmids encoding HA-AGO1 (wild-type or mutants) 
or HA-MBP (as negative control) were included in the transfection mixtures as 
indicated. For each condition, firefly luciferase activities and mRNA levels were 
normalized to those of the Renilla luciferase transfection control and set to 100% in 
the absence of miR-1 (100% values are only shown for control cells). (K) Normalized 
firefly luciferase activities and mRNA levels. (L) Northern blot of representative 
RNA samples. In all panels bars represent mean values and error bars represent 
standard deviations from at least three independent experiments (see also 
Supplemental Fig. S2). (M) A tethering assay using the F-Luc-5BoxB-poly(A) 
reporter was performed in S2 cells. The transfection mixtures included plasmids 
expressing GFP or GFP-DCP1* as indicated. The panel shows a northern blot of 
representative RNA samples. The positions of the polyadenylated (An) and 
deadenylated (A0) mRNA reporter are indicated on the right. (N) A tethering assay 
using the β-globin-6xMS2 reporter and MS2-tagged proteins was performed in 
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HEK293T cells. The transfection mixtures contained plasmids expressing wild-type 
DCP2 (-) or the catalytic DCP2* mutant (+). The panel shows a northern blot of 
representative RNA samples.  
 
Figure 3. AGO, GW182/TNRC6 and NOT1 silence mRNA reporters translated via a 
scanning independent mechanism. (A) Schematic representation of the Dm reporters 
used in panels (B,C). (B,C) Tethering assay using the F-Luc-5BoxB reporters shown 
in panel (A) and λN-HA-tagged GW182, AGO1 and NOT1 in S2 cells. F-Luc activity 
and mRNA levels were normalized to those of the R-Luc transfection control and 
analyzed as described in Fig. 2A,B. Quantification of the corresponding northern 
blots is shown in Supplemental Fig. S4A. (D) Schematic representation of the 
reporters used in panels (E–G). (E,F) Tethering assay using the R-Luc-5BoxB 
reporters shown in panel (D) and λN-HA-tagged TNRC6A-SD, AGO2 and NOT1 in 
HEK293T cells. R-Luc activity and mRNA levels were normalized to those of the F-
Luc transfection control and analyzed as described in Fig. 2C,D. The corresponding 
quantification of mRNA levels is shown in Supplemental Fig. S4B. (G) Human 
HEK293T cells were transfected with the R-Luc reporters shown in (D). A F-Luc 
reporter whose translation was dependent on the Hepatitis C virus (HCV) IRES was 
included as a control. One day after transfection, cells were treated with DMSO or 
Silvestrol. R-Luc activity in Silvestrol treated cells was normalized to that measured 
in control cells. The corresponding values for the HCV IRES-F-Luc reporter are 
shown in Supplemental Fig. S4C. In all panels, bars represent mean values and error 
bars standard deviations from at least three independent experiments.  
 
Figure 4. eIF4A2 binding to mRNAs is not influenced by silencing. (A) HEK293T 
cells were transfected with the R-Luc-MS2-A95-MALAT1 reporters containing the 
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indicated 5'-UTRs and HCV IRES-F-Luc control. Silvestrol treatment was performed 
as described in Fig. 3G. The corresponding values for HCV IRES-F-Luc reporter are 
shown in Supplemental Fig. S5A. (B,C) Lysates from HEK293T cells expressing the 
indicated R-Luc-MS2-A95-MALAT1 reporters and a F-Luc transfection control were 
immunoprecipitated (IP) using anti-eIF4A2 antibodies. The RNAs 
coimmunoprecipitating with eIF4A2 were analyzed by northern blot. R-Luc mRNA 
levels were normalized to those of the F-Luc control. The normalized values in the IP 
were divided by those in the input and set to 100 for the reporter containing a 219-nt 
5'-UTR. (D–G) Tethering assays using the indicated R-Luc-MS2-A95-MALAT1 
reporters and MS2-HA-tagged TNRC6A-SD, AGO2 and NOT1 in human cells. R-
Luc activity and mRNA levels were normalized to those of the F-Luc transfection 
control and set to 100 in cells expressing MS2-HA. (E,G) Northern blots of 
representative RNA samples. (H–J) Lysates from HEK293T cells expressing R-Luc-
MS2-A95-MALAT1 reporter and MS2-HA tagged proteins were immunoprecipitated 
using anti-eIF4A2 antibody as described in panels (B,C). (H) Normalized R-Luc 
activities. (I) Representative western and northern blot of input and IP fractions. (J) 
The efficacy of the immunoprecipitation was analyzed as described in (B,C). Error 
bars represent standard errors from at least three independent experiments. 
Translation efficiencies for the reporters used in this figure are shown in 
Supplemental Fig. S5D–G.  
 
Figure 5. Ribosome scanning is not required for degradation of silenced mRNAs. 
(A,B) Tethering assay using the 6nt-F-Luc-5BoxB-poly(A) reporter in S2 cells. 
Firefly luciferase activities and mRNA levels were normalized to those of the Renilla 
luciferase and analyzed as described in Fig. 2A,B. (C,D) Tethering assay using the 
TISU-R-Luc-6MS2-poly(A) reporter in human HEK293T cells. Samples were 
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analyzed as described in Fig. 2C,D. (E–G) Tethering assay using the β-globin-6MS2-
poly(A) reporter in human HEK293T cells treated with Silvestrol or DMSO. Panel E 
shows the inhibitory effect of silvestrol on the translation of a cotransfected R-Luc 
reporter. In panels (F,G), samples were analyzed as described in Fig. 2C,D. 
 
Figure 6. Ribosome scanning is not required for miRNA target degradation. (A–D) 
S2 cells were transfected with polyadenylated F-Luc-nerfin-1 or F-Luc-par6 reporters 
containing a 6-nt or 107-nt 5'-UTR and the corresponding miRNAs. A plasmid 
expressing Renilla luciferase (R-Luc) served as transfection control. Firefly luciferase 
activities and mRNA levels were normalized to those of the Renilla luciferase and set 
to 100 in the absence of miRNAs. Panels (A) and (C) show normalized firefly 
luciferase activities and mRNA levels. Northern blot analysis of representative RNA 
samples are shown in (B) and (D). (E,F) HEK293T cells were transfected with 
plasmids expressing the indicated R-Luc-let-7 reporters or the corresponding reporters 
carrying mutations in the let-7 binding sites and a plasmid expressing F-Luc as a 
transfection control. Renilla luciferase activities were normalized to those of the F-
Luc and set to 100 in cells transfected with the reporter lacking the let-7 binding sites 
and analyzed as described in (A–D). (G) Interaction of GFP-NOT1 (wild-type or a 
mutant that does not bind DDX6, Mut) with HA-DDX6 in human cells. (H–K) 
Tethering assay using the R-Luc-5BoxB reporters containing the MALAT1 3'-UTR 
(H,I) or a poly(A) tail (J,K) and λN-HA-NOT1 (wild-type or Mut). R-Luc activity and 
mRNA levels were normalized to those of the F-Luc transfection control and 
analyzed as described in Fig. 2C,D. See also Supplemental Fig. S6A–D. 
 
Figure 7. DDX6 represses translation independently of ribosome scanning. (A–D) 
Tethering assay using the R-Luc-6xMS2-A95-MALAT1 reporters containing the 
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indicated 5'-UTRs and MS2-HA-tagged DDX6 or a DDX6 mutant (DDX6*) that does 
not bind to NOT1 in human cells. R-Luc activity was normalized to that of the F-Luc 
control and analyzed as described in Fig. 2C,D. (E) Western blot showing the 
interaction of DDX6 or DDX6* with GFP-NOT1 in HEK293T cells. (F) Tethering 
assay using the F-Luc-5BoxB-A95-C7-Hhr reporters containing a 6-nt or a 107-nt 5'-
UTR and λN-HA-Me31B in S2 cells. F-Luc activity and mRNA levels were analyzed 
as described in Fig. 2A,B. (G,H) Tethering assay using the R-Luc-6xMS2-A95-
MALAT1 reporter and MS2-DDX6 in human cells. In panel (G) Luciferase activity 
was analyzed as described in Fig. 2C. The association of the R-Luc reporter and the 
F-Luc control with polysomes was analyzed by sedimentation through a sucrose 
gradient. Panel (H) shows the amount of the R-Luc mRNA in each fraction 
normalized to the total amount across all fractions in cells expressing MS2 (black 
curve) or MS2-DDX6 (red curve). Lower panels show representative northern blots. 
Data corresponding to the F-Luc control and the corresponding ribosomal RNA 
profiles are shown in Supplemental Fig. S6E,F. 
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Supplemental Material 
 
Supplemental Methods 
DNA constructs 
The plasmids for expression of the β-globin-6xMS2 and the control β-globin-GAP 
mRNAs in human cells were kindly provided by Dr J. Lykke-Andersen and were 
described previously (Lykke-Andersen et al. 2000). The plasmid for expression of the 
R-Luc-5BoxB-poly(A) reporter in human cells was kindly provided by Dr W. 
Filipowicz and was described previously (Pillai et al. 2004). The reporter containing 
the MALAT1 3'-end was generated as described in Bhandari et al. (2014). All 
constructs were fully sequenced to confirm the presence of the mutations and the 
absence of additional mutations. Protein mutants used in this study are listed in 
Supplemental Table S1. 
 
Coimmunoprecipitation assays in S2 cells 
The interaction of AGO1 (wild-type or mutants) with endogenous miRNAs and 
GW182 was tested as described previously (Rehwinkel et al. 2005; Eulalio et al. 
2008). Briefly, 2.5 × 106 cells were seeded per well in 6-well plates and transfected 
with 1.5 µg HA-tagged proteins (MBP and AGO1 wild-type or mutants). Three days 
after transfection, the cells from 8 wells were pooled and resuspended in 2 ml of NET 
buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100 
and 10% glycerol) supplemented with protease inhibitors (Roche-EDTA free 
protease-inhibitor cocktail tablet). The cells were lysed by sonication (3 times 30 sec 
followed by 30 sec on ice) and incubated for 15 min on ice. Cell debris were removed 
by 15 min centrifugation at 16,000 g at 4°C. Aliquots for western (2.5%) and northern 
(5%) blot analysis were taken and the remaining cell lysate was incubated with anti-
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HA antibody (8 µg, Covance) for 1 hour at 4°C. Next, protein G-Sepharose beads 
(GammaBind G-Sepharose, GE Healthcare) were added to the lysate (100 µl of a 50% 
slurry) and incubated for an additional hour. Beads were washed three times with 
NET buffer. An aliquot of beads (20%) was directly resuspended in SDS-PAGE 
sample buffer for western blot analysis. The remaining beads were resuspended in 
200 µl of buffer containing 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 5 mM EDTA 
pH 8.0 and 0.5% SDS and treated with proteinase K (1.5 mg/ml) for 2.5 hours at 
50°C. RNA isolation and analysis was performed as described by Rehwinkel et al. 
(2005). miR-2a and tRNAAla were detected using radioactively labeled antisense 
oligonucleotide probes (miR-2a: GCTCATCAAAGCTGGCTGTGATA, tRNAAla: 
CTCACATGCTAAGCGAGCGCTCTAC).  
 
Coimmunoprecipitation assays in HEK293T cells 
To test the interaction of AGO2 (wild-type or mutants) with endogenous miRNAs and 
GFP-tagged TNRC6s, HEK293T cells (4 × 106/10-cm dish) were seeded one day 
before transfection using Turbofect (Thermo Scientific). The transfection mixtures 
contained plasmids expressing λN-HA tagged MBP (4 µg) or AGO2 [either wild-type 
(9 µg) or mutant (12 µg)] and 8 µg of plasmid expressing GFP-tagged TNRC6s. Cells 
were harvested 48 hours after transfection. Cells corresponding to 4 dishes were 
pooled, washed with PBS and lysed on ice for 15 min in 1 ml of NET buffer. 
Immunoprecipitations were performed as described for S2 cells. The oligonucleotide 
probes used for detection of miR-16 and tRNAAla were as follows: 
CGCCAATATTTACGTGCTGCTA (miR-16) and 
CTCTACCGCTTGAGCTAATTCCCC (tRNAAla). 
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RNA immunoprecipitation in HEK293T cells 
HEK293T cells (4 × 106/10-cm dish) were seeded 24 hours before transfection with 
Lipofectamine 2000. The transfection mixtures contained 5 µg of pEGFP-N3-F-Luc  
transfection control reporter and any one of the following reporters: pCIneo-R-Luc-
6xMS2-A95-MALAT1 (10 µg), pCIneo-TISU-R-Luc-6xMS2-MALAT1 (8 µg), 
pCIneo-CAA-R-Luc-6xMS2-A95-MALAT1 (15 µg) or pCIneo-CGG-R-Luc-6xMS2-
A95-MALAT1 (8 µg). Cells were washed with ice-cold PBS and lysed in 500 µl of 
NET buffer for 15 min on ice. The cell debris were removed by a 15 min 
centrifugation at 16,000 g at 4°C. Aliquots (5%) were taken for western and northern 
blot analysis. The remaining lysate was incubated with 3 µg of anti-eIF4A2 antibody 
(Abcam, ab31218) for 2 hours at 4°C. Next, protein G-Sepharose beads were added to 
the lysate (100 µl of a 50% slurry) and incubated for additional 2 hours. After 2 hours 
incubation, beads were washed 3 times with NET buffer and resuspended in 1 ml 
NET buffer without detergent. An aliquot (20%) of the bead suspension was directly 
resuspended in SDS-PAGE sample buffer for western blot analysis. The remaining 
beads were used for RNA isolation using TriFast (Peqlab Biotechnologies). At this 
stage, samples were spiked with 4 µg of double stranded RNA. RNA samples were 
treated with DNase I (Turbo DNA-free kit, Ambion, AM1907). Input and precipitated 
fractions were analyzed by western and northern blotting. Note that the protein G-
Sepharose beads used for RNA immunoprecipitation were preincubated with yeast 
RNA (250 µg of yeast RNA /100 µl of 50% slurry) and washed with PBS before use. 
 
Tethering assays  
For tethering assays in S2 cells, the transfection mixtures contained 0.1 µg of Firefly 
luciferase reporter plasmid (or 0.3 µg for the reporter containing a 6-nt 5'-UTR), 0.4 
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µg of Renilla luciferase transfection control and 4 ng of plasmids expressing the λN-
HA tagged proteins. In the experiment described in Fig. 2M, the transfection mixtures 
contained in addition 0.95 µg of plasmids expressing GFP or GFP-DCP1 GSSG 
mutant (Chang et al. 2014). For tethering assays in human cells, HEK293T cells (0.8 
× 106/well in six-well plates) were transfected using Lipofectamine 2000 (Life 
technologies). The transfection mixtures contained 0.25 µg of Renilla luciferase 
reporter plasmids, 0.25 µg of the pEGFP-N3-F-Luc transfection control and 0.1–1 µg 
of plasmids expressing λN-HA or HA-MS2 tagged proteins (0.1 µg for TNRC6A-SD, 
AGO2 and DDX6 and 1 µg for NOT1).  
In the experiment described in Fig. 2N and Fig. 5E–G, the transfection mixtures 
contained 0.5 µg of the control plasmid (β-globin-GAP), 0.5 µg of the plasmid 
encoding the β-globin-6xMS2, plasmids expressing the MS2-HA tagged proteins (0.2 
µg for TNRC6A-SD, 0.1 µg for AGO2 and 2 µg for CNOT1). In Fig. 2N, the 
transfection mixtures contained in addition plasmids expressing HA-tagged DCP2 
(either wild-type or catalytically inactive DCP2* mutant; 1 µg).  
 
Polysome profiling in HEK293T cells 
HEK293T cells (9 × 106/15-cm dish) were seeded one day before transfection with 
Lipofectamine 2000 (Life Technologies). The transfection mixtures contained 20 µg 
of the R-Luc-6xMS2-(A)96-MALAT1 reporter, 4 µg of the pEGFP-N3-F-Luc 
transfection control and 6 µg of a plasmids expressing MS2-HA or MS2-HA-DDX6. 
Cells were treated with cycloheximide 48 hrs after transfection at a final 
concentration of 50 µg/ml for 30 min. Cells were washed once with ice-cold PBS 
(containing 50 µg/ml cycloheximide), and lysed in 300 µl of ice-cold buffer 
containing 10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 1.5 mM MgCl2, 0.5% Triton X-
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100, 2 mM DTT, 1 U/µl RiboLock RNase inhibitor, 0.5% Na-deoxycholate and 50 
µg/ml cyclohexamide for 10 min on ice. The cell debris were removed by a 10 min 
centrifugation at 10,000 g at 4°C. The supernatants were layered on top of a linear 
10–50% (w/v) sucrose gradient (prepared using Gradient Master 107ip Biocomp) in 
10 mM Tris-HCl (pH 7.4), 75 mM KCl, 1.5 mM MgCl2, and 50g/ml cycloheximide. 
Centrifugation was carried out in a Beckmann, SV55Ti rotor at 41,000 r.p.m. for 2 
hours at 4°C.  
Fractions were collected using a density-gradient fractionation system (Teledyne 
Isco), and polysome profiles were monitored by absorbance of light at 254 nm. 
Fractions were spiked with 10 µg of double-stranded RNA and treated with proteinase 
K (0.1 mg/ml, in 10 mM Tris-HCl (pH 8.0), 5 mM EDTA, 0.5% SDS) for 30 min at 
42°C. Total RNA was isolated by two rounds of phenol:chloroform extraction 
followed by one chloroform extraction. RNA samples were treated with DNase I and 
analyzed by northern blotting.  
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Supplemental Table S1. Mutants used in this study. 
 
Protein Name of the 
construct 
Mutations 
Dm AGO1 
NM_166020.1 
 
P1 P714G + A744F 
P2 L819Y 
P1+2 P714G + A744F + L819Y 
Hs AGO2 P1 P593A + A623F 
P2 L697Y + K663A 
P1+2 P593A + A623F + L697Y + K663A 
Dm DCP1 
NM_137998.2 
DCP1* (GSSG) R70G + L71S + N72S + T73G 
Hs DCP2 
AY135173.1 
DCP2* E148Q 
Hs NOT1 
EF553522.1 
 
NOT1 Mut F1101S + N1105A + K1114A + 
R1138A + N1144A + F1145A + 
K1276A + F1281A + E1284A 
Hs DDX6 
NM_004397.3 
DDX6* R94E + F101D + Q322A + N324A 
+ R375A 
Hs TNRC6A 
AY035864.1 
TNRC6A-SD Residues 1272–1709 
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Supplemental Table S2. Reporters used in this study. 
 
 
 
  
Organism Name of the Reporter Vector 
Dm 
 
F-Luc-5BoxB-poly(A) pAc5.1C 
F-Luc-5BoxB-A95-C7-HhR pAc5.1C 
6nt-F-Luc-5BoxB-A95- C7-HhR pAc5.1C 
6nt-F-Luc-5BoxB-poly(A) pAc5.1C 
F-Luc-poly(A) pAc5.1C 
F-Luc-par6-poly(A) pAc5.1C 
6nt-F-Luc-par6-poly(A) pAc5.1C 
R-Luc- A95-HhR pAc5.1C 
F-Luc-Nerfin-1-poly(A) pAc5.1C 
6nt-F-Luc-Nerfin-1-poly(A) pAc5.1C 
F-Luc-cg5281-poly(A) pAc5.1C 
Hs 
R-Luc-5BoxB-poly(A) pCI-neo 
R-Luc-5BoxB-MALAT1 pCI-neo 
TISU-R-Luc-5BoxB-MALAT1 pCI-neo 
R-Luc-poly(A) pCI-neo 
R-Luc-6xMS2 pCI-neo 
R-Luc-6xMS2-MALAT1 pCI-neo 
R-Luc-6xMS2-A95- MALAT1 pCI-neo 
TISU-R-Luc-6xMS2- MALAT1 pCI-neo 
TISU-R-Luc-6xMS2 pCI-neo 
CAA-R-Luc-6xMS2-A95- 
MALAT1 
pCI-neo 
CGG-R-Luc-6xMS2bs-A95- 
MALAT1 
pCI-neo 
β-Globin-GAPDH (Control) pcDNA3.1 
β-Globin-6xMS2-poly(A) pcDNA3.1 
F-Luc pEGFP-
N3 
R-Luc-8xlet7 pCI-neo 
R-Luc-Scramble pCI-neo 
TISU-R-Luc-8xlet7 pCI-neo 
TISU-R-Luc-Scramble pCI-neo 
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Supplemental Table S3. Sequence of 5'-UTRs used in this study. 
 
Organism Reporter Sequence  
Dm 
107nt-F-Luc aucacuaccguuugaguucuugugcuguguggauacuccucccgacacaaagccgcucc
aucagccagcagucgucuaauccagagaccccggaucgggguaccaacAUGGCU 
6nt-F-Luc aucacuAUGGCU 
   
 
 
 
 
Hs 
219nt-R-Luc gucagaucacuagaagcuuuauugcgguaguuuaucacaguuaaauugcuaacgcaguc
agugcuucugacacaacagucucgaacuuaagcugcagugacucucuuaagguagccuu
gcagaaguuggucgugaggcacugggcagguguccacucccaguucaauuacagcucuu
aaggcuagaguacuuaauacgacucacuauaggcuagccaccAUGGCU 
TISU-R-Luc gucagauccaagAUGgcggcaGCU 
CAA-R-Luc gucagauccaacaacaacaacaacaacaacaacaacaacaacaacaacaacaacaacaacaa
gccaccAUGGCU 
CGG-R-Luc gucagauccuagguugaaaguacuuugacggcggcggcggucaaucuuacggcggcgg
cggacauagauacggcggcggcgguagaaacuacggcggcggcggauuagaauaguaaa
gccaccAUGGCU 
 
Residues in red indicate the transcription start site. There are 3 potential start sites for 
the Dm reporters.  The first AUG is indicated in bold and underlined. 
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Supplemental Table S4. Antibodies used in this study. 
 
Antibody Source Catalog 
Number 
Dilution Monoclonal/ 
Polyclonal 
Anti-HA-HRP 
(For western blots) 
Roche 12 013 819 001 1:5,000 Monoclonal 
Anti-HA (for 
immunoprecipitations) 
Covance MMS-101P  Mouse 
Monoclonal 
Anti-GFP (for Western 
blotting) 
Roche 11 814 460 001 1:2,000 Mouse 
Monoclonal 
Anti-GFP (for 
immunoprecipitations) 
In house   Rabbit 
polyclonal 
Anti-tubulin Sigma Aldrich T6199 1:10,000 Monoclonal 
Anti-mouse IgG-HRP GE Healthcare NA931V 1:10,000 Sheep 
Polyclonal 
Anti-rabbit IgG-HRP GE Healthcare NA934V 1:10,000 Donkey 
Polyclonal 
Anti-Hs DDX6 Bethyl 
Laboratories 
A300-461A 1:3,000 Rabbit 
polyclonal 
Anti-Hs PABP Abcam ab21060 1:5,000 Rabbit 
polyclonal 
Anti-Dm GW182 In house  1:2,000 Rabbit 
polyclonal 
Anti-Dm NOT1 Kind gift from E. 
Wahle 
 1:1,000 Rabbit 
polyclonal 
Anti-Dm AGO1 Abcam Ab5070 1:1,000 Rabbit 
polyclonal 
Anti-Dm Me31B In house  1:3,000 Rabbit 
polyclonal 
Anti-Hs TNRC6 Bethyl 
Laboratories 
A302-329A 1:1000 Rabbit 
polyclonal 
Anti-Hs eIF4A2 (for 
immunoprecipitations) 
Abcam Ab31218  Rabbit 
polyclonal 
Anti-Hs eIF4A2 (for 
Western blotting) 
In house  1:1,000 Rabbit 
polyclonal 
Anti-V5 AbD Serotec MCA1360GA 1:5,000 Mouse 
Monoclonal 
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Figure S1. The W-binding pockets are conserved in the AGO proteins that interact 
with GW182/TNRC6 proteins. (A) Ribbon representation of Hs AGO2 (PDB ID: 
4OLB) showing the position of the tryptophan-binding pockets. Residues lining the 
pockets are shown as green sticks or as red sticks when the residues were mutated. 
The tryptophan residues are shown as blue sticks. (B) Structure-based sequence 
alignment of the PIWI domain of human AGO1, AGO2, AGO3 and AGO4, 
Drosophila melanogaster AGO1 and AGO2, Neurospora crassa (Nc) QDE2, 
Schizosaccharomyces pombe AGO1 and the human PIWI-like clade. Residues lining 
the tryptophan-binding pockets 1 and 2 are shaded in pale green and orange, 
respectively. Residues forming the catalytic tetrad are highlighted in red. Residues 
mutated in this study are marked with a red asterisk. Residues lining the W-binding 
pockets are conserved in Hs AGO1, AGO3 and AGO4 as well as in Dm AGO1, 
which is the AGO protein dedicated to the miRNA pathway in Dm (Okamura et al. 
2004; Schirle and MacRae 2012). By contrast, these residues are less conserved in the 
PIWI clade of Argonaute proteins and in Dm AGO2, which do not interact with 
GW182 (Behm-Ansmant et al. 2006; Miyoshi et al. 2009). To abolish the interaction 
of Hs AGO2 and Dm AGO1 with GW182 proteins, we substituted a proline residue in 
pocket 1 with glycine to prevent hydrophobic stacking interactions with tryptophan 
residues and an alanine with a bulky phenylalanine to block tryptophan binding 
(mutant P1). In pocket P2, we substituted a leucine residue with a bulky tyrosine to 
block the pocket and a lysine residue with alanine to prevent hydrophobic stacking 
interactions (mutant P2). See Supplemental Table S1. 
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Figure S2. The silencing activity of AGOs depends on the integrity of the W-binding 
pockets. (A,B) Tethering assay using the indicated luciferase reporters lacking the 
5BoxB sites in Dm and human cells expressing λN-HA-tagged Dm AGO1 and Hs 
AGO2 (wild-type or mutants), respectively. The assays with the corresponding 
reporters containing 5BoxB sites are shown in Fig. 2A–D. Samples were analyzed as 
described in Fig. 2. (C) Complementation assay. Control S2 cells (treated with β-Gal 
siRNA) or cells depleted of endogenous AGO1 were transfected with a mixture of 
three plasmids: one expressing the F-Luc-cg5281 reporter; another expressing miR-
12 primary transcript or the corresponding empty vector; and a third expressing 
Renilla luciferase (R-Luc). Plasmids encoding HA-AGO1 (wild-type or the indicated 
pocket mutants) or HA-MBP (as negative control) were included in the transfection 
mixtures as indicated. For each condition, firefly luciferase activities and mRNA 
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levels were normalized to those of the Renilla luciferase transfection control and set 
at 100% in the absence of the miR-12. Panel (C) shows normalized firefly luciferase 
activities and mRNA levels. Error bars represent standard deviations from at least 
three independent experiments (see also Fig. 2K,L). (D) A complementation assay 
was carried out using the F-Luc-nerfin-1 reporter and miR-9b or miR-279. F-Luc 
activity was analyzed as described in (C).  
 
 
Figure S3. Translation efficiencies of the reporters used in Fig. 3. (A–D) S2 cells 
were transfected with the F-Luc-5BoxB reporters shown in Fig. 3A. (A) Absolute 
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values of luciferase activity (not normalized). Background levels are indicated by a 
dashed red line. (B) Luciferase activity normalized to that of the R-Luc transfection 
control and set to 100 for the polyadenylated reporter containing a 107-nt 5'-UTR. (C) 
Northern blot of representative RNA samples. (D) The translation efficiency for each 
reporter was calculated by dividing the normalized values for F-Luc activity shown in 
(B) by the normalized mRNA levels, shown in (C). Translation efficiencies were set 
to 100 for the polyadenylated reporter containing a 107-nt 5'-UTR. Note that although 
the translation efficiency of the reporters lacking a poly(A) tail is reduced, the 
absolute F-Luc values are three orders of magnitude greater than background levels 
(panel A). (E–G) A 107-nt-F-Luc-5BoxB-poly(A) reporter containing a N-terminally 
truncated F-Luc ORF starting at Met31 is expressed but no F-Luc activity is detected 
above background (red dashed line). These results indicate that F-Luc activity will not 
be detectable if ribosomes bypass the first AUG and start translation at the first in-
frame Met. (H) Western blot analysis showing the expression of HA-GST reporters 
containing 5'-UTRs of 107-nt (lanes 1 and 2) and 6-nt (lanes 3 and 4). Transfection 
mixtures contained either 100 or 300 ng of reporter plasmids. HA-MBP served as a 
transfection control. (I–L) HEK293T cells were transfected with R-Luc-5BoxB 
reporters shown in Fig. 3D. R-Luc activity, mRNA levels and translation efficiencies 
were analyzed as described in (A–D). (M) Western blot analysis showing the 
expression of TISU-HA-R-Luc. F-Luc-GFP served as a transfection control. In all 
panels, the mean values are indicate above the corresponding bars.  
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Figure S4. AGO, GW182/TNRC6 and NOT1 silence mRNA reporters translated via 
a scanning independent mechanism. (A,B) Normalized luciferase mRNA levels 
corresponding to the experiment shown in Fig. 3B and Fig. 3E, respectively. Error 
bars represent standard deviations from at least three independent experiments. (C) 
Luciferase activity for a bicistronic GFP-IRESHCV-F-Luc reporter, which served as a 
transfection control in the experiment shown in Fig. 3G. Note that when cap-
dependent translation is inhibited by silvestrol treatment, IRES-mediated translation 
increases, as reported before (Cope et al. 2014), which precludes the use of IRES 
reporters as normalization controls. Therefore, R-Luc and F-Luc activities measured 
in silvestrol treated cells were normalized to the respective values obtained in control 
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cells treated with DMSO. 
 
 
Figure S5. AGO, GW182/TNRC6 and NOT1 silence mRNA reporters independently 
of mRNA secondary structure in the 5’-UTR. (A) Luciferase activity for a bicistronic 
GFP-IRESHCV-F-Luc reporter, which served as a transfection control in the 
experiments shown in Fig. 4A. F-Luc activities measured in silvestrol treated cells 
were normalized to the respective values obtained in control cells treated with DMSO 
as described in Supplemental Fig. S4C. (B,C) Tethering assays using the indicated R-
Luc-MS2-A95-MALAT1 reporters and MS2-HA-tagged TNRC6A-SD, AGO2 and 
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NOT1 in human cells. R-Luc activity was normalized to that of the F-Luc transfection 
control and set to 100 in cells expressing MS2-HA. (D–G) The translation efficiency 
of the MS2 reporters shown in Fig. 4 was analyzed as described in Supplemental Fig. 
S3A–D. Note that although the translation efficiency of the TISU reporters is very 
low, the absolute R-Luc values are 2–3 orders of magnitude greater than background 
levels (panel D). In all panels bars represent mean values, which are indicated above 
the bars.  
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Figure S6. DDX6 represses translation initiation. (A) Tethering assay using the R-
Luc-5BoxB-A95-MALAT1 reporter and λN-HA tagged TNRC6A-SD and NOT1 in 
control HeLa cells or cells depleted of DDX6. Samples were analyzed as described in 
Fig. 2. (B) Western blot showing DDX6 knockdown efficiency. Dilutions of control 
cell lysates were loaded in lanes 1–4 to estimate the efficacy of the depletion. PABP 
served as a loading control. (C) Tethering assay using the F-Luc-5BoxB-A95-C7-HhR 
reporter and λN-HA tagged GW182, AGO1 and NOT1 in control S2 cells or cells 
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depleted of Me31B. Samples were analyzed as described in Fig. 2. (D) Western blot 
showing Me31B knockdown efficiency. Dilutions of control cell lysates were loaded 
in lanes 1–4 to estimate the efficacy of the depletion. PABP served as a loading 
control.  (E) Polysome profiles corresponding to Fig. 7G. The absorbancy at 254 nm 
of each fraction was quantitated and normalized to the total intensity across all 
fractions. The presence of 18S and 28S rRNAs in each fraction was analyzed on 
denaturing agarose gels. The spike RNA added to the fractions prior RNA isolation 
indicated. (F) The amount of F-Luc control reporter corresponding to Fig. 7G was 
quantify in each fraction of the gradient and normalized to the total amount across all 
fractions. 
 
